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particular environment. For instance the higher prevalence E. histolytica / 
E. dispar and Blastocystis spp., during the rainy season suggests they are 
waterborne and perhaps less resistant to drier conditions. The fact that 
Ancylostoma spp. was most frequent in the dry season is consistent with 
the reproductive cycle of geohelminths. Its life cycle is more effective in 
moist soils but the intensity of the rains during the wet season could be 
having a wash off effect. Besides seasonal variations in the weather other 
factors also moderate transmission such as the indigenous population’s 
life style in which villagers live in communal homes of more than six 
individuals. For instance in the wet season they spend more time in their 
dwellings. This linked to their hygienic habits contributes to increased 
person-person transmission. Besides this environmental degradation leads 
to changes in habits which is another factor effecting intestinal parasite 
transmission in this indigenous community.
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A NOVEL THERAPEUTIC OPTION FOR BALAMUTHIA 
MANDRILLARIS INFECTION
Dalila Y. Martínez, Francisco Bravo, Eduardo Gotuzzo
Universidad Peruana Cayetano Heredia, Lima, Peru
Balamuthia mandrillaris infection is an uncommon disease characterized 
by involvement of the skin with subsequent extension to the central 
nervous system, where it causes granulomatous encephalitis which is 
almost invariably fatal. No optimal therapy is available for this lethal 
condition. To report the outcomes of seven patients with B. mandrilaris 
infection treated with a combination regimen of miltefosine, fluconazole 
and albendazole. A case report is presented. Indirect immunofluorescence 
staining and PCR using the primer mitochondrial 16SrRNA gene were 
used to identify B. mandrillaris from tissue biopsies. Seven patients are 
included in this report. Four had granulomatous encephalitis (range of 
age: 8 to 46 years-old; three of them had in association skin lesions (Two 
on one of their knees and the other on his nose), and the fourth had 
rhinosinusitis. The skin lesion was one extensive violaceous plaque, which 
preceded the neurological involvement (range: 4 - 60 months). The brain 
MRI features were ring enhancing lesions (one or multiple). A combination 
regiment including miltefosine (2mg/kg/day), fluconazole (8mg/Kg/day) 
and albendazole (800mg/day) was initiated after observing compatible 
histopathology features. Five patients received in addition amphotericin 
B deoxycholate (total cumulative dose of 25mg/kg); and two patients 
had a surgical resection of a skin lesion in addition to medical therapy. 
Four patients had significant improvement and are currently alive with no 
evidence of active disease after receiving treatment for 6 to 18 months, 
only one developed neurological involvement. Three patients died after 
three weeks to 6 months on treatment. Two had extensive centrofacial 
lesion and granulomatous encephalitis with multiple lesions. Although the 
prognosis of B. mandrillaris infections is still ominous, it seems that is not 
invariably fatal. The combination regimen of fluconazole, albendazole and 
the amebicidal drug miltefosine may be included in the limited existing 
armamentarium for treating free living amoebic infections.
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EVALUATION IN VITRO OF THE ANTI ENTAMOEBA 
HISTOLYTICA EFFECT OF TWO FLAVONOIDS: EPICATECHIN 
AND KAEMPFEROL
Sindy Galicia-Vega1, Elizabeth Barbosa-Cabrera1, Luis Escareño-
Ramirez1, Adriana Jarillo-Luna2, Victor Rivera-Aguilar3, Rafael 
Campos-Rodriguez1, Judith Pacheco-Yepez1
1Postgraduate and Research Section, Superior Medicine School, National 
Polytechnic Institute, Mexico City, Mexico, 2Morphology Sciences 
Coordination, Superior Medicine School, National Polytechnic Institute, 
Mexico City, Mexico, 3Microbiology UBIPRO, Fes-Iztacala, Universidad 
Nacional Autonoma de Mexico, Mexico City, Mexico
Entamoeba histolytica is the parasite that causes amebiasis, a parasitic 
infection commonly treated efficiently with metronidazole. However, it 
has been reported that some ameba strains have become resistant to 
the drug. Research about new therapies to eliminate E. histolytica is an 
important health priority. We evaluated the in vitro anti-amebic activity 
of two flavonoids, epicatechin and kaempferol, at different times of 
incubation by spectrophotometric assay. Control samples were incubated 
with different concentrations of metronidazole and a vehicle. The viability 
of amebas incubated with epicatechin at 689 µmol/L was diminished by 
10, 20 and 30% at 2, 3 and 4 h, respectively. At the same incubation 
times, the reduction of amebic viability with epicatechin at 1379 µmol/L 
was 25, 30 and 45%, respectively, and with epicatechin at 2068 µmol/L 
the reduction was 30, 50 and 53%, respectively. On the other hand, 
kaempferol at 698 µmol/L diminished amebic viability by 30, 33 and 50% 
at 2, 3 and 4h, respectively. At the same incubation times, the decrease 
of amebic viability with kaempferol at 1397 µmol/L was 50, 53 and 
55%, respectively, and with kaempferol at 2096 µmol/L the decrease 
was 60, 70 and 75%, respectively. At similar times, metronidazole at 698 
µmol/L reduced the amebic viability by 52, 65 75%, respectively, and at a 
concentration of 1392 µmol/L the reduction was 70 and 78%. The highest 
dose of metronidazole (2096 µmol/L) diminished amebic viability by 73, 75 
and 78% at 2, 3 and 4 h. In the present work we demonstrated the anti-
amebic effect of epicatechin and kaempferol, as well as showing that such 
an effect is dose- and time-dependent, evidenced by the fact that amebic 
viability decreased with increasing doses and with a greater time elapsed.
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GIARDIA LAMBLIA GENOTYPING IN CHILDREN AND DOGS 
FROM A HIGHLY ENDEMIC AMERINDIAN COMMUNITY IN 
PANAMA
Vanessa Pineda, Dayra Alvarez, Kadir Gonzalez, Ana Maria 
Santamaria, Carlos Justo, Chystrie Rigg, Jose E. Calzada, Azael 
Saldaña
Gorgas Institute for Health Research, Panama, Panama
Giardia lamblia, is the etiologic agent of giardiasis, a gastrointestinal 
parasitic disease of humans and animals. Giardiasis is an important public 
health concern among children living in rural and indigenous population 
in Panama. Genetic characterization of G. lamblia isolates has revealed the 
existence of two groups (assemblages A to B) which are found in humans 
and in other mammals including domestic dogs. However, the role of 
these pets in the epidemiology of human infection is still unclear, despite 
the fact that the zoonotic potential of Giardia has been recognized. 
The present work aimed to evaluate the genetic identity of human and 
dog G. lamblia isolates from fecal samples collected in the indigenous 
community of Ipetí Choco, Ditrict of Chepo, Panama. After obtaining an 
informed consent from parents and dog owners, 81 fecal samples from 
children less than 10 years old and 76 dogs were examined for intestinal 
parasites by microscopy (formalin-acetate concentration procedure). Of 
the human and dogs evaluated, 42% (34/81) and 11.8% (9/76) were 
positive for Giardia cysts respectively. DNA was extracted from these 
positive samples. Genotyping was performed using a PCR-RFLP analysis 
based on the polymorphisms of the tpi and β-giardin genes. Additionally, 
a real time PCR of the SSU rRNA gene was used. According to the tpi 
and β-giardin genes analysis, the most frequent human genotype was 
assemblage B (76,6%, 23/30). Assemblage A and mixed infections (AB) 
were present in one sample (3.3%, 1/30) each one. In dogs assemblage 
B was found in 2.6% (2/76) and assemblage A in 1.3% (1/76). Using 
the real time PCR analysis, mixtures of assemblages in individual isolates 
were commonly observed. Human isolates were identified as AB (46.6%, 
14/30); B (36.6%, 11/30) and A (3.3%, 1/30). While dog Giardia isolates 
were characterized as AB (33.3%, 3/9 and B (11.1%, 1/9). Apparently, the 
frequency of canine giardiasis is low in Ipeti Choco community. However, 
the zoonotic potential of giardiasis under the observed epidemiological 




ROLE OF REACTIVE OXYGEN SPECIES AND ANTIOXIDANT 
ENZYME CAPACITY DURING EXPERIMENTAL AMOEBIC LIVER 
ABSCESS
Luis Escareño-Ramírez1, Teresita Cruz-Hernandez1, Sindy Galicia-
Vega1, Alexander Kormanovski1, María E. Quintanar-Quintanar2, 
Luz M. Cárdenas-Jaramillo3, Rafael Campos-Rodríguez1, Judith 
Pacheco-Yepez1
1Postgraduate and Research Section, Superior Medicine School, National 
Polytechnic Institute, Mexico City, Mexico, 2Pharmacology Coordination, 
Superior Medicine School, National Polytechnic Institute, Mexico City, 
Mexico, 3Morphology Sciences Coordination, Superior Medicine School, 
National Polytechnic Institute, Mexico City, Mexico
In an amoebic liver abscess (ALA), polymorphnuclear cells surround 
Entamoeba histolytica (E. h) amoebas to impede their contact with 
hepatocytes. Although amoebas in a necrotic area of ALA are usually 
not viable, parenchymal cells and leukocytes generally suffer damage. 
This suggests that necrosis could be caused by toxic molecules, including 
reactive oxygen species (ROS). A decrease in antioxidant enzyme activity 
may contribute to the extension of parenchymal damage. The present 
study was undertaken to determine the role of ROS as well as the status of 
antioxidant enzymes during ALA development. Hamsters were inoculated 
with E. h. and sacrificed at 12h, 48 h and 7 d of ALA evolution. Control 
animals were not infected. We determined the percentage of liver lining 
with lesion, and in liver homogenates measured (by spectrophotometric 
methods) oxidative stress (TBARS), total antioxidant capacity (TAS), and the 
enzymatic activity of superoxide dismutase (SOD), glutathione peroxidase 
(GPx) and catalase (Cat) in the necrotic area and normal parenchyma. 
Compared to the control group, the following significant differences were 
observed in infected animals: a rise in TBARs (P=0.001) and a decrease in 
TAS (P=0.01104) in the necrotic area at 7 d; an increase (at 12 h) and a 
decrease (at 48 h) in SOD in the abscess in both the lesion area (P=0.008) 
and hepatic parenchyma (P=0.009); an elevated (at 12 h; P=0.03) and 
a diminished (at 7 d; P=0.048) CAT production in the lesion. In necrotic 
areas, high ROS levels suggest an important role by these molecules in 
the pathogenesis of ALA. The reduction of TAS and antioxidant activity 
indicates a failure in defense systems, contributing to the extension of 
ALA.
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ASSESSING SEROLOGICAL TESTS OF TOXOPLASMOSIS IN 
PREGNANT WOMEN FROM 2002 TO 2010 IN SENEGAL
Daouda Ndiaye, Mouhamadou Ndiaye, Baba Dieye, Yaye Die 
Ndiaye, Lamine Gueye, Beckenbauer Diatta, Babacar Faye, Jean 
Louis Ndiaye, Roger Tine, Omar Ndir
Cheikh Anta Diop University, Dakar, Senegal, Dakar, Senegal
In many African countries including Senegal, toxoplasmosis is not subject 
of a real understanding. The purpose of this study was to update data on 
toxoplasmosis antibody prevalence based on antenatal surveillance tests 
in pregnant women in Dakar, Senegal. The test has been performed in 
1310 pregnant women at the laboratory of parasitology and mycology 
at Le Dantec teaching hospital from 2002 to 2010. immunoenzymatic 
method in solid phase has been used. To accomplish this evaluation, two 
serological tests (S1 and S2), using venous blood at 3 weeks of interval, 
are carried out among these pregnant women. The second serology will 
allow confirming a toxoplasmosis from an immune response, or a non 
specific antibody fixation. from the 1255 patients tested, we found a 
prevalence of 8,7% and 0% for (IgM+IgG-) respectively at serology S1 and 
S2; 24% and 27,1% for (IgM-IgG+), 13,8% and 11% for (IgM+IgG+). 
37% of pregnant women present toxoplasmosis antibody, a progress from 
previous data collected in Senegal. These data confirm the presence of 
toxoplasmosis among pregnant women in Dakar.
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INDICATION OF HIGH RISK OF MOTHER-TO-CHILD 
TOXOPLASMA GONDII TRANSMISSION IN GHANA
Kofi D. Kwofie1, Anita Ghansah1, Joseph H. Osei1, Helena 
Quaynor1, Samuel Obed2, Eric H. Frimpong3, Irene Ayi1
1Noguchi Memorial Institute for Medical Research, Accra, Ghana, 
2Obstetrics and Gynaecology Department, Korle-Bu Teaching Hospital, 
Accra, Ghana, 3Department of Clinical Microbiology, Kwame Nkrumah 
University of Science and Technology, Kumasi, Ghana
Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii 
which can be acquired by ingestion of infective stages of the parasite 
or congenitally from mother to child. Infection can be acute with 
tachyzoites in circulation or chronic with formation of cysts in muscles 
and organs. Acute infection may be primary or as a result of re-activation 
of chronic infection. Congenital infection of infants is known to result 
in ophthalmic disorders later in life. Recent research in Ghana revealed 
high sero-prevalence among pregnant women and eye patients. This 
study sought to determine the risk of transmission of T. gondii infection 
from mother-to-child among women at delivery in a hospital facility. The 
study involved 76 pregnant women aged 20 to 45 years who consented 
to participate. Blood and Tissue samples were taken from the maternal 
side of each placenta after delivery. Umbilical cord blood samples were 
also taken after they were separated from the infants. Finger-prick blood 
was taken from infants from participating mothers two to six weeks 
post-natal. ELISA was used to detect IgG and IgM antibodies against T. 
gondii in all blood samples while Nested-PCR was used to detect T. gondii 
DNA extracted from placental tissue. Data collected were analysed using 
SPSS. Results showed 42.1% (32/76) of maternal blood to be positive for 
anti- T. gondii IgG-ELISA (CTK Biotech, Inc.) with 42% of corresponding 
umbilical cord blood also being positive for IgG. 32.5% (13/40) of post-
natal infant blood was positive for anti- T. gondii IgG. All of the same 
blood samples were negative for IgM. Nested-PCR detected T. gondii DNA 
in 40.2% of placental tissue. 3 (3.94%) maternal blood were positive 
for IgG but the corresponding placental tissue samples were negative 
for PCR. The presence of anti T. gondii IgG antibodies only and T. gondii 
DNA in placental tissues which could be from cysts indicate the women 
might have had the infection during the pregnancy. In addition, detection 
of anti-parasite antibodies in umbilical cord and post-natal infant blood 
suggests a high risk of congenital transmission of the infection to the 
infants. These results provide baseline data for future work to ascertain 
the rate of mother-to-child transmission in Ghana.
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EVALUATION OF INDICATORS OF BOVINE BABESIOSIS 
IN TICKS RHIPICEPHALUS (BOOPHILUS) MICROPLUS 
AND CATTLE FROM THREE TO NINE MONTHS OF THE 
COLOMBIAN MIDDLE MAGDALENA
Sandra Rios
University of Antioquia, Envigado, Colombia
Babesia sp. is a parasite transmitted by ticks affecting livestock in 
the world. The Magdalena Medio region of Colombia is enzootic 
for babesiosis, but no studies that demonstrate the behavior of its 
transmission cycle. The objective was to evaluate entomological and 
parasitological indicators of infection with Babesia sp. in cattle and ticks 
in the region, through direct microscopic and molecular techniques. 
We designed a descriptive study of representative non-probability, the 
number of calves sampled was 237, to which was extracted from blood 
and adult female ticks for analysis by direct microscopic and molecular 
techniques to detect infection Babesia sp. We obtained a positive for B. 
bigemina of 59.9% and mixed infection (B. bovis + B. bigemina) of 3.4% 
was not found positive for B. bovis as a single agent. In ticks, a total of 
770 specimens captured, analyzed for hemolymph, the total percentage 
of ticks positive for B. bigemina was 79.2% and 9.4% mixed infection. 
The total infestation area was 3.2 ticks per calf. The calves of 6-7 months 
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had the highest degree of infestation with 4.7 ticks per calf. A positive 
correlation was established between the frequencies of the bath over time 
ticks and parasite burden in cattle. In conclusion, monitoring is needed of 
the disease in pastoral areas, with new entomological and parasitological 
indicators that account for the complexity of fenómeno. These results 
infer that a higher frequency of acaricide treatments 90 days in stable 
areas is an abiotic factor that favors the acquisition of protective immunity 
in calves, a positive influence on the natural control of infection and the 
absence of disease over time. CODI
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DEGRADATION AND UTILIZATION OF COMPLEX 
CARBOHYDRATES BY TRICHOMONAS VAGINALIS
Andrew Brittingham, Ryan D. Huffman, Lauren D. Nawrocki, 
Tyler J. Nielsen, Wayne A. Wilson
Des Moines University, Des Moines, IA, United States
Trichomonas vaginalis is a protozoan parasite that is the causative agent 
of trichomoniasis, a widespread sexually transmitted disease that affects 
millions worldwide. Several reports suggest that infection with this 
protozoan correlates with a decrease in the glycogen content of the 
vaginal epithelium. Most studies of T. vaginalis include the maintenance 
of parasites in media containing either glucose or maltose as carbohydrate 
sources. Here, we demonstrate that T. vaginalis grows equally well in 
media containing the glucose polymers amylopectin or glycogen as the 
principal carbon source. Having demonstrated the ability of Trichomonas 
to grow and utilize these polymers to support growth, we sought to 
analyze cell pellets and culture supernatant for hydrolytic activity towards 
amylopectin. We hypothesized that Trichomonas utilizes glucose polymers 
by first degrading the polymers into smaller subunits. Our data indicate 
that T. vaginalis possess both cell-associated and secreted hydrolytic 
activity towards glucose polymers and that activity accumulates in the 
medium during growth. Furthermore, carbohydrate limitation triggers an 
increase in both activities. Our initial analysis of the secreted activity reveals 
enzymatic properties consistent with those of an α-amylase. Collectively, 
our data provide evidence for a potential role of glucohydrolases in the 
growth of T. vaginalis.
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PENTATRICHOMONAS HOMINIS IS ASSOCIATED WITH 
DIARRHEAL EPISODES IN CAPTIVE-BRED OWL MONKEYS 
(AOTUS NANCYMAAE)
Jorge Nuñez1, Rito Zerpa2, Carmen M. Lucas1, Luis A. Lugo-
Roman1, Michael J. Gregory1, Ryan C. Maves1, Drake H. Tilley1, 
Geral C. Baldeviano1, Kimberly A. Edgel1, Paul C. Graf1, Andres G. 
Lescano1
1U.S. Naval Medical Research Unit No.6, Lima, Peru, 2Instituto Nacional de 
Salud del Niño, Lima, Peru
Owl monkeys (Aotus nancymaae) are small New World, non-human 
primates found in Brazil, Colombia and Peru. This species has been 
extensively used in biomedical research in the areas of infectious diseases, 
glomerulonephritis, atherosclerosis, immunology, and vision research. 
They have also been established as animal models for diarrhea caused 
by enterotoxigenic Escherichia coli, Campylobacter jejuni, and Shigella 
flexneri. Protozoan organisms such as Giardia intestinalis, Cryptosporidium 
spp., and Entamoeba histolytica are known to cause gastroenteritis in 
New World primates. On the contrary, Trichomonads and Blastocystis 
spp. are commonly found in these species but normally no clinical signs 
are observed and treatment is not routinely warranted. However, after a 
small increase in diarrhea rates at our laboratory facility, we investigated 
the prevalence of intestinal protozoa in captive-bred owl monkeys and its 
association with abnormal stool consistency. Four hundred sixty-one stool 
samples were collected irrespective of stool consistency at the NAMRU-6 
Laboratory Animal Facility between 2009 and 2012. Identification of 
intestinal protozoa was performed by microscopy. Trichomonad species 
was determined by sequencing the ITS locus. Diarrhea was defined as 
non-formed stool and association with protozoan presence was analyzed 
with regression methods. Overall, trichomonads and Blastocystis spp. 
were found in 54% and 39% samples, respectively. Two hundred fifty-
eight (56%) samples were classified as diarrhea. The prevalence of 
diarrhea in animals with and without trichomonads was 72% and 38%, 
respectively (ratio: 1.91, 95%, p<0.001). Similarly, the prevalence of 
diarrhea in animals with and without Blastocystis spp. was 72% and 46%, 
respectively (ratio: 1.56, 95%, p<0.001). In regression analyses, both 
protozoa had highly significant and independent effects (trichomonad 
ratio: 1.76, p<0.001, Blastocystis ratio: 1.34, p<0.001). Sequencing 
analysis of trichomonas organisms found showed 99% homology to 
Pentatrichomonas hominis. While intestinal trichomoniasis is normally non-
pathogenic, infection due to P. hominis in research non-human primates 
may result in diarrhea and could influence the outcome of gastroenteritis 
research studies. Careful evaluation of research animals should be 
instituted and treatment alternatives should be considered to treat and 
prevent diarrhea due to trichomoniasis.
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CONGENITAL TOXOPLASMOSIS IN BRAZIL: MODELING THE 
COST OF MATERNAL SCREENING
Eileen Stillwaggon1, Larry Sawers2
1Gettysburg College, Gettysburg, PA, United States, 2American University, 
Washington, DC, United States
Toxoplasma gondii is a protozoal parasite infecting a high proportion 
of the world’s population, although infection is generally asymptomatic 
in immunocompetent people. Congenital infection can result in fetal 
death or mild to profound visual, cognitive, and hearing impairment. 
A decision-analytic model applying the European protocol of universal 
maternal screening/ treatment to the low-prevalence US population 
found cost saving of $1 billion and prevention of avoidable injury in 
thousands of children every year. Using TreeAge Pro Suite software, we 
constructed a decision-analytic model to estimate costs of untreated 
toxoplasmosis and costs of screening, treatment, and follow-up for 3 
high-prevalence Brazilian states. The model includes probabilities of 
maternal and fetal infection, fetal loss due to congenital toxoplasmosis 
(CT), post-natal infection, distribution of visual, hearing, and central 
nervous system injury, treatment efficacy, and non-probabilistic variables, 
such as costs of screening tests and treatment. Brazil has very high 
prevalence of toxoplasmosis, from 30% to 80% in different states, with 
different ecologies and quality of water and sanitary infrastructure. High 
adult prevalence is associated with high incidence during pregnancy due 
to acquisition in adolescence and young adulthood. High incidence of 
CT is compounded by a more virulent strain than found in Europe. The 
Brazilian strain affects 1 in 500 births and also can produce blindness 
when acquired post-natally, even in immunocompetent persons. Clinical 
experience in Brazil indicates that the local strain, if untreated, produces 
more profound injuries than the European strain, but that prenatal 
treatment is equally effective in preventing or mitigating injury. High levels 
of exposure, including from the water supply, make pre-natal and post-
natal incidence a serious public health problem. In this high-incidence 
population, maternal screening is found to be cost-saving. Universal 
screening also has spillover benefits in community education, reducing 




ASSESSMENT OF CRYOPROTECTANT TOXICITY ON 
THE VIABILITY OF CRYPTOSPORIDIUM PARVUM AND 
EVALUATION OF A CRYOPRESERVATION METHOD FOR 
SPOROZOITES
Kathleen Glaser, Robert E. Molestina
BEI Resources, ATCC, Manassas, VA, United States
Cryptosporidum parvum is an obligate intracellular parasite that can 
cause life-threatening infections among immunocompromised individuals. 
Successful cryopreservation and recovery of viable C. parvum has not 
been achieved in spite of multiple studies. This constitutes an obstacle to 
the establishment of standardized isolates or cloned stocks. Compounds 
used as cryoprotectants may have detrimental effects on parasite 
viability, thus toxicity studies should be pursued before developing any 
cryopreservation method. The present study assessed the effects of 
different cryoprotective agents on the viability of C. parvum and evaluated 
the infectivity of sporozoites following cryopreservation. Treatment of C. 
parvum oocysts with ethylene glycol (EG), propylene glycol (PG), dimethyl 
sulfoxide (DMSO), glycerol, or sucrose did not result in incorporation 
of propidium iodide at cryoprotectant concentrations ranging from 0.5 
to 4 M. In addition, excystation of sporozoites was not impaired by the 
treatment of oocysts with these compounds. Treatment of excysted 
sporozoites with EG, PG, DMSO, or sucrose did not affect the infectivity 
of C. parvum as determined by the presence of intracellular meront stages 
in infected HCT-8 cells. Moreover, the expression of the C. parvum genes 
TRAP, COWP, and 18S rRNA in infected HCT-8 was unaffected by prior 
treatment of sporozoites with cryoprotectants. Following cryopreservation 
of sporozoites in a cocktail of DMSO and sucrose, infectivity of HCT-8 
cells was observed up to 4 days of infection. In summary, oocysts are 
highly resistant to potentially toxigenic concentrations of cryoprotectants, 
an observation that is in all likelihood attributed to the low permeability 
of the thick cyst wall. In addition, sporozoites are able to withstand 
concentrations of cryoprotectants commonly used in freezing protocols 
and are amenable to cryopreservation as assessed by an in vitro infection 
assay. We have established a framework to monitor the concentrations 
of cryoprotectants and cooling parameters as work continues towards 
developing an optimal freezing method for the long term storage of C. 
parvum.
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OPPORTUNISTIC INTESTINAL PARASITES AND 
MALNUTRITION IN MADAGASCAR: HOW TO DESIGN 
STUDIES?
Guillaume Roux1, Fabiola Gosinary1, Gisele Raherinampinaina2, 
Rindra Randremanana1, Jeanine Holianjovony3, Elisoa Hariniaina1, 
Annie Robinson2, Ronan Jambou1
1Institut Pasteur de Madagascar, Antananarivo, Madagascar, 2Tsaralalana 
children’s Hospital, Antananarivo, Antananarivo, Madagascar, 3Regional 
Reference Hospital Antsirabe, Antsirabe, Madagascar
Opportunistic intestinal parasites (cryptosporidia, microsporidia, etc.) 
were mostly described in Europe after emergence of the HIV outbreak 
but their prevalence fall down dramatically with effective antiretroviral 
tritherapies. Some of these parasites could affect immune-competent 
hosts and are described in travellers coming back from their trip with 
diarrhoea. In tropical countries prevalences of opportunistic parasites 
seem to be higher than in Europe, but are not well documented. 
Moreover, in tropical areas other causes of immune-depression can occur 
like malnutrition or tuberculosis. In Madagascar chronic malnutrition 
concerns 50% of children fewer than 5 years. Chronic malnutrition could 
induce immunodepression and opportunists have thus to be intensively 
researched in these children during diarrhea. To address this link between 
malnutrition and opportunists, we started studies on four pathogens: 
cryptosporidias, microsporidias, Isospora belli and Cyclospora cayetanensis. 
However the difficulty is to define a technical procedure usable i) to 
analyse large set of stools collected in the same time on the field, ii) 
sensitive, specific and at low cost and iii) which do not require trained 
personal. Quantitative PCR could be the best solution for epidemiological 
campaigns. However pitfall in definition of PCR is the low number of 
genes potentially targeting due to the low number of sequences available 
to do multiple alignment. Moreover in tropical countries water and 
vegetables can be a huge source of parasites in transit. Overall we choose 
a three steps procedure for epidemiological studies: Q-PCR / microscopy / 
sequencing, using ribosomal small subunit sequences. In the same time we 
setup studies in two hospitals to target under-fed children. A third study 
was conducted on samples already collected to analyse causes of diarrhea 
in children leaving in the suburban area of Moramanga (Madagascar). 
Studies are still in process but associations of cryptosporidias and 
microsporidias have been already found in several patients.
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ELECTRON MICROSCOPY CHARACTERIZATION OF 
DIENTAMOEBA FRAGILIS VIRUS LIFE CYCLE
Gouri B. Banik1, Debra Birch2, Damien Stark1, John T. Ellis2
1University of Technology, Sydney, NSW, Australia, 2Macquarie University, 
Sydney, NSW, Australia
Dientamoeba fragilis is a pathogenic trichomonad parasite found in the 
gastrointestinal tract of humans and is implicated as a cause of diarrheal 
disease. The objective of this study was to describe, by transmission 
electron microscopy, the presence and morphological details of the virus 
population found in different clinical isolates of D. fragilis growing in xenic 
culture. These virus populations comprise different sizes ranging from 
40-200 nm. Their most common shape was spherical, enclosing a dense 
core, a middle electron-lucent layer and an outer coat. In addition, these 
VLP populations have an icosahedral capsid structure. The D. fragilis VLPs 
were found in the cytoplasm closely associated with the Golgi complex, 
with some VLPs budding from the Golgi while other VLPs were detected 
adjacent to the plasma membrane. These VLPs attach and penetrate 
into D. fragilis by endocytosis and are maintained within vacuoles during 
batch culture for several daily passages and excreted through exocytosis. 
Virus-like particles are abundant in the growth media of stationary- 
phase D. fragilis cultures. This is the first study to describe in detail the 
ultrastructural characteristics of a Dientamoeba fragilis virus (DFV) and its 
mode of replication in different cultured isolates of D. fragilis.
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PERKINSUS MARINUS, THE AGENT RESPONSIBLE FOR 
DERMO DISEASE IN OYSTERS, DOES NOT INDUCE 
PATHOLOGY IN HUMANIZED HLA-DR4 MICE AND 
STIMULATES ORAL IMMUNITY
Wathsala Wijayalath1, Luis Paw-Sang2, Rebecca Danner1, Gerardo 
R. Vasta3, Eileen Villasante1, Thomas L. Richie1, Teodor D. 
Brumeanu4, Jose-Antonio Fernandez-Robledo3, Sofia A. Casares1
1Naval Medical Research Center/Walter Reed Army Institute of Research, 
Silver Spring, MD, United States, 2Uniformed Services University of the 
Health Sciences, Bethesda, MD, United States, 3University of Maryland 
Baltimore, Baltimore, MD, United States, 4Uniformed Services University of 
the Health Sciences, Bethesda, MD, United States
Perkinsus marinus (Phylum Perkinsozoa) is a marine protozoan parasite 
closely related to dinoflagellates (responsible for harmful algal blooms) 
and apicomplexans (e.g. Toxoplama, Plasmodium) that has devastated 
natural and farmed oyster populations in some areas of the USA, 
significantly affecting the shellfish industry and the estuarine environment. 
P. marinus range extension in the northeastern USA has been associated 
with global warming, and currently Dermo disease is under surveillance 
by the World Organization for Animal Health (http://www.oie.int/). The 
infection prevalence has been estimated in some areas to be as high as 
100% often causing death of infected oysters within 1-2 years post-
infection. Human consumption of infected oysters is thus likely to occur, 
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but to our knowledge it has not been investigated in humans or other 
mammals whether P. marinus induces gut pathology or whether oral 
immunization occurs upon consumption. Here we used a humanized 
mouse model expressing HLA-DR4 molecules and at the same time lacking 
expression of mouse MHC-II molecules (C57/BL6 background) to address 
these questions. Oral feeding with live P. marinus PRA240 did not induce 
pathology as manifested by histological examination of the gastrointestinal 
tract, lungs, and kidneys. Furthermore, PCR testing showed absence of the 
oyster parasite in fecal material, indicating that P. marinus cannot replicate 
and/or infect cells in the gastrointestinal tract. Interestingly enough, the 
humanized mice elicited strong humoral (IgG) and cellular responses to 
the oyster parasite. Our results thus demonstrate that P. marinus does not 
induce pathology and stimulates gut immunity in HLA-DR4 humanized 
mice. Ongoing studies are aimed to address whether anti-P. marinus 
immunity can protect humanized mice against malaria.
265
A STUDY OF MUSSELS PERNA PERNA INFECTED WITH 
CRYPTOSPORIDIUM SPP. INTENDED FOR HUMAN 
CONSUMPTION INDICATING ENVIRONMENTAL 
CONTAMINATION
Teresa Cristina Bergamo Bomfim, Geisi Ferreira Mariné, 
Marcelo de Freitas Lima
Universidade Federal Rural do Rio de Janeiro, Rio de Janeiro, Brazil
Sources of contamination such as water drainage of the animal faeces, 
the use of organic fertilizers and the release of part or untreated sewage 
contamination favor of various aquatic environments by this parasite 
since the oocysts are eliminated in the feces of the host. In the seas the 
presence of Cryptosporidium spp. directly affects the quality of fish such 
as mussels present in the Brazilian coast and is therefore limiting the 
consumption of food. The study aimed to diagnose and characterize 
genetically type (s) and/or genotype (s) of Cryptosporidium in mussels 
taken from rocky shores at two locations, Lage Preta and Saco´s Beach, in 
the Mangaratiba city, State of Rio de Janeiro, performing the sequencing 
and phylogenetic analyzes, including the deposit of Cryptosporidium 
sequences from GenBank, to correlate the presence of the parasite with 
the index of rainfall in the region and to establish possible risks of eating 
mussels, by identifying the genotype (s) and or species with zoonotic 
potential. Mussels were collected monthly from March 2009 to February 
2010 totaling 12 samples. During data collection, 30 animals were 
separated from each location and divided into three groups of 10 animals 
each, totaling 72 samples. For the analyzes, the DNA extracted from 
tissues of mussels was used in the amplification of sequences 18SSU rRNA 
by nested-PCR technique. Results: For species identification, the amplicons 
were sent for sequencing. During all the study samples was possible to 
diagnose mussels Cryptosporidium positive for at least one of the study 
sites. It was possible to identify three species C. andersoni, C. meleagridis 
and C. parvum in samples obtained from two locations of mussels, by 
observing the similarity of 99% when compared to existing sequences 
in GenBank. It is possible the occurrence of human cryptosporidiosis by 
the consumption of mussels, raw or partially cooked, from the city of 
Mangaratiba. Statistical analysis showed no influence of rain in positivity 
of the samples of mussels for Cryptosporidium.With these results we 
conclude that there is likelihood of human exposure through ingestion of 
mussels from the region studied.
266
EPIDEMIOLOGIC ASPECTS OF INFECTION CRYPTOSPORIDIUM 
SPP. IN CALVES DAIRY AND GENETIC CHARACTERIZATION OF 
SPECIES AND SUBTYPES
Teresa Cristina Bergamo do Bomfim Cristina Bomfim, Melissa 
Carvalho Couto, Marcelo de Freitas Lima Freitas Lima
Universidade Federal Rural do Rio de Janeiro, Rio de Janeiro, Brazil
The bovine cryptosporidiosis is caused mainly by four different species, 
Cryptosporidium parvum, C. bovis, C. ryanae and C. andersoni. The first 
one is of great concern for both livestock and public health. With regard 
to public health, the species is the subject of several studies due to its 
high zoonotic potential. The study aimed to: Perform the genotypic 
characterization of Cryptosporidium species and subtypes obtained from 
fecal samples from calves under one year of age, from dairy farms in 
the State of Rio de Janeiro, Brazil, establishing the potential for zoonotic 
species C. parvum through diagnosed subtype. Methods: The aim of this 
study is to determine the occurrence of Cryptosporidium species and 
subtypes in calves up to one year of age, throughout PCR technique usin 
18S and GP60 as gene target. The occurence of Cryptosporidium species 
in calves up to 1-year-old was determined for 143 animals on three dairy 
farms on the state of Rio de Janeiro, Brazil. A fecal samples collected 
directly from each calf rectum was processed to concentrate oocysts using 
the centrifugal flotation technique in saturated sugar solution before 
being evaluated microscopically. Results: Of the 28 positive samples in 
microscopy, 23 were confirmed by Nested-PCR using gene 18SrRNA. 
After each PCR-positive specimen was sequenced, the presence of three 
species of Cryptosporidium was observed infecting calves at different 
ages. Pre-weaned calves were infected with C. parvum (7%), whereas 
post-weaned calves were infected with C. andersoni (15%) and C. ryanae 
(1%). All positive samples are being submitted to a second Nested-
PCR using gene GP60 as target. A new sequencing will be made for C. 
parvum positive samples, to observe the most prevalent subtype in the 
area. Conclusions: Were diagnosed by means of molecular techniques C. 
parvum and zoonotic subtypes, C. andersoni, species of importance for 
dairy production and C. ryanae, this species is the first report infecting 
calves in the state of Rio de Janeiro and the second description of the 
species in Brazil.
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MALNUTRITION IS ASSOCIATED WITH INCREASED 
MORTALITY IN ADULT MEDICAL INPATIENTS AT A REGIONAL 
REFERRAL HOSPITAL IN SOUTHWESTERN UGANDA
Stephen B. Asiimwe1, Christopher C. Moore2
1Mbarara University of Science and Technology, Mbarara, Uganda, 
2University of Virginia, Charlottesville, VA, United States
The contribution of malnutrition to the course of acute illness and 
hospital-based mortality in adults in sub-Saharan Africa (SSA) is not 
fully described. To determine if malnutrition is associated with increased 
mortality in hospitalized patients in SSA we conducted a prospective 
observational study of 318 adult (age ≥ 18 years) medical inpatients 
admitted to the Mbarara Regional Referral Hospital in southwestern 
Uganda. For each patient, we calculated body mass index (BMI) and a 
mini-nutritional assessment short form (MNA-SF) score. We followed 
patients until death or 30 days from admission. The cohort included 
152 (48%) women and the mean (± SD) age was 42 (± 8) years. There 
were 144 (45%) HIV infected patients and 132 (42%) had suspected 
tuberculosis (TB). Other diagnoses included severe anemia with HB ≤ 7 g/
dl (89, 28%), diarrhea (52, 16%), pneumonia (44, 14%), kidney disease 
(24, 8%) and stroke (11, 4%). Malnutrition (MNA-SF ≤ 7) occurred in 187 
(59%) patients and 149 (47%) patients had a BMI of <18.5 kg/m2. The in-
hospital mortality was 18% (57 of 318). Of the 261 patients discharged, 
only 27 (10%) were lost to 30 day follow-up. The 30 day mortality was 
40% (117 of 291). In the univariate analysis, malnutrition, an abnormal 
temperature (≥38 ºC or <36 ºC), HIV infection, and presence of suspected 
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TB were significantly associated with mortality (p < 0.05). In the 
multivariate analysis, only malnutrition (adjusted OR 3.7, 95% CI 1.6-8.6, 
p = 0.002) and abnormal temperature (adjusted OR 2.0, 95% CI 1.0-3.9, 
p = 0.04) remained independently associated with mortality. Our findings 
indicate that malnutrition contributes strongly to mortality in acutely ill 
hospitalized adults in SSA. Additional research is urgently needed to better 
understand the pathophysiology of malnutrition in acutely ill hospitalized 
adults in SSA and ways to mitigate its effect.
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TOXOPLASMA MYOCARDITIS IN IMMUNOCOMPETENT 
REQUIRING CARDIAC TRANSPLANTATION 
Mahesh Menon
Nepean Hospital, Penrith, Sydney, Australia
Toxoplasma gondii is a common protozoan parasitic zoonosis with varying 
prevalence. Toxoplasmosis is predominantly of concern in pregnant 
women and in immunocompromised hosts either as a primary infection 
or reactivation. It presents as a self limiting illness in immunocompetent 
persons but rarely presents as chorioretinitis, encephalitis, polymyositis, 
pneumonitis, hepatitis and myocarditis. Severe infections are rare 
because the parassitemia is short lived due to the transformation of 
tachyzoites into bradyzoites. There were fewer than 50 reported cases of 
severe toxoplasmosis and 15 cases of myocarditis in immunocompetent 
subjects worldwide. We report the case of an 18 year old Caucasian 
immunocompetent female living in tropical Australia who was diagnosed 
with Toxoplasma myopericarditis causing fulminant heart failure and 
cardiogenic shock requiring urgent BiVAD implantation as a bridge 
to cardiac transplantation. Patient did not have a significant travel or 
exposure history other than to a cat. Prodromal symptoms were very 
nonspecific but in 4 weeks, patient developed pulmonary oedema and 
ECG showed widespread ST elevation. Echocardiogram revealed a non 
dilated left ventricle with an ejection fraction of 20 percent. Toxoplasmosis 
was diagnosed by EIA levels and the low avidity index of IgG indicating 
an acute infection. Trimethoprim and Co-Trimoxazole were commenced 
and an extensive negative test panel excluded other causes. Viruses were 
not isolated on biopsied ventricular tissue and histopathology did not 
reveal any micro organisms on special stains. CD3 positive T lymphocyte 
predominant lymphocytic myocarditis with extensive myocyte necrosis 
was reported. Patient developed progressive cardiogenic shock requiring 
urgent BiVAD implantation. Patient underwent cardiac transplantation and 
device removal 61 days after presenting to hospital. To our knowledge, 
this is the first reported case of severe myopericarditis secondary to 
Toxoplasma infection in an immunocompetent host requiring a ventricular 
assist device and cardiac transplantation.
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IDENTIFICATION OF THREE CANDIDA AFRICANA STRAINS IN 
SENEGAL
Doudou Sow
Parasitology- Mycology/UCAD, Dakar, Senegal
Frequency of candidiasis has increased dramatically in recent years. 
Candida albicans is the most common species. However, other species 
which are pathogenic and resistant to usual antifungal agents beginning 
to emerge. Among theme C. dubliniensis and C. africana are the most 
frequent. These two species presented morphological similarities. Thus, 
it is important from epidemiological point of view to identify the fungal 
isolates in Senegal. This study was undertaken to identify new species 
among Candida strains isolated in Dakar. Oropharyngeal and vaginal 
swabs were performed at Fann Hospital in Dakar. The strains were 
identified by the germ tube test, the chlamydospore production test 
and an auxanogram. Then identification by PCR targeting the hyphal 
wall protein 1(hwp1) gene, was carry out in order to discriminate C. 
albicans between, C. dubliniensis and C. africana. Among the 243 yeasts, 
95% (231/243) were isolated from vaginal swab and 5% (12/243) 
from oropharyngeal swab. Species identified by phenotypic methods 
are C. albicans which is the most frequent, C. tropicalis, C. glabrata, C. 
dubliniensis, C. kefyr and C. lusitaniae. Of the 150 strains analyzed by 
PCR, 75% (112/150) were positive. Among the 112 strains of C. sp PCR 
positive, 97% (109/112) were identified as strains of C. albicans and 3% 
(3/112) as C. africana. No strains of C. dubliniensis was not found in our 
study. In conclusion, this study isolates C. africana for the first time in 
Senegal. Further studies on a larger sample will better know the actual 
proportion of these three species among the isolated yeasts.
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ENTAMOEBA HISTOLYTICA MENINGOENCEPHALITIS IN A 
SAMOAN TODDLER WITH ACUTE ONSET SEIZURES
Lucy M. Goh, James R. Marrone, Lana Y. Flippo, Kamlesh Kumar, 
Amelita L. Mejia, Tagiliima I’Atala, Saipale Fuimaono, Seini Biukoto
LBJ Tropical Medicine Center, Pago Pago, American Samoa
Invasive amebiasis causes extraintestinal disease via hematogenous 
spread to the liver, lung, brain and rarely other organs. The medical 
literature reports amebic brain abscesses, which represent advanced 
infection that is often fatal, but to our knowledge Entamoeba histolytica 
meningoencephalitis has not been described in the modern literature, 
which is distinct from that caused by free-living amebae. We report what 
may be the first case of E. histolytica meningoencephalitis diagnosed in 
American Samoa in a 16 month old Samoan boy. Without brain or liver 
abscesses on CT scan, he developed acute onset seizures while receiving 
appropriate dose oral metronidazole for intestinal amebiasis and, CSF 
exam revealed 2+ motile trophozoites. He was treated with intravenous 
metronidazole for 2 weeks during a complicated ICU course, and had 
apparent full recovery with no further seizures to date. E. histolytica 
is endemic on the island and is the most common intestinal parasitic 
infection diagnosed in our lab in the past 2 years. Hence, in American 
Samoa and other areas endemic for E. histolytica, where similar cases 
might be escaping diagnosis, pediatricians should have a high index of 
suspicion for CNS amebic infection in a child with intestinal amebiasis and 
new onset seizures.
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ATYPICAL RABIES: A CASE REPORT FROM A RABIES 
OUTBREAK IN KENYA
Eric Ogola1, Sergio Recuenco2, Michael Niezgoda2, Gilchrist 
Lokoel3, Alex Gentile A4, Samuel Oketch3, Titus Kwambai5, 
Godfrey Bigogo1, Peter Omemo6, Barry Fields2, Joel Montbomery2, 
Charles Rupprecht2, M. Kariuki Njenga2
1Kenya Medical Research Institute, Kisumu, Kenya, 2Centers for Disease 
Control and Prevention, Atlanta, GA, United States, 3Kenya Field 
Epidemiology and Laboratory Training Program, Nairobi, Kenya, 4George 
Washington University, Washington, DC, United States, 5Ministry of Public 
Health and Sanitation, Nairobi, Kenya, 6Ministry of Livestock Development, 
Nairobi, Kenya
An outbreak of canine and human rabies occurred in the Kisumu East 
district of Western Kenya between December 2011 and March 2012, 
resulting in 369 human exposures, primarily through dog bites. Of these, 
201(35.3%) persons began post-exposure vaccination. Two human deaths 
were reported. Seven (41.2%) of 17 dogs were diagnosed rabid via the 
direct fluorescent antibody test. One of the cases was a 4½ year-old 
boy that was admitted at a district hospital on 7th February, 2012 with a 
3-day history of verborrhea, hyperactivity, dysphagia, vomiting, fever, and 
decreased urine flow. The boy acquired a 3-month old puppy 2 months 
earlier. However, a week before biting the boy, the puppy had been bitten 
in the head by a stray dog. The puppy died a few days after biting the boy. 
Despite a negative laboratory test, the boy was treated for cerebral malaria 
because it is a malaria endemic zone. Later, the diagnosis was changed 
to meningitis, after the patient developed a stiff neck. On learning of the 
rabies outbreak in the region, the patient began post-exposure rabies 
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vaccination, administered on days 0, 3 and 12, but without rabies immune 
globulin. The patient’s condition deteriorated on day 7 with bouts of 
vomiting. The patient subsequently developed paraparesis and dyspnoea 
before dying on day 13. Postmortem specimens were obtained from the 
brain stem, cerebrum and cerebellum. Rabies virus-specific antigens were 
detected using a direct rapid immune-histochemistry test (dRIT). Although 
the patient did not have access to intensive care, he survived for two 
weeks in the hospital whereas typically rabies cases do not survive more 
than a week without intensive care. This is the first human rabies case 
to be diagnosed using the dRIT in a developing country. Rabies vaccine 
administration to the patient after illness was in conflict to existing 
recommendations and confounded ante-mortem diagnostic testing. The 
WHO recommendation is to administer the post-exposure vaccine on days 
0,3,7,14 and 28. Immune globulins should also be administered.
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A STUDY TO ASSESS INITIAL PARENTAL RESPONSE TO FEVER 
IN CHILDREN IN MBARARA, UGANDA, A MALARIA ENDEMIC 
REGION
Ijeoma Ejigiri1, Manfred Amanya2, Data Data Santorino2
1Emory University, Atlanta, GA, United States, 2Mbarara University of 
Science and Technology, Mbarara, Uganda
Malaria remains one of the leading causes of morbidity and mortality 
in the developing world, with the greatest burden of which being in 
sub-Saharan Africa, especially in countries like, Uganda. Traditionally, 
development of fever in endemic areas has been correlated with malaria, 
and several cross sectional studies performed in sub-Saharan Africa, have 
shown that fever is one of the most recognized signs of malaria within the 
community. It is important to examine parental initial responses to fever 
as delaying seeking out treatment for malaria and other common causes 
of childhood fever can be associated with worse outcomes. Our objective 
was to determine the initial response to fever among parents presenting 
with febrile children to the pediatric ward at, Mbarara Regional Referral 
Hospital, in southwestern Uganda. We also aimed to identify factors 
that determine a parent’s initial response to fever. A questionnaire was 
administered to 74 parents of sick children who presented with a chief 
complaint of fever. The questionnaire included questions on demographics 
of the parents and children, and assessed initial parental decisions in 
response to their child’s fever. Despite the fact the majority of the study 
participants had little formal education and had poor socioeconomic 
status, the most favored parental response to fever was to utilize a nearby 
clinic. However only 40% of the respondents reported seeing a healthcare 
worker within 24 hours of onset of fever. Almost 30% of the respondents 
reported waiting more than 72 hours to seek out a healthcare worker. The 
majority of the respondents who did not go to the clinic first reported that 
they didn’t feel the child was sick enough or reported that transportation 
was a barrier. Given these findings, parents in this region, should be 
counseled not to delay seeking assistance when their child becomes febrile 
to help aid in the diagnosis and treatment of malaria, and other potentially 
life-threatening non-malarial causes of fever such as pneumonia and 
gastroenteritis.
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ESTIMATION OF THE RIFT VALLEY FEVER BURDEN OF 
DISEASE IN THE 2006/2007 OUTBREAK IN KENYA
Austine B. Orinde1, Tabitha Kimani2, Esther Schelling3, Jared 
Omolo1, Gideon M. Kikuvi4, Kariuki M. Njenga5
1Ministry of Public Health and Sanitation, Nairobi, Kenya, 2International 
Livestock Research Institute, Nairobi, Kenya, 3Swiss Tropical and Public 
Health Institute, Basel, Switzerland, 4Jomo Kenyatta University of 
Agriculture and Technology, Nairobi, Kenya, 5Centers for Disease Control 
and Prevention, Nairobi, Kenya
Rift Valley Fever (RVF) virus causes severe epidemics in livestock and 
humans resulting in considerable economic losses from disruption of 
livestock production and market chain and morbidity and mortality in 
humans. This study estimated the burden of RVF disease in humans 
using disability adjusted life years (DALYs), assessed human health RVF 
epidemiological parameters and private and public health costs during 
the last RVF epidemic in the 2006/2007 in Kenya. We interviewed family 
members that cared for an infected person in eligible household and key 
informants in the public health sector in Garissa and Kilifi districts that 
were heavily affected by the epidemic and at the public health leaders at 
the national level to assess the private and public health costs. An eligible 
household was household that had an RVF cases during the 2006/2007 
outbreak as identified from the linelist. Secondary data from the Ministry 
of Health and published literature were reviewed for epidemiological 
parameters including age and sex categorized incidences, proportions 
of disease manifestation, and mortality rates in order to compute DALYs 
using methods developed by the World Health Organization. A total of 
127 eligible households were enrolled in to the study with one member 
interviewed in each household. Those interviewed in these households 
included 54% males and ranged from 19 to 81 years old with 40 and 45 
years as mode and median age, respectively. The RVF virus predominantly 
infected males during the outbreak with an annual incidence of 0.7 per 
1,000 population compared to females at 0.5 per 1,000 population. The 
burden of RVF during the 2006 and 2007 outbreak was 3.4 DALYs per 
1000 population, representing 1% of the total DALYs and estimated 
household costs of USD120 for every human case reported. In comparison, 
the total burden of HIV/AIDS and malaria in Kenya is the highest at 24.2% 
and 7.2% DALYs, respectively. Our results provide vital data on burden of 
RVF for use by the Government and other institutions to guide in health 
policy making and resource allocations for prevention and control.
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BURDEN OF PODOCONIOSIS IN EAST AND WEST GOJAM 
ZONES, NORTHERN ETHIOPIA 
Yordanos B. Molla
Brighton and Sussex Medical School, Brigthon, United Kingdom
Podoconiosis is geochemical elephantiasis of the lower legs that 
affects barefoot individuals exposed to red clay soil of volcanic origin. 
Podoconiosis can be prevented, early forms of the disease can be treated, 
and disease progression can be curbed. Podoconiosis is an important 
public health problem in Africa, Central America and northern India. 
The aim of this study was to assess the burden of podoconiosis in East 
and West Gojam Zones, northern Ethiopia. A cross-sectional household 
survey was conducted in two districts covering all 17,553 households in 
20 randomly selected kebeles (administrative subunits). Following this, 
detailed structured interview was conducted on all cases identified. The 
prevalence of podoconiosis in the population aged 15 years and above 
was found to be 3.3% (95% CI, 3.2% to 3.6%). 87% of cases were in 
the economically active age group (15-64 years). On average, patients 
sought treatment five years after the start of the leg swelling. Most 
subjects had second (42.7%) or third (36.1%) clinical stage disease, 
97.9% had mossy lesions, and 53% had open wounds. On average, 
patients had five episodes of acute ALA per year. The commonest 
treatment facilities visited were health centers (28.7%) and traditional 
healers (29.4%). The most common coping measures employed against 
ALA were staying in bed (55.6%), resorting to less laborious work 
(44.2%), use of antibiotics (25.8%) and local herbs (20.5%). The median 
age of first use of shoes and socks were 22 and 23 years, respectively. 
More men than women owned more than one pair of shoes (61.1% 
vs. 50.5%; χ²= 11.6 p=0.001). At the time of interview, 23.6% of the 
respondents were barefoot, of whom about two-thirds were women. This 
study showed high prevalence of podoconiosis and associated morbidities 
such as ALA, mossy lesions and open wounds in northern Ethiopia. 
Predominance of cases at early clinical stage of podoconiosis indicates 





ACCESS TO TREATMENT FOR CHAGAS DISEASE IN MEXICO: 
A POLICY ANALYSIS
Jen Manne1, Callae S. Snively1, Janine M. Ramsey2, Michael Z. 
Levy3, Till Bärnighausen1, Michael R. Reich1
1Harvard School of Public Health, Boston, MA, United States, 2Instituto 
Nacional de Salud Publica, Tapachula, Mexico, 3University of Pennsylvania, 
Philadelphia, PA, United States
The most recent prevalence estimates from the World Health Organization 
indicate that as many as 1.1 million people in Mexico are infected with 
Trypanosoma cruzi, the etiologic agent of Chagas disease. However, 
limited information is available about access to treatment for this 
disease. The aims of this study were to assess the current extent of 
access in Mexico, analyze the national and state barriers to access, and 
suggest strategies to overcome them. Morelos was used as a state case 
study and data were collected from this state and the national Chagas 
program. Semi-structured in-depth interviews were conducted with 
16 key informants and policymakers at both levels. Government policy 
documents about Chagas disease treatment in Mexico were collected, 
analyzed to assess treatment access and used to triangulate interview 
data. Interview responses and information from policy documents were 
analyzed according to the health systems “control knobs”, as defined 
in the Flagship Framework for Pharmaceutical Policy Reform: regulation, 
financing, payment, organization, and persuasion. The data showed 
that 2,847 new cases of Chagas disease were registered nationally from 
2007-2011 and in each year but one, the number of new cases was 
below the national program’s target by 11-36%. The Morelos case study 
revealed that this state made a concerted effort to increase access by 
purchasing benznidazole, consistent with state responsibility for medicine 
procurement. The national program mainly coordinated donation of 
nifurtimox from the WHO Nifurtimox Donation Program. The procurement 
process used by Morelos was complex and reflected important obstacles 
at the national level such as exclusion of antitrypanosomal medicines from 
the national formulary (regulation), exclusion of Chagas disease from 
the Seguro Popular social insurance package (organization) and limited 
understanding of the disease by providers (persuasion). The study proposes 
strategies to overcome these barriers, including adding these medicines to 
the national formulary and increasing education about the disease.
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RELATIONSHIP BETWEEN NUTRITIONAL STATUS AND THE 
PREVALENCE OF MALARIA AND ANEMIA AMONG CHILDREN 
IN THE KASSENA-NANKANA DISTRICT OF GHANA
Simone Y. Asare1, Elijah Paintsil2, Kwadwo Koram3, Frank 
Atuguba4, Victor Asoala4, Debbie Humphries1
1Yale School of Public Health, New Haven, CT, United States, 2Yale School 
of Medicine, New Haven, CT, United States, 3Noguchi Memorial Institute 
for Medical Research, Accra, Ghana, 4Navrongo Health Research Center, 
Navrongo, Ghana
Under nutrition, malaria and anemia are significant public health concerns 
in northern Ghana, especially among children under five years. There 
is growing interest in the effects of nutritional status on clinical malaria 
outcomes in pre-school age children. The study objectives were to 
characterize the effects of indicators of dietary risk on clinical malaria 
during both the wet and dry seasons. Cases of clinical malaria (wet season 
n=40, dry season n=42) and matched controls (wet season n=47, dry 
season n=37) were identified from records of the longitudinal Birth Cohort 
Study (BCS). Clinical indicators (Hgb, malaria parasitemia, weight) were 
extracted from study records, and retrospective household questionnaires 
captured indicators of household hunger, dietary diversity, household food 
security, and malaria risk behavior. Children from households classified 
as having very low food security had an increased risk of being clinical 
malaria cases compared to children from households not classified as 
having very low food security. (OR=1.78; 95% CI (.92-3.45); p=.087) 
17.1% of the matched clinical malaria cases consumed meat compared 
to only 8.1% of the matched clinical malaria controls. Children who had 
consumed meat within the 12 month recall period from the administration 
of the nutritional history questionnaire had an increased risk of being 
clinical malaria cases compared to children who did not consume meat 
during the same time period. (OR=3.33; 95% CI (.92-12.11); p=.067) 
Parasitemia concentrations were significantly higher in cases when 
compared to controls (Wilcoxon Rank-Sum Test p-value: <.001.); the mean 
P. falciparum density for matched clinical malaria controls was 6,531.3 
parasites/ul of blood compared to 42,199.0 parasites/ul of blood for the 
matched clinical malaria cases. Higher parasitemia levels are statistically 
associated with clinical malaria case status; very low food security and 
meat consumption may affect clinical malaria outcomes among children in 
the Kassena-Nankana District (KND).
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ADDRESSING THE NEGLECTED TROPICAL DISEASE 
PODOCONIOSIS IN NORTHERN ETHIOPIA: LESSONS LEARNED 
FROM A NEW COMMUNITY PODOCONIOSIS PROGRAM
Sara M. Tomczyk1, Gail Davey2, Abreham Tamiru3
1London School of Hygiene and Tropical Medicine, London, United 
Kingdom, 2Brighton and Sussex Medical School, Brighton, United 
Kingdom, 3International Orthodox Christian Charities, Debre Markos, 
Ethiopia
Despite its great public health importance, few control initiatives 
addressing podoconiosis (non-filarial elephantiasis, a geochemical 
neglected tropical disease) exist. In June 2010, the first podoconiosis 
program in Northern Ethiopia, consisting of prevention, awareness, and 
care and support activities, began in Debre Markos, Northern Ethiopia. 
This study aims to document and disseminate the lessons learned from 
a new community podoconiosis program in Debre Markos. We used a 
content analysis approach to examine and evaluate data from a series of 
sources. These sources include conducted interview transcripts, a focus 
group discussion transcript and secondary sources including monitoring 
and evaluation field reports, observation notes, and research obtained 
from a literature review. Themes were identified and grouped into matrix 
tables. Overall, sixteen program steps were identified and grouped into 
6 domains: Initial preparation, training and sensitization, foundation 
building, treatment activity implementation, awareness, and follow-up. 
Emphasis is placed on the need for baseline data, effective training, local 
leadership, experience-sharing, mass-awareness, cross-cutting sector issues 
(i.e. water and waste management), and integration with government 
health systems. Related successes and challenges are also described, as 
are stakeholder roles and misconceptions and socio-cultural challenges 
affecting the program start-up. Many of the identified successes and 
challenges are relevant to the aim of the podoconiosis program to be 
sustainable and community-led. Much of this information has already 
been used to improve the Debre Markos program. We also anticipate 
that the domains and steps identified will be useful in guiding new 
programs in other settings where podoconiosis is highly prevalent. We 
hope to encourage partnerships and collaboration among podoconiosis 
stakeholders in future growth and disease control expansion.
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CHRONIC LIVER DISEASE IN HEMODIALYSIS 
Osama El-Minshawy, Twafik Ghabra, Eman El Bassuoni
University of Tabuk School of Medicine, Tabuk, Saudi Arabia
The functional integrity of the liver is crucial to vitality in normal people 
and end stage renal disease (ESRD) patients; the prevalence of chronic 
liver disease (CLD) in hemodialysis (HD) patients differs according to the 
country or even the region in the same country. Hepatitis C virus (HCV) 
was recognized as an important cause and consequence of chronic kidney 
disease. We aim to investigate the prevalence of CLD among HD patients 
in Tabuk, Saudi Arabia. All HD patients were offered to participate in the 
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study, interview, medical records including; demographics, family history, 
and investigation, were the main source of information. Blood samples 
were taken, before start of HD to detect HBsAg, HCV antibodies and 
biochemical tests. Abdominal sonar was performed to scan liver, spleen, 
portal vein and to become aware of ascites. The prevalence of ESRD was 
350 per million populations, mean HD duration 40±15 month, mean 
age 44±18 year, BMI 23±2 kg/m2, serum albumin 3.2±0.5 (g/dl), males 
(52 %). Etiology of ESRD was vague in 33% of HD patients, HCV +Ve 
in 31%, HBsAg +Ve in 6% and 1% +Ve for both, 4% had nonalcoholic 
steatohepatitis, 3% had compensated liver cirrhosis, 1% ascitis. Most of 
the CLD patients did not have symptoms. Older age, low education, living 
in pastoral areas and longer duration of HD appear to be risk factors for 
CLD in HD patients. Despite no evidence suggests that HD patients are 
more prone to suffer from hepatic toxic effects than people with normal 
kidney function, but HD patients usually receive multiple medications; 
that may have a role in the pathogenesis of drug induced liver disease in 
this population. Chronic hepatitis C and B among HD patients are mild in 
disease activity, and are not progressive, perhaps due to immunological 
abnormalities in HD patients. CLD were more prevalent in HD patients 
with vague etiology of ESRD so, more extensive investigations are required 
as HCV, or any CLD may be incriminated in the development of ESRD with 
vague etiology.
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OUTPATIENT TREATMENT OF SEVERE ACUTE MALNUTRITION 
AFTER THE PORT-AU-PRINCE EARTHQUAKE: A SINGLE-
CENTER REVIEW OF OUTCOMES FROM 2010 AND 2011
Nicholas H. Carter1, Elizabeth E. Dawson-Hahn1, Michael P. 
Koster1, Margarette Blaise-Jean2
1Brown University, Warren Alpert School of Medicine, Providence, RI, 
United States, 2Foundation St. Luc, Tabarre, Haiti
Malnutrition is a major contributor to preventable child mortality in Haiti. 
Pneumonia and diarrheal disease cause nearly half of all child mortality 
under age 5 in Haiti, and malnutrition is well-established as a primary 
risk factor for death from these infections. We conducted a single-center 
retrospective review of admission and discharge data for children ages 
6-60 months who presented to an outpatient treatment program for 
severe acute malnutrition between April 1, 2010 and December 31, 2011. 
Recorded data included age in months at entry; neighborhood; gender; 
grade of edema; mid-upper arm circumference (MUAC); admission 
weight, height and weight/height z-score; criteria for entry into the 
program; corresponding anthropometric data at the time of discharge and 
co-morbid conditions. The records of 1,695 patients were reviewed. Eight 
patients were excluded due to incomplete discharge data. There were 851 
(50%) male patients, 1441 (85%) were between the ages of 6 and 24 
months, 234 patients (14%) were referred to a malnutrition clinic closer 
to their residence and 132 (8%) were admitted for inpatient malnutrition 
treatment. Of those enrolled, 1083 (82%) children sucessfully completed 
the outpatient treatment program, while 45 (3%) did not respond to 
treatment, 31 (2%) abandoned the program, 18 (1%) were transferred to 
a cholera treatment center, and 131 (10%) were transferred to unspecified 
medical facilities. Patients identified 21 distinct geographic zones as 
their current location of residence, the most common being Cite Soleil, 
Petionville, Croix-des-Bouquets, Delmas, and Tabarre (all within 10km of 
the program). Among these localities, Croix-des-Bouquets had the highest 
rate of program completion (84%). Cite Soleil had a lower completion 
rate than the four other common zones combined (75% vs. 83%, 
p=0.015). In the two years after the earthquake, this outpatient treatment 
program achieved recovery rates similar to those previously reported 
from diverse settings. Root causes for neighborhood differences in rate 
of program completion are likely multifactorial and include geographic 
and socioeconomic obstacles to care. These results demonstrate that 
outpatient treatment for pediatric severe acute malnutrition can be 
successfully completed in a complex post-disaster setting.
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USING LONGITUDINAL STUDIES TO ESTABLISH 
NORMAL REFERENCE RANGES FOR HEMATOLOGIC AND 
IMMUNOLOGICAL PARAMETERS IN HEALTHY PREGNANT 
WOMAN AND YOUNG CHILDREN IN MALI
Joseph P. Shott1, Bakary S. Diarra2, Moussa B. Kanoute2, Charles 
Luswata3, Aissata Ongoiba2, Kassoum Kayentao2, Silvia Portugal4, 
Jacqueline Moebius4, Boubacar Traore2, Alassane Dicko2, Ruth D. 
Ellis5, Michal Fried5, Peter D. Crompton4, Patrick E. Duffy5
1Office of the Director, Division of Intramural Research, National Institute 
of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 
MD, United States, 2Mali International Center for Excellence in Research 
(ICER), University of Sciences, Techniques and Technologies (USTT), 
Bamako, Mali, 3Medical Science and Computing, Inc. (MSC), Rockville, 
MD, United States, 4Laboratory of Immunogenetics, Division of Intramural 
Research, National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, Bethesda, MD, United States, 5Laboratory of Malaria 
Immunology and Vaccinology, Division of Intramural Research, National 
Institute of Allergy and Infectious Diseases, National Institutes of Health, 
Bethesda, MD, United States
Accurate assessments of hematologic safety profiles and immunological 
responses to investigational products such as vaccines are often 
complicated by a lack of normal reference ranges (RR) in the target 
population, and a poor understanding of how age, gender, genetics, 
diet and underlying medical conditions influence these parameters. Two 
specific populations that lack normal RR in Mali are pregnant women 
and children under five years. We performed a RR study on peripheral 
whole blood collected from healthy participants enrolled in longitudinal 
studies, and compared these data to established RR from Uganda and 
the U.S. We analyzed leukocyte, erythrocyte, and platelet profiles for 
hematologic RR; and B-cell, T-cell and monocyte subsets for immunological 
RR. Hematologic profiles varied with pregnancy status, age, gender 
and geographic location, and the latter suggests a possible genetic 
effect. Immunological profiles also varied with these parameters, but 
to a lesser degree. Site-specific normal RR are necessary to accurately 
establish baseline hematologic and immunological parameters in a target 
population. In the future, these RR will facilitate the accurate inclusion 
or exclusion of potential study volunteers, will make the assessment of 
research-related adverse events more reliable, and will improve the clinical 
management of patients in Mali.
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INTEGRATING DENGUE AND DIARRHEA CONTROL IN 
RURAL SCHOOLS IN COLOMBIA: A CLUSTER RANDOMIZED 
CONTROLLED TRIAL
Hans J. Overgaard1, Maria Ines Mátiz2, Juan Felipe Jaramillo2, 
Victor Alberto Olano2, Sandra Lucia Vargas2, Diana Sarmiento2, 
Neal Alexander3, Audrey Lenhart4, Razak Seidu1, Thor Axel 
Stenström1
1Norwegian University of Life Sciences, Ås, Norway, 2Universidad El 
Bosque, Bogota, Colombia, 3London School of Hygiene and Tropical 
Medicine, London, United Kingdom, 4Liverpool School of Tropical 
Medicine, Liverpool, United Kingdom
Diarrheal diseases and dengue fever are major global health problems. 
Where provision of clean water is inadequate, water storage is crucial. 
Fecal contamination of stored water is a common source of diarrheal 
illness, but stored water also provides breeding sites for dengue vector 
mosquitoes. Poor household water management is therefore a potential 
determinant of both diseases. Little is known of the role of stored water 
for the combined risk of diarrhea and dengue, yet a joint role would be 
important for developing integrated control efforts. Even less is known of 
the effect of integrating control of these diseases in school settings. This 
trial investigates whether interventions against diarrhea and dengue can 
reduce diarrheal disease and dengue risk factors in rural primary schools 
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in Colombia. This is the first trial investigating the effect of integrating 
dengue and diarrhea control interventions and it is also the first trial to 
do this in school settings. A 2x2 factorial cluster randomized controlled 
trial is being carried out in rural primary schools in La Mesa and Anapoima 
municipalities, Cundinamarca, Colombia. Schools were randomized to 
one of four study arms: diarrhea interventions (DIA), dengue interventions 
(DEN), combined diarrhea and dengue interventions (DIADEN), and control 
(C). Schools were allocated publicly in each municipality at the start of the 
trial. The objective of the trial is to investigate whether these interventions 
will significantly reduce diarrhea incidence and dengue entomological risk 
factors. The primary outcome for diarrhea is incidence rate of diarrhea in 
school children and for dengue entomological risk, Aedes aegypti adult 
density per school. A total of 873 pupils from 34 schools are enrolled in 
the trial. Here we report results from baseline and the first follow-up data 
collections.
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A CAMBODIAN DERMATOLOGY NEEDS ASSESSMENT
Claire Fuller1, Sitech Mey2, Christoph Bendick3
1Chelsea and Westminster Hospital, London, United Kingdom, 2Preah 
Kossamak-Hospital, Phnom Penh, Cambodia, 3University of Health 
Sciences, Phnom Penh, Cambodia
There are no epidemiological studies published in the English literature 
describing the common skin diseases found in Cambodia. Dermatology 
services are at an early stage of development and, in order to provide 
information for policy makers and dermatology training course designers a 
simple needs assessment was undertaken in the environs of Phnom Penh. 
The aim of the study was to identify the common dermatoses and their 
impact on those presenting with them. Four different sites were selected; 
2 semi-rural and 2 urban. The necessary permission was obtained via 
Ministry of Health officials. Patients were invited to attend a clinic where 
they completed an administered questionnaire and were then examined 
by a team of dermatologists and their diseases recorded. Patients were 
then given appropriate free treatment. 625 patients were assessed with 
76 different diagnoses recorded however the 10 commonest disorders 
accounted for nearly 60% of the cases with acne, eczema and scabies 
being the top three. The majority of patients had disease classified as mild 
to moderate and for a median duration of 12 months. 53% of patients 
had previously spent an average of $10 on treating their skin disease 
unsuccessfully. The most likely group of patients to have previously paid to 
not get rid of their disease was those with scabies (65.3% of those with 
scabies). The study dermatologists estimated that 97.1% of patients could 
have been appropriately managed with treatments available in Cambodia. 
There are no previously published studies assessing the impact of skin 
disease on patient in Cambodia. Scabies, eczema and acne were the 
commonest dermatoses with scabies being the most costly to the patient. 
This supports the notion that educating communities and basic healthcare 
workers about simple management of common skin diseases with locally 
available treatment could significantly reduce the impact of dermatoses for 
the patient and community alike.
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ACCIDENTAL CAUSTIC SODA INGESTION IN GHANA - AN 
ALARMING AND INCREASING PROBLEM DEMANDING EARLY 
DETECTION AND INTERVENTION
Emma Weldon1, Pamela Martey2
1Newcastle upon Tyne University, Newcastle upon Tyne, United Kingdom, 
2KNUST, Kumasi, Ghana
The morbidity and mortality associated with accidental chemical ingestion 
are preventable. A sudden increase in the numbers of children admitted 
to Okomfo Anokye Teaching Hospital in 2010 following caustic soda 
ingestion led to a detailed case note review of all admissions with 
poisoning from January 2009 to June 2010. The purpose of the review 
was to identify possible causes for the increase and then develop an 
effective public health strategy to reverse the trend. There was a six fold 
increase in the number of children suffering from caustic soda poisoning 
from Jan-Jun 2010 (13) compared with Jan-June 2009 (2), whilst numbers 
of cases of poisoning for all causes (19 vs 34) poisoning had doubled. 
The majority of cases were under three years old and males accounted 
for 50 of the 72 cases. All children received palm oil to induce vomiting. 
Complications included oesophageal ulceration, aspiration pneumonia 
and death. A number of hypotheses for these increases are postulated 
including a new National Health Insurance Scheme (NHIS) leading to an 
increase in the number of cases who present to health care facilities; 
a possible increase in the use of caustic soda as a domestic cleaning 
agent and the introduction of water bottles which are reused to sell and 
store caustic soda. We favour the last of these hypotheses because the 
introduction of these drinking bottles has occurred simultaneously to the 
increase in presentations and we refute the other hypotheses offered. 
We propose that a public health awareness campaign via radio and text 
message be used to spread the message of the risk to children of the 
use of caustic soda and the danger of palm oil as first aid. This should be 
accompanied by a campaign to restrict and regulate sales of the corrosive 
chemical.
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INSUFFICIENT IODIZED SALT COVERAGE AT COMMUNITY 
LEVEL POSES A RISK FOR INDIVIDUAL-LEVEL IODINE 
DEFICIENCY: THE FOURTH THAI NATIONAL HEALTH 
EXAMINATION SURVEY 2009
Wit Wichaidit1, Virasakdi Chongsuvivatwong1, Rassamee 
Sangthong1, Wichai Aekplakorn2
1Prince of Songkla University, Hat Yai, Thailand, 2Mahidol University, 
Bangkok, Thailand
Thailand was re-classified by the World Bank as an upper-middle income 
country in 2010. However, iodine deficiency disorder (IDD) remains 
a significant public health problem due to lack of robust control on 
salt iodization. This study evaluated the coverage of salt iodization at 
household and community levels, and their association with iodine 
deficiency in Thai children. The fourth Thai National Health Examination 
Survey (NHES IV) was a nationally representative cross-sectional survey 
conducted in 2009 by three-stage stratified sampling. Children aged 
1-14 years were sampled for the study. Children’s primary caretaker was 
interviewed about food intake using a food frequency questionnaire and 
a 24-hour food recall. Urine iodine of children was tested to measure 
iodine level. Data were analyzed with descriptive statistics and multi-level 
logistic regression using R software and epicalc and lmer4 packages. A 
total of 9035 children were recruited. Nationally, the prevalence of iodine 
deficiency was 30.8%, with significant regional variations (p<0.0001). 
Multi-level logistic regression showed that individual-level iodine deficiency 
was significantly associated with insufficient iodine content in household 
salt (adjusted OR = 1.22; 95% CI = 1.05 - 1.41) and prevalence of 
insufficiently iodized salt at sub-district level (adjusted OR = 1.44; 95% CI 
= 1.09 - 1.91). The analysis was adjusted for for weekly consumption of 
seafood, age, gender, household income, and maternal education. Despite 
the high success in economic and social development, IDD is still a serious 
problem in Thailand. The higher strength of association between iodine 
deficiency and prevalence of insufficiently iodized salt at the community 
level implies a need for universal coverage of iodized salt, not just iodized 




A QUALITATIVE STUDY ON BARRIERS TO CONSISTENT 
USE OF FOOTWEAR IN WOLAITA ZONE, SOUTH ETHIOPIA: 
IMPLICATIONS FOR PREVENTION AND CONTROL OF 
PODOCONIOSIS
Desta A. Alembo1, Emi Watanabe2, Getnet Tadele3, Colleen 
McBride2, Gail Davey4
1IOCC Podoconiosis Research, Addis Ababa, Ethiopia, 2National Institutes 
of Health, Bethesda, MD, United States, 3Addis Ababa University, Addis 
Ababa, Ethiopia, 4Brighton & Sussex Medical School, Brighton, United 
Kingdom
Effectiveness of prevention and control of podoconiosis depends on a 
community’s consistent use of footwear. However, little is known about 
factors impeding the use of footwear among communities at high risk of 
podoconiosis through exposure to red clay soil. This study explored the 
shoe wearing practices of communities in Wolaita, Southern Ethiopia, and 
identified major barriers to use of footwear with the aim of informing 
evidence-based preventive strategies. The study was entirely qualitative 
involving 38 in-depth interviews, 28 focus group discussions and 7 
case studies in four selected communities in Wolaita Zone. In total, 307 
informants (52 children and 255 adults) participated in the study, using 
convenience sampling from affected and unaffected segments of the 
population. Data were coded and analyzed using the NviVO-9 software. 
Perceiving shoes to have either protective or social value facilitated use of 
footwear. Although shoe wearing was commonly intermittent, patients 
were more likely to wear shoes regularly than non-patients. Financial 
issues, low perceived risk of podoconiosis and lack of access to higher 
quality protective shoes were major reasons hampering consistent shoe 
use in the community. Further, lack of sufficient knowledge about the 
cause of the disease and misconceptions about shoe wearing resulted 
in irregular use of footwear. Interventions must emphasize changing 
mindsets about footwear and improving accessibility to protective shoes in 
the community. Implications of the findings on preventing podoconiosis in 
Wolaita district are discussed.
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TRAUMA TRAINING COURSES AVAILABLE AROUND THE 
WORLD: A SYSTEMATIC REVIEW
Fahim F. Pyarali1, Maureen McCunn2, Jeffrey Tillus2, Rebecca M. 
Speck2, Sheida Bunting2, Adam L. Kushner3, Tarek Razek4, Michel 
B. Aboutanos5
1University of Texas Medical Branch, Galveston, TX, United States, 
2University of Pennsylvania, Philadelphia, PA, United States, 3Columbia 
University, New York, NY, United States, 4McGill University Health Center, 
Montreal, QC, Canada, 5Virginia Commonwealth University Medical 
Center, Richmond, VA, United States
Injury deaths are increasing in low-, middle-, and some high- income 
countries. This burden of disease is greatest in economies that are least 
equipped to manage trauma care. The availability of trauma training 
courses to guide management of trauma care throughout the world 
is not known. We performed a systematic review of English language 
literature using the search terms “trauma” and “education”. In addition, 
professional colleagues were contacted, and a world-wide web Internet 
search was completed in an effort to identify all available trauma training 
courses. 44 courses were identified in total. 71% of all courses identified 
were developed in high-income countries (HIC); 67% of courses are 
taught in high-income countries. Of courses implemented in low-middle 
income countries, 60% of them were developed in HIC. Few courses 
(14%) are designed exclusively for physicians. Most courses (43%) include 
health care providers with variable levels of education and training. 
Trauma care training courses are given throughout the world, many for 
non-physician providers. It is unknown if additional courses are available 
yet unidentifiable via our search methodology of scientific publications, 
internet search, and personal communication. In view of the current 
global burden of injury, dissemination of training and education in the 
management of acutely injured patients is essential.
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ANALYSIS OF MEASLES SURVEILLANCE DATA FOR 
DECISIONS ON SUPPLEMENTARY IMMUNIZATION 
CAMPAIGN IN SOUTHERN ETHIOPIA
Adamu Addissie Nuramo, Desalegn Dalecha
Addis Ababa University, Addis Ababa, Ethiopia
In 2010, Ethiopian Ministry of Health implemented measles supplementary 
immunization activity (SIA) campaigns targeting children 9 months-5 
years. Despite the campaign, measles outbreaks continued to occur in the 
Southern regions of the country affecting several districts in the region. 
Regional epidemiologic and laboratory measles surveillance data from 
July 2010 to February 2011 i.e. before and after the SIA were reviewed 
to guide public health decisions to advise the implementation of the 
campaign. Atotal of 34,782 cases and 64 deaths were reported from 32 
of the 125 districts in the region with an incidence of 863 per 100,000 
populations and case fatality rate of 0.18%. About 87% (30,366/34,872) 
of the patients were children below 15 years of age. The incidence 
was 218 per 100,000 population among children < 5 years and 92 per 
100,000 populations among 5-14 years of age before the campaign. After 
the campaign, the incidence was 346 per 100,000 populations among 
children age <5years, and 193 per 100,000 populations among 5-14 
years of age. The incidence in adults was 12 and 38 cases per 100,000 
populations before and after the campaign respectively. The proportion 
of reported patients from targeted age group was 49% (5,732/11,808) 
before and 43% (9,110/22,974) after the campaign and proportion 
from non-targeted age group was 42% (5,017/11,808) before and 45% 
(10,507/22,974) after the campaign. In conclusion, the 2010 measles 
SIA decreased the proportion of reported patients from targeted age 
group after the campaign, but did not prevent further spreading of the 
outbreak. Changing target age group and schedule follow-up SIAs based 
on local epidemiology may help to control ongoing outbreaks using such 
campaigns. Accordingly it is recommended that the SIA started inclusive of 
age groups beyond
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THE ROLE OF ANGIOGENIC AND INFLAMMATORY FACTORS 
IN THE PATHOGENESIS OF PREECLAMPSIA
Dorotheah Obiri
University of Ghana, Accra, Ghana
Pre-eclampsia, a pregnancy complication characterized by hypertension 
and proteinuria is still a major cause of neonatal and maternal mortality, 
and acute and long-term morbidities for both mother and neonate. There 
is mounting evidence that an imbalance between angiogenic factors, such 
as VEGF (vascular endothelial growth factor) or PlGF (placental growth 
factor), and inflammatory factors such as interleukin 1 (IL-1) and Tumour 
Necrosis Factor (TNF) are closely related to the pathogenesis of pre-
eclampsia.This study was conducted to determine the role of angiogenic 
and inflammatory factors in the endothelial dysfunction of the placenta 
and onward pathogenesis of preeclampsia by measuring and comparing 
maternal serum levels Ang 1, Ang 2 and Tie receptor 2 with PlGF, sFlt-
1 to cytokines IL-1 and TNF. Venous blood would be collected from 
the Obstetrics and Gynaecology Department of the Korle-Bu Teaching 
Hospital. The study would involve healthy non-pregnant women, healthy 
pregnant women and pregnant women between the ages of 16 and 
45. The samples would then be centrifuged at room temperature for 
15 minutes at 1000 x g. Maternal serum would be analyzed by ELISA 
for levels of Angiopoietin 1 and 2, PlGF, IL-1 and TNF. It is expected that 
there would be a correlation between the angiogenic and inflammatory 
86
www.astmh.org
cytokines in the pathogenesis of preeclampsia which would add to existing 
knowledge of the syndrome and aid in early diagnosis, treatment and 
prevention.
289
USE OF TELEMEDICINE TO DIAGNOSE RINGWORM IN 
KENYAN SCHOOL CHILDREN
Sarah E. Smith1, John T. Ludwig1, Vernon M. Chinchilli1, Khanjan 
Mehta2, Jose A. Stoute1
1The Pennsylvania State University College of Medicine, Hershey, PA, 
United States, 2The Pennsylvania State University College of Engineering, 
University Park, PA, United States
Internet-based telemedicine has the potential to alleviate the problem of 
limited access to healthcare in developing countries. The Mashavu project 
aims to deploy kiosks that transmit health data and pictures to clinics 
for analysis by trained personnel. To test this principle, we investigated 
whether dermatophytic fungal infections (ringworm) could be diagnosed 
by Kenyan clinicians from pictures of lesions. Six physicians, five physician 
assistants, and five nurses from Nyeri Provincial Hospital took a test 
consisting of 15 pictures of KOH prep-confirmed ringworm lesions and 
15 pictures of KOH prep negative skin lesions affecting local children. 
The mean (SD) sensitivity and specificity of ringworm diagnosis for the 
whole group was 73% (19) and 83% (11) respectively. The physicians had 
the highest sensitivity and specificity, although only sensitivity reached 
statistical significance when compared to physician assistants. These results 
suggest that telemedicine can be used to diagnose simple skin conditions 
with reasonable sensitivity and specificity.
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HAS TANZANIA EMBRACED THE GREEN LEAF? IMPACT OF 
AFFORDABLE MEDICINES FACILITY - MALARIA (AMFM) ON 
ANTIMALARIAL PROVISION IN TANZANIA
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Admirabilis Kalolella2, Mark Taylor2, Katia Bruxvoort1, Sarah 
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Tanzania, 3ICF International, Washington, DC, United States
In Tanzania the first line antimalarial is artemisinin based combination 
therapy (ACT), but uptake remains low. The Affordable Medicines Facility 
- malaria (AMFm) was launched in 2010 in eight national-scale pilots, 
to increase access by subsidizing quality-assured ACTs (QAACTs), which 
have a green leaf logo. We conducted nationally representative surveys 
of public and private antimalarial outlets before AMFm implementation 
and one year after to assess impact on QAACT affordability, availability 
and market share. Here we present detailed results for mainland Tanzania, 
stratified by rural/urban area and outlet type. This work was commissioned 
by the Global Fund to Fight AIDS, Tuberculosis and Malaria as part of 
the AMFm Phase 1 Independent Evaluation. We randomly selected 49 
wards at baseline (2010) and follow up (2011), and visited all outlets with 
potential to stock antimalarials, collecting data on outlet characteristics 
and stocking patterns from outlets with antimalarials in stock. 3,151and 
3,785 outlets were enumerated at baseline and endline respectively, of 
which 631 and 788 stocked antimalarials and were interviewed. Analysis 
of results of availability, affordability, and market share. Availability: 78.6% 
of public health facilities (PHFs) stocked QAACTs compared to 10.7% of 
private for profit (PFP) outlets. Within PFP outlets, pharmacies were most 
likely to stock QAACTs (65.3%), compared to less than 10% of drug 
stores and general stores. Affordability: 78% of QAACTs in PHFs were 
provided free; the rest had a median price of $0.47 per adult equivalent 
treatment dose. QAACTs were most costly in PFP outlets (median $4.93), 
especially in urban areas ($7.04). Among PFP outlets, non-artemisinin 
drugs, such as SP and amodiaquine, were the cheapest antimalarials. 
Market share: QAACTs had a market share of 49.1% in urban areas, while 
non-artemisinin therapy dominated the rural market (78.2%). QAACT 
market share was very low in PFP outlets (1.0%), compared to 96% for 
non-artemisinin therapies. These findings will be compared with results at 
follow up to assess the impact of AMFm on these key indicators.
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HEALTH INFORMATION TECHNOLOGY APPROACHES FOR 
CONTINUOUS QUALITY IMPROVEMENT OF ANTIRETROVIRAL 
PROGRAMS IN DEVELOPING COUNTRIES
Kristin Johnson1, Malia Duffy1, John Carper1, Thomas Minior2, 
Robert Ferris2, Bisola Ojikutu1
1John Snow, Inc., Boston, MA, United States, 2United States Agency for 
International Development, Washington, DC, United States
Health information technology (HIT) has potential to support continuous 
quality improvement (CQI) of antiretroviral ARV) programs. The fields of 
CQI and HIT, however, have yet to become fully integrated. To narrow this 
gap an assessment of various types of HIT used in CQI was conducted. A 
comprehensive systematic literature review of PubMed, Google Scholar, 
ACM Digital Library and IEEE Explore was performed to develop a 
compendium of HIT approaches for CQI. Resources were included if they 
addressed the feasibility, implementation, or evaluation of innovative HIT 
that directly supported CQI of ARV programs or patient outcomes in low 
and middle income countries. The literature review identified 379 articles 
addressing HIT and HIV programs or outcomes since 2002; 15% (57) used 
HIT for CQI. At the programmatic level (n=21), geographic information 
services, health information management systems and electronic 
medical records are methods to longitudinally track program and facility 
characteristics to assess overall performance, determine best practices and 
facilitate planning. At the clinic level (n=15); electronic medical records 
and cellular phones provide tools to aide clinical decision-making and 
more efficiently manage patient information leading to improve patient 
outcomes. At the patient level (n=21); cellular phones can be used to 
remind patients about adherence as well as clinic follow-up and electronic 
adherence monitors can provide a mechanism to remotely monitor and 
promote ARV adherence. Special consideration must be given to the 
local context, including the technical expertise and physical infrastructure 
required to implement, sustain and potentially modify the technology. HIT 
can facilitate CQI to better inform program planning and support clinical 
care. When implemented with due planning, these technologies can be 
powerful tools to longitudinally track the quality of HIV care and facilitate 
solutions for improvement.
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HEALTH WORKERS IMMUNIZATION STATUS AGAINST 
HEPATITIS B VIRUS IN BURKINA FASO
Gautier H. Ouedraogo1, Seni Kouanda1, Herman Lanou1, Leatitia 
Ouedraogo/Nikiema1, Eli Tiendrebeogo1, Yves Traore2, Blaise 
Sondo3
1Institut de Recherche en Sciences de la Santé (IRSS/CNRST), 
Ouagadougou, Burkina Faso, 2Université de Ouagadougou, 
Ouagadougou, Burkina Faso, 3Public Health Department, Université de 
Ouagadougou, Ouagadougou, Burkina Faso
The health workers are among the groups most at risk for infection with 
hepatitis B. Our study assessed the immunization status against hepatitis 
B infection among healthcare workers of two health districts of Burkina 
Faso. We conducted a cross-sectional survey using a self administered 
questionnaire followed by blood sampling of health workers during 
August and September 2010. The blood samples were analyzed in the 
IRSS laboratory to search for anti-HBs antibody. On a total of 462 health 
workers interviewed, only 59.5% had a immunization card, 47.7% 
reported receiving at least one dose of HBV vaccine, and only 15.1% had 
been properly vaccinated (three doses of vaccine according the vaccination 
schedule). Our results show a variation of the vaccination status according 
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to sex, age, occupational category and seniority in the profession. The 
search for anti-HBs antibody (biological markers of immunity against 
HBV) has shown that vaccinees were significantly better protected (p = 
0.01) against HBV infection than those who reported never having been 
vaccinated (76.7% against 58%). In conclusion, results demonstrate the 
shortcomings of the infection prevention of occupational health in Burkina 
Faso. It would be desirable to define strategies that can help strengthening 
the prevention through routine vaccination of all workers in the health 
profession.
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VIRTUAL EXPERT PANELS: BRIDGING COMMUNITIES TO 
PROMOTE EXCHANGE IN GLOBAL HEALTH DELIVERY
Rebecca Weintraub1, Sarah Arnquist1, Sophie Beauvais1, Marie 
Connelly1, Yue Guan1, Aaron VanDerlip1, Keri Wachter2, Aaron 
Beals1
1The Global Health Delivery Project; Brigham and Women’s Hospital, 
Division of Global Health Equity, Boston, MA, United States, 2The Global 
Health Delivery Project; Harvard Medical School, Department of Global 
Health and Social Medicine, Boston, MA, United States
GHDonline.org Expert Panels were designed to foster knowledge 
exchange among multiple disciplines in an asynchronous online 
conference. Panels capture practical knowledge and bridge disciplines and 
professional groups to generate new strategies in delivering health care. 
Traditionally venues for professional public health exchange have included 
academic conferences, published literature, and other colloquia. Until 
recently, few alternatives existed. For global health professionals, the need 
for a web-based, no-fee forum is paramount. In 2008, the Global Health 
Delivery Project at Harvard launched GHDonline.org, a virtual platform 
that now hosts nine public and 51 private communities for over 6,500 
health professionals. Members share resources, recommendations, and 
experiences on diverse topics from how to scale male circumcision for 
HIV prevention to ventilation design in TB clinics. Each month, GHDonline 
hosts “Expert Panels,” virtual, asynchronous conferences led by experts 
that users may read and respond to during a two-week window. Given 
the electronic nature of the conference, GHDonline can track page views, 
downloads, member contributions, and other statistics. A recent panel, 
“Strengthening Health Systems - The Role of NGOs,” was moderated by 
leaders including Dr. Agnes Binagwaho, Rwanda’s Minister of Health. Over 
695 participants from 87 countries representing 472 organizations joined 
the panel, exchanging 124 commentaries and 23 resources. The data and 
content from this panel, and all panels, are published in Discussion Briefs, 
available to all GHDonline users. Expert Panels are an innovative alternative 
for generating robust discussion, connecting diverse practitioners, and 
uncovering knowledge from the field. The GHDonline Expert Panel 
model is transforming the availability and depth of exchange among 
health professionals, especially those working in remote, resource-limited 
settings. Insights, perspectives, and experiences shared among experts, at 
no cost, contribute significantly to the emerging knowledge base in the 
field of global health delivery.
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KEUR SOCE HEALTH AND DEMOGRAPHIC SURVEILLANCE 
SITE SYSTEM IN SENEGAL: SITE DESCRIPTION, BASELINE 
FINDINGS AND POLICY IMPLICATION
Mahamadou M. Ndiath, Aly Guéye, Roger Tine, Jean Louis 
Ndiaye, Badara Cissé, Babacar Faye, Oumar Gaye
UCAD/Senegal, Dakar, Senegal
The objective of this study was to analyze baseline results from first phase 
Demographic and Health Surveillance in Keur Soce Subdistrict, Senegal. 
To compare results with national and international data and comment 
on their relevance to health development. Multi-round prospective 
community based study, Initial Census 2010. Keur Soce is located in 
rural areas in the region of Kaolack, in the district of Ndiédieng. The 
area lies between longitudes 16°00’14.8’’and 16°07’13’’W and latitudes 
13°51’53’’ and 14°00’00’’N. It is located at 230 km from Dakar in the 
Sudano-Sahelian region of Senegal and covers an area of 478 sq. km. 
The estimated population is 29645 inhabitants and composed mostly of 
Wolof (90%) and lives mainly on agriculture and livestock. This population 
is distributed in 73 villages with an average density of 62.7 inhabitants/
km ². Almost all of the area is not electrified, running water (from deep 
wells) is available in just over half the area, otherwise the water comes 
from traditional wells.The climate is characterized by the alternation of a 
long and dry season from November to June and a short rainy season from 
July to October.The area has a 2 health post and 09 functional health huts. 
Baseline description of each resident including age, sex, marital status, 
relationship with HH, education. A full demographic profile was given. The 
total population is 29,645 inhabitants. Forty two were under 15 years of 
age. The sex ratio is more pronounced for male than female regarding all 
age categories, except for the reproductive age group. Over 50% of the 
population are not married. Thus, the married monogamous represent 
20% of the population and married polygamous represent 18% of the 
population. A small proportion of the population
295
PRELIMINARY RESULTS OF A SYSTEMATIC REVIEW OF THE 
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INCOME COUNTRIES (LMICS)
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Health workers (HWs) play key roles in improving quality and coverage 
of health interventions. In LMICs, however, HW performance is often 
inadequate. Existing reviews of strategies to improve performance are 
outdated or have important methodological limitations. To characterize 
the effectiveness and costs of strategies to improve HW performance in 
LMICs, we conducted a systematic review of 15 electronic databases, 29 
document inventories of international organizations, and bibliographies 
of 510 articles. We focused on studies with methodologically “adequate” 
designs (eg, trials with comparison groups). After screening, data from 
relevant reports were double-abstracted and entered into a database. 
Effect sizes were estimated as absolute changes in performance outcomes. 
Outcomes included HW practices, patient outcomes, and economic 
measures. As studies often used different outcomes, we calculated a 
summary measure: the median effect size (MES) for all primary outcomes 
from a study. We screened >105,000 citations, and 841 reports met our 
inclusion criteria. Numerous performance improvement strategies have 
been studied, usually with multiple components. Most strategies had small 
MES (<10 percentage-points [%-points]), although some had large effects 
(>25 %-points). Among eight mutually exclusive strategy groups, MES 
for most (e.g., training +/- supervision +\- job aids, community activities) 
were similar (median MES: 7-11 %-points). Job aids alone seemed 
less effective (median MES = 2 %-points) and strategies that provided 
commodities seemed more effective (median MES = 17 %-points). 
Contextual and methodological heterogeneity made comparisons difficult. 
Preliminary results suggest that the effectiveness of strategies to improve 
performance varies substantially, with many strategies having small effect 
sizes. Standardization of methods would facilitate efforts to synthesize the 
evidence. Additional analyses will identify factors associated with increased 
effectiveness. Results from this review will inform recommendations on 




THE ECONOMIC IMPACT AND BURDEN OF DENGUE ILLNESS 
IN NICARAGUA
Zachary S. Wettstein1, Michael Fleming1, Aileen Y. Chang1, 
David J. Copenhaver1, Angela R. Wateska2, Sarah M. Bartsch2, 
Bruce Y. Lee2, Rajan P. Kulkarni1
1Dengue Relief Foundation, Managua, Nicaragua, 2Public Health 
Computational and Operations Research (PHICOR), University of 
Pittsburgh, Pittsburgh, PA, United States
Over the past two decades, the number of cases and burden of dengue 
has steadily risen in Nicaragua, though there have been comparatively 
few efforts to quantify the economic cost and burden [measured 
in disability-adjusted life years (DALYs)] of dengue to society. In this 
study, we utilize source data from the Nicaraguan Ministry of Health 
(MINSA) to estimate the cost and burden of dengue illness from 1996-
2010, including both epidemic and endemic seasons of illness. Costs 
incorporated both direct costs, which included medical expenditures, 
prevention campaigns, and vector control costs, and indirect costs, which 
stemmed from lost productivity secondary to illness. Expansion factors 
were utilized to account for the large portions of underreported and 
primarily asymptomatic cases. Monte-Carlo simulations and probabilistic 
sensitivity analyses were conducted on key parameters in the DALY and 
costs calculations using primary data from MINSA and other previously 
published literature values. From 1996-2010, the annual burden of disease 
ranged from 99-805 DALYs per million, with a mean of 347 DALYs per 
million, and a majority resulting from classic dengue fever (DF). The total 
cost of dengue illness ranged from US $5.1-27.6 million per year, with 
the cost per case ranging from US $125-273, resulting in a per capita cost 
of US $0.97-5.44 over this study period. This analysis will be important 
for re-assessment of scarce resources for dengue control in Nicaragua 
and Latin America, as well as for determining cost-effectiveness of novel 
vaccine candidates and other therapeutics. Such a comprehensive analytic 
approach can be easily applied to dengue and similar illnesses in the 
region to yield a more complete picture of the combined costs of disease 
to the nation.
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RESEARCH CAPACITY BUILDING IN INDIA: LESSONS 
LEARNED IN NETWORK COORDINATION, RESEARCH 
CAPACITY BUILDING AND RESEARCH WITH THE INDOX 
RESEARCH NETWORK
Alexander E. Finlayson, Shameq Sayeed, Mary Foulkes, Raghib 
Ali
INDOX, Oxford, United Kingdom
INDOX is an academic partnership between Oxford University and eleven 
of the top cancer centres in India. We work under three domains of 
activity; network collaboration, research capacity building, and research. 
Network coordination is administered by a number of permanent staff and 
through a system of internal governance, annual network meetings, and 
weekly teleconferences based around 7 cancer site specialty groups made 
up of specialists from across all the INDOX centres to focus on the specific 
cancers that are more common in India. Our research capacity building 
work targets the creation of a network of investigators with sufficient 
training to conduct multicenter trials. We facilitate research opportunities 
and award training fellowships to scientists and clinicians from India. 
Over 100 members of the Network have been awarded fellowships and 
have attended training courses in Oxford and India. The scheme has 
covered several areas of clinical research including: early phase trials, 
protocol design, randomised controlled trials, medical statistics, and good 
clinical practice. Our research focus is on identifying and answering those 
questions which address local priorities and in trialling solutions which 
can be applied locally. As such we are currently conducting a case-control 
study to investigate the risk factors for common cancers in the India. This 
study is being conducted across all centres and is the biggest study to date 
of risk factors associated with cancer in India. Two sections of this study, in 
breast and colorectal cancers, have already begun and are expected to be 
complete in two years. The researchers will recruit a 10,000 people newly 
diagnosed with these two cancers, and a further 10,000 people as healthy 
controls. As we endeavour to exploit priorities determined from analysis 
of the epidemiology we have coordinated the centres to participate in 
investigator initiated and sponsor initiated studies. At each site there is 
a dedicated INDOX Site Principal Investigator and Site Coordinator, who 
together form the core of the network. Through the process we have 
sought to mediate the spend of pharmaceutical companies on trials in 
India and ensure that trials are aligned with local needs; designed with 
local ethical knowledge; and executed in such a way that capacity is built 
in India. We report here on the lessons learnt and the barriers encountered 
in delivering our tripartite mission in the Indian context.
298
STRATEGIES TO MOBILIZE COMMUNITY INCENTIVES FOR 
THE COMMUNITY DRUG DISTRIBUTORS IN CAMEROON
Julie Akame1, George Mbenda Behalal2, Desiré Djombini2, Joseph 
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In Cameroon, onchocerciasis control uses community-directed treatment 
with ivermectin (CDTI) that uses community volunteers as drug distributors 
(CDDs) in the villages. The distribution takes 1-2 weeks per year. One of 
the challenges is to motivate and retain trained CDDs. In Littoral region, 
a new strategy was tested to stimulate a greater contribution from 
the communities to support the CDDs. A 6-step strategy was used: 1) 
identifying people in charge of organizing the community and clarifying 
their role and training on the process; 2) helping the community define 
clear objectives by estimating the cost to support the CDDs; 3) listing 
the potential sources of support; 4) meeting with identified potential 
donors (community members, associations, churches, leaders, local 
NGOs) to discuss the role of the community, giving the estimated budget, 
and asking for a voluntary contribution; 5) collecting the funds; and 
6) reporting to the Health District (HD) and communities the amount 
collected and their use as managed by the communities. In 2011, more 
than $4000 were collected in the Littoral region. A survey in 3 HDs with 
high, medium and low performance on collecting funds showed that the 
CDD work was recognized as important for the community (96% in 3 
HDs). All communities recognized CDD should receive incentives (93, 8%), 
and most community members would contribute (78%). The difference 
in the collection of funds was tied to: 1) the way CDDs are selected in 
communities; 2) communication about the objective of the strategy to 
mobilize community incentives for CDDs (not only to the decision makers); 
3) diversified sources of contributions; and 4) decisions made communally 
rather than by individual. Most CDDs said that they were motivated to 
serve their community (34/36), but many mentioned that incentives from 
the community in money or in-kind support would help (22/36). The 
lessons learnt and experience gained will be used to improve the strategy 




EVALUATION OF ANTIBODY RESPONSE AGAINST GLOSSINA 
SALIVA IN CATTLE: A SUPPLEMENTARY OR ALTERNATIVE 
APPROACH TO ASSESS EXPOSURE OF TSETSE BITES
Martin Bienvenu Somda1, Zakaria Bengaly1, Anne Poinsignon2, 
Sylvie Cornelie2, Françoise Mathieu-Daude2, Emilie Thérèse Dama1, 
Edith Demettre-Verceil3, Franck Remoue2, Antoine Sanon4, Bruno 
Bucheton5
1URBIO, CIRDES and LAMIVECT, Bobo-Dioulasso, Burkina Faso, 2UMR 224 
MIVEGEC, IRD, Montpellier, France, 3FPP, CNRS, Montpellier, France, 4LEFA, 
UO, Ouagadougou, Burkina Faso, 5UMR 177 INTERTRYP and LAMIVECT, 
IRD/CIRAD, Montpellier, France
Our study proposes a new strategy, alternative or complementary to 
the entomological methods based on trapping tsetse flies, to target 
zones at risk and evaluate tsetse flies control programs in animal african 
trypanosomosis. It aims to develop a sero-epidemiological tool to assess 
cattle exposure to tsetse bites. IgG responses against Glossina saliva was 
assessed by ELISA on bovine that were experimentally exposed to tsetse 
flies and other bloodsucking arthropods in order to detect the cross-
reactivities between Glossina spp saliva and these arthropods saliva. Only 
the saliva of Tabanidae spp has cross-reacted with Glossina spp saliva. In 
any case, antibody (Ab) response to Glossina spp saliva is transient and 
decreases within 4 weeks after the stop of experimental exposure. This 
character is a major advantage to design a biomarker of exposure based 
on the Ab response to tsetse saliva. Immunoproteomic screening followed 
by mass spectrometry and bioinformatics tools using has permitted to 
identify three peptides whose two of Tsal1 (Tsetse salivary gland protein1) 
and one of Tsal2 (Tsetse salivary gland protein2). These peptides will be 
produced and validated on bovine serum of CIRDES and PATTEC-Burkina 
(Pan African Tsetse and Trypanosomiasis Eradication Campaign) in order 
to develop an easy and reproducible test with higher specificity for the 
evaluation of Glossina exposure.
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LYMPHATIC FILARIASIS MID-TERM IMPACT ASSESSMENT 
FOLLOWING THREE EFFECTIVE ROUNDS OF MASS DRUG 
ADMINISTRATION IN SIERRA LEONE
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Lymphatic filariasis (LF) mapping in 2005 using Immunochromatographic 
Test cards indicated that all 14 health districts (HDs) of Sierra Leone were 
endemic (prevalence >1%) and needed treatment for LF: 2 had low 
(1%-4.99%), 1 moderate (5%-9.99%) and 11 high (≥10%) prevalence. 
Baseline microfilaraemia (mf) studies using the thick blood film method 
in 2007/8 indicated that prevalence was <1% in 2 districts (1 had 0%), 
low in 8 and moderate in 2 HDs. MDA with ivermectin and albendazole 
implemented by community-selected distributors was piloted in 6 HDs in 
2007, extended to 12 HDs in 2008 and another 2 HDs in 2010. 4,385,467 
(coverage 70.1%), 4,694,711 (coverage 73.2%) and 4,749,556 (coverage 
75.1%) people were targeted in 2008, 2009 and 2010 respectively in 12 
of the 14 HDs. Geographic coverage of villages/urban areas was 100% 
in all 12 HDs and program coverage was ≥65.0% in all except for 1 HD 
that had 59.5% in 2008. A study of mf prevalence was conducted in 
2011, 6 months after the last MDA, to determine impact of 3 MDAs 
on mf prevalence in the 12 HDs. The mf prevalence and density was 
determined using the thick blood film method. A total of 6,023 people 
≥5 years were examined, male 3,170 (52.6%) and female 2,853 (47.4%). 
Overall mf prevalence was 0.30% (95% CI: 0.19 - 0.47%); population mf 
density was 0.05 mf/ml (95% CI: 0.03-0.08 mf/ml) and positive-only mf 
density was 17.59 mf/ml (95% CI: 15.64-19.55 mf/ml). Compared with 
baseline data, an overall reduction of 87.5% in mf prevalence, 95.5% in 
population mf density and 65.0% in positive-only mf density (p<0.0001) 
was noted. Mf prevalence reduced to 0.0% (100.0% decrease) in 4 HDs 
and by 70.0-95.0% in 7 HDs. Only 1 of the 12 HDs still had mf prevalence 
>1.0% (1.58%) and this district had the highest baseline mf prevalence 
(6.9%). The results show that after 3 rounds of MDA mf prevalence 
has decreased to <1.0% in all but 1 of the 12 HDs. The LF elimination 
programme in Sierra Leone is progressing well and on course to eliminate 
LF by year 2020 in these 12 HDs.
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Five health districts in Sierra Leone were found highly (≥50%) and two 
moderately endemic for Schistosoma mansoni. The remaining 7 districts 
had no or low endemicity (<10%). MDA with praziquantel (PZQ), 
mplemented by health workers (HWs), started in 2009 in 6 districts 
targeting school-going children and treating 562,980 children (coverage 
89%). It was scaled up to include all school aged children (SAC) and at risk 
adults in 7 districts in 2010 treating 1,831,383 persons (coverage 77%) 
and in 2011 treating 1,781,037 persons (coverage 82%). To minimize 
side effects expected in heavily parasitized individuals a pre-PZQ meal was 
funded, implemented by head teachers and/or communities. A survey was 
performed in 26 sentinel sites in 2012, 9 months after the third round 
of MDA in the 7 districts. Fresh stool samples from 50 SAC per site were 
examined by Kato-Katz method for S.mansoni infections, recorded as 
eggs per gram of feces (epg). A total of 1,286 SAC were examined, male 
642 (49.9%) and female 644 (50.1%). Overall prevalence was 15.2% 
(95% CI: 13.3-17.3%) and arithmetic mean intensity of infection was 
129epg (95% CI: 105.56-152.97epg). Compared with the baseline data 
collected in 2008-9, it showed a significant overall reduction of 66.3% 
in prevalence and 51.7% in intensity of infection (p<0.0001). In seven 
districts, the prevalence ranged from 0.5% (95% CI: 0.0-2.8%) in Bo to 
36.0% (95% CI: 26.6-46.2) in Koinadugu. Overall 1.2% of SAC were 
heavily parasitized (≥400epg) and 3.3% were moderately parasitized 
(100-399epg), a significant reduction from 8.8% and 18.2% respectively. 
Twelve sentinel sites were highly endemic in 2008-9 and only 2 sites, 
Bumbuna in Tonkolili and Sinkunia, in Koinadugu were still highly endemic 
in 2012. The results suggest that there had been a significant reduction 
in S. mansoni endemicity level across Sierra Leone following 3 rounds 
of MDA. Effective MDA required planning and coordination at national, 
district and chiefdom levels, trained and motivated HWs, informed and 
cooperative communities and their leaders, and monitoring, funding and 
drug supplies to treat the common side effects experienced by heavily 
parasitized individuals. Continued targeted MDA is required to achieve 
the national objective of schistosomiasis control. Maintenance of long 





DEVELOPING, MONITORING AND EVALUATING CAPACITY 
DEVELOPMENT OF CENTRE FOR NEGLECTED TROPICAL 
DISEASES (CNTD) SUPPORTED LABORATORIES AND STAFF 
MEMBERS IN ENDEMIC COUNTRIES
Benjamin G. Koudou, Moses J. Bockarie
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Impact assessment, of interventions against neglected tropical diseases in 
resource poor settings, requires good technical support through diagnostic 
laboratories manned by highly skilled technical staff. Many countries in 
Africa and Asia, endemic for NTDs (Neglected Tropical Diseases), lack 
the technical capacity and laboratory facilities that will facilitate good 
practices in impact assessment. To alleviate this problem, Centre for 
Neglected Tropical Diseases (CNTD) in 2009 embarked on an initiative to 
strengthen five regional laboratories to support national NTD intervention 
programmes and to reinforce the capacity of NTD endemic countries staff 
by training 10 members of staff through PhD studies on epidemiology 
and integrated control of lymphatic filariasis (LF) in countries of very low 
capacity, in Africa and Southeast Asia. The main goal of this capacity 
building effort is to ensure national programmes were able to demonstrate 
value for money for the funding provided by DFID to eliminate LF as a 
public health problem. To assist with this mission, CNTD has requested 
support from LSTM’s Capacity Development Impact Research (CDIR) 
unit to design, monitor and evaluate capacity development of these five 
laboratories (Ghana, Kenya, Malawi, Sierra Leone and Sri Lanka) and the 
research activities of the recruited PhD students in line with the activities 
and outputs specified in the project logframe. Each laboratory and in-
country NTD staff will be at different stages of capacity development and 
they will progress at different rates so each must be monitored separately 
using both qualitative and quantitative indicators. Capacity development 
plans will incorporate activities at the levels of individuals, laboratories 
and national/international context and the plans and indicators will be 
developed and agreed with all key stakeholders. Although it is anticipated 
that there will be a need for ongoing inputs to capacity development of 
laboratories and training of NTD staff members in endemic at all levels, 
this project will cover the period 1st April 2012 - 31st March 2015.
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IMPROVING NEGLECTED TROPICAL DISEASE (NTD) CONTROL 
OUTCOMES THROUGH NORTH-SOUTH GLOBAL HEALTH 
PARTNERSHIPS
Deogratias Damas1, Upendo Mwingira2, Andreas Nshala1
1IMA World Health, Dar Es Salaam, United Republic of Tanzania, 2Ministry 
of Health and Social Welfare, Dar Es Salaam, United Republic of Tanzania
In Tanzania, over 45 million people are at risk of infection with 2 or more 
of the 5 Preventive Chemotherapy (PCT)-targeted Neglected Tropical 
Diseases (NTDs) which include Onchocerciasis, Lymphatic Filariasis, Soil 
Transmitted Helminthiasis, Trachoma and Schistosomiasis. Recognizing the 
need for increased cost-effectiveness in a resource limited environment, 
the Ministry of Health and Social Welfare has adopted an integrated 
approach to NTD control with support from various global organizations 
and NGOs. In 2009, the program targeted 36 out of 132 districts for 
integrated Mass Drug Administration (MDA) and in 2010-2011, with 
support from USAID through RTI/IMA, an additional 44 districts were 
targeted. In 2012, with increased commitment from multiple partners 
like USAID/RTI/IMA, DFID, SCI and CNTD, 23 additional districts will 
be targeted, taking the total coverage to 93 out of 132 districts. 
With support from USAID, WHO, APOC, RTI and IMA, the number of 
treatments distributed has increased from 15.4 million in 2009 to 25 
million in 2011. These valuable north-south partnerships provide support 
to local governments and communities to conduct MDA through training, 
advocacy and supportive supervision. In the 3 years that the integrated 
approach has been used, MDA trainings have been provided to 115,966 
community drug distributors, 23,985 teachers and 11,259 frontline health 
workers. USAID support has allowed for the allocation of 3 IMA staff with 
specialized skills to the national NTD secretariat, thereby contributing to 
capacity building at the national level. To address the shortage of human 
resources at the national secretariat, IMA staff work jointly with Ministry 
staff to provide guidance and supervision at all levels of MDA. The 
various north-south partnerships that have been successfully established 
are helping to ensure that the NTD program is on the road to national 
coverage in Tanzania. Establishing similar partnerships in countries where 
they do not yet exist can further contribute to the control and elimination 
of NTDs globally.
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Onchocerciasis, or river blindness, is a major cause of preventable 
blindness around the world. Caused by parasitic worms (Onchocerca 
volvulus) transmitted to humans through the bite of the blackfly, 
onchocerciasis typically affects poor, rural communities near fast-flowing 
streams and rivers. Mass administration campaigns of the microfilariacide 
drug ivermectin have significantly reduced the burden of the disease 
in many mesoendemic and hyperendemic regions to the extent that 
elimination has become a possibility. Assessment and monitoring of 
elimination requires rapid diagnostic tests that are sensitive and highly 
specific for exposure to O. volvulus. (Ov). We describe a new rapid 
diagnostic test (RDT) that detects IgG4 antibodies specific to a previously 
validated Ov antigen Ov16. To facilitate confirmatory reading of the 
results and thus quality control of epidemiological survey results, test 
results must be stable for a long period of time (>24 hours). We describe 
a novel approach to ensure test result stability on a lateral flow format. 
Performance data for this test based on panels of well-characterized Ov-
infected sera and control sera (including other non-Ov filarial infections) 
demonstrate that the Ov16-based RDT performs equal to or better than 
Ov-16-based ELISAs, can be used within whole blood, and has the design 
properties required (in terms of environmental temperature, humidity 
exposure profiles, and potential cost) by stakeholders in Ov-endemic 
regions of Africa and the Americas.
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PITFALLS AND OPPORTUNITIES IN CONTROLLING CO-
INFECTIONS
Laith Yakob1, Gail Williams1, Darren J. Gray1, Kate Halton2, Juan-
Antonio Solon3, Archie C. Clements1
1University of Queensland, Brisbane, Australia, 2Queensland University 
of Technology, Brisbane, Australia, 3University of Philippines, Manila, 
Philippines
There is increasing momentum in public health and the veterinary sciences 
towards a model of integration whereby multiple pathogens are targeted 
simultaneously. Little is known, however, about the epidemiology of co-
infections and strategy for their control is nascent. Using gastro-intestinal 
nematodes as an example, we construct an epidemiological model that 
is used to simulate the between-parasite species interactions reported 
in published field studies and animal models. Many previous studies of 
nematode co-infections have attempted to infer species interactions based 
upon infection prevalence data and we demonstrate how this can give 
rise to spurious results. Uncovering the true nature of between-species 
interactions is critical in informing control and this is exemplified by the 
phenomena we describe as ‘slaving’ and ‘release’. ‘Slaving’ refers to the 
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tethering of synergistic pathogens co-circulating in a host population. 
In the situation whereby no effective chemotherapy is available for a 
particular pathogen, its control can still be achieved by targeting its 
co-circulating synergist. ‘Release’ refers to the inadvertent increase in 
a pathogen’s prevalence resulting from the control of a co-circulating 
antagonist. The success of integrated control programs, therefore, not 
only rests in the efficacy and spectrum of the available chemotherapeutics, 
but also in the interactions of the extant pathogen community.
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CONTROL OF NEGLECTED TROPICAL DISEASES IN POST-
CONFLICT COUNTRIES IN AFRICA: CHALLENGES FOR 
LYMPHATIC FILARIASIS ELIMINATION IN LIBERIA
Marnijina Moore1, Dziedzom K. de Souza2, Karsor Kollie1, 
Fatorma Bolay3, Daniel A. Boakye2, Moses J. Bockarie4
1Neglected Tropical Diseases/Non Communicable Diseases Program, 
Ministry of Health and Social Welfare, Liberia, Monrovia, Liberia, 
2Parasitology Department, Noguchi Memorial Institute for Medical 
Research, University of Ghana, Accra, Ghana, 3Liberian Institute for 
Biomedical Research, Liberia, Monrovia, Liberia, 4Centre for Neglected 
Tropical Diseases/Liverpool School of Tropical Medicine, Liverpool, United 
Kingdom
More than half of the 32 Lymphatic filariasis (LF) endemic countries in 
Africa are yet to implement mass drug administration (MDA) for the 
elimination of the disease, 11 years after the Global Programme to 
Elimination LF (GPELF) was launched in 2000. Majority of the countries 
that have not started MDA are post-conflict countries like Liberia which 
has a fragile health system in a resource poor setting recovering from the 
ravages of war. LF is endemic in 13 out of the 15 counties in Liberia with 
prevalence of infection ranging from 1-46%. Recent efforts to initiate 
MDA for the elimination of LF in the country have revealed enormous 
challenges. Planning for LF elimination on the platform for the integrated 
control of neglected tropical diseases (NTD) required inter-sectoral 
collaborations that did not exist. There has been strong resistance to the 
incorporation of vertical programmes for other NTDs, like onchocerciasis 
and soil transmitted helminths (STH), into a single integrated national 
NTD control programme. Liberia also faces logistical challenges for MDA 
implementation. The 14 year war destroyed technical capacity and physical 
infrastructure on a massive scale. Nevertheless significant progress has 
been made to ensure a successful launch of MDA implementation for LF 
elimination in 2012 using the CDI strategy. A massive social mobilization 
campaign is planned for hard to reach communities to sensitize them 
about the benefits of MDA and encourage volunteers to serve as 
community drug distributors. In this presentation, the baseline data 
collection, launching and scaling up of MDA activities in Liberia will be 
described in detail.
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HOW EFFECTIVE IS SCHOOL-BASED DEWORMING FOR 
THE COMMUNITY WIDE CONTROL OF SOIL TRANSMITTED 
HELMINTHS?
Deirdre Hollingsworth1, James Truscott1, Rachel Pullan2, Simon 
Brooker2, Roy Anderson1
1Imperial College London, London, United Kingdom, 2London School of 
Hygiene and Tropical Medicine, London, United Kingdom
The recent London Declaration on neglected tropical diseases was based 
in part on a new roadmap from WHO to “sustain, expand and extend 
drug access programmes to ensure the necessary supply of drugs and 
other interventions to help control by 2020”. Drug donations from the 
pharmaceutical industry form the backbone to this aim, especially for 
helminth infections. The increased availability of funds to control soil 
transmitted helminths (STHs) raises the question of how best to use 
these resources, given that treatment must be administered repeatedly in 
endemic areas in the absence of improvements in water and sanitation. 
Deworming for STHs is often targeted at school children because they 
are at greatest risk of morbidity and because school-based deworming 
is remarkably cost-effective. However, the impact of school-based 
deworming on overall transmission in the wider community remains 
unclear. We examine the effect on transmission by estimating the 
proportion of parasites targeted by school-based deworming. We use 
methods derived from the description of the transmission dynamics of the 
worms, demography and school enrolment, and data from a small number 
of example settings where age-specific intensity of infection (either worms 
or eggs) has been measured for all ages. In these settings <30% of the 
population are 5-15 years old. Combining this demography with the age-
intensity profile we estimate that in one setting school children output as 
little as 10% of hookworm eggs whereas in another setting they harbour 
up to 50% of ascaris worms (the highest proportion of parasites for our 
examples). In addition, it is estimated that from 40-70% of these children 
are enrolled at school. Thus, whilst school-based programmes have 
many important benefits, the proportion of infective stages targeted by 
school-based deworming may be limited, particularly where hookworm 
predominates. We discuss the consequences for transmission for a range 
of scenarios, including when infective stages deposited by children are 
more likely to contribute to transmission than those from adults.
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THE BENEFITS OF USING MOBILE PHONES IN MONITORING 
HEALTH INTERVENTIONS: THE PERSPECTIVE FROM THE 
NEGLECTED TROPICAL DISEASES CONTROL IN TANZANIA
Mwelecele N. Malecela1, Upendo J. Mwingira1, Andreas M. 
Nshala2, Irene Mremi1, Bernard Kilembe2, Donnan Mbando3, E. 
Michael4
1National Institute for Medical Research, Dar Es Salaam, United Republic 
of Tanzania, 2Neglected Tropical Diseases Control Program, Dar Es Salaam, 
United Republic of Tanzania, 3Ministry of Health and Social Welfare, Dar Es 
Salaam, United Republic of Tanzania, 4Notre Dame University, Notre Dame, 
IN, United States
Tanzania’s health care system is overwhelmed with huge volumes of 
clients seeking care and served with a handful of qualified staff. This 
East African nation is ravaged by non-infections and infectious diseases 
including the Neglected tropical diseases like- lymphatic Filariasis, soil 
transmitted helminthiasis, Schistosomiasis Onchocerciasis and trachoma, 
most of which are nonexistent in the developed world. Inefficient service 
delivery mechanisms resulting from poor record keeping and reporting 
mechanisms further hamper proper planning and decision-making. 
The Tanzania Neglected Tropical Diseases (NTD) control program has 
successfully piloted Mass Drug Distribution (MDA) to over 9,000 at risk 
population using mobile phone technology synergized with web and 
desktop applications. Forty (40) community drug distributors (CDDs) 
were trained and equipped to use mobile phones to conduct house-to-
house census, and later distribute Ivermectin and Albendazole to eligible 
population. The exercise run parallel with the existing/routing paper based 
census, drug distribution and reporting mechanism. The CDDs were able 
to quickly acclimatize to QWERTY mobile phone keyboards, learned the 
mobile application and conducted the census while uploading the data 
in real time -via internet-- to the central server. With the data in time, the 
district, regional and national office could calculate drug need and allocate 
supplied accordingly. Mass drug administration was conducted with 
coverage report live updates in the central server and via the web. This 
allowed early intervention decision-making by relevant authorities. Mobile 
phones provide user-friendly, timely and efficient mechanisms to monitor 
and evaluate Neglected tropical diseases control activities-e.g. mass drug 
administration- at the village and sub-village level. In resource-limited 
setting, they provide a viable solution to data collection and reporting of 





PATENT EXTENSION: IMPROVING THE FDA’S NEGLECTED 
TROPICAL DISEASES REVIEW VOUCHER
Laureano Mestra
World Health Organization/TDR Clinical R&D Fellow Program, Woodcliff 
Lake, NJ, United States
A Neglected Tropical Disease (NTD) is a condition that, despite its 
frequency is not necessarily low, has been for different reasons, especially 
for affecting the poorest people of the world, submitted to the ostracism 
of low investment to find better therapeutic options. The burden of 
disease coming from the NTDs is really high and is very close to other 
very prevalent conditions in terms of disability-adjusted life years (DALYs). 
But, none less important is the burden of annual losses on productivity 
within the low-income countries affected by NTDs. NTDs are not only 
a health problem, they are also an economic and social problem that is 
delaying the economies of these countries and why not, the whole world. 
Therefore, it is important to find the best way to stimulate the funding 
in the NTDs research arena. Unfortunately, it seems to be that not only 
good intentions are enough in order to obtain the funds to shorten the 
pipeline to find new compounds for these diseases. In 2006 a group of 
academics proposed what today we know as the FDA’s NTDs Voucher. 
The idea is quite simple; if a pharmaceutical company succeeds getting 
the approval from FDA of a compound for one of the NTDs, this company 
will obtain a Priority Review Voucher (PRV). This means that the time it 
takes FDA, within the Fast Track Program (FTP), to review a new drug 
application is reduced. The goal for completing a Priority Review is six 
months. This is supposed to be a tool that can be very useful to put new 
compounds for NTDs into the market but the outcomes so far are not like 
they were expected at the beginning. An improved version of the voucher 
to stimulate the development of drugs for NTDs is proposed. The idea is 
based on granting a Patent Extension Voucher (PEV) for the companies 
that achieve in marketing an NTD compound, but taking into account 
the possibility of second use compounds for NTDs, a demonstrated 
effectiveness, impact on the targeted NTD and the current advantages of 
the FDA’s PRV. Finally, a way to calculate the value of the proposed PEV is 
explained.
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DYNAMICS OF HELMINTH INFECTIONS IN EASTERN 
INDONESIA DURING AND THREE YEARS FOLLOWING A 
MASS DRUG ADMINISTRATION CAMPAIGN TO ELIMINATE 
LYMPHATIC FILARIASIS
Peter U. Fischer1, Yenny Djuardi2, Mark Bradley3, Rahmah 
Noordin4, Paul Rueckert5, Taniawati Supali2
1Washington University School of Medicine, St. Louis, MO, United States, 
2Department of Parasitology, University of Indonesia, Jakarta, Indonesia, 
3Global Community Partnerships, GlaxoSmithKline, Brentfort, United 
Kingdom, 4Institute for Research in Molecular Medicine, Universiti Sains 
Malaysia, Penang, Malaysia, 5GIZ, Jakarta, Indonesia
The lymphatic filarial parasite Brugia timori occurs only in eastern 
Indonesia, where it causes high morbidity. We evaluated the effect of mass 
drug administration (MDA) with albendazole and diethycarbamazine in a 
sentinel, B. timori endemic, village on Alor Island in annual surveys over a 
period of 10 years. Prior to the first round of MDA, the microfilaria (MF) 
prevalence was 26%, and 80% of the residents had filaria-specific IgG4 
antibodies as determined by the Brugia Rapid test. In 2010, 34 months 
after the 6th and final round of MDA, the MF rate had dropped to 0.2%, 
and the antibody rate had decreased to 6.4%. The MDA campaign also 
had a beneficial effect on STH infections. Pre-MDA prevalence rates for 
Ascaris, hookworm and Trichuris were 34, 28, and 11%, respectively; 
these rates were the lowest after the 5th round of MDA with 27, 4, and 
2%. Unfortunately, STH rates increased after cessation of MDA and were 
close to the pre-MDA rates 34 months after the 6th round of MDA. 
However, intensities of STH infections were still lower than baseline 
levels, and no heavy infections were detected. This study showed that 
MDA with DEC/albendazole has had a major impact on B. timori MF and 
IgG4 antibody rates, and it provides a proof of principle that elimination 
should be feasible. Our results also documented the value of annual DEC/
albendazole as a mass de-worming intervention and emphasize the need 
for continued STH intervention after cessation of MDA for lymphatic 
filariasis.
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DISCOVERY OF ANTIGENS FOR DIAGNOSIS OF SOIL-
TRANSMITTED HELMINTH INFECTIONS
Jodi Beattie1, David Elsemore2, Laurie Flynn2, Jinmeng Geng2, 
Jeffrey Bethony3, David Diemert3, James McCarter1, Michael 
Crawford1
1Monsanto Company, Saint Louis, MO, United States, 2IDEXX Laboratories, 
Inc., Westbrook, ME, United States, 3George Washington University, 
Washington, DC, United States
The human soil-transmitted helminths whipworm (Trichuris trichiura), 
Ascarids (Ascaris lumbricoides), and hookworms (Necator and 
Ancylostoma) create a substantial burden for worldwide public health, 
with an estimated one-third of the world’s population infected with one or 
more of these nematode parasites. The current global strategy to control 
infections with intestinal nematodes involves mass drug administration 
of anthelmintic medicines without prior diagnosis. However, cure is 
often not complete, and the limited variety of available drugs has 
fueled concerns of parasite resistance. The most widely-used diagnostic 
method is the microscopic detection of parasite eggs, a labor-intensive 
technique with inadequate sensitivity and specificity. Therefore a rapid, 
sensitive, specific, and inexpensive method to detect parasitic worm 
infections without laboratory infrastructure or trained personnel would 
offer enormous advantages over current protocols. Using closely-related 
veterinary parasites, informatic and immunological research efforts have 
provided strong proof-of-concept that specific and sensitive detection of 
parasite antigens by ELISA and lateral flow assays is achievable. Controlled 
timecourse infections in canines show that pre-patent infections are 
detected and the antigens are quickly diminished following effective 
anthelmintic treatment. Building upon these data, studies are in progress 
to clone, express, and purify nematode targets from human parasites. 
Preliminary results demonstrate that antisera specific to A. lumbricoides 
antigens specifically recognize infected samples with a high level of 
sensitivity.
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IMPLEMENTING PROGRAMS FOR LYMPHATIC FILARIASIS IN 
ONCHOCERCIASIS ENDEMIC COMMUNITIES: CHALLENGES 
TO BASELINE MEASUREMENTS IN ETHIOPIA
Darin Evans1, Aseged Taye2, Tekola Tilahun2, Patricia Graves1, 
Moses Katabarawa1, Frank Richards1
1The Carter Center, Atlanta, GA, United States, 2The Carter Center, Addis 
Ababa, Ethiopia
Current (2011) WHO guidelines for launching a lymphatic filariasis 
(LF) program call first for mapping for the disease using the 
immunochromatographic card tests (ICT) in areas suspected to be endemic 
for W. bancrofti. In areas where ICT rates are >1%, sentinel sites are 
selected for monitoring impact of annual mass drug administration on 
prevalence of the disease. When microfilaremia in the sentinel sites are 
<1% (generally by year 5 of MDA), then a Treatment Assessment Survey 
(TAS) to determine if transmission has been interrupted and MDA can 
cease. In Ethiopia in 2007, mapping for LF using ICT found the disease 
to be co-endemic with onchocerciasis in three zones: Bench Maji, North 
Gondar, and Metekel. MDA with IVM has been ongoing in these Zones 
since 2004. In 2011, six sentinel sites (two each zone) were selected 
based on having populations of ≥500 and the highest ICT positivity 
(range 21%-65%) and baseline testing for Mf was conducted. The total 
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population in the six sites was 5,337 of which 2,748 were tested for Mf. 
Results found only 1 mf positive person in Bench Maji (0.11%), 3 in North 
Gondar (0.17%), and 2 in Metekel (0.12%), all of which are below the 
1% threshold expected to be found after 5 years of MDA. Ivermectin is a 
known microfilaricide and its historic use for onchocerciasis in these zones 
has likely caused the LF Mf to fall below the 1% threshold. Mf prevalence, 
however, is a poor indicator for adult W. bancrofti worms and therefore 
cannot reliably be used to determine whether the adult worm population 
is still viable. For this reason, and because of the relatively low cost of 
adding ALB to the existing IVM MDA for onchocerciasis, we have decided 
to continue with MDA for LF (by adding albendazole to ivermectin) 
according to the WHO recommended strategy.
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ATORVASTATIN AND ARTEMETHER COMBINATION THERAPY 
REDUCES INFLAMMATION AND IMPROVES RECOVERY OF 
MICE WITH LATE-STAGE EXPERIMENTAL CEREBRAL MALARIA
Nana O. Wilson, Wesley Solomon, Mingli Liu, Jonathan Stiles
Morehouse School of Medicine, Atlanta, GA, United States
Plasmodium falciparum infection can cause a diffuse encephalopathy 
known as cerebral malaria (CM), a major contributor to malaria associated 
mortality. Despite appropriate anti-malaria treatment using quinine or 
artemisinin derivatives, CM mortalities may be as high as 30% while 
25% of survivors experience neurological complications. Thus, adjunctive 
therapies are urgently needed to prevent or reduce such mortalities. A 
number of clinical trials involving potential adjunctive therapies for CM 
have not proven beneficial and some interventions have been deleterious 
stressing the need for better understanding of CM pathogenesis and 
development of effective therapies. Chemokines and cytokines have been 
implicated in the development of CM and CM associated mortalities. 
Interferon γ induced protein 10 (CXCL10) was recently found to be 
associated with fatal human CM in field studies in India and Ghana and 
linked to severity of other infectious diseases. Mice deficient in CXCL10 
gene were partially protected against experimental cerebral malaria (ECM) 
mortality when infected with P. berghei ANKA indicating the importance 
of CXCL10 in the development of CM. We tested the hypothesis that 
utilizing synthetic products that reduce or neutralize the excessive 
production of CXCL10 during CM pathogenesis will increase survival and 
reduce mortality. Atorvastatin is a widely used synthetic drug that lowers 
cholesterol levels in blood by blocking the enzyme HMG-CoA reductase 
and has been shown to specifically reduce plasma CXCL10 levels. We 
determined the effects of atorvastatin/artemether combination therapy 
on CM outcome in ECM. We assessed immune determinants of severity 
of CM, survival, and parasitemia in mice receiving the combination 
therapy from day 6 to 9 post-infection in infected mice and compared the 
results with controls. The results showed that treatment with atorvastatin 
significantly reduced systemic inflammation (lower IL-1α, IL-6, IL-17, 
CCL4, CCL11, and IL-2), reduced potent anti-angiogenic factor CXCL10 
and increased angiogenic factor VEGF production. Treatment of the late-
stages of ECM in mice with a combination of atorvastatin and artemether 
improved survival (100%) over treatment with artemether monotherapy 
(70%), p<0.05. Thus, adjunctively reducing CXCL10 and enhancing VEGF 
levels by atorvastatin during anti-malarial therapy may represent a novel 
approach to treating CM patients in the future. 
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In Uganda antimalarials are often prescribed when malaria is unlikely, a 
problem that is becoming critical following the adaptation of effective 
but expensive ACTs as the 1st line treatment for uncomplicated malaria. 
Less known is the extent of irrational use of anti-malarials among 
hospitalized patients. We present data on anti-malarial prescription 
practices among hospitalized children with microscopy results. As 
part of an inpatient malaria surveillance program data was collected 
from three public hospitals in Uganda: Tororo (high transmission), Jinja 
(medium transmission) and Kambuga (low transmission). At each site, a 
standardized case record form was used to collect individual patient level 
data, including medicines prescribed during hospitalization. Between Jan 
to Dec11, 15748 children were hospitalized in all three hospitals; Tororo 
(4949), Jinja (9202) and Kambuga (1597). Over 97% of patients had a 
thick blood smear performed. Proportion of hospitalized children with 
a positive blood smear was 60% in Tororo, 47% in Jinja and 34% in 
Kambuga. Of children with negative blood smear, 280 (14%) in Tororo, 
3003 (63%) in Jinja and 683 (66%) were prescribed an antimalarial. 
Quinine was the most commonly prescribed anti-malarial among children 
with positive (94%) and negative (84%) test results. Among children 
prescribed an anti-malarial, the unadjusted odds of death was higher 
among those with negativeresults as compare to those with positiveresults 
(OR1.65 95%CI 1.25-2.17, P <0.001). When underlying diagnosis, severity 
of illness, age and antibiotic use were adjusted for in logistic regression 
no significant difference in the odds of death was noted between the 
two groups. Much as there has been improvement in the proportion of 
children tested for malaria at the sites, prescription of anti-malarials to 
patients with negative malaria test results remains unacceptably high at 
two of the sites. With no clear benefit of this practice there is an urgent 
need to better understand reasons why clinicians continue to treat 
patients for malaria even when test results are negative.
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NAMIBIAN MEDICINAL PLANT EXTRACTS AND THEIR 
MECHANISM OF ACTION AGAINST PLASMODIUM 
FALCIPARUM IN AN IN VITRO MODEL
Charwan I. Du Preez, Davis R. Mumbengegwi, Ronnie A. Bock
University of Namibia, Windhoek, Namibia
New medicines for malaria are urgently needed, especially in developing 
countries where malaria is endemic. Malaria treatment depends strongly 
on traditional medicine as a source for inexpensive treatment of the 
disease in these countries. In Namibia, malaria is on the decline and the 
country is moving towards pre-elimination of the disease. However, some 
communities preferring traditional medicines and not accepting allopathic 
medicine may prevent elimination. Ethnomedicines need to be integrated 
into mainstream malaria case management to achieve malaria elimination 
by 2020. To do so, they need to be scientifically validated to allow for 
their safe and effective use. In this study, extracts from indigenous 
medicinal plants Vahlia capensis, Nicolasia costata, and Dicerocarym 
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eriocarpum, were previously shown to contain classes of antimalaria 
compounds through phytochemical screening. Growth inhibition studies 
using cellular infection models of Plasmodium falciparum 3D7 and D10 
were carried out to determine anti-plasmodial effects of the extracts. In 
addition, mechanistic studies were conducted to determine the mode 
of action of the three plants. Organic extracts of V. capensis, N. costata 
and D. eriocarpum showed antiplasmodial activity at concentrations 
ranging from 50-250 µg/mL. Extracts from D. eriocarpum showed the 
highest activity with an IC50 of 63.17µg/mL followed by V. capensis and 
N. costata at 93.29µg/mL and 86.63µg/mL, respectively. All the plant 
extracts inhibited haemazoin accumulation with D. eriocarpum exhibiting 
the highest inhibition. The extracts also inhibited protease activity at the 
early ring stage where infection of red blood cells was being established 
and at the trophozoite stage where metabolism of the parasites was 
increased. These results support the ethno-medicinal uses for these 
plants as complementary medicine for malaria and provide a basis for 
further studies to determine the potential of the plants as sources of new 
antimalarial medicines.
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MALARIA CHEMOPREVENTION IN A HIGH TRANSMISSION 
SETTING: A RANDOMIZED CONTROLLED TRIAL OF 
MONTHLY DIHYDROARTEMISININ-PIPERAQUINE VERSUS 
MONTHLY SULFADOXINE-PYRIMETHAMINE VERSUS 
DAILY TRIMETHOPRIM-SULFAMETHOXAZOLE VERSUS NO 
THERAPY FOR THE PREVENTION OF MALARIA
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The burden of malaria remains high for infants in some parts of Africa 
despite the use of insecticide treated bednets (ITNs). Chemoprevention 
offers a potential means of reducing the malaria burden in infants, 
however, optimal drug and dosing strategies are unclear in areas were 
transmission occurs throughout the year and antifolate resistance is high. 
A cohort of infants aged 4-5 months were enrolled using convenience 
sampling in Tororo, Uganda, a rural area with perennial high transmission 
intensity. Infants received an ITN at enrollment and were followed for 
all their health care needs 7 d/wk. At 6 months of age, infants were 
randomized using an open label study design to one of four treatment 
arms; no therapy, monthly sulfadoxine-pyrimethamine (SP), daily 
trimethoprim-sulfamethoxazole (TS), or monthly dihydroartemisinin-
piperaquine (DP). Study drugs were self-administered at home and 
continued until the infants reach 24 months of age. The primary end 
point was the incidence of malaria using passive surveillance between 
6-24 months of age or early study termination. Malaria incidence was 
compared using a negative binomial regression model with measures of 
association expressed as the protective efficacy (PE=1-incidence rate ratio). 
Preliminary results are presented here. Of 400 infants enrolled, 393 were 
randomized to therapy of which; 38 were withdrawn before 24 months 
of age, 277 are actively being followed and 78 have reached 24 months 
of age. The incidence of malaria is 5.69 episodes per person year (PPY) 
among those randomized to no therapy; 5.47 episodes PPY among those 
randomized to monthly SP (PE=7%, 95% CI -17-26%); 4.32 episodes PPY 
among those randomized to daily TS (PE=26%, 95% CI 7-42%); and 2.32 
episodes PPY among those randomized to monthly DP (PE=60%, 95% 
CI 48-68%). Preliminary results suggest that monthly SP is not effective 
at preventing malaria, daily TS is associated with only modest protective 
efficacy, and monthly DP is the most effective regimen. Final results will be 
available after Sept. 2012 when all infants reach 24 months of age.
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PRESCRIPTION PRACTICES AMONG PUBLIC AND PRIVATE 
HEALTH FACILITIES FOR UNCOMPLICATED MALARIA IN 
RURAL GHANA
Vida Ami Kukula
Dodowa Health Research Centre, Accra, Ghana
Malaria control continues to rely on the diagnosis and prompt treatment 
of both suspected and confirmed cases through the health care structures. 
The irrational use of drugs is a major problem for present day medical 
practice with consequences as the development of resistance to wide 
range of medicines, ineffective treatment, adverse effects and an 
economic burden on the patients and economies. No study has been 
published in Ghana on the prescription practices of both private and 
public health providers. This study compared the prescription practices 
of private and public health care providers in Dangme West District 
of Ghana from February to July 2011. The study was conducted in a 
demographic surveillance site located in the Greater Accra region of 
Ghana, with perenial malaria transmission. It is prospective study of 
patients presenting at eleven public and five private health facilities 
diagnosed and treated with an antimalarial. 4247 patients prescribed an 
antimalarial were recruited, of these, 2606 (61.4%) and 1641 (38.6%) 
represented public and private provider attendants respectively. 31.5% 
of the patients from public providers were blood slide or rapid diagnostic 
test diagnosed and 68.5% clinically diagnosed compared to 33.5% and 
66.5% for private provider attendants. The mean number of drugs per 
prescription was 4.2 for public and 4.0 for private providers. Public care 
providers were more likely to prescribe more drugs than private providers 
with a minimum prescription of 1 for both providers and a maximum of 
10 and 7 respectively. Both providers prescribed an analgesic, antibiotic 
and a multivitamin as top three drugs in addition to an antimalarial. In 
conclusion, although malaria treatments were varied, there were not great 
differences between the public and private providers. Monotherapy with 
artemisinin derivatives were relatively common. A mishmash of regulatory 
and non-regulatory interventions, aimed at providers and consumers must 
be implemented to improve diagnosis and prescription practices of health 
care providers. 
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CLINICAL EFFICACY AND SAFETY OF ARTESUNATE-
AMODIAQUINE AND ARTEMETHER LUMEFANTRINE 
FOR THE TREATMENT OF UNCOMPLICATED MALARIA 
AND PREVALENCE OF DRUG RESISTANCE MARKERS IN 
NGAOUNDERE, NORTH CAMEROON
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Cameroon, 2Laboratory for Public Health Research Biotechnologies, 
University of Yaounde 1, Yaounde, Cameroon, 3Faculty of Health 
Sciences, University of Buea, Buea, Cameroon, 4Laboratory for Public 
Health Research Biotechnologies, The Biotechnology Centre, University of 
Yaounde 1, Yaounde, Cameroon
Cameroon switched policy for treatment of uncomplicated malaria 
to antimalarial to artesunate-amodiaquine (AS-AQ) and fixed dose 
artemether-lumefantrine (AL) respectively in 2004 against a backdrop 
of amodiaquine treatment failure. After four years of implementation 
of this drug policy, country-specific evidence-based data to support the 
continuous efficacy and safety profile of ACTs are still needed. This study 
was carried out in collaboration with the national malaria control program 
to generate data to support the continuous use of ACTs for malaria case 
management. A randomised open label trial was conducted between 
September and December 2007 at the Ngaoundere Protestant Hospital, 
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Ngaoundere, Cameroon. One hundred and fifty patients between six 
months to 14 years of age with uncomplicated malaria were randomized 
to receive standard doses either AS-AQ (73) or AL (77) and followed up 
for 28 days according to WHO 2003 protocol. Drug safety was evaluated 
using standard clinical and laboratory parameters and safety concerns 
classified according to the common toxicity criteria. Response was 
classified according to WHO and isolates were genotyped for the msp-2 
gene to determine recrudescent parasites. Pre-treatment blood samples 
were used to determine the prevalence of resistant mutations in the pfcrt, 
pfmdr1, dhfr and dhps genes by sequencing. Ethical and administrative 
clearances were obtained from the National Ethics Committee and the 
Ministry of Public Health in Cameroon respectively. PCR-corrected cure 
rates were 100% for AL, and 96.4% for AS-AQ. The combinations 
were well tolerated clinically and biologically. By Day 14, the mean total 
bilirubin, creatinine and ALAT values were slightly increased in subjects 
treated with AS-AQ. Changes in white cell counts and platelet count 
were significantly different (p< 0.05) in the two drug groups, but were 
of no clinical significance. All side-effects were transient and therefore 
disappeared by the end of treatment. Both AS-AQ and AL are highly 
effective and well-tolerated for the treatment of uncomplicated falciparum 
malaria in Ngaoundere, Cameroon supporting their continuous use. High 
prevalence of mutant pfcrt and pfmdr1 alleles confirm long standing 
North to South increase in high level CQ resistance and might compromise 
AQ use in combination therapy. Long-term monitoring of safety and 
efficacy and molecular markers is however, highly solicited.
319
PATTERN OF HEALTH SEEKING BEHAVIOR FOR PREVENTION 
AND TREATMENT OF MALARIA IN BANDA SLUM, KAMPALA, 
UGANDA
Steven Baveewo1, Maina Gakenia Wamuyu2, John Ssempebwa2, 
Moses R. Kamya1
1Makerere University School of Medicine, Kampala, Uganda, 2Makerere 
University School of Public Health, Kampala, Uganda
Children in slum communities are vulnerable to malaria compared to 
ones in rural areas. With fever slum residents seek health care in private 
facilities, health institutions or do not seek care. There was no such data 
about slums in Uganda. This study assessed the health seeking behavior 
for respondents with children aged 6-36months in Banda slum Kampala.  
In February 2009, by cross sectional study interviewed 449 respondents 
who ≥ one child aged 6-36 months in Banda parish. We asked about 
where they seek health services, accessibility, reasons for choice, 
satisfaction, malaria treatment given in case of fever, and where the child 
aged 6-36 months was treated when s/he had fever 2 weeks prior to the 
interview. Ethical approval was provided by the Makerere University School 
of Public health and Uganda National Council of science and technology. 
Findings are presented as frequencies and percentages. Population 
characteristics: Of the 449, 416(92.7%) household respondents had only 
one child aged 6-36 months. Education of the 316 respondents, was 
190(60.13%)≤ P.7, 105(33.23%) S1-S4 and 21(6.65%) >S.4. Utility of 
Health Services:Of the 449, 315(70.5%) sought treatment from a private 
clinic or a drug shop, 122(27.17%) from a health centre or hospital. 
Determinants for the choice of health facilities: Of the 396, 233(58.84%) 
near home, 79(19.95%) had skilled staff, 19(4.8%) drugs available and 
65 (16.41%) treatment affordable. Level of satisfaction with the health 
services: Of the 432, 337(78%) were satisfied, 95(22%) were dissatisfied. 
Reason being dissatisfied in 86 was inadequate medicines 36(41.9%), 
expensive 36(41.8%), unavailability of staff 9(10.5%) and long queues 
5(5.8%). Mosquito net use:Of 449, 304(67.71%) had mosquito net, 
282/(62.9%) children slept under a mosquito net a night prior to the 
interview. Treatment for malaria of 229 was with chloroquine 53(23%), 
quinine 65(28.4%), Coartem 20(8.73%), and 6 (2.62%) herbal medicine. 
Conclusions: Provide training, ACT drugs and diagnostic tests through 
a public-private partnership in return for subsidized patient charges. 
Investigate for typhoid as a differential.
320
SAFETY OF ARTEMISININS DURING EARLY PREGNANCY, 
ASSESSED IN 62 SUDANESE WOMEN
Elhassan Mohamed Ishag1, Ishag Adam Ahmed2, Gamal Khalid 
Ahmed3
1University of Gezira, Wad Medani Maternity Teaching Hospital, Sudan, 
2University of Khartoum, Khartoum, Sudan, 3University of Gadarif, Gadarif, 
Sudan
Between June 2006 and October 2008, the safety of artemisinins during 
early human pregnancy was assessed in central-eastern Sudan. Pregnant 
women in the first or second trimester who were attending antenatal-
care clinics at the Wad Medani, Gadarif and New Halfa hospitals were 
interviewed. Each was asked if they had had malaria in the first trimester 
of the index pregnancy and, if so, what treatment they had received. 
The women who had received artemisinins were then followed-up until 
delivery and their babies were followed-up until they were 1-year-olds. 
Overall, 62 of the pregnant women reported receiving artemisinins - 
artemether injections (48), artesunate plus sulfadoxine-pyrimethamine 
(11) or artemether plus lumefantrine (three) - during the first trimester. 
Medical records were available for 51 (82%) of these 62 women, and, 
in each case, these records showed the reported treatment and that 
malaria had been confirmed. Only nine (15%) of the 62 women given 
artemisinins had not known that they were pregnant when treated. 
Two of the treated women (both given artemether injections in the first 
trimester) had miscarriages, one at 20 weeks of gestation and the other 
at 22 weeks, each while receiving quinine infusions for a second attack 
of malaria. The other 60 women who had received artemisinins delivered 
apparently healthy babies at full term. No congenital malformations were 
detected, there was no preterm labor, no maternal deaths were recorded 
during the follow-up, and none of the babies died during their first year of 
life. It therefore appears that artemisinins may be safe to use during early 
pregnancy, although further study is clearly needed.
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A MARKOV MODEL TO EVALUATE THE COST-EFFECTIVENESS 
OF DIHYDROARTEMISININ-PIPERAQUINE VS. ARTEMETHER-
LUMEFANTRINE FOR FIRST-LINE TREATMENT OF 
UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN 
AFRICAN CHILDREN
Johannes Pfeil1, Steffen Borrmann2, Yesim Tozan3
1Childrens Hospital, University of Heidelberg, Heidelberg, Germany, 
2Department of Infectious Diseases, Heidelberg University School of 
Medicine, Heidelberg, Germany, 3Department of International Health, 
Boston University School of Public Health, Boston, MA, United States
Recent randomized multi-center trials showed that dihydroartemisinin-
piperaquine (DHAPQ) is as efficacious as artemether-lumefantrine (AL) in 
treating uncomplicated malaria in African children in different endemicity 
settings, with comparable safety profiles. The study results also indicate 
that DHAPQ has a longer post-treatment prophylaxis effect than AL, 
thus reducing the risk of re-infection following treatment and averting 
morbidity and mortality. The objective of our economic evaluation is to 
compare the health outcomes and costs of treatment with DHAPQ or AL 
as first line therapy in children below six years of age with uncomplicated 
malaria, in view of the differing post-treatment prophylactic effect profiles 
of these two drugs. We developed a Markov model to simulate the 
effectiveness of the two treatment strategies in a hypothetical cohort of 
1,000 children over a one-year period. Monte Carlo simulation is used 
to account for uncertainty in model parameters. The preliminary results 
of our model show that the estimated number of cases of acute malaria 
illness are 1545.9 (95%CI: 1543.3--1548.5) and 1716.4 (95%CI: 1713.4-
-1719.4) per 1,000 children over one year when treated with DHAPQ 
or AL as first line therapy, respectively. The estimated number of severe 
malaria infections per 1,000 children are 25.3 (95%CI: 24.8--25.9) with 
DHAPQ and 28.1 (95%CI 27.5--28.7) with AL treatment in a scenario 
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where 90% of children with recurrent infections have access to early 
treatment for uncomplicated malaria. The number of deaths are estimated 
to decline from 17.6 (95%CI: 17.2--18.1) to 16.0 (95%CI: 15.6--16.4) 
per 1,000 children over a one-year period when AL is substituted with 
DHAPQ as first-line therapy. We conclude that even though the post-
treatment prophylactic advantage of DHAPQ seems to be relatively small, 
changing the first-line therapy of uncomplicated falciparum malaria from 
AL to DHAPQ has the potential to significantly reduce malaria-associated 
morbidity and mortality and thus may provide substantial benefit to the 
population and appears to be cost-effective when the costs of the drugs 
are the same.
322
ASSESSING THE EFFECT OF THE RECOMMENDED 
ARTEMETHER-LUMEFANTRINE DOSING REGIMEN ON THE 
RISK OF TREATMENT FAILURE IN PATIENTS DIAGNOSED 
WITH UNCOMPLICATED FALCIPARUM MALARIA
Patrice Piola, on behalf of the WWARN AL Dose Impact Study 
Group
WorldWide Antimalarial Resistance Network, Oxford, United Kingdom
Artemether-Lumefantrine (AL), the first line antimalarial treatment in 49 
countries, is administered according to four weight bandings, patients 
at the margins of which deviate significantly from the optimal target 
dose. To assess the efficacy of administered lumefantrine through the 
total mg/kg spectrum, individual patient level data (N=8,927) from 43 
clinical efficacy studies of uncomplicated Plasmodium falciparum treated 
with 6 doses of AL conducted between 1996 and 2011 (7,399 from 
Africa; 1,588 from Asia) were collated using standardised procedures. 
Factors associated with PCR adjusted efficacy were evaluated using Cox 
regression model with shared frailty to account for study effects. 24 
studies ended follow-up at 28 days while 19 studies followed up for 42 
days or longer. 192 recrudescent and 1,101 new infections were reported. 
The median total dose of lumefantrine administered was 65.5mg/kg [IQR: 
55.4-77.8 mg/kg], with children under 1 year receiving the greatest dose 
(median=90.0mg/kg, IQR=80.0-102.9 mg/kg), compared to those aged 
1-5 (median=65.5mg/kg, IQR: 55.4-80.0 mg/kg), 5-12 (median=72mg/
kg, IQR: 65.5-84.7 mg/kg) and greater than 12 years (median=54.3 mg/
kg, IQR: 48.0-62.6 mg/kg). The median mg/kg dose of lumefantrine in 
patients failing the treatment was 65.5 mg/kg (IQR: 57.5-79.3 mg/kg) 
which was similar to those who were cured (median=65.5, IQR: 55.4-77.9 
mg/kg). In the multivariate model, the risk factors for recrudescent failures 
were: low weight category (AHR=2.1 [1.1-4.1], P=0.0330) and logged 
baseline parasitaemia (AHR= 1.1 [1.0-1.2], P=0.048). After controlling 
for confounding factors the dose of lumefantrine administered was not 
associated significantly with treatment failure. Current dosing strategies 
of AL are robust, but will need careful monitoring particularly as drug 
resistance to either partner drug emerges and spreads. The WWARN 
data repository provides an excellent format for this timely and global 
monitoring
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TREATMENT EFFICACY OF ARTESUNATE-AMODIAQUINE 
TREATMENT REGIMENS FOR UNCOMPLICATED FALCIPARUM 
MALARIA: COMPARISON OF FIXED VERSUS CO-BLISTER 
FORMULATIONS
Philippe J. Guerin, on behalf of the WWARN ASAQ Dose Impact 
Study Group
WorldWide Antimalarial Resistance Network, Oxford, United Kingdom
Artesunate-Amodiaquine (AS-AQ) is the first line antimalarial treatment in 
25 countries and until 2007 was available in a co-blistered, non fixed dose 
formulation. A fixed dose combination (FDC) of AS-AQ was introduced 
in 2007 to optimize the AS: AQ ratio and improve adherence. Current 
dosing recommendations for the FDC are according to three age ranges 
with 3 dosing strengths available. To assess the spectrum of total mg/kg 
dose of AQ administered and compare the effect on treatment efficacy 
of fixed and non fixed AS-AQ combinations, individual patient level data 
from clinical efficacy studies of uncomplicated P. falciparum were collated 
using standard algorithms. Factors associated with PCR adjusted efficacy 
were evaluated using Cox regression model with shared frailty to account 
for study effects. Data were available on 5410 patients from 24 studies 
conducted between 2003 and 2011 (5313 from Africa; 97 from Asia). 
20 studies had 28 days follow up and 4 studies were followed up for 35 
days or longer. 142 recrudescent cases were reported, the median time 
to recrudescence was 21 days [IQR: 21-28]. In the multivariate model risk 
factors for recrudescence were lower age categories categories [age < 1 
year (AHR: 5.11, 95% CI: 1.30-20.06, P=0.0190), age 1-5 years (AHR: 
6.53, 95% CI: 1.76-24.14, P=0.0049)], logged baseline parasitaemia 
(AHR: 1.17 [1.02-1.34], P=0.0240) and total mg/kg drug dosage received 
(AHR: 0.96, 95% CI: 0.93-0.99, P=0.0160). Adjusting for confounding 
factors the most significant risk factor for recrudescence was the use 
of non fixed dose formulation (AHR: 3.07 [1.51-6.21], P=0.0021). 
Patients treated with the FDC received a greater mg/kg dosage of AQ 
(median=29.56, IQR: 26.39-40.00) compared to those receiving a non 
FDC (median=25.00, IQR: 23.33-34.01).The fixed dose formulation 
provides better efficacy results than co-blisters probably related to 
improved dosages. Prospective comparative studies of ASAQ formulations 
are warranted to confirm the benefits on efficacy and effectiveness of 
fixed dose formulations and a higher target dose of AQ.
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PROBABILISTIC RECORD LINKAGE FOR MONITORING THE 
SAFETY OF ARTEMISININ BASED COMBINATION THERAPY IN 
THE FIRST TRIMESTER OF PREGNANCY IN RURAL SENEGAL
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There are insufficient data on the safety in early pregnancy of the 
artemisinin-type antimalarials. Assessing the risk of teratogenicity requires 
large sample sizes. Limited pharmacovigilance infrastructure exists in 
malaria-endemic countries. Monitoring drug safety in the first trimester is 
especially challenging as it requires prospective follow-up to reduce recall 
and survival biases and accurate assessment of gestational age. Record 
linkage approaches for pregnancy pharmacovigilance using routinely 
generated health records could be an efficient approach, but it has not 
been evaluated in resource-poor settings. The aim of this pilot study was 
to assess the feasibility of record linkage using routinely collected health 
care data as pragmatic means of monitoring the safety of artemisinin-
based combination therapy (ACT) in early pregnancy in Senegal. Data 
(2004-2008) were extracted from paper-based registers from out-patient 
clinics, antenatal (ANC) and the delivery unit from a dispensary in rural 
Senegal and entered into databases. Probabilistic record linkage was used 
to identify pregnancies exposed to ACT in the first trimester of pregnancy. 
Two record linkage software packages (Link-Plus and FRIL) were compared 
and output data were reviewed independently by two investigators. 
Information on 685 pregnancies was extracted, 536 of which were 
eligible for record linkage; 95.3% of them resulted in live-births, 2.3% 
in stillbirths and 2.5% in miscarriages. Major congenital malformations 
were identified in 1.6% of births. Seventy-one and 75 matches between 
pregnancy outcome and the outpatient treatment registers were identified 
by both software packages. All the 7 pregnancies exposed to ACTs in 
the first trimester identified resulted in normal live-births. Probabilistic 
record linkage is a potential cost-effective method to assess the safety of 
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antimalarials in early pregnancy in resource-poor settings. It is suited to 
assess the risk of major birth defects and stillbirths in settings with good 
existing health records and well-defined target populations.
325
EMPOWERING VILLAGE HEALTH TEAMS, A VALUE ADDITION 
TO HEALTH SERVICES DELIVERY IN RESOURCE LIMITED 
SETTINGS; CASE STUDY OF KIBOGA AND KYANKWANZI 
DISTRICTS IN UGANDA
Elizabeth Margret Asiimwe1, Fredrick Kabikira1, Denis Kayiwa1, 
Sylla Thiam2
1AMREF Uganda, Kampala, Uganda, 2AMREF HQ, Nairobi, Kenya
The majority of the people in Uganda, especially children, can not easily 
access health care, because of distant health facilities and a critical 
shortage of health workers. This has resulted in high mortality rates 
especially due to malaria (23%), pneumonia (21%), and diarrhoea 
(17%). Emerging evidence supports the unique role of community health 
workers referred to in Uganda as Village Health Teams (VHTs) play in 
providing first level health care in their communities. This paper provides 
a case study on how VHTs have increase health care provision for children 
under 5years for malaria, diarrhoea and respiratory tract infections in 
central Uganda. In the districts of Kiboga and Kyankwanzi, records of 4 
government health facilities and VHTs attached to them were reviewed. 
Out Patient Department (OPD) attendance records and VHT data registers 
for children under 5 years between January to October for the years 2009 
and 2011 was done. Data on malaria, diarrhoea and respiratory tract 
infections was analysed under four variables of OPD attendance, access 
to treatment, timeliness of treatment, and patient referral. Two third (2/3) 
of children with the three diseases accessed treatment and were healed 
in the communities by VHTs. Sixty four percent (64%) of malaria, 78% 
of diarrhoea and 65% of acute respiratory infections have been seen 
by VHTs. Only 12% of the children were referred to health facilities for 
further management. Furthermore 44% of all the children treated by 
VHTs, received their treatment within 24 hours of onset of illness. VHTs 
reduce attendance in OPD. This implies that there is reduced workload for 
the already constrained human resource at facility level. Timely treatment 
of diseases at community level is likely to reduce children that may slide 
into complications.
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A PILOT STUDY ON ANTI-MALARIAL INTERVENTIONS FOR 
MALARIA IN PREGNANCY IN EDO STATE, NIGERIA
Ehijie F. Enato1, Petra F. Mens2, Augustine O. Okhamafe3, Henk 
D. Schallig2
1Department of Clinical Pharmacy and Pharmacy Practice, University 
of Benin, Benin, Nigeria, 2Parasitology Unit, KIT Biomedical Research, 
Amsterdam, The Netherlands, 3Department of Pharmacuetics & 
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Malaria in pregnancy (MiP) is a major public health problem in Nigeria, 
despite available interventions. This abstract describes the collaborative 
efforts between (inter)national organizations, local communities, and 
stakeholders in the fight against MiP in Nigeria. In 2009, a study was 
undertaken in some communities in Edo State, Nigeria, assessing 
knowledge, attitude and practice (KAP) of MiP among women of 
reproductive age (15 - 49 yrs), and primary healthcare providers. 
Thereafter, interventions, including peer education on KAP of MiP were 
provided for health workers, and the women, through workshops, 
rallies, and door-to-door campaign. In addition, women advocacy groups 
were inaugurated and supported to continue the dissemination of 
appropriate KAP of MiP to all stakeholders in the communities. Finally, 
post-intervention survey was conducted to assess the impact of the 
intervention among the women. Furthermore, some factors responsible 
for low utilization of anti-malarial intervention during pregnancy were 
noted, including non-availability of insecticide treated bed nets (ITNs) 
and anti-malarial medications. A total of 1955 women of reproductive 
age (mean age ±sd, 27.88 ± 9.98) was surveyed. In all, 109 primary 
care providers (medical officers, nurses, community health extension 
workers, etc), and 37 women peer educators were trained. The flag-off 
awareness campaign attracted a large audience, via in-person and local 
television station. The door-to-door campaign and rallies reached about 
3,000 persons within the study communities. Overall, peer education was 
effective in improving knowledge on malaria prevention among women 
of productive age, as knowledge increased significantly between pre- 
and post- intervention studies. Following the study, the National Malaria 
Control Program of Nigeria’s Federal Ministry of Health, in 2011, through 
a local NGO, CHRADiP, freely distributed over 1000 long lasting ITNs to 
pregnant women and young children across the various communities in 
the state. The educational intervention improved KAP of MiP among the 
stakeholders in the communities. In addition, the primary care workers, 
and the entire community were mobilized and empowered on appropraite 
KAP of malaria. The provided free ITNs were appreciated. A national scale-
up of a similar intervention is recommended.
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EFFICACY OF ARTESUNATE AND ARTESUNATE-
AZITHROMYCIN FOR THE TREATMENT OF UNCOMPLICATED 
PLASMODIUM FALCIPARUM MALARIA IN VIETNAM
Nguyen X. Thanh1, Trieu N. Trung2, Nguyen C. Phong1, Huynh H. 
Quang2, Bui Dai1, Dennis Shanks3, Marina Chavchich3, Michael D. 
Edstein3
1Military Institute of Hygiene and Epidemiology, Hanoi, Vietnam, 2Institute 
of Malariology, Parasitology and Entomology, Qui Nhon, Vietnam, 
3Australian Army Malaria Institute, Brisbane, Australia
Reports of reduced susceptibility of artesunate in the treatment of 
uncomplicated Plasmodium falciparum malaria in western Cambodia 
highlights the urgent need to contain and reduce the spread of artesunate 
resistant strains. As part of this effort it is important to monitor the spread 
artesunate resistance and to evaluate new artemisinin based combination 
therapies (ACT). The objective of the present study was to determine the 
efficacy of artesunate alone and artesunate-azithromycin for the treatment 
of uncomplicated P. falciparum malaria in south-central Vietnam. The latter 
ACT was assessed because of azithromycin’s favourable pharmacokinetic 
properties and safety record in young children and pregnant women. In 
an open-labelled study carried out in 2010, 36 patients (children aged 
6-14 years, n=10, adults aged 15-60 years, n=26) were allocated a 7-day 
course of artesunate (~4 mg/kg on D0, 2 mg/kg daily for D1 to D6) with a 
follow-up period of 28 days and 38 patients (children: n=14, adults: n=24) 
received a 3-day course of artesunate (4 mg/k daily) plus azithromycin 
(~20 mg/kg daily) with a follow-up period of 42 days. The treatments 
were well tolerated, with no obvious drug associated adverse events. The 
PCR genotype corrected cure rate was 91% for both treatment groups. 
This study showed that the malaria strains at the study site were still 
highly susceptible to artesunate alone. Artesunate-azithromycin was also 
efficacious in the treatment of P. falciparum malaria and may provide 





A SURVEILLANCE SYSTEM TO MONITOR THE QUALITY 
AND AUTHENTICITY OF ARTEMISININ COMBINATION 
TREATMENTS IN AFRICA AND SOUTHEAST ASIA
Harparkash Kaur1, Albert van Wyk1, Naiela Malik1, Caroline 
Lynch1, Shunmay Yeung1, Paul N. Newton2, Prabha Dwivedi3, 
Dana Hostetler3, Isabel Swamidoss4, Michael D. Green4, Facundo 
Fernandez3
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, 
Oxford University, Oxford, United Kingdom, 3Georgia Institute of 
Technology, School of Chemistry and Biochemistry, Atlanta, GA, United 
States, 4United States Centers for Disease Control and Prevention, Atlanta, 
GA, United States
Poor quality Artemisinin Combination Therapies (ACTs) in malaria-endemic 
countries pose an enormous threat to malaria patients. The lack of reliable 
estimates of the prevalence of poor quality ACTs and their impact on 
public health makes it difficult for the national regulatory authorities 
(NRAs) to determine the need and scale of interventions to put in place. 
Our aim is to provide robust estimates of the frequency of substandard, 
counterfeit and degraded artemisinin containing drugs, and to develop 
standardised methodologies for sample collection. As part of the overall 
project we have explored the use of different sampling strategies to collect 
drugs from public and private healthcare providers in Rwanda, Cambodia, 
Ghana and Tanzania, with sampling in other locations underway. Once 
collected all samples are logged onto a database, the packages scanned 
and, tablets weighed and measured. Qualitative (mass spectrometry, near 
infrared and Raman spectroscopy) and quantitative (high performance 
liquid chromatography and high performance liquid chromatography-
mass spectrometry) content analyses are then conducted. Thus far over 
3,500 ACTs have been analysed. Preliminary content analyses indicate 
that a number of samples fall below the internationally recommended 
thresholds (90-110 %) for their stated active pharmaceutical ingredient 
with variations found to occur both between and within batches of the 
same brand. To assist in classifying whether the ACTs are degraded, 
due to environmental impact rather than manufacturing practices, we 
are investigating the ageing of a set of patented ACTs in field and in 
laboratory based studies, with quantitative analysis carried out on these 
samples at regular intervals over a period of four years. Following cross 
verification between the three collaborating laboratories, the results will 
be shared with the country specific NRA and stored on the “Counterfeit 
Drug Forensic Network - CODFIN” database.
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LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP): A 
NOVEL TOOL TO INVESTIGATE MIXED MALARIA INFECTIONS 
IN MALARIA ELIMINATION SETTINGS
Sumudu Britton1, James McCarthy1, Eloise Thompson2, Bismarck 
Dinko2, Colin Sutherland2
1Queensland Institute of Medical Research, Brisbane, Australia, 2London 
School of Hygiene and Tropical Medicine, London, United Kingdom
Improved diagnostics for malaria will be required if elimination is to 
be achieved. We aimed to modify a novel nucleic acid amplification 
system, loop-mediated isothermal amplification (LAMP), to serve as a 
high-throughput, sensitive and specific diagnostic technique for the 
identification of sub-patent malaria infection. We developed a high-
throughput 96-well plate LAMP (htLAMP) assay using a colorimetric agent 
that produces a visually detectable colour change. The htLAMP assay 
was applied to filter paper (FP) control parasitemia samples ranging from 
0.0005- 2% to determine analytical sensitivity. HtLAMP was also applied 
to 98 whole blood (WB) samples from the Gambia and 25 FP samples 
from Ghana. Using primers to Plasmodium falciparum (htLAMP-Pf) and 
Plasmodium genus (htLAMP-Pg) on control samples the assay had a limit 
of detection of 0.0005% parasitemia (approximately 25 parasites/µL). 
Applied to WB samples from symptomatic children from the Gambia, 
htLAMP-Pg was positive in a sample containing 7.5 parasites/µL and, 
combined with htLAMP-Pf, correctly identified a Plasmodium malariae 
monoinfection.HtLAMP on FP samples from asymptomatic school children 
from Ghana identified the lowest parasitemia of 40 parasites/µL. The 
sensitivity of htLAMP-Pf and htLAMP-Pg compared with microscopy was 
91% and 96% respectively and compared with nested PCR was 88% and 
96% respectively.The performance of htLAMP has demonstrated good 
sensitivities when compared with microscopy and nested PCR for both 
whole blood and filter paper samples. Further optimization of the htLAMP 
assay would be required to achieve the desired analytical sensitivity of 
<10 parasites/µL.The high-throughput, colorimetric htLAMP assay shows 
promise as a diagnostic tool for rapid detection of low parasitemias 
encountered in elimination settings.
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DIAGNOSING MALARIA IN PREGNANCY: COMPARING 
IMMUNOFLUORESCENT MICROSCOPY TO OPTICAL 
MICROSCOPY AFTER GIEMSA STAINING
Rebecca A. Tanjong
University of Buea, Buea, Cameroon
Malaria in pregnancy remains a significant threat in sub-Saharan Africa 
as it is associated with sub-optimal pregnancy outcomes. The current 
standard of diagnosis, optical microscopy after staining with Giemsa, 
requires well trained microscopists and may require as long as two 
hours before results are obtained. Alternate rapid diagnostics tests thus 
need to be evaluated, particularly in pregnancy when changes in the 
immune response could potentially affect the performance of rapids tests 
based on antibody detection. We assessed the diagnostic performance 
of an alternate method, fluorescent microscopy, compared to optical 
microscopy after Giemsa staining.As part of baseline studies of mother-
to-child transmission of HIV in the Buea Health District, 407 consenting 
pregnant women were enrolled. Venous blood samples were collected 
and tested by optical microscopy after Giemsa staining (OM) and by 
fluorescent microscopy (FM) using the Partec-Cyscope (Partec GmbH, 
Munster, Germany). All participants were asymptomatic at the time of 
enrollment. Both slides were read by experienced microscopists and 
evaluated qualitatively as being positive or negative for plasmodia.Of the 
407 samples tested by OM, 255 (62.5%) were plasmodium-positive. Of 
these 255, 207 were also plasmodium-positive by FM, thus a sensitivity 
of 81.1% (95%CI: 75.8, 85.8%). Of the 152 samples negative by 
OM, 75 were also negative by FM, thus a specificity of 49.3% (95%CI: 
41.1, 57.6%). The positive and negative predictive values of FM were 
respectively 72.9% (95%CI: 67.3, 78.0%) and 61.0% (95%CI: 51.8, 
69.6%). The percentage agreement between both methods was 69.3% 
(Kappa=0.32, p-value<0.01). There was moderate agreement between FM 
and OM. The low specificity and negative predictive value of FM suggest a 
high likelihood of false negative results if FM is used in place of OM.
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THERMAL CONTRAST SIGNIFICANTLY IMPROVES THE 
SENSITIVITY OF LATERAL FLOW ASSAYS FOR MALARIA 
DIAGNOSIS
Zhenpeng Qin1, Chandy C. John1, Gregory S. Park1, Elissa K. 
Bulter1, Max von Hohenberg1, David R. Boulware1, Taner Akkin1, 
Warren C. Chan2, John C. Bischof1
1University of Minnesota, Minneapolis, MN, United States, 2University of 
Toronto, Toronto, ON, Canada
Malaria rapid diagnostic tests (RDTs) using lateral flow immunoassays 
(LFAs) are one of the few low-cost assays that can diagnose malaria in 
a point of care setting without laboratory infrastructure. With LFAs, a 
positive detection occurs when the test region of the assay membrane 
strip appears visibly red if the target analyte from a patient’s sample is 
captured by an antibody bound to the membrane and an antibody bound 
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to the surface of gold nanoparticles. This sandwich capture occurs as 
antigen-bound gold nanoparticles migrate across the membrane to form 
the test line. When compared to microscopy, the best of the current LFAs 
have >95% sensitivity and specificity for Plasmodium falciparum infections 
in which parasitemia is ≥200 parasites/µL, but have significantly decreased 
sensitivity for infections with <200 parasites/µL and for P. vivax, P. ovale 
and P. malariae. Malaria elimination campaigns will require RDTs with a 
sensitivity that exceeds that of microscopy. We recently demonstrated that 
the sensitivity of RDTs can be dramatically enhanced by laser heating of 
the gold nanoparticles resulting in quantifiable release of heat. An infrared 
camera can then measure the heat released, which is directly proportional 
to the number of gold nanoparticles, and this technique can quantitatively 
measure the antigen burden in the sample. This new technology is 
termed thermal contrast and was recently demonstrated for Cryptococcal 
meningitis, as reported previously. Herein we show that this technology 
can also be used to enhance the sensitivity of RDTs for malaria, showing 
an 8-fold increase in sensitivity as compared to standard RDT testing 
during serial dilutions of clinically positive P. falciparum blood samples. 
Thus, while current RDTs have a limit of detection at 200 parasites/
µL, thermal contrast can enable detection at the level of ~25 parasites/
µL, significantly improving the sensitivity of RDTs to malaria in those 
with low-level parasitemia. Further improvement on the order of 100-
fold in sensitivity is possible with redesign of LFAs to reduce nonspecific 
background laser absorption and enhance specific gold nanoparticle 
absorption. Finally, inexpensive existing technologies are being evaluated 
to design a robust, battery operated point-of-care RDT thermal contrast 
reader (<$100) for resource limited settings.
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PERSPECTIVES ON MALARIA RAPID DIAGNOSTIC TESTS 
AFTER NATIONAL ROLLOUT IN TANZANIA’S PUBLIC SECTOR - 
PROVIDER AND CONSUMER VIEWS FROM MBEYA REGION
Clarence Mkoba1, Denise Roth Allen2, Emmy Metta1, Admirabilis 
Kalolella1, Catherine Goodman3, Salim Abdulla1, S. Patrick Kachur2
1Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania, 
2Centers for Disease Control and Prevention, Atlanta, GA, United States, 
3London School of Hygiene and Tropical Medicine, London, United 
Kingdom
As part of its national strategy to improve malaria case management, 
Tanzania has been gradually rolling out malaria rapid diagnostic tests 
(mRDT) in the public sector since 2008. A multidisciplinary evaluation to 
assess the effectiveness of this strategy is currently underway. We present 
results of qualitative research conducted in two districts in Mbeya Region 
where mRDTs were introduced in February 2011. Qualitative interviews 
were conducted with health authorities, providers and community 
members about their experiences with malaria diagnosis and treatment 
post mRDT implementation. A total of 28 interview transcripts were 
reviewed for content analysis. Several conflicting views and practices with 
respect to mRDTs emerged. Whereas laboratory and pharmacy officers 
were more likely to express confidence in the accuracy of mRDTs, other 
health authorities were less convinced of their usefulness as a diagnostic 
tool; some suggested more studies to assess the quality of mRDTs were 
needed. Others expressed concerns that clinicians were ignoring negative 
mRDTs in favor of artemether-lumefantrine (ALu) treatment. Our interviews 
with providers and community members confirm their suspicions. While 
some providers acknowledged ignoring negative mRDTs results for 
patients with malaria symptoms, they also noted that such patients often 
improved after ALu treatment. Other providers adopted a “wait and 
see” approach, advising their patients to return in 2-3 days if symptoms 
persisted. Although the extent of such practices is not known, the use of 
ALu for negative mRDTs was cited as one of the malaria challenges for 
the region. Stock outs of mRDTs were mentioned as another. Regional 
authorities noted that within the first 8 months of implementation, 4 out 
of 8 districts had experienced a stock out. Although mRDT stock outs were 
less disruptive for facilities that also practiced microscopy, facilities without 
microscopes reported reverting to clinical diagnosis. These challenges 
will need to be addressed early on if improvements in malaria case 
management are to be achieved. Strategies to consider include identifying 
effective measures to improve provider adherence to mRDTs, as well as 
addressing bottlenecks in the mRDT supply chain.
333
STUDY OF HOSPITAL BASED MALARIA CASES IN THE 
PEDIATRIC DEPARTMENT OF KORLE BU TEACHING HOSPITAL, 
GHANA
Felix A. Botchway1, Cecilia Elorm Lekpor2, Seth Amankwah1, 
William Ababio3, Patience B. Williams4
1University of Ghana Medical School, Accra, Ghana, 2Pathology 
Department, University of Ghana Medical School, Accra, Ghana, 3Child 
Health Department, University of Ghana Medical School, Accra, Ghana, 
4Hematology Department University of Ghana Medical School, Accra, 
Ghana
Malaria kills about one million children, under five years of age, each year 
worldwide, with nine out of 10 deaths occurring in sub-Saharan Africa. 
This study was carried out to determine the incidence of malaria in the 
pediatric department of Korle Bu Teaching Hospital from January 2011 to 
October 2011, and to compare available diagnostic tests for malaria. 978 
suspected cases of malaria (507 males and 471 females, aged 1 day - 12 
years), attending the OPD and admitted as inpatients in the ER of the 
Pediatric Department were included in this study. 1.0 mls of blood sample 
was collected into EDTA bottle. Thick and thin smears were prepared, 
stained and examined. Subsequently, the blood samples were subjected 
to antigen detection using the First Response Malaria pLDH/ HRP 2 
Combo Test according to the manufacturer’s instructions. The results were 
tabulated and analyzed statistically. 51 cases out of 978 suspected cases 
were positive for malaria, with an incidence of 5.2%. Out of these 40 
(78.4%) were positive for Plasmodium falciparum, 5 (9.8%) were positive 
for P. malariae, 2 (3.9%) were positive for P. ovale, and 4 (7.8%) were 
positive for both P. falciparum and P. malariae. The First Response Malaria 
pLDH/ HRP 2 Combo Test detected 51 positive cases compared with the 
blood smear study, which detected 41 cases. 36 cases were detected both 
by the First Response Malaria pLDH/ HRP 2 Combo Test and blood smear 
study. 15 cases were positive by the First Response Malaria pLDH/ HRP 2 
Combo Test, but not by the blood smear study. 5 cases detected to be 
positive by the blood smear study were found to be negative by the First 
Response Malaria pLDH/ HRP 2 Combo Test. 937 cases were negative both 
by the First Response Malaria pLDH/ HRP 2 Combo Test and the blood 
smear study. Among 51 positive cases, 35 were males with a percentage 
of 68.6% as compared to females (31.4%).The sensitivity, specificity, 
positive predictive value, negative predictive value, and diagnostic 
efficiency of the First Response Malaria pLDH/ HRP 2 Combo Test when 
compared to microscopy, were 87.5, 96.8,90, 98.9, and 96%, respectively. 
In conclusion, the incidence of malaria in this present study was 5.2%. The 
sensitivity of First Response Malaria pLDH/ HRP 2 Combo Test is very close 
to microscopy. It is a simple, sensitive, and effective diagnostic test for P. 




ADDRESSING OVER- AND UNDER-DIAGNOSIS OF MALARIA 
IN TANZANIA: AN EVALUATION OF LARGE-SCALE 
IMPLEMENTATION OF MALARIA RAPID DIAGNOSTIC TESTS 
(MRDTS) IN THREE REGIONS WITH VARYING MALARIA 
EPIDEMIOLOGY
Admirabilis B. Kalolella1, Katia Bruxvoort2, Rebecca Thomson2, 
Charles Festo1, Happy Nchimbi1, Matthew Cairns2, Julie Thwing3, 
Mark Taylor2, Catherine Goodman2, Patrick Kachur3
1Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania, 
2London School of Hygiene and Tropical Medicine, London, United 
Kingdom, 3Centers for Disease Control and Prevention, Atlanta, GA, 
United States
Artemisinin based combination therapy (ACT) is the first line drug in most 
malaria-endemic countries, but there are concerns that quality of care 
remains poor. Patients needing ACT often do not receive it, but there is 
also considerable over-treatment due to the lack of accurate diagnosis 
and inappropriate management. In 2010-2012, Tanzania rolled-out 
malaria rapid diagnostic tests (mRDTs) at government health facilities 
to improve treatment of febrile illness. Here, we report results of health 
facility surveys to assess treatment practices before and after mRDT scale 
up in three regions with varying malaria epidemiology. Patients with fever 
in the previous 48 hours were enrolled at 320 randomly selected health 
facilities in Mwanza, Mbeya, and Mtwara regions in May - October 2010 
and March - August 2012. Patients were interviewed following their 
consultation, and data were collected on patient characteristics, previous 
treatment for fever, and care received at the facility. Finger prick blood 
samples were taken by study staff to test for malaria parasitemia. Health 
workers seeing patients were also interviewed about their training and 
supervision, knowledge, and facility stocks of antimalarials and mRDTs. 
At baseline, data were collected on 1746 patients, of which only 15.9% 
received a diagnostic test from facility health workers. Based on study 
blood smears, 20.9% tested positive in Mtwara, 6.6% in Mwanza, and 
1.6% in Mbeya. An ACT was obtained by 65.8% of patients testing 
positive by the study blood slide and 39.0% of patients testing negative, 
meaning that overall only 58.5% of patients received appropriate malaria 
treatment given their study blood smear result. We will compare these 
results with those from 2012 to evaluate the success of mRDT roll-out at 
addressing over- and under-diagnosis of malaria, and the role of stock-
outs and health worker practices in addressing these key problems. These 
data will contribute to enhancing interventions to increase appropriate 
treatment of patients with and without malaria in Tanzania and other 
malaria-endemic countries.
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ACCURACY OF TWO RAPID DIAGNOSTIC TESTS FOR 
DIAGNOSIS AND MONITORING TREATMENT OF MALARIA IN 
A HIGH TRANSMISSION SETTING IN UGANDA
Phoebe K. Mbabazi
Makerere University College of Health Sciences, Kampala, Uganda
Rapid diagnostic tests (RDTs) for malaria are simple to perform and may 
improve fever management in malaria endemic areas where microscopy 
is not readily available. Most RDTs detect Histidine- rich protein 2 (HRP2) 
which persists in the blood stream for variable lengths of time after 
treatment. Plasmodium lactate dehydrogenase (pLDH) based RDTs 
become negative more quickly. We assessed the accuracy of HRP2 and 
pLDH based malaria RDTs for initial diagnosis of uncomplicated malaria, 
treatment monitoring and diagnosis of recurrent episodes of malaria in 
young children in a hyperendemic area in Uganda. Accuracy of the RDTs 
for diagnosis of malaria was compared using expert microscopy as a gold 
standard in 308 episodes of fever in a cohort of children under five years. 
We followed up 131 children with microscopically confirmed malaria at 7 
day intervals for 28 days to determine clearance time of HRP2 and pLDH 
antigenemia. Both RDTs were done for children with recurrent episodes 
of fever after treatment of malaria. Of the 308 children tested, sensitivity 
was 98% for HRP2 and 87.1% for pLDH; specificity was 54.7% for HRP2 
and 95.3% for pLDH. Positive predictive value (PPV) was 80.5% for HRP2 
and 97.2% for pLDH; negative predictive value (NPV) was 93.5% for HRP2 
and 79.5% for pLDH. Persistent antigenemia from recent malaria episodes 
contributed to the low specificity of HRP2 while the lower sensitivity of 
pLDH was due to poor antigen detection at low parasite densities. The 
mean duration of antigenemia was 21 days for HRP2 and 2 days for pLDH.
Pre-treatment parasite density predicted the duration of antigenemia of 
HRP2. We documented 61 episodes of fever after antimalarial treatment. 
For these, HRP2 had sensitivity of 100%, specificity of 34.5%, PPV of 
62.7% and NPV of 100%. pDLH had sensitivity of 90.6%, specificity of 
100%, PPV of 100% and NPV of 90.6%. The HRP2 based RDT though 
accurate for initial diagnosis of malaria, was limited by low specificity due 
to persistent antigenemia.The pLDH based RDT showed rapid clearance 
of antigenemia and was accurate for diagnosis of malaria in children with 
recurrent fever after treatment. In patients who have had malaria in the 
previous three weeks and present with fever, pLDH based RDTs should be 
used to monitor treatment and diagnose new episodes of malaria.
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THE DIAGNOSTIC VALUES OF RAPID DIAGNOSTIC TEST 
BASED ON HISTINE RICH PROTEIN II OF CARESTARTTM 
MALARIA IN DETECTING MALARIA INFECTION IN PREGNANT 
WOMEN SAN AND KITA
Moussa Djimde, Mohamed Keita, Hamadoun Diakite, Moussa 
Niangaly, Sidiki Konate, Nouhoum Guindo, Etienne Guirou, 
Etienne Guirou, Binta Barry, Kassoum Kayentao, Ogobara K. 
Doumbo
Malaria Research and Training Center, University of Bamako, Mali, 
Bamako, Mali
We conducted from July 2009 to February 2010 in San and Kita (Mali), 
a study on the diagnostic values of the Histine Rich Protein II (HRP-II) 
CareStartTM Malaria compared to the thick smear for the detection of 
malaria infection during pregnancy as part of a pilot study for monitoring 
the therapeutic efficacy of Sulfadoxine-Pyrimethamine during in vivo 
testing of 42 days. Result showed both the sensitivity and specificity of 
95%. Positive and negative predictive values were of 86% and 98% 
respectively, and a kappa value was 0.87. There were 5% of false positives 
and negatives.When tracking in vivo, the proportion of positive HRP-II 
CareStartTM was higher than that observed in the thick film. CareStartTM 
Malaria positivity is proportional to parasite density detected by the thick 
film. HRP-II of CareStartTM Malaria is simple to use and fast. The HRP-II 
TDR can be used in the detection of malaria infection among pregnant 
women.
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EVALUATION OF PRE- AND POST-TRAINING KNOWLEDGE 
AND PRACTICES OF HEALTH WORKERS IN THE USE OF RAPID 
DIAGNOSTIC TEST FOR PARASITOLOGICAL DIAGNOSIS OF 
UNCOMPLICATED MALARIA IN CAMEROON
Albertine K. Lele1, Olivia A. Achonduh1, Joelle Pamen-Ngako1, 
Joel N. Ambebila1, Ignatius C. Ndong1, Sarah N. Ndive1, Barnabas 
B. Orang-Ojong1, Theresia M. Njuabe1, Lindsay Mangham2, 
Virginia Wiseman2, Wilfred F. Mbacham1
1Laboratory for Public Health Research Biotechnologies, Biotechnology 
Center, University of Yaounde I, Yaounde, Cameroon, 2London School of 
Hygiene and Tropical Medicine, London, United Kingdom
Rapid diagnostic tests (RDTs) for malaria diagnosis have attracted interest 
in recent years because of their high specificity and sensitivity and 
are suitable for resource-constrained settings as they require minimal 
infrastructure. However, many health workers who are the main players 
for the effective use of this new technique do not yet master it. The 
Cameroon National Malaria Control Programme (NMCP) only recently 
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introduced RDTs in 50 pilot districts in 2011. Health workers (HWs) from 
mission and public health facilities in Yaounde and Bamenda cluster 
randomized in a research to evaluate the provision of appropriate 
treatment to malaria patients were invited to attend a 1 day and 3 
days workshop on “Ensuring appropriate treatment for uncomplicated 
malaria” and “Improving quality of care for management of suspected 
malaria” respectively. All workshop attendees completed a pre training 
questionnaire which covered aspects such as clinical manifestation and 
methods of malaria diagnosis, the role of an RDT, who should conduct 
an RDT, the practical steps, time to read and interpretation of the 
results, treatment according to test results. During the training, HWs 
received lectures and practical exercises on all the above mentioned 
aspects including practical steps with assistance of a 16- step WHO RDT 
job aid and treatment guidelines from NMCP. Participants were also 
individually supervised during the performance of an RDT and graded 
using a checklist. The same questionnaire was used for post training 
evaluation. Of the 54 HWs from Yaounde, 62.5% were nurses, 20.8% 
medical doctors and 16.7% laboratory technicians. The knowledge 
increase on clinical manifestation and diagnostic methods for malaria for 
pre and post training was 10.42% while knowledge on RDT use had an 
increase of 52.3%. Knowledge on treatment based on test results had an 
increase of 28.2% while practical skills improved from 0% to 80%. Of 
the 40 HWs from Bamenda, 62.5% were nurses, 25% medical doctors 
and 12.5% laboratory technicians. The knowledge increase on clinical 
manifestation and diagnostic methods for pre and post training was 8.9% 
while knowledge on the RDT had a 35.4% increase. The knowledge 
on treatment based on test results had an increase of 17.6% while 
practical skills improved from 0% to 86%. If HWs are given appropriate 
training, clear instructions with appropriate job aids, they can use RDTs 
appropriately irrespective of their cadre and setting.
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MALARIA PARASITE DENSITY ESTIMATED FROM ACTUAL 
WBC COUNT OF PATIENTS CORRELATES WITH ESTABLISHED 
WBC REFERENCE VALUE IN CENTRAL GHANA
Dennis Adu-Gyasi, Mohammed Adams, Sabastina Amoako, 
Emmanuel Mahama, Maxwell Nsoh, Seeba Amenga-Etego, Frank 
Baiden, Kwaku Poku Asante, Sam Newton, Seth Owusu-Agyei
Kintampo Health Research Centre, Kintampo North, Ghana
White Blood Cells count (WBCc) is a bed-rock in the estimation of 
malaria parasite density in malaria field trials, interventions and patient 
management. WBCs are indirectly and relatively used in microscopy to 
estimate the density of malaria parasite infections. Due to frequent lack 
of facilities, in some malaria endemic countries, to quantify WBCc of 
patients, an assumed WBCc of 8.0 X 109/L has been set by the WHO to 
help in estimating malaria parasite densities. The comparative analysis 
study, in Central Ghana, compiled laboratory data of 5902 Plasmodium 
falciparum (Pf) malaria parasite positive samples. Samples were obtained 
from consented participants of age-group less than 5 years. Full Blood 
Counts (FBC) of participants’ samples were analysed using the ABX Micros 
60 Haematology Analyzer. Blood slides were read by two competent 
microscopists to produce concordant results. All internal and external 
quality control measures were carried out appropriately. Parasite densities 
were calculated using participants’ absolute WBCc and assumed WBCc of 
5,000 to 10,000 per microlitre of blood. From the 5902 Pf malaria positive 
samples, the mean (SD) WBCc and geometric mean parasite density were 
10.4 (4.6) × 109/L and 7557/µL (95% CI 7144/µL to 7994/µL) respectively. 
The difference in the geometric mean parasite densities calculated using 
absolute WBCs and compared to densities with assumed WBCs counts 
were significantly lower for 5.0 × 109/L; 3937/µL, 6.0 × 109/L; 4725/
µL and 8.0 × 109/L; 6300/µL. However, the difference in geometric 
mean parasite density, 7874/µL (95% CI, 7445/µL to 8328/µL), with 
assumed WBCc of 10.0 × 109/L was not significant. In conclusion, using 
the assumed WBCc to estimate malaria parasite densities in Pf infected 
children less than 5years could result in significant errors in the estimation 
of parasite burden in a malaria endemic region. Assumed WBCc of 10.0 
× 109/L at 95% CI of geometric mean of parasite density statistically 
agreed with the parasite densities produce by the absolute WBCc of 
participants. This correlates with the established reference value for WBC 
in Central Ghana. We therefore suggest where available, the use of the 
WBC reference value to estimate malaria parasite density when obtaining 
absolute WBCc is not possible especially in drug efficacy and vaccine trials.
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PRODUCTION OF VERTICAL FLOW RAPID MALARIA TEST KIT 
TO DETECT PLASMODIUM FALCIPARUM AND PLASMODIUM 
VIVAX
Pongwit Bualombai1, Patcharin Boon-in1, Ponlawat 
Ruangsirarak1, Kanungnit Congpuong1, Aiemumporn Kanchana2, 
Wichai Satimai1, Panadda Dhepaksorn3
1Bureau of Vector Borne Diseases, Nonthaburi, Thailand, 2Center for 
National Blood, Bangkok, Thailand, 3Department of Medical Science, 
Nonthaburi, Thailand
An endeavour to produce in-house rapid diagnostic test in Thailand to 
supplement the use of various commercial test kits available the market. 
The test aimed to produce a vertical flow immunoclomatographic test to 
detect either Plasmodium falciparum or PAN malaria parasites and hoped 
to be the alternative tool for field users. The test were produced by using 
the in-house monoclonal antibodies produced against either Plasmodium 
lactate dehydrogenase (pLDH) or Plasmodium glyceraldehydes-3-
phosphate dehydrogenase (pGAPDH). Preliminary study was done against 
38 wild type malaria and 39 negative control samples and found that the 
test kit gave sensitivity and specificity to P. falciparum 89.5 % and 98.3 
% and to P. vivax 82.4 % and 98.8 % respectively. Even the test gave 
somewhat high diagnostic values but its sensitivity positive correlated with 
parasitemia levels. However, at least, this study got an alternative RDT 
prototype to be validated its feasibility for using in field onward.
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INTRODUCING RAPID DIAGNOSTIC TESTS INTO 
COMMUNITY-BASED MANAGEMENT OF MALARIA: 
EVIDENCE FROM A CLUSTER-RANDOMIZED TRIAL IN TWO 
AREAS OF HIGH AND LOW TRANSMISSION IN UGANDA
Richard Ndyomugyenyi1, Kristian S. Hansen2, Sham Lal2, Clare 
Chandler2, Anthony K. Mbonye3, Pascal Magnussen4, Sian E. 
Clarke2
1Vector Control Division, Ministry of Health, Kampala, Uganda, 2ACT 
Consortium, London School of Hygiene and Tropical Medicine, London, 
United Kingdom, 3Department of Community Health, Ministry of Health, 
Kampala, Uganda, 4DBL Centre for Health Research and Development, 
Faculty of Health and Medical Sciences, University of Copenhagen, 
Copenhagen, Denmark
Universal access to diagnostic testing for malaria is now recommended by 
WHO, to encompass all levels of health care, including community-based 
treatment programmes. Rapid diagnostic tests (RDTs) provide a simple 
means of confirming malaria diagnosis in locations lacking electricity 
and qualified health staff. Some countries have begun to introduce 
RDTs at community level, and data on the impact of diagnostic testing 
on treatment and referral practices by community health workers is 
still limited. A cluster-randomised trial to evaluate the impact and cost-
effectiveness of RDTs when used by community medicine distributors 
(CMDs), compared with presumptive treatment, has been conducted 
in two areas with contrasting malaria transmission in Rukungiri District, 
Uganda since June 2010. The trial aims to evaluate the impact of 
diagnostic testing on the proportion of children who receive appropriate 
ACT treatment and referral under low and high transmission, as defined 
by malaria microscopy on a research slide collected at the same time as the 
RDT. The study will also provide evidence on the operational challenges 
and community acceptability of RDTs. A total of 120 communities (379 
CMDs) were randomised to training either in use of RDTs or presumptive 
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diagnosis of malaria. All CMDs were trained on how to give antimalarial 
treatment with ACTs, rectal artesunate pre-referral treatment, and when 
to refer. Supporting interventions included activities to raise community 
awareness, and close support supervision to CMDs for the first six months 
of implementation. Since January 2011, supervision has been scaled back 
to mimic levels typically seen in health systems in rural Africa. Nonetheless, 
adherence to RDT results by CMDs has remained high, with over 95% of 
ACT treatments given being consistent with the results of the RDT test. 
We will present data on adherence to RDT result and treatment guidelines 
by CMDs; compare referral practices and frequency of patients following 
through with referral in the two arms; and changes in these outcomes, 
over the first 18 months of the trial.
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INTRODUCING RAPID DIAGNOSTIC TESTING FOR MALARIA 
INTO THE PRIVATE SECTOR: EVIDENCE FROM A CLUSTER-
RANDOMIZED TRIAL IN REGISTERED DRUG SHOPS IN 
UGANDA
Anthony K. Mbonye1, Clare Chandler2, Kristian S. Hansen2, Sham 
Lal2, Bonnie Cundill2, Richard Ndyomugyenyi3, Pascal Magnussen4, 
Sian E. Clarke2
1Department of Community Health, Ministry of Health, Kampala, Uganda, 
2ACT Consortium, London School of Hygiene and Tropical Medicine, 
London, United Kingdom, 3Vector Control Division, Ministry of Health, 
Kampala, Uganda, 4DBL Centre for Health Research and Development, 
Faculty of Health and Medical Sciences, University of Copenhagen, 
Copenhagen, Denmark
Universal access to diagnostic testing for malaria is now recommended 
by WHO, to encompass all treatment providers. Many malaria cases are 
treated outside the formal health sector, with drug shops often being 
the first, and only, source of treatment. Rapid diagnostic tests (RDTs) 
provide a simple means of confirming malaria diagnosis in drug shops, 
and improved diagnosis may also help to ensure that the drugs sold are 
appropriate. As yet, there is little evidence of the impact of diagnostic 
testing on antimalarial drug sales and referral practices by drug shops, 
particularly in Africa. A cluster-randomised trial to evaluate the impact and 
cost-effectiveness of using RDTs in registered drug shops, compared with 
presumptive treatment, has been conducted in Mukono District, Uganda 
since October 2010. The trial aims to evaluate the impact of diagnostic 
testing on the proportion of drug shop clients who receive appropriate 
ACT treatment, in line with parasitological status as defined by malaria 
microscopy on a research slide collected at the same time as the RDT. The 
study will also provide evidence on the feasibility; operational challenges 
and acceptability of this approach. A total of 60 drug shops were 
randomised to receive training either in the use of RDTs or presumptive 
diagnosis of malaria. All drug shop vendors (DSVs) were trained on the 
national malaria treatment guidelines, use of rectal artesunate pre-referral 
treatment, and when to refer. Supporting interventions included activities 
to raise community awareness, and close support supervision to DSVs for 
the first 3 months of implementation. Since January 2011, supervision 
has been scaled back to mimic levels typically seen in health systems in 
rural Africa. Nonetheless, adherence to RDT results by DSVs has remained 
high, with over 95% of ACT treatments sold being consistent with RDT 
test results. We will describe the design of the intervention in drug shops, 
and present data on adherence to RDT result and treatment guidelines by 
DSVs; referral practices; and changes over the first 15 months of the trial.
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SCALING-UP RAPID DIAGNOSTIC TESTS FOR MALARIA: 
BARRIERS AND OPPORTUNITIES IN NIGERIA’S PRIVATE 
SECTOR
Anna Y. De La Cruz1, Jenny Liu1, Eric Schatzkin1, Karen Schlein1, 
Sepideh Modrek2, Oladimeji Oladepo3, Dominic Montagu1
1University of California San Francisco, San Francisco, CA, United States, 
2Stanford University, Stanford, CA, United States, 3University of Ibadan, 
Ibadan, Nigeria
Throughout Nigeria, about 80% of treatment for fevers occurs in private 
shops, pharmacies and clinics. Many private practitioners presumptively 
diagnose childhood fevers and a multitude of other symptoms as 
malaria without conducting blood tests, for a variety of reasons. With 
the increased availability of artemisinin combination therapy (ACTs) 
to effectively treat malaria, there is growing recognition that accurate 
diagnosis prior to treatment is needed. Effective diagnosis not only saves 
on health expenses and reduces the risk of drug resistance, but also 
reduces the risk of misdiagnosis and delayed treatment of non-malaria 
illness. The Global Health Group at UCSF conducted qualitative research 
in early 2012 in collaboration with the University of Ibadan, Nigeria, to 
determine the availability and acceptability of using Rapid Diagnostic 
Tests (RDTs) as an easy and inexpensive tool for diagnosis of malaria in 
the absence of microscopy. Results from qualatative analysis indicate very 
little knowledge or use of RDTs and that significant structural barriers exist 
in deploying RDTs within the private sector. These barriers include legal 
and technical constraints among different types of providers; regulatory 
limitations; widespread beliefs that diagnostic tests are not needed 
and that results are unreliable; and inadequate incentive structures for 
balancing profit motives with priorities for providing quality care. This 
research suggests that private sector providers may respond to patient 
requests for diagnosis prior to treatment if awareness of the value of 
diagnosis is increased and greater demand for RDTs can be fostered. A 
second phase of research is underway which will test malaria prevalence 
as well as acceptability and adherence to RDT results among purchasers of 
anti-malaria medication at private outlets in Nigeria.
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HIGH FREQUENCY MALARIA PARASITE DETECTION BY 
BUFFY-COAT SMEAR AMONG PATIENTS WITH NEGATIVE 
THICK BLOOD FILM TESTS
Noppadon Tangpukdee, Chatnapa Duangdee, Polrat 
Wilairatana, Srivicha Krudsood
Mahidol University, Bangkok, Thailand
Malaria remains one of the world’s most serious global health concerns. 
Prompt and accurate diagnosis is critical to effective management of 
malaria. Although microscopy by thin- and thick-blood smears is the 
current standard for malaria diagnosis, there is a risk of false negative 
results when the patient has recently been treated with antimalarial 
medications. To explore how frequently falciparum malaria parasites are 
detected, by quantitative buffy-coat capillary tube test, among patients 
with prior negative results by thick-film blood-smear tests. We studied 
36 patients with uncomplicated falciparum malaria, confirmed by 
conventional thick- and thin-film microscopy diagnostic methods. The 
patients were admitted and treated at the Bangkok Hospital for Tropical 
Diseases. Fingerpricks for conventional blood smear and concurrent 
buffy coat blood smears were conducted every 6 hours until the patients 
exhibited negative parasitemia, and then finger-prick tests were performed 
daily until each patient was discharged from hospital. A negative result 
by conventional thick-film test was compared with the concurrent buffy-
coat thick-film test. By study method, we found that of 36 patients with 
negative thick films, buffy-coat smears detected 10 patients (27.8%) with 
asexual form Plasmodium falciparum. We concluded that quantitative 
buffy coat capillary tube tests can accurately and efficiently detect malaria 




COMPARATIVE EFFICACY OF UNCONTROLLED AND 
CONTROLLED INTERMITTENT PREVENTIVE TREATMENT 
DURING PREGNANCY (IPTP) WITH COMBINED USED OF 
LLTNS IN HIGH RESISTANCE AREA TO SULFADOXINE-
PYRIMETHAMINE IN CÔTE D’IVOIRE
Offianan A. Toure1, Penali L. Kone1, M’Lhanhoro A. Coulibaly1, 
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David Koffi1, Sarr Demba2, Jambou Ronan3, Kone Moussa4
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Biologiques University of Cocody, Abidjan, Côte D’Ivoire
In recent years, Intermittent Preventive Treatment for pregnancy (IPTp) 
with SP has become policy in much of sub-Saharan Africa. But resistance 
to SP has been spreading across sub-Saharan Africa and thus the 
effectiveness of SP-IPT has been questioned. The present study, therefore, 
sought to assess incidence of placental malaria, LBW and aneamia of 
two approaches IPTp-SP (DOT scheme versus no DOT) in Anonkoua-
kouté and Samo where the reported prevalence of dfr single mutant 108 
was respectively 62% and 52,2%. The study was a longitudinal design 
involving pregnant women and was conducted in Anonkoua-kouté (Côte 
d’Ivoire), a suburban area, and Samo, a rural area, from January 2008 
through March 2009. Women of a pregnancy less than 28 weeks duration 
were randomized to receive SP (1500 mg of sulfadoxine and 75 mg of 
pyrimethamine) in a single intake twice and were followed up monthly 
until delivery. Doses were administered under supervision in the controlled 
IPTp group, while in the uncontrolled IPTp group, drug was given free to 
women and it was recommended to take it at home. The primary end 
point was the proportion of low birth-weight (LBW) infants (body weight 
<2500 g) and the secondary, the rate of severe anaemia and placental 
malaria detected at delivery. A total of 420 pregnant women were 
enrolled (212 and 208 respectively in controlled and uncontrolled groups). 
Delivery outcome was available for 378 women. In the modified intention 
to treat (ITT) analysis, LBW infants were born from 15.5% of women of 
the uncontrolled IPTp group and from 11.9% of women on controlled 
IPTp group (p= 0.31). The per-protocol population (PP) analysis showed 
consistent results. The proportions of women with placental malaria 
infection, moderate anemia (Hb<11 g/dL), and severe anemia (Hb <8 g/dL) 
at delivery were similar between the two groups (p>0.05). In conclusion, 
the study showed that the two approaches were equivalent suggesting 
the use of unsupervised IPTp with SP free of charge in areas where 
implementation of DOT scheme suffer from many constraints.
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EFFICACY OF ARTEMETHER/LUMEFANTRINE SINCE ADOPTED 
AS A FIRST LINE TREATMENT FOR UNCOMPLICATED 
PLASMODIUM FALCIPARUM MALARIA IN ETHIOPIA IN 2004
Moges K. Mekonnen
Ethiopian Health and Nutrition Research Institute, Ministry of Health, 
Addis Ababa, Ethiopia
In Ethiopia, unacceptably high level of resistance to sulphadoxine/
pyrimethamine prompted the change to a combination of artemether 
and lumefantrine (AL) as a national first line treatment for uncomplicated 
Plasmodium falciparum malaria in 2004. Regular monitoring of the 
efficacy of the recommended regimen for falciparum malaria is essential 
to suggest whether the required high level of efficacy is maintained or to 
detect any early indication of resistance. These studies were conducted to 
assess the current level of AL efficacy in the country and provide credible 
information to national malaria control program managers for evidence 
based decision making. The studies were conducted between 2007-2011 
malaria peak transmission seasons in seven sentinel sites using the revised 
WHO protocol. A minimum of ninety patients with uncomplicated P. 
falciparum malaria aged six months and above were enrolled in each study 
site. Each patient was treated with a standard six dose regimen of AL 
given twice daily for three days under partial supervision. The clinical and 
parasitological responses were assessed during a twenty eight days follow 
up period. Outcome of treatment were defined according to the standard 
WHO classification. Recurrent parasitaemia were genotyped to distinguish 
between recrudescence and new infection. PCR corrected adequate 
clinical and parasitological response (ACRP) at Day twenty eight in the per 
protocol analysis was greater than 95% in all sites except in Shele where 
the ACRP was 92.5%. There was no early treatment failure and most of 
the recurrent infections were due to late parasitological failure. Parasite 
and fever clearance rates were rapid and all patients were cleared of their 
gametocytes by day 14. Mean hemoglobin value had also improved on 
day twenty eight compared with the baseline. No serious adverse events 
were reported. However, mouth ulcer was recorded in some children after 
treatment and resolved spontaneously. A regimen of AL is highly effective 
in the study localities, after six years of use as first line treatment in the 
country. The high cure rate of AL reported in this study is encouraging 
and support the continued use as first line treatment for uncomplicated 
falciparum malaria in the country. However the 7.5% recrudescence 
infections observed in Shele highlights the need for regular monitoring the 
efficacy in Shele and other part of the country.
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ASSESSMENT OF THE MOLECULAR MARKER OF 
PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE 
(PFCRT) IN SENEGAL AFTER SEVERAL YEARS OF 
CHLOROQUINE WITHDRAWAL
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United Kingdom, 3Centre for Medical Parasitology, Department of 
International Health, Immunology and Microbiology, University of 
Copenhagen, Copenhagen, Denmark
Since 2006, the artemisinin- combination therapies (ACTs); artemether–
lumefantrine (AL) and artesunate plus amodiaquine (AS/AQ) were adopted 
for uncomplicated malaria treatment. After several years of CQ withdrawal 
the current study wished to determine the level of CQ resistance at the 
molecular level in selected sites in Senegal since interest in using CQ again 
has been raised by the scientific community. Finger prick blood samples 
were collected from Plasmodium falciparum positive children below the 
age of 10 (n = 474) during cross sectional surveys conducted in two study 
sites in Senegal with different malaria transmission level. All samples were 
analyzed for single nucleotide polymorphisms (SNPs) in the P. falciparum 
chloroquine resistance transporter gene (Pfcrt – codons 72-76) using 
PCR-SSOP ELISA and Real Time-PCR methods. In total, 449 blood samples 
(94.7%) were PCR positive, 285 and 164 from Central and Southern sites 
of Senegal, respectively. In both study areas the prevalence of the Pfcrt 
wild type single CVMNK haplotype was very high; Central study at 70.5% 
in 2009 and 74.8% in 2010 and in Southern study site at 65.4% in 2010 
and 71.0% in 2011. Comparing data with older studies in Senegal, a 
sharp decline of the mutant type Pfcrt prevalence is evident. From 65%, 
64% and 59.5% in samples collected from various sites in 2000, 2001 
and 2004, to approximately 30% in our study. A similar decrease in 
mutant type prevalence is noted in other neighboring countries. With the 
continued development of increased CQ susceptibility in many African 
countries it may be possible to re-introduce CQ again in the near future, 
in a drug combination, possibly given to non-vulnerable groups and 





MONITORING ANTIMALARIAL DRUG RESPONSE IN 
PLASMODIUM FALCIPARUM FIELD ISOLATES USING AN EX 
VIVO DAPI ASSAY
Baba Dieye1, Daria Van Tyne2, Rachel Daniels2, Amy Bei2, Yaye Dié 
Ndiaye1, Mouhamadou Ndiaye1, Omar Ndir1, Souleymane Mboup1, 
Clarissa Valim2, Amanda Lukens2, Dan Milner2, Sarah K. Volkman2, 
Dyann F. Wirth2, Daouda Ndiaye1
1Universite Chekh Anta Diop, Dakar, Senegal, 2Department of Immunology 
and Infectious Diseases, Harvard School of Public Health, Boston, MA, 
United States
Malaria treatment efforts are hindered by the rapid emergence and 
spread of drug resistant parasites. Simple assays to monitor parasite 
drug response in clinical samples are important, as they can detect drug 
resistance before it becomes clinically apparent as well as inform changes 
in treatment policy to help prevent the spread of resistant parasites. We 
surveyed malaria cases in a clinic in Thiés, Senegal from 2008-2011 and 
employed a DAPI-based ex vivo drug assay to test parasite response to 
amodiaquine, chloroquine and mefloquine in approximately 400 clinical 
isolates. We genotyped known drug resistance-associated mutations and 
culture adapted a subset of parasites in order to compare their in vitro 
and ex vivo drug responses. The DAPI ex vivo drug assay is comparable or 
superior to SYBR-based assays using clinical samples, with a median signal 
to noise ratio of 4:1 and excellent agreement between technical replicates. 
Mutations in pfcrt and pfmdr1 were associated with changes in drug 
response, and we observed strong concordance between the ex vivo and 
in vitro IC50s of culture adapted parasites. Overall, the DAPI ex vivo assay is 
robust and can be used to monitor parasite response to antimalarial drugs 
in field settings.
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SNPS ON ABC TRANSPORTERS AND IN VIVO MALARIA 
PARASITE NON CLEARANCE AFTER CHLOROQUINE 
TREATMENT IN MALIAN CHILDREN
Mamadou Wele1, Abdoul Habib Beavogui2, Mahamadou Tekete1, 
Antoine Dara1, Demba Dembele1, Abdoulaye Djimde1
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Mafèrinyah, Guinea
Plasmodium falciparum malaria remains one of the major causes of 
morbidity and mortality in sub-Saharan Africa. PfCRT K76T mutation 
was demonstrated to play a central role in the P. falciparum resistance 
to chloroquine. Previous study have shown that SNPs on several ABC 
transporters genes are associated with in vitro chloroquine resistance. 
We aimed to find any association between SNPs on ABC transporter and 
the in vivo parasite non clearance after chloroquine treatment in Mali. 
We carried out a chloroquine efficacy study in the rural village of Kollé, 
Mali. P falciparum DNA was extracted from filter paper and SNPs on Pfcrt, 
Pfmdr1, PfG30 and PfG47 were analyzed by nested and MS PCR.The study 
protocol and informed consent document were reviewed and approved 
by the National ethical committee.The data were statistically analysed 
by Epi Info® and STATA. 196 children suffering from uncomplicated 
malaria were included and 54 (27.5%)of them failed to the treatment at 
D14. The mutant alleles Pfcrt 76T and Pfmdr1 86Y were associated with 
parasite non clearance with p=0.00001 and 0.03 respectively. However, 
the association of SNPs on PfG30 and PfG47 genes with parasite non 
clearance was not statistically significant, p =0.43 and 0.57 respectively. 
The logistical regression analysis showed that the mutant allele Pfmdr186Y 
contributed positively to the Pfcrt 76T parasites non clearance (p=0.02). 
This gene has been already described as a modulator of chloroquine 
resistance in several in vitro and in vivo studies from different settings. 
However, the SNPs on PfG30 and PfG47 genes did not contribute to the 
parasite non clearance. In conclusion, our findings have shown a lack of 
association between SNPs on the new putative transporters genes and 
parasite non clearance in children in Mali. But Pfcrt76T and Pfmdr186Y 
alleles were associated with the in vivo parasite non clearance in these 
settings.
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PREVALENCE OF MUTATION OF PFCRT AFTER THE USE OF 
AMODIAQUINE IN INTERMITTENT PREVENTIVE TREATMENT 
IN CHILDREN (IPTC) IN SENEGAL
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Chloroquine was until 2002 the most commonly drug used against 
uncomplicated malaria in Africa in general and Senegal in particular. 
After several years of the withdrawal of chloroquine due to an high 
level of resistance of Plasmodium falciparum. Studies were conducted 
in Africa and showed a decline in the prevalence of resistance marker 
pfcrt-76T, molecular marker of P. falciparum resistance to chloroquine and 
amodiaquine. In Senegal the IPTc is a strategy for proventing malaria in 
children using sulfadoxine-pyrimethamine and amodiaquine. So the aim 
of this study is to evaluate the prevalence of pfcrt mutation in Senegal 
after three years of implementation of IPTc. This study was conducted 
in three health districts in Senegal (Mbour, Fatick and Bambey) with 54 
health posts. The genotype of the pfcrt gene for polymorphisms C72S 
and K76T was determined in at least two multiplex real-time PCR runs 
with full agreements using the Rotorgene 3000 platform representing 
CVIET, CVMNK and SVMNT haplotypes. 3D7, Dd2 and 7G8 DNA obtained 
from the Malaria Research Reagent Resource (MR4) was used to provide 
sequence-specific positive control and nuclease free water was included 
as a negative control. Analysis was done with 47 isolates in 2008, all 
2009 samples (n= 42) and 116 of the 125 isolates in 2010, were PCR 
positive. 10 (21%), 21 (48%) and 48 (41%) carried the CVIET haplotypes 
in 2008, 2009 and 2010 respectively. The SVMNK haplotypes were 
found in 32 (68%), 18 (42%) and 58 (50%) isolates in 2008, 2009 and 
2010 respectively. Mixed haplotypes infections (CVMNK/CVIET) were 
found in 5 (10%), 3 (6%) and 10 (8%) of the 2008, 2009 and 2010 
samples respectively. The SVMNT haplotypes was not found in any of the 
isolates. The prevalence of pfcrt mutation between 2004 and 2006 was 
approximately 60% in Senegal and Kenya, as reported previously. In our 
study, we found a decrease in the prevalence of pfcrt gene resistance 
compared to previous level in Senegal and in Africa. However this level 
remains high with percentages of 48% observed in 2009.
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PREVALENCE OF MOLECULAR MARKERS OF SULPHADOXINE-
PYRIMETHAMINE RESISTANCE IN AN AREA OF INTENSE, 
YEAR-ROUND MALARIA TRANSMISSION IN RURAL MALAWI
Dyson A. Mwandama
University of Malawi College of Medicine, Blantyre, Malawi
Malaria infection in pregnancy is associated with severe maternal 
morbidity and increased perinatal mortality. Although sulphadoxine-
pyrimethamine (SP) is no longer recommended as treatment for 
uncomplicated malaria due to resistance, SP is still recommended for 
intermittent preventive treatment in pregnancy (IPTp). Increasing resistance 
threatens the use of SP for IPTp. In 2010, we conducted cross sectional 
studies of the prevalence of molecular markers of resistance to SP among 
parasitemic patients presenting to the outpatient department (OPD) and 
delivery ward of Machinga District Hospital. In addition, pregnant women 
between 16 and 32 weeks of gestation with asymptomatic parasitemia 
were enrolled from antenatal clinic (ANC). Polymerase chain reaction 
was performed to examine molecular markers for SP resistance. Not all 
specimens could be amplified at all loci, therefore, percentages are given 
out of those that were amplified. We enrolled 196 OPD attendees and 291 
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pregnant women: 245 from ANC, and 46 at delivery. Primigravidae made 
up 44% of those from ANC and 59% of those at delivery. The overall 
prevalence of double (Gly-437/Glu-540 dhps), triple (Asn-108/Ile-51/
Arg-59 dhfr) and quintuple mutants (double plus triple) was high (98%, 
93%, and 92%, respectively), with no statistical difference among the 
groups. The prevalence of dhfr 164 was low (2%). The prevalence of dhps 
613 was higher in OPD attendees than pregnant women (19% vs 5.4%, 
p-value=0.003). The prevalence of dhps 581 was high among pregnant 
women at delivery (37% vs 2.6% at ANC and 1.3% in OPD, p-value 
<0.0001). In this study characterizing molecular markers of Plasmodium 
falciparum resistance to SP in Malawi, the prevalence of the quintuple 
mutant was high, while the prevalence of dhfr 164 remained uniformly 
low. The prevalence of dhps 581 is significantly higher among pregnant 
women at delivery, suggesting that IPTp with SP during pregnancy is 
selecting for this mutation. Given the high levels of molecular resistance to 
SP, we need to develop new tools for preventing malaria in pregnancy.
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RESISTANT HAPLOTYPES IN THE SOUTH BUT NOT IN THE 
NORTH OF CÔTE-D’IVOIRE
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The national malaria treatment policy changed twice in 2003 from 
Chloroquine to Amodiaquine, then in 2005 (adoption of ACT). However, 
the gap between the time of decision and the effective implementation 
of switch to ACT favored an abusive used of CQ and SP. The nationwide 
coverage of recommended ACTs is not quite effective due in part to 
disparities in the distribution of heath care infrastructures which are more 
concentrated in the south and mainly in Abidjan the economical capital 
of Cote-d’Ivoire. The level of resistance to CQ and SP in the country may 
greatly varies according to local usage of these two drugs. A prospective 
study was undertaken in Côte-d’Ivoire in 2008–2009 to assess by means 
of the pyrosequencing technology, the distribution of allelic frequencies 
of molecular markers associated with resistance to CQ and SP between 
two sites from the south and one site from the north, in 2008, after the 
changes of treatment policy for acute Plasmodium falciparum malaria in 
Côte-d’Ivoire. A total of 123, and 86 samples were collected from two 
southern sites, Ayamé and Anonkoua-kouté respectively, and 121 samples 
were collected from, Dabakala up north. Out of the samples collected 
from each of the three sites, 98 samples from the district of Ayamé were 
successfully amplified, 80 from Anonkoua-kouté, and 117 from Dabakala. 
As major finding this work points out that in 2008, the prevalence of the 
three key resistance-conferring haplotypes, the triple mutants Pfcrt IET 
and Pfdhfr IRN, and the simple mutant Pfdhps SGK, were higher in Ayamé 
and Anonkoua-kouté in the south while the sensitive haplotype Pfcrt MNK 
significantly predominated in Dabakala. The triple mutant IRN was rare 
at North. While ACTs are strongly recommended in the country to treat 
malaria, our work indicates a variable CQ and SP pressure nationwide. 
Mainly, these two drugs are still in used in the south where pressure is 
higher than up north. There could be a variable level of compliance to 
malaria treatment recommendations from the malaria control program.
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INVESTIGATING THE ROLE OF CANDIDATE MOLECULAR 
MARKERS OF LUMEFANTRINE AND AMODIAQUINE 
RESISTANCE IN CLINICAL OUTCOMES OF ARTEMISININ 
COMBINATION THERAPIES (ACT) OF PLASMODIUM 
FALCIPARUM MALARIA
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States, 2Tropical Medicine Research Institute, Khartoum, Sudan, 
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The initial reduction in peripheral Plasmodium falciparum parasitemia 
following artemisinin-based combination therapy (ACT) is driven 
predominantly by the potency and rapid action of the artemisinin 
component, but overall efficacy requires sustained therapeutic 
concentrations of the longer-acting partner drug. Candidate molecular 
markers associated with resistance in the pfcrt and pfmdr1 genes of P. 
falciparum have been reported to be involved in decreased sensitivity to 
amodiaquine and lumefantrine. However, the utility of these markers 
for predicting therapeutic responses to artesunate-amodiaquine and 
artemether-lumefantrine remains unclear. Correlation studies are 
confounded by the overall high PCR-corrected parasitological cure rates 
associated with these ACTs and by regional variation in immunity and 
parasite genetic background. Seventeen research groups have pooled 
their data on treatment outcomes and candidate resistance markers from 
efficacy studies conducted in different parts of the world. A total of 27 
studies with 5,300 patients in 15 countries were included in the analysis. 
Our objectives were to investigate whether known polymorphisms in 
P. falciparum can predict treatment outcomes following artemether-
lumefantrine and artesunate-amodiaquine therapy, and to determine 
whether resistance-associated genotypes are selected in recurrent 
infections. We have investigated associations between polymorphisms 
in pfcrt and pfmdr1 at the time of treatment and parasite clearance, 
recurrence, and PCR-determined recrudescence and reinfection. We have 
also assessed early and post-treatment selection of resistance-mediating 
genotypes. The results of these pooled analyses will clarify the roles of 
molecular markers for partner-drug resistance in monitoring ACT efficacy 
and will help to guide the selection of informative genetic markers in 
future studies.
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ASSOCIATION OF PFMDR1 AND PFCRT POLYMORPHISMS 
WITH SLOW CLEARANCE OF PLASMODIUM FALCIPARUM 
AFTER ARTEMISININ COMBINATION THERAPY IN WESTERN 
KENYA
Khalid B. Beshir, Rachel Hallett, Teun Bousema, Colin Sutherland
London School of Hygiene & Tropical Medicine, London, United Kingdom
Artemisinin Combination Therapies (ACTs) are now considered the best 
treatment for Plasmodium falciparum malaria and have been widely 
deployed. A decline in the efficacy of artemisinin monotherapy in 
western Cambodia, characterized by slow parasite clearance, has recently 
been reported. The molecular mechanism of this reduced response to 
artemisinins has not been established. Artemisinins are thought to act 
within the parasite digestive vacuole and proteins found on the vacuole 
membrane may play a role in modulating drug sensitivity. Genes encoding 
two such proteins, pfcrt and pfmdr1, have been analyzed for sequence 
polymorphisms in samples collected during a clinical trial of artemether-
lumefantrine (AL) and dihydroartemisinin-piperaquine (DHA-PIP) in Kenya 
in 2009. Genotypic analysis of the results showed significant associations 
between slow parasite clearance and CQ-sensitive haplotypes of pfmdr1 
and pfcrt as measured by real-time quantitative PCR. The amino acid NFD 
haplotype at codons 86, 184, 1246 of pfmdr1 and CVMNK haplotype at 
codons 72-76 of pfcrt have also shown evidence of selection on day-3 
after ACT treatment compared to day-0 prevalence. Previously published 
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data suggest that the selection of parasites carrying CQ-sensitive 
haplotypes of pfmdr1 and pfcrt could be attributed to the non-artemisinin 
partner drugs such as lumefantrine. This in vivo genotypic data in the 
present study supports the in vitro correlation between CQ-sensitive 
haplotypes of pfmdr1 and pfcrt and decreased sensitivity to artemisinins 
found in other studies. This study indicates for the first time that the 
CQ-sensitive haplotypes of pfmdr1 and pfcrt are associated with reduced 
response to artemisinins in vivo.
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Village/ Mobile Malaria Workers (VMWs/MMWs) are a critical component 
in Cambodia’s national strategy to reduce malaria morbidity and 
mortality. Since 2004, VMWs have been providing free malaria diagnosis 
and treatment using Rapid Diagnostic Tests and Artemisinin-based 
Combination Therapies in hard-to-reach villages (>5km from closest 
health facility). VMWs play a key role in control and prevention, diagnosis 
and treatment of malaria as well as in delivering behavioral change 
communication (BCC) interventions to this target population. To evaluate 
the implementation of these activities performed by VMW/MMWs, a 
quantitative and qualitative assessment was conducted in 5 provinces 
of western Cambodia in order to: (i) understand job satisfaction of 
VMWs and MMWs vis-a-vis their roles and responsibilities; (ii) assess their 
performance according to their job descriptions; and (iii) gain insights 
into the challenges faced in delivery of diagnosis, treatment and health 
education activities to their communities. A total of 196 VMWs/MMWs 
were surveyed in October 2011 using a combination of quantitative 
and qualitative methods. Triangulation of quantitative and qualitative 
data helped to gain a deeper understanding of the success factors of 
this intervention and the challenges faced in implementation. Overall, 
levels of VMW performance were in line with the expected performance 
(80%); however, some performance gaps were identified in the areas of 
knowledge of malaria symptoms, treatment regimens, and key messages. 
In particular, there were low levels of practice of the recommended direct 
observed therapies (DOTs) approach for malaria treatment (especially for 
the second and third doses), reportedly caused by stock-outs, distance 
and transportation. The national malaria program should aim to focus 
on improving knowledge of VMWs in order to address misconceptions 
and barriers to effective implementation of DOTs at community-levels. 
In addition to the findings, the tools developed, will potentially help the 
national program to come up with better indicators in the near future. 
Findings from this evaluation are being used to inform planning of future 
activities and interventions such as DOT in a context where artemisinin 
drug resistance is a significant public health issue.
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SELECTION OF PLASMODIUM FALCIPARUM STRAINS WITH 
REDUCED SENSITIVITY TO THE HIV PROTEASE INHIBITOR 
LOPINAVIR
Christian Nsanzabana, Philip J. Rosenthal
University of California San Francisco, San Francisco, CA, United States
Some HIV protease inhibitors (PIs) are active against cultured malaria 
parasites at concentrations that are clinically relevant. Lopinavir acted 
against multiple laboratory strains of Plasmodium falciparum with an IC50 
of 1-3µM, and against two freshly cloned strains from Tororo, Uganda 
with IC50 of 1.7µM. With standard dosing of lopinavir/ritonavir, lopinavir 
circulates at ~9-19 µM. Importantly, in an ongoing clinical trial, children 
treated for HIV infection with a lopinavir-ritonavir-based antiretroviral 
regimen experienced a 41% decrease in the incidence of malaria 
compared to children treated with a non-nucleoside reverse transcriptase-
based regimen. Impacts of the PI on malaria were likely due principally to 
pharmacokinetic interactions between ritonavir and lumefantrine, but also 
the direct antimalarial activity of lopinavir. The antimalarial mechanism of 
action of HIV PIs is uncertain, although it is likely that they act against one 
or more of the ten plasmodial aspartic proteases known as plasmepsins. 
To help to characterize mechanisms of action and resistance, we selected 
malaria parasites with decreased sensitivity to lopinavir. We cultured the 
P. falciparum multidrug resistant reference strain W2 and the sensitive 
strain 3D7 with selective concentrations of lopinavir for fourteen months. 
Changes in sensitivity were selected only very slowly. The strains obtained 
after culture for 212 cycles under lopinavir pressure had IC50s of ~10µM 
for both strains, corresponding to three times the IC50 of the parental 
strains. We are currently cloning parasites with reduced sensitivity to 
lopinavir and assessing the stability of the phenotype when drug pressure 
is removed. Differences between parasites with varied sensitivity will 
be assessed, including sequencing of plasmepsin genes. Our goal is to 
determine if alterations in lopinavir sensitivity selected in culture are due 
to specific genetic changes in plasmepsin genes or other portions of the P. 
falciparum genome. If alterations mediating changes in lopinavir sensitivity 
are identified, surveillance for these genetic determinants may help to 
guide optimal antiretroviral therapy in HIV-infected children at risk of 
malaria.
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MOLECULAR MARKERS OF ANTIMALARIAL DRUG 
RESISTANCE IN SOUTH-CENTRAL VIETNAM
Marina Chavchich1, Kerryn Rowcliffe1, Nguyen Dang Kim2, Vu 
Huy Chien2, Nguyen Xuan Thanh2, Trieu Nguyen Trung3, Nguyen 
Chinh Phong2, Nguyen Xuan Thien3, Huynh Hong Quang3, Bui 
Dai2, George Dennis Shanks1, Michael Douglas Edstein1
1Australian Army Malaria Institute, Enoggera, Australia, 2Military Institute 
of Hygiene and Epidemiology, Hanoi, Vietnam, 3Institute of Malariology, 
Parasitology and Entomology, Qui Nhon, Vietnam
Malaria control programs introduced in Vietnam since 1990s have 
resulted in significant reduction in the number of malaria cases and 
deaths from the disease. Introduction of artemisinin derivatives and later 
artemisinin-based combination therapies (ACTs) for malaria treatment 
have contributed greatly to the overall success of this program. However, 
recent reports by WHO of reduced susceptibility of artesunate in Binh 
Phuoc Province in south Vietnam is of immense concern, which may 
hamper future efforts to control malaria in the country. Since 2006, we 
have conducted four drug efficacy trials (i.e. artemisinin-piperaquine, 
dihydroartemisinin-piperaquine and two formulations of artesunate-
amodiaquine) in Phuoc Chien Commune, Ninh Thuan Province in 
south-central Vietnam for the treatment of uncomplicated Plasmodium 
falciparum malaria. The ACTs were found to be highly effective with 
PCR-corrected cure rates >98%. In the present study we have analysed 
the in vitro susceptibility of the field isolates collected in these trials 
to the commonly used antimalarials, as well as the polymorphism in 
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the major drug resistant markers: pfcrt, pfdhfr-ts and pfmdr1. Data on 
the prevalence of polymorphisms in these markers, as well as the drug 
susceptibility profiles of the clinical isolates will be discussed in the context 
of the ACT efficacy trials results. We also compared our findings at Ninh 
Thuan Province with published data from Binh Phuoc Province.
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CONTRASTING PATTERNS OF PLASMODIUM 
VIVAX MULTIDRUG RESISTANCE GENE 1 (PVMDR1) 
POLYMORPHISMS IN THAILAND AND CAMBODIA
Jaymin C. Patel1, Jessica T. Lin2, Oksana Kharabora2, William 
Rogers3, Jetsumon Sattabongkot4, Ratawan Ubalee4, Anthony 
Schuster4, Duong Socheat5, Chansuda Wongsrichanalai6, Jonathan 
J. Juliano2
1Department of Epidemiology, Gillings School of Global Public Health, 
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 
2Division of Infectious Diseases, University of North Carolina School of 
Medicine, Chapel Hill, NC, United States, 3Naval Medical Research Unit #2, 
Phnom Penh, Cambodia, 4Department of Entomology, U.S. Army Medical 
Component Armed Forces Research Institute of Medical Science, Bangkok, 
Thailand, 5National Malaria Center, Phnom Penh, Cambodia, 6Institut 
Pasteur du Cambodge, Phnom Penh, Cambodia
Plasmodium vivax remains a major source of malaria-related morbidity 
in Thailand and Cambodia. Data on drug resistance polymorphisms in 
vivax malaria populations from this region remains sparse. Studies have 
linked polymorphisms in the P. vivax multidrug resistance (pvmdr1) gene 
to chloroquine resistance and increase in pvmdr1 copy number to reduced 
susceptibility to mefloquine and other ACT partner drugs. In this study, 
we compared pvmdr1 resistance patterns between clinical isolates from 
northwestern Thailand and southern Cambodia collected between 2006 
and 2009. Pvmdr1 copy number was quantified by a novel multiplex 
Taqman® real time PCR assay in 109 Cambodian and 49 Thai samples. 
Copy number was considered increased if the calculated value was greater 
than 1.7. Isolates were also sequenced to characterize the prevalence 
of two pvmdr1 mutant SNPs (Y976F and F1076L). In total, a greater 
proportion of Cambodian isolates harbored the 976F mutation correlated 
with chloroquine resistance (90% vs. 7.1%, p<0.001), while a greater 
proportion of Thai isolates displayed increased Pvmdr1 copy number 
(20% vs. 0.9%, p<0.001). Prevalence of double mutants was higher 
among Cambodian isolates than Thai isolates (95% vs. 7.7%, p<0.001). 
The 1076L single mutant was dominant among Thai samples; while both 
mutations occurred together in the vast majority of Cambodian samples. 
Our data highlight contrasting patterns of pvmdr1 polymorphisms in 
Thailand versus Cambodia. Selection for different Pvmdr1 haplotypes in 
these two areas has likely been shaped by different drug policies in the 
two countries. Further studies looking at the distribution of drug resistance 
alleles using microsatellites will help us gain a better understanding of the 
evolution of drug resistant P.vivax malaria.
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COMPARING CHANGES IN EFFICACY OF ARTESUNATE-
MEFLOQUINE COMBINATIONS FOR THE TREATMENT OF 
UNCOMPLICATED FALCIPARUM MALARIA IN THAILAND 
DURING FIVE YEARS OF CLOSED DRUG MONITORING (2006-
2010)
Wichai Satimai1, Kanungnit Congpuong1, Pongwit Bualombai1, 
Arunya Pinyorattanachote2, Kalaya Tunchan3, Somchai 
Inthanakom4
1Bureau of Vector Borne Diseases, Nonthaburi, Thailand, 2Office of Disease 
and Prevention No. 11, Nakornsithammarat, Thailand, 3Office of Disease 
Prevention and Control No. 9, Tak, Thailand, 4Office of Disease Prevention 
and Control No. 12, Songkla, Thailand
The treatment of uncomplicated Plasmodium falciparum malaria in 
Thailand has been modified several times during the past 30 years to 
counter the rapid emergence and spread of drug resistance. This study 
was to compare the changes in efficacy of two-day and three-day 
combination of artesunate and mefloquine (ASM2 and ASM3). The study 
was conducted during 2006-2010 in 7 international bordered provinces 
to Burma, Cambodia and Malaysia. A total of 1,034 Uncomplicated 
falciparum malaria patients were enrolled in two phases, during 2006 and 
2007, received ASM2 while those recruited during 2008-2010 received 
ASM3. All were followed for 42 days. This study found that the efficacy of 
artesunate-mefloquine combination was not only based on the drugs, but 
also the treatment regimen and variation of parasite genetics in different 
locations. Continuation of the monitoring of antimalarial drugs efficacies 
are necessary to cope up with the changing in efficacies.
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A RANDOMIZED TRIAL OF TEXT MESSAGE REMINDERS TO 
INCREASE ADHERENCE TO MALARIA TREATMENT
Julia Goldberg, Guenther Fink
Harvard School of Public Health, Cambridge, MA, United States
Despite the massive international efforts made over the past decades, 
malaria continues to be one of the primary causes of under-5 mortality 
worldwide. Several recent studies document low adherence to artemisinin-
based combination therapies (ACTs). Low adherence undermines the 
chances of patients fully recovering from acute malaria and increases 
the likelihood of the emergence of resistant strains of the parasite. We 
conducted a randomized controlled trial to investigate the impact of 
text message reminders on adherence to ACTs in Tamale, Ghana. One 
thousand one hundred forty participants were recruited from drug 
shops, licensed chemical sellers, public and private hospitals, and other 
ACT vendors when purchasing malaria medicine. Participants were 
randomized by automated system to the treatment group or the control 
group. Patients in the treatment group received six reminders, one for 
each dose of malaria treatment, sent out in 12 hour intervals. The primary 
outcome was adherence based on completion of treatment regimen. 
Adherence was assessed through observation of pill-packets and through 
self-reports at unannounced home follow-up visits timed to coincide with 
the completion of treatment. The follow-up rate was 99.6%. Receiving 
text message reminders increased the odds of adherence by 34% (95% 
CI [0.992-1.810], p-value 0.056) when a short message was used, and 
by 0% (95% CI [0.747-1.316], p-value 0.954) when a long message was 
used. Text message reminders appeared to work best when sent to the 
caretaker of child patients, with short messages increasing the odds of 
adherence by 125% (95% CI [1.299-3.890], p-value 0.004).
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THE INFLUENCE OF ENVIRONMENTAL RISK FACTORS AND 
INDIVIDUAL BEHAVIORS ON MALARIA OCCURRENCE IN 
LAHAD DATU DISTRICT OF SABAH, MALAYSIA: A CASE 
CONTROL STUDY
Abdul Marsudi Manah1, Shamsul Azhar Shah2, Rohaizat 
Hassan2, Mohd Yusof Ibrahim3
1Sabah State Health Department, Keningau, Malaysia, 2National University 
of Malaysia, Kuala Lumpur, Malaysia, 3Sabah State Health Department, 
Kota Kinabalu, Malaysia
Malaria is a parasitic disease and continue to be a major public health 
problem worldwide, it is estimated that 300 million people were infected 
by malaria with more than a million deaths throughout the world. 
In Malaysia, malaria incidence has decreased from 23.4 per 10 000 
population in 1991 to 2.8 cases per 10 000 population in 2003. The 
incidence of malaria in the state of Sabah is the highest in Malaysia. In 
2004, the incidence was 9.56 cases per 10 000 population which was 
the highest among the states. In the same year, Lahad Datu district 
recorded incidence of 24 cases per 10 000 population. Thus, this study 
was conducted to identify the factors which influence malaria infection in 
Lahad Datu district of Sabah. Malaria cases which were notified to district 
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health office from 1st January until 31st July 2008 which met with the 
inclusion criteria were included in the study. A total of 166 pairs of cases 
and controls which were matched by age, sex and mukim were analyzed. 
McNemar Odds Ratio (ORM) calculated using McNemar Calculator for 
bivariate analysis while Conditional Logistic Regression was used for 
multivariate analysis. Data were coded and analyzed by using SPSS version 
12.0. From the results, most of the malaria patients (95%) that included 
in the study were below 50 years old. 80.7% were male and only 19.3% 
were female. Based on ORM it was found that socioeconomic status, risk 
perception, movement, preventive behaviours, house structure and design, 
and presence of potential mosquito-breeding place were risk factors for 
malaria infection. Multivariate analysis showed cases were more likely to 
have a high risk occupation (OR= 4.14, 95% CI= 1.04-16.57), low risk 
perception towards danger of malaria (OR= 6.01, 95% CI= 1.22-29.63), 
no residual spray done at home (OR=3.70, 95% CI=1.02-13.39) and have 
history of movement in the last two weeks (OR=5.25, 95% CI= 1.03-
26.71). As a conclusion, some individual behaviours and preventive factors 
are strong risk factors for the occurrences of malaria cases in Lahad Datu 
district. With the identification of the potentially modifiable risk factors, a 
proper public health intervention can be implemented.
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ELEVATED INCIDENCE OF NON-FALCIPARUM MALARIA 
DURING THE RAINY SEASON 2011 IN NIGER
Gary L. Roark1, Patrick J. Hickey2
1CURE Hospital, Niger, Niamey, Niger, 2Tropical Public Health Department 
of Preventive Medicine and Biometrics, Uniformed Services University of 
the Health Sciences, Bethesda, MD, United States
Non-falciparum malarias are not benign disease states, but little attention 
is devoted to them in sub-Saharan Africa due to the prominence of 
falciparum malaria and its attendant complications. Most studies in sub-
Saharan western Africa describe the frequency of non-falciparum malarias 
as 10% or less. Following implementation of a 2 step protocol utilizing 
both light microscopy (LM) and the addition of a malaria rapid diagnostic 
test (RDT) (Standard Diagnostics, Malaria Antigen, 05FK60) a retrospective 
review of laboratory records for 282 patients during a single four month 
rainy season was performed. Results indicated a higher than anticipated 
frequency of 24.6% positive tests for non-falciparum malaria species and 
79.4% falciparum-positive tests. When LM alone was used for diagnosis, 
the rate of positive smears was 79%. When LM was combined with 
an RDT, the rate of positive tests decreased to 32%. With a population 
suffering from high prevalence of malnutrition and disadvantaged 
economic status, the Nigerien population is at significant risk from non-
falciparum malarias. Potential reasons for an elevated incidence of non-
falciparum malaria in this population are discussed.
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THE EVALUATION OF EASY ACCESS GROUPS AS A 
TOOL FOR MONITORING TEMPORAL CHANGES IN 
MALARIA TRANSMISSION AND COVERAGE OF CONTROL 
INTERVENTIONS IN MALAWI: THE EVALMAL STUDY
Sanie S. Sesay1, Arantxa Roca-Feltrer1, David Lalloo2, Feiko ter 
Kuile2, Sanjoaquin Miguel3, Dianne Terlouw4
1Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, 
Malawi, 2Liverpool School of Tropical Medicine, Liverpool, United 
Kingdom, 3Malawi-Liverpool-Wellcome Trust Clinical Research Programme 
and Liverpool School of Tropical Medicine, Blantyre, Malawi, 4Malawi-
Liverpool-Wellcome Trust Clinical Research Programme and Liverpool 
School of Tropical Medicine, Liverpool, United Kingdom
Currently recommended tools for measuring progress of malaria control 
involve large, logistically and financially demanding population-based 
household surveys that provide national and provincial level estimates at 
intervals of 2 - 5 years. Since malaria transmission intensity and disease 
incidence can vary widely within a country though, programmatic 
decisions are often made at district level. With the change of focus from 
control of burden to reduction of transmission and the recent progress 
made, malaria trends in older (and asymptomatic) age groups become 
more important. Timely, valid, low-cost district and local level estimates of 
short- and medium-term control progress are urgently needed to support 
the move towards the control and elimination of malaria. Opportunistic 
sampling in planned or spontaneous aggregations of sub-groups of the 
population, the so-called Easy Access Groups (EAGs), offers the prospect 
of a less resource intensive method of deriving estimates of control 
progress. Children >4 months presenting at the EPI vaccination clinic at 
Chikwawa District Hospital, any accompanying older sibling(s) aged <15 
years, and their parents/guardians were surveyed monthly since April 
2011. A modified version of the RBM MERG MIS questionnaire will be 
administered to the parent/guardian. A finger blood sample was collected 
for a blood film, a malaria rapid diagnostic test, haemoglobin assessment 
and a filter-paper blood spot for serology. The estimates of burden of 
disease and uptake of control interventions were compared to that of a 
rolling Malaria Indicator Survey (rMIS) in the same population. The data 
presented is from the first year of the study (April 2011 - March 2012). 
The results will focus on the comparison of estimates derived from the EPI 
EAG and the rMIS. In conclusion, we determined if valid population level 
estimates of malaria intervention coverage and burden indicators and their 
short-term temporal trends can be obtained from opportunistic sampling 
in EAGs
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NON-RANDOM ASSOCIATIONS OF T-CELL EPITOPES IN 
PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN, 
LILONGWE, MALAWI
Nagesh (Nash) R. Aragam1, Nabi Nge2, Irving Hoffman1, Feng-
Chang Lin1, Colin J. Sutherland2, Jeffrey A. Bailey3, Jonathan J. 
Juliano1
1University of North Carolina, Chapel Hill, NC, United States, 2London 
School of Tropical Medicine and Hygiene, London, England, United 
Kingdom, 3University of Massachusetts School of Medicine, Worcester, 
MA, United States
Cellular immunity to Plasmodium falciparum circumsporozoite protein 
(CS) is mediated by two immunodominant T cell epitopes (TH2 and 
TH3). Recent studies have found non-random associations between 
these epitopes in natural parasite populations, suggesting constraints 
on permissible TH2/TH3 combination haplotypes. Using sequence data 
from parasites from Lilongwe, Malawi (235 isolates) and The Gambia (44 
isolates), we evaluated the extent of non-random association between 
the epitopes. In both populations, T-cell epitopes did not assort randomly. 
In fact, some combinations of TH2 and TH3 epitopes occurred more 
frequently than expected by random chance in both populations. The 
mechanism driving this deviation from random assortment is unclear; 
however it appears similar in parasite populations from East and 
West Africa. Potential explanations would include selection of certain 
combinations (by human immunity or within the mosquito host) or 
functional constraints on protein secondary/tertiary structure. Interestingly, 
among the Malawian isolates some of the most over represented 
combinations were highly similar to the T-cell epitopes contained in the 
RTS,S vaccine. In total, we found 118 (50.2%) isolates having at least 
a TH2 or TH3 epitope within one amino acid of the RTS,S vaccine type, 
while 230 (97.9%) have a TH2 or TH3 epitope within two amino acids of 
the RTS,S. Further characterization of this phenomenon is ongoing and is 




DIFFERING SIGNATURES OF SELECTION ON TWO 
PLASMODIUM VIVAX CANDIDATE VACCINE ANTIGENS
Christian M. Parobek1, Duong Socheat2, William O. Rogers3, 
Jonathan J. Juliano4
1School of Medicine, University of North Carolina at Chapel Hill, Chapel 
Hill, NC, United States, 2National Malaria Center, Phnom Penh, Cambodia, 
3Naval Medical Research Unit #2, Phnom Penh, Cambodia, 4Division of 
Infectious Diseases, University of North Carolina at Chapel Hill School of 
Medicine, Chapel Hill, NC, United States
To date, candidate vaccine antigens for Plasmodium vivax have primarily 
been selected based on their orthology to P. falciparum vaccine candidates. 
In several studies, falciparum antigens have shown genomic signatures 
of immune selection. However, few studies have evaluated if candidate 
vivax antigens show similar signatures of selection. We explored the 
genetic diversity of two P. vivax vaccine candidates, the circumsporozoite 
surface protein (pvcsp) and the merozoite surface protein 1 (pvmsp1), in 
a panmictic Cambodian vivax population, using scalable next-generation 
sequencing. We assessed these loci for evidence of selection and 
compared the results to similar analyses of other, geographically distinct P. 
vivax populations. In geographically diverse P. vivax populations, the 42-kd 
region of pvmsp1 consistently displayed a signature of strong balancing 
selection. Moreover, interspecies comparisons of orthologous antigens 
revealed that a subregion within the 42-kd block of pvmsp1 is under 
strong selection for non-synonymous nucleotide changes. In contrast 
to pvmsp1, the N-terminal and C-terminal conserved regions of pvcsp 
showed minimal evidence of balancing or directional selection. However, 
pvcsp sequences were highly heterogeneous, due to the central repeat 
region which appears to be under immune selection. As evidence, VK210 
repeat arrays display a significantly higher proportion of non-synonymous 
nucleotide polymorphisms compared to VK247 arrays. In addition, repeat 
length polymorphisms appear to have occurred by a rapid and recent 
expansion as determined by mismatch distributions of the repeat arrays. 
These results demonstrate that immune selection on these antigens likely 
results in two different adaptive patterns, each increasing the genetic 
diversity of these candidate vaccine antigens in a different way. Similar to 
falciparum malaria, genomic approaches to detect alleles under immune 
selection may identify novel targets of immunity.
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THE EFFECT OF MALARIA AT DELIVERY ON FETAL ANEMIA 
AND THE ROLE OF INTERMITTENT PREVENTIVE TREATMENT 
DURING PREGNANCY IN MALAWI
Elizabeth T. Rogawski1, Ebbie Chaluluka2, Malcolm E. 
Molyneux2, Gaoqian Feng3, Stephen J. Rogerson4, Steven R. 
Meshnick1
1University of North Carolina, Chapel Hill, NC, United States, 2Malawi-
Liverpool-Wellcome Trust Clinical Research Program, College of Medicine, 
University of Malawi, Blantyre, Malawi, 3Burnet Institute, Melbourne, 
Australia, 4Department of Medicine (RMH/WH), University of Melbourne, 
Melbourne, Australia
Fetal anemia is common in malarious areas and is a risk factor for infant 
morbidity and mortality. Malaria during pregnancy may decrease cord 
hemoglobin (Hb) and cause fetal anemia among newborns. Intermittent 
preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine 
(SP) is protective against malaria, but has also been hypothesized to 
contribute to fetal anemia by affecting hematopoiesis. Peripheral, 
placental, and cord blood were examined for malaria parasitemia and 
hemoglobin concentration in a cross-section of 3,848 mothers and 
infants delivered at Queen Elizabeth Central Hospital in Blantyre, Malawi 
between 1997 and 2006. Unconditional linear and logistic regressions 
were performed with multiple imputation for missing covariates to assess 
the associations between malaria, IPTp with SP, and fetal anemia (cord Hb 
<12.5 g/dL). The overall prevalence of fetal anemia was 7.9% (n=304). 
Malaria parasitemia at delivery was associated with an decrease in cord Hb 
of 0.24 g/dL (95% confidence interval (CI): 0.05, 0.42), adjusting for SP 
use, gravidity, year, and season of delivery. The adjusted prevalence odds 
ratio (POR) for the effect of malaria on fetal anemia was 1.41 (95% CI: 
1.05, 1.90). Primigravidae who did not take IPTp had infants at highest 
risk for fetal anemia (adjusted POR: 3.37; 95% CI: 1.68, 6.78), and 
density of parasitemia was correlated with a decrease in cord Hb of 0.33 
g/dL (95% CI: 0.14, 0.53) and 0.35 g/dL (95% CI: 0.13, 0.57) per log 
increase in placental and peripheral parasitemia respectively. There was 
no significant association between SP use and cord Hb or fetal anemia 
(adjusted POR: 0.98; 95% CI: 0.69, 1.39). Malaria during pregnancy, but 
not IPTp, decreases cord Hb and is a risk factor for fetal anemia in Malawi. 
IPTp with SP may continue to be safe and effective in preventing malaria 
during pregnancy and fetal anemia despite development of SP resistance.
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MODELLING THE DEVELOPMENT OF ACQUIRED IMMUNITY 
TO PLASMODIUM FALCIPARUM MALARIA
Elizabeth N. Githae
KEMRI Wellcome Trust Research Programme, Kilifi, Kenya
Development of immunity to malaria is a significant epidemiological 
process. It influences the transmission dynamics of the infection and 
disease, dictates how severe an infection will be and influences the 
evolutionary dynamics of the parasite due to host immune pressure. 
Despite the importance of immunity, it is unclear what mechanisms are 
involved in its development. The primary goal of this project is to describe 
the process of acquisition of immunity in a population with repeated 
exposure using a mathematical model of malaria transmission. A plethora 
of malaria control strategies have been implemented and others such as 
a malaria vaccine offer future prospects. The impact of these programmes 
on malaria transmission and subsequently the effect they have on the rate 
of development of immunity will also be evaluated in this study.
367
GENOTYPING OF PLASMODIUM FALCIPARUM USING 
ANTIGENIC POLYMORPHIC MARKERS AND TO STUDY 
ANTI-MALARIAL DRUG RESISTANCE MARKERS IN MALARIA 
ENDEMIC AREAS OF BANGLADESH
Jasmin Akter1, Kamala Thriemer2, Wasif Ali Khan1, Sullivan 
David3, Harald Noedl2, Rashidul Haque1
1International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh, 2Tropical Medicine, Medical University of Vienna, Vienna, 
Austria, 3Johns Hopkins Malaria Research Institute, Baltimore, MD, United 
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In the past many regions of Bangladesh were hyperendemic for malaria. 
Malaria control in the 1960s to 1970 eliminated malaria from the plains 
but the Chittagong Hill Tracts remained as a difficult to control reservoir. 
Northeastern Bangladesh with many tea plantations has malaria rates 
below 1% with approximately 10-20% Plasmodium vivax. The Chittagong 
Hill Tracts have areas with between 1 and 10% annual malaria rates 
predominately 90-95% P. falciparum. In southeastAsia multiplicity of 
infection for hypoendemic regions has been approximately 1.5. Few 
studies on the population dynamics of P. falciparum have been performed 
in Banlgadesh. Here we report polymorphic and drug resistant genotype 
analysis on 33 paired recrudescent infections after drug treatment in 
the period 2004-2008 in the Chittagong Hill Tracts which is just prior to 
countrywide provision of artemisinin combination therapy. Overall the 
multiplicity of infection for MSP-1 was 2.7 with a slightly smaller parasite 
diversity post-treatment. The 13 monoclonal infections by both GLURP and 
MSP-1 were evenly divided between pre- and post-treatment. The MSP-
1 MAD block was most frequent in .66 of the samples. The prevalence 
of the K76T PfCRT chloroquine resistant allele was approximately 82% 
of the samples, while the resistant Pfmdr1 N86Y was present in 33% of 
the samples. Interestingly the post-treatment samples had a small but 
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significantly higher amount of the sensitive PfCRT alleles by RT-PCR. In 
conclusion, the parasite population retains a high population diversity 
despite hypoendemic transmission with retention but decrease in the 
chloroquine resistant allele and Pfmdr1 resistant alleles.
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POPULATION STRUCTURE AND SPATIAL DISTRIBUTION OF 
PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN 
NANP REPEATS IN LILONGWE, MALAWI
Natalie M. Bowman1, Seth Condon1, Tisungane Mvalo2, Francis 
Martinson2, Irving Hoffman1, Steven R. Meshnick1, Jonathan J. 
Juliano1
1University of North Carolina School of Medicine, Division of Infectious 
Diseases, Chapel Hill, NC, United States, 2University of North Carolina 
Project Malawi, Lilongwe, Malawi
Humoral immunity to Plasmodium falciparum circumsporozoite protein 
(CS) is mediated by a central region of the protein containing a repetitive 
tetra-amino-acid repeat termed the “NANP repeat.” Genetic analysis 
suggests that variants with different repeat lengths have spread recently 
in the population by a rapid mechanism such as slip-strand mispairing. 
It has been suggested that this is an adaptive mechanism of the parasite 
to evade immune recognition by the host. In some studies of RTS,S 
vaccine efficacy, levels of antibodies to this region of CS have been the 
most highly correlated marker of protective immunity. To date there 
have been no descriptions of the population structure of P. falciparum 
based upon differences in these repeats. Using filter paper blood spots 
from 100 participants in a study in Lilongwe, Malawi, we used capillary 
electrophoresis to determine the size of the NANP repeat region of 
parasite variants. Preliminary results confirm that infection by multiple 
genetically distinct variants of the parasite is common and that genetic 
diversity of P. falciparum infections is similar in adults and children. As each 
participant is geolocalized, this allows us to assess the spatial distribution 
of parasite variants, spatial variation in parasite diversity and the impact of 
environmental factors (such as proximity to water) in a multivariable spatial 
model of this diversity using our ArcGIS database. Isolation-by-distance 
among parasites has been suggested in falciparum malaria in the past. 
The impact of parasite genetic diversity on many critical issues for malaria 
control remains unclear. Investigating parasite population structure and 
diversity can help us better understand immunity, response to selective 
pressures and evolution of the parasite.
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GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 
PREVALENCE IN THE GAMBIA
Joseph Okebe1, Alfred Amambua-Ngwa1, Jason Parr2, Sei 
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Current malaria treatment guidelines recommend the use of primaquine 
as gametocytocidal treatment for falciparum malaria in settings targeting 
elimination. However, fears on the primaquine’s potential hemolytic 
effect in individuals with glucose-6-phosphate dehydrogenase deficiency 
(G6PDd) have precluded its implementation, particularly in sub-Saharan 
African countries where the prevalence of G6PDd is either unknown or 
outdated. In this study, we present genotype and phenotype data in The 
Gambia and describe phenotype profiles for mutations with reported high 
prevalence in the Senegambia region. Filter paper blot spots from 3,100 
healthy children aged 6-14 years collected during a school survey were 
analysed. Enzyme activity was determined quantitatively with a commercial 
test Kit (Atlas Medical®) and results adjusted for individual haemoglobin 
level. The frequencies for the A (A376G) and A- variant mutations; 
G202A, T968C and A542T were determined using Taqman® assays. The 
correlations between genotype and enzyme activity was also studied. 
Fifty-two percent of children were male and the mean haemoglobin was 
12.4 (SD 1.3) g/dl. Preliminary analysis showed median activity of 6.5 
(range 0-22) U/g/Hb in the analysed subset. The prevalence the A (A376G) 
and A- (A202G) mutations was 37.8% and 4.0%, respectively. The wide 
range of enzyme activity observed together with a low prevalence of the 
A- (A202G) genotype suggests that phenotype-based assessment may be 
needed before wide scale use of primaquine.
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RESPONDENT-DRIVEN SAMPLING ON THE THAILAND-
CAMBODIA BORDER. I. CAN MALARIA CASES BE CONTAINED 
IN MOBILE MIGRANT WORKERS?
Piyaporn Wangroongsarb
Bureau of Vector Borne Disease, Nanthaburi, Thailand
Reliable information on mobility patterns of migrants is a crucial part of 
the strategy to contain the spread of artemisinin-resistant malaria parasites 
in Southeast Asia, and may also be helpful to efforts to address other 
public health problems for migrants and members of host communities. 
In order to limit the spread of malarial drug resistance, the malaria 
prevention and control programme will need to devise strategies to 
reach cross-border and mobile migrant populations. The Respondent-
Driven Sampling (RDS) method was used to survey migrant workers from 
Cambodia and Myanmar, both registered and undocumented, in three 
Thai provinces on the Thailand-Cambodia border in close proximity to 
areas with documented artemisinin-resistant malaria parasites. 1,719 
participants (828 Cambodian and 891 Myanmar migrants) were recruited. 
Subpopulations of migrant workers were analysed using the Thailand 
Ministry of Health classification based on length of residence in Thailand of 
greater than six months (long-term, or M1) or less than six months (short-
term, or M2). Key information collected on the structured questionnaire 
included patterns of mobility and migration, demographic characteristics, 
treatment-seeking behaviours, and knowledge, perceptions, and practices 
about malaria. Workers from Cambodia came from provinces across 
Cambodia, and 22% of Cambodian M1 and 72% of Cambodian M2 
migrants had been in Cambodia in the last three months. Less than 6% 
returned with a frequency of greater than once per month. Of migrants 
from Cambodia, 32% of M1 and 68% of M2 were planning to return, 
and named provinces across Cambodia as their likely next destinations. 
Most workers from Myanmar came from Mon state (86%), had never 
returned to Myanmar (85%), and only 4% stated plans to return. In 
conclusion, information on migratory patterns of migrants from Myanmar 
and Cambodia along the malaria endemic Thailand-Cambodian border 
within the artemisinin resistance containment zone will help target health 
interventions, including treatment follow-up and surveillance.
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MALARIA AND GRAVIDITY INTERACT TO MODIFY 
MATERNAL HAEMOGLOBIN CONCENTRATIONS DURING 
PREGNANCY
Smaïla Ouédraogo1, Florence Bodeau-Livinec2, Valérie Briand2, 
Bich-Tram Huynh3, Ghislain Kobto Koura2, Achille Massougbodji1, 
Michel Cot2
1Faculty of Medicine in Cotonou, Cotonou, Benin, 2French Institute of 
Research for Development (IRD), Paris, France, 3Institut Pasteur, Paris, 
France
Since the implementation of intermittent preventive treatment (IPTp) in 
sub-Saharan Africa, the effect of malaria-focused preventive measures 
on anaemia in relation to gravidity has been seldom investigated. We 
analysed data from 3 studies carried out in nearby areas in south Benin 
between 2005 and 2012. At inclusion (ANV1) women’s age, area of 
residence, schooling, parity, gestational age, weight and height were 
recorded. Thick blood smears were performed on ANV1, second visit 
(ANV2) and at delivery. Women’s serum ferritin and CRP concentrations 
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were also assessed. The impact of gravidity on maternal haemoglobin 
(Hb) was analysed using a logistic or linear regression depending on the 
outcome. The statistical significance was set to P < 0.05. 
The study was approved by the Ethics Committee of the Faculty of 
Medicine of Cotonou in Benin. In total, data from 3591 pregnant 
women were analysed. Both univariate and multivariate analyses 
showed a constant association between Hb concentrations and 
gravidity in the 3 periods of Hb assessment (ANV1, ANV2 and delivery). 
Mean Hb concentration was significantly lower in primigravidae than 
in multigravidae at ANV1 (mean difference = -2.4 g / L, P < 0.001). 
Afterwards, it increased importantly in primigravidae only, with a tendency 
to reversal between primigravidae and multigravidae which was confirmed 
at delivery (mean difference = 2.8 g / L, < 0.001). The prevalence of 
malaria was halved between ANV1 and delivery in primigravidae while it 
decreased only by 38% among multigravidae, who were less prone to be 
infected (malaria prevalence at ANV1, 20% and 10% respectively). Iron 
deficiency was more common in multigravidae, and it decreased slightly in 
this group between ANV1 and delivery. In a context of IPTp, primigravidae 
were shown to improve progressively haemoglobin concentration 
throughout pregnancy. In multigravidae, the improvement was less 
perceptible as anaemia was mainly due to iron deficiency. There is a need 
to reinforce malaria prevention strategies in both groups
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ASSESSING THE ASSOCIATION BETWEEN MALARIA 
CHEMOPREVENTION AND THE NUTRITIONAL STATUS OF A 
COHORT OF YOUNG AFRICAN CHILDREN
Victor I. Bigira1, James Kapisi1, Stephen Kinara1, Florence 
Mwangwa1, Beth Osterbauer2, Jaffer Okiring1, Barnabas 
Natamba3, Tamara Clark2, Jane Achan1, Moses Kamya1, Grant 
Dorsey2
1Infectious Diseases Research Collaboration, Kampala, Uganda, 2University 
of California San Francisco, San Francisco, CA, United States, 3Division of 
Nutritional Sciences, Cornell University, Ithaca, NY, United States
Malaria and malnutrition are common causes of morbidity and 
mortality in African infants. Data are limited as to whether antimalarial 
chemoprevention improves nutritional status. We compared the 
nutritional status of 393 infants living in Tororo, Uganda and randomized 
to 4 antimalarial chemoprevention arms at 6 months of age; no 
therapy, monthly sulfadoxine-pyrimethamine (SP), daily trimethoprim-
sulfamethoxazole (TS) or monthly dihydroartemisinin-piperaquine 
(DP). Anthropomorphic measures were made monthly and the primary 
outcomes of interest were a drop of > 1 standard deviation (SD) in the 
height-for-age (HAZ) and weight-for-age (WAZ) z-scores from 6 to 18 
months of age. Covariates of interest included breastfeeding status, 
maternal age, household wealth and chemoprevention arm. Associations 
between worsening nutritional status and covariates of interest were 
estimated using multivariate logistic regression. Mean baseline HAZ and 
WAZ scores were -0.98 and -0.42, respectively. From 6 to 18 months of 
age, 45% and 23% of infants had a drop of > 1 SD in their HAZ and WAZ 
scores, respectively. Continued breastfeeding at 18 months was protective 
against a > 1 SD drop in the HAZ (OR=0.53, p=0.04) and WAZ (OR=0.18, 
p<0.001) score. Compared to a maternal age of over 25 years, a maternal 
age of 18 years or younger was protective against a > 1 SD drop in the 
HAZ (OR=0.30, p=0.001) and WAZ (OR=0.36, p=0.03) score. There were 
no significant associations between household wealth or chemoprevention 
and worsening nutritional status and with the exception of a trend 
towards a lower odds of a > 1 SD drop in the WAZ score (OR=0.46, 
p=0.06) among infants randomized to monthly SP compared to those 
randomized to no therapy. In this cohort of infants living in a rural area of 
Uganda with high malaria transmission intensity, chemoprevention did not 
clearly improve nutritional status but sustained breastfeeding and younger 
maternal age were protective against worsening nutritional status from 
6 to 18 months of age. Results will be updated through September 2012 
when all infants have reached 24 months of age.
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MALARIA TREATMENT COST IN HEALTH SYSTEM: WHAT IS 
THE CHILDREN UNDER FIVE YEARS OLD MALARIA PROVIDER 
COST IN BURKINA FASO (WEST AFRICA)?
Danielle M. Yugbare Belemsaga
IRSS, Ouagadougou, Burkina Faso
Malaria is the major cause of morbidity in Burkina Faso especially among 
children under 5 years old. The cost related to the treatment of this 
disease in the country has not been well documented at the household 
and health system levels. Knowledge about the cost of treating malaria 
can affect the health care seeking behaviour of people and the use of 
different malaria prevention products. This paper estimates the health 
system cost due to simple or severe malaria with children under 5 years 
old in order to make available better understanding of the burden of 
malaria. Data have been collected from the following health facilities: the 
Nanoro religious district hospital, primary health facilities (5). We reviewed 
also Medical outpatient (243) and inpatient (122) records. We interviewed 
46 Outpatient (OPD) and 10 inpatient (IPD) caregivers. Health system cost 
was estimated per component drug and lab test, personnel, and building. 
Malaria was ascertained not by parasitological tests but through fever at 
primary facilities. Lab test was used at district hospital. The survey was 
conducted from July to September 2010, during the high transmission 
season. Simple malaria unit cost for OPD at facility level was 1.9 USD 
for medicine, 0.2 USD for lab test, 0.3 and 0.4 USD for nurse at primary 
centre and district hospital, 0.3 and 1.0 USD for infrastructure at primary 
and district hospital. For severe malaria, IPD cost at district hospital was 
4.5 USD for medicine, 7.2 USD for consumable, 18.7 for lab test, 2.0 for 
nurse, 6.2 for MD and 4.5 for building. The average cost of treating an 
episode of the disease including direct and indirect costs for household 
was 8.5 USD at OPD exit interview and 71.19 USD at IPD exit interview. 
For simple malaria, drug cost was the highest. Laboratory tests had the 
highest unit cost of severe malaria followed by consumables and personnel 
(MD) cost. Simple malaria cost without co-morbidity was 1.57 USD, with 
one co-morbidity 2.52 USD and with 2-3 co-morbidities 3.96 USD. Severe 
malaria cost without morbidity was 19.12 USD, with one co-morbidity 
23.60 USD and with 2-3 co-morbidities 25.23 USD. In conclusion. malaria 
cost for health system is higher with co-morbidities. The introduction of 
prevention measures could reduce the cost of the treatment of malaria. In 
addition, the better implementation and monitoring of abolition of user 
fees policies could reduce the morbidity of malaria.
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MATERNAL ANEMIA IN PREGNANCY: ASSESSING THE 
IMPACT OF PREVENTIVE MEASURES IN A MALARIA 
ENDEMIC AREA
Smaila Ouedraogo1, Ghislain Kobto Koura2, Florence Bodeau-
Livinec2, Manfred Mario Accrombessi1, Achille Massougbodji1, 
Michel Cot2
1Faculty of Medicine in Cotonou, Cotonou, Benin, 2French Institute of 
Research for Development (IRD), Paris, France
Although widely implemented, the effectiveness of anaemia preventive 
measures (intermittent preventive treatment in pregnancy (IPTp), anti-
helminthic and haematinics) on maternal anaemia at different time points 
of gestation in sub-Saharan Africa still need to be documented. 
1005 pregnant women participating in a clinical trial of IPTp were 
followed from early pregnancy until delivery between 2010 and 2012 
in southern Benin, where malaria transmission is perennial. On inclusion 
(ANV1), baseline characteristics of the women were recorded. At ANV1, 
the second antenatal visit (ANV2) and delivery, gestational age was 
assessed and anthropometric measurements were made. The first and 
second intakes of IPTp were given on ANV1 and ANV2 under supervision. 
A treatment dose of albendazole and haematinics were given at ANV1 to 
be taken home. At all time points, haemoglobin (Hb) levels, malaria and 
helminth infections were determined. Serum iron, folate, vitamin B12, 
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CRP concentrations were also measured. The effectiveness of preventive 
measures on the risk of anaemia and Hb concentrations was assessed 
at ANV2 and delivery by comparing the risk factors between ANV1 and 
after interventions (ANV2 and delivery). Multivariate linear and logistic 
regressions were used as appropriate. 63.8% of the women were anaemic 
at ANV1, 64.7% at ANV2 and 40.6% at delivery. The prevalence of 
malaria decreased from 15.1% at ANV1 to 4.0% at ANV2, and increased 
again at delivery to 9.6%, malaria infection being associated with a lower 
mean Hb at ANV1 and delivery. Helminth prevalence decreased from 
11.1% at ANV1, to 7.2% at ANV2 and 2.4% at delivery. Iron deficiency 
stayed high throughout pregnancy (33.3% at ANV1, 36.3% at ANV2 and 
30.7% at delivery). IPTp and anti-helminthic treatments were efficacious 
to clear parasitic infections and to improve haematologic status, whereas 
the effectiveness of daily iron and folate supplements to correct iron and 
folate deficiencies and to decrease anaemia was less marked.
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A PILOT SCHOOL SURVEY TO ESTIMATE THE MALARIA 
BURDEN IN A SETTING WITH DECLINING ENDEMICITY 
Ebako N. Takem1, Joseph Okebe1, Serign Ceesay1, Musa Jawara1, 
Eniyou Oriero1, Muna Affara1, Davis Nwakanma1, Margaret 
Pinder1, John Townend1, Alfred Ngwa1, Makie Taal2, Kalifa Saidy2, 
Momodou Sowe2, Amicoleh Mbaye3, Sulayman Cham3, Wandifa 
Fatty3, Umberto D’Alessandro1
1Medical Research Council Unit, Fajara, Gambia, 2National Public Health 
Laboratory, Kotu, Gambia, 3Ministry of Basic and Secondary Education, 
Banjul, Gambia
In a setting with declining malaria endemicity such as The Gambia, 
identification of malaria infected individuals is increasingly harder. School 
surveys may represent an easy and inexpensive method to identify foci 
of malaria transmission. The aim of this study was to evaluate the use 
of school surveys to estimate the malaria burden and identify foci of 
transmission, in the population. We carried out a school survey in the 
Upper River Region, The Gambia, in May-June 2011, before the start of 
the malaria transmission season. Thirty two primary schools were selected 
with probability proportional to size and in each of them 100 pupils were 
randomly enrolled. Data on socio-demographic variables and was collected 
through a questionnaire. A blood sample was collected for 1) detection 
of antimalarial antibodies against merozoite surface protein (MSP) 1, 
MSP2, and apical membrane antigen-1 (AMA-1) by ELISA, 2) microscopy 
(asexual forms and gametocytes), 3) PCR detection of malaria infection, 
and 4) haemoglobin by Hemocue. Three thousand two hundred seventy 
seven children (48% girls) were included in the survey. The mean age was 
10 years (range: 4-21). Bed net use was 73%. About 17% had a history 
of fever in the past 48 hours while 3% had fever (axillary temperature 
≥37.5ºC) at the time of the survey; none was positive by rapid diagnostic 
test. About 11% of the children had anaemia (haemoglobin<11g/dL). 
The parasite prevalence was 10% (309/2681) for Plasmodium genus, 
and 9% (277/2871) for P. falciparum species. There was evidence of 
heterogeneity in the parasite prevalence across schools. In addition there 
was heterogeneity in age, reported use of bed nets, and anaemia across 
the schools. School survey data can be used to determine the malaria 
burden and identifying foci of malaria transmission in regions of declining 
endemicity. These foci will be sites for other studies to determine the 
cause of heterogeneity and interventions that can contribute to malaria 
elimination efforts.
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THE MALARIA HOUSEHOLD COST OF CHILDREN UNDER FIVE 
YEARS OLD IN BURKINA FASO (WEST AFRICA)
Danielle M. Yugbare Belemsaga
IRSS, Ouagadougou, Burkina Faso
An estimated 700,000-2.7 million persons die of malaria each year, 
75% of them African children . This disease is the major cause of health 
facilities use. This paper estimates the direct and indirect cost of simple 
and severe malaria for under 5 years children for household in order to 
provide a better understanding of the burden of malaria to household. 
Data have been collected from 506 households of 24 villages of Nanoro’s 
demographic surveillance site in Burkina Faso. A random sampling of 
household was done. We included household with children under five 
years old and we exclude children enrolled on the malaria vaccine trial. The 
obtained informations has beene used to estimate the direct and indirect 
costs of malaria treatment. The direct cost of malaria treatment includs all 
cash expenditures on seeking malaria care by patients and their caretakers. 
The indirect costs included all cash expenditures on transportation and non 
medical supplies. Households were interviewed about their expenditure on 
malaria treatment for children under 5 years old. Simple random sampling 
was used to select villages and households with at least one child under 5 
years old. Malaria was ascertained not by parasitological tests but through 
fever using a recall period of one month. The survey was conducted 
during the high transmission season in 2010. Durinh household survey, 
the average cost of treating an episode of the disease including direct and 
indirect costs for household were 7.83USD. During exit interview this cost 
were evaluated 8.5 USD at OPD and 71.19 USD respectively at Outpatient 
OPD and Inpatient IPD. The average total cost for rich households was 
higher than the poorest one. The productivity cost was 6.01 USD at 
household survey, 5.72 USD at OPD and 37.71 USD at IPD exit interview. 
In conclusion, there is an equity access of malaria care for children under 5 
years old.. Productivity cost are the most important for household.Indirect 
cost reduction will contribute to individuals and family well being
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DRUG THERAPY OF SUSPECTED MALARIA CASES BEFORE 
THEIR ADMISSION IN A DISTRICT HOSPITAL IN BURKINA 
FASO DURING THE DRY SEASON
Téné Marceline Yaméogo1, Carole G. Kyelem1, Sanata Bamba1, 
Léon G. Savadogo1, Adama Sanou2, Abdel Aziz Traoré3, Issaka 
Sombié1, Macaire S. Ouédraogo1, T. Robert Guiguemdé1
1Institut Supérieur des Sciences de la Santé, Bobo - Dioulasso, Burkina 
Faso, 2District sanitaire de Dô, Bobo - Dioulasso, Burkina Faso, 3UFR - SDS, 
Ouagadougou, Burkina Faso
Misuse of antimalarials drugs has led to the emergence of resistant 
Plasmodium falciparum strains. Malaria treatment protocols were reviewed 
at the beginning of 2000 in African countries and artemisinine based 
combination therapy (ACT) was introduced. To describe the treatment 
itinerary of suspected cases of malaria before their admission to the district 
hospital of Do, seven years after the introduction of ACT in Burkina Faso. 
From December 2010 to May 2011, we conducted a cross-sectional 
survey of suspected malaria cases admitted at the district Hospital during 
the dry season (malaria low incidence season). We included all patients 
aged 6 months or above, recorded as suspected malaria according to the 
criteria of national malaria control program, excluding those with chronic 
defects. 476 suspected cases, out of which 422 (88.7%) uncomplicated 
and 54 (11.3%) complicated, were recruited, representing 7.9% of the 
admissions. The number of cases decreased from December (207 cases) to 
May (14 cases) with a monthly average of 79 cases. The average age was 
14.4 years, ranging from 6 months to 76 years. Cases under 5 years were 
168 (35.3%). Treatment itineraries were mainly: initial consultation in a 
health facility of first resort (public or private clinic), 20 cases (4.2%); direct 
consultation to the district hospital, 104 cases (21.8%) ; initial consultation 
with a traditional healer, 3 cases (0.6%); initial self-medication, 346 cases 
(72.7%); out of the latter, 331 cases (95.6%) then consulted directly 
at the district hospital. The practice of self-medication did not differ 
between those aged less than 5 years and those above 5 years and over 
(OR = 0.6, 95% IC = 0.4 - 1.0), or by gender (OR = 1.2, 95% IC = 0.8 - 
1.9). Self-medication drugs involved were mainly antipyretics (n = 327) 
and antimalarials (n = 58). Out of the latter, ACT was used in 39.6% of 
cases, quinine in 19.0% and non-recommended antimalarials, such as 
sulfadoxine-pyrimethamine, amodiaquine and chloroquine, in 41.4%. A 
total of 112 cases (23.5%) had positive thick blood smear, including 18 
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cases (16.1%) who had taken an antimalarial. During the dry season, the 
treatment itinerary of suspected malaria cases is marked by a short circuit 
at health care level and use of non recommended antimalarials by self-
medication. Complementary analysis of the itinerary during the epidemic 
season may help to define more appropriate strategies to sensitize the 
population.
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REGIME SHIFTS, HETEROGENEOUS TRENDS AND INDIAN 
OCEAN DIPOLE INDUCED SYNCHRONY IN MALARIA TIME 
SERIES FROM KENYAN HIGHLANDS
Luis F. Chaves1, Akiko Satake1, M. Hashizume2, N. Minakawa2
1Hokkaido University, Sapporo, Japan, 2Nagasaki University, Nagasaki, 
Japan
Large malaria epidemics in the East African highlands during the mid 
and late 1990s kindled a stream of research on the role that global 
warming might have on malaria transmission. Most of the inferences 
using temporal information have been derived from a malaria incidence 
time series from Kericho. Here we examined whether observed patterns 
in that time series were common across other localities in the lake Victoria 
basin of Western Kenya. We found that temporal trends were decreasing 
yet heterogeneous. Time series from localities above 1600 m showed 
regime shifts that coincided with the 1998 Indian Ocean Dipole, IOD. We 
found all the time series to more closely follow the interannual patterns 
of Variability of the IOD than El Niño Southern Oscillation, and we found 
the time series had a synchronous pattern that resembled a Moran 
effect, i.e., their patterns of concerted fluctuation were higher than the 
observed environmental correlation. The heterogeneity in malaria trends 
probably reflects the multitude of factors that can drive trends of malaria 
transmission and highlights the need for both spatially and temporally 
fine-grained data to make sound inferences about the impacts of 
climate change on secular changes in malaria transmission. Nevertheless, 
synchronous malaria epidemics call for the integration of knowledge on 
the forcing of malaria transmission by environmental variability to develop 
robust malaria control and elimination programs.
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ASYMPTOMATIC PLASMODIUM SPP. INFECTION AND 
COGNITION AMONG PRIMARY SCHOOLCHILDREN AGED 
6-14 YEARS IN A HIGH MALARIA TRANSMISSION SETTING IN 
UGANDA
Joaniter I. Nankabirwa1, Bonnie Wandera1, Sarah G. Staedke2, 
Moses Kamya1, Simon Brooker2
1Makarere University Kampala, Kampala, Uganda, 2London School of 
Hygiene and Tropical Medicine, London, United Kingdom
In areas of high malaria transmission, asymptomatic Plasmodium infection 
is commonplace among school children, yet little is known about its 
impact on children’s cognitive function. We investigated the association 
between asymptomatic Plasmodium infection and measures of sustained 
attention and abstract reasoning among primary school children in 
Tororo district, Uganda, a high malaria transmission area. In randomized 
placebo controlled trial assessing the impact of intermittent preventive 
treatment for malaria on morbidity and cognitive function, 740 children 
were enrolled. A detailed history and physical examination was conducted. 
Stool samples were examined for helminth infections and blood smears 
for malaria parasites. Two tests of cognition were administered to children: 
Raven’s matrices for abstract reasoning and code transmission tests for 
sustained attention. Differences in mean test scores were analysed using 
t-tests and multivariable linear regression models. Of the 740 children 
at baseline, the mean (SD) age was 9.9 (4.3) years and 53.3% were 
females. The prevalence of Plasmodium spp. infection was 30.1%, with 
the majority of infections due to P. falciparum. Ninety percent of children 
reported coming from a household with at least one mosquito net but 
net use the previous night was only 36%. Children with Plasmodium 
infection had significantly lower mean scores in tests of abstract reasoning 
(37.6 versus 42.7 p<0.0001) and sustained attention (42.2 versus 49.5 
p<0.0001) compared to uninfected children. Other factors significantly 
associated with poor scores in the cognitive function tests included sex, 
age and weight. In conclusion, despite high household coverage of 
mosquito nets, net use is unacceptably low among schoolchildren and 
Plasmodium infection remains highly prevalent and is strongly associated 
with poor cognition in schoolchildren. Such results underline the need for 
targeted approaches to malaria prevention and control in schoolchildren.
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PREVALENCE AND CORRELATES OF MALARIA PARASITEMIA 
IN PEOPLE LIVING WITH HIV/AIDS ATTENDING THE 
LAQUINTINIE HOSPITAL IN DOUALA, CAMEROON
Julius Atashili, Gervais G. Tchinda, Henri-Lucien F. Kamga, Anna 
L. Njunda, Eric A. Achidi, Peter M. Ndumbe
University of Buea, Cameroon, Buea, Cameroon
A substantial number of people living with HIV/AIDS (PLWHA) inhabit areas 
of high malaria transmission. To provide data to improve the prevention 
and care of malaria in such patients, we assessed the prevalence and 
socio-demographic and clinical correlates of malaria parasitaemia in 
PLWHA. Between April-June 2010, a cross-sectional study of adult 
PLWHA attending the Douala Laquintinie Hospital was conducted. After 
obtaining consent, socio-demographic and clinical data were obtained via 
a standardized questionnaire. Malaria parasitaemia was determined by 
blood smear microscopy. To determine correlates, means were compared 
using t-tests while proportions were compared using chi-square tests. The 
238 PLWHA enrolled had a mean age of 40.8(±10.5) years. Most (67.6%) 
were females, 48.3% were on antiretroviral therapy and 41.4% had CD4+ 
counts<200 cells/ml. The proportion of participants who reported using 
bed nets and insecticides were 36.1% and 37.4% respectively. Overall, the 
malaria prevalence was 24.8%. Malaria prevalence was not significantly 
lower in patients using bed nets (23.3%), using insecticides (23.6%), nor 
in those on antiretroviral therapy (24.4%). Although malaria prevalence 
was higher in patients with CD4+ counts <200 cells/ml (30.6%) compared 
to those with CD4+ counts ≥200 cells/ml (20.1%) this did not achieve 
statistical significance (P=0.07). Malaria parasitaemia was prevalent in 
this population of PLWHA. Very few patients reported using preventive 
methods and even then, the self-reported measures taken to prevent 
malaria did not seem to be effective. Because of the potential for worse 
HIV outcomes in the presence of malaria (even when asymptomatic), 
malaria prevention and treatment (if indicated) needs to be reinforced.
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MALARIA GAMETOCYTE PREVALENCE IN NORTHERN 
KWAZULU-NATAL, SOUTH AFRICA
Jaishree Raman1, Eric Raswiswi2, Rajendra Maharaj1
1South African Medical Research Council, Durban, South Africa, 2KwaZulu-
Natal Provincal Malaria Control Programme, Jozini, South Africa
South Africa has embarked on the ambitious goal of halting malaria 
transmission within its borders by 2018. If this goal is to be attained, 
all malaria cases must be detected and effectively treated. It has been 
suggested that primaquine become standard first line treatment together 
with artemether-lumfantrine to prevent onwards transmission. This 
suggestion has raised some health concerns as primaquine has been 
associated with heamolysis in glucose-6-phosphate dehydrogenase 
(G6PD) deficient individuals. To address this issue a pilot study to assess 
gametocyte carriage in northern KwaZulu-Natal was conducted during 
2011/2012 malaria season. The Umkhanyakude Municipality of KwaZulu-
Natal, South Africa was selected for the study due to its relative high 
malaria prevalence. Filter paper finger prick blood spots were collected 
during a community based survey. Parasite mRNA extracted from the 
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filter paper samples was subjected to a gametocyte specific reverse 
transcriptase PCR. Results from this study will be used to inform a policy 
on primaquine usage in KwaZulu-Natal.
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AN EVALUATION OF CHART ABSTRACTION TO ASSESS THE 
QUALITY OF CASE MANAGEMENT FOR INPATIENTS WITH 
SEVERE MALARIA - BENIN, 2010
Kimberly E. Mace1, Abdou Salam Gueye1, M. Esther Tassiba2, 
Michael F. Lynch1, Alexander K. Rowe1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Population Services International, Cotonou, Benin
Ensuring high quality care for inpatients with malaria is critical. Chart 
abstraction offers a potentially efficient method to assess quality of 
care. However, as the availability and quality of inpatient charts in Benin 
was unknown, we conducted a study of the feasibility of sampling 
and abstracting charts, the validity of abstracted data, and the extent 
of missing data. Chart abstraction was conducted in July 2010 from 
a probability sample of inpatients (any age) in five Beninese hospitals 
(method 1). We also compared abstraction to interviews with health 
workers (HWs) and their patients admitted 12-48 hours earlier (N=11) 
(method 2), and interviews with HWs regarding patients they discharged 
within 72 hours (N=10) (method 3). Analysis of all methods focused on 11 
signs of suspected malaria and severe disease, test results, and treatment. 
For method 1, we sampled 4% (60/1383) of inpatients admitted in 
June 2010. Of 60 patients sampled, 45 (75%) charts were retrieved and 
abstracted; 43 suspected malaria cases were identified. Of 473 signs, 
179 (37%) were documented in charts. In 74% (32/43) of charts, at least 
one sign was present to identify severe disease. Antimalarial treatment 
was documented in 81% of charts of patients with suspected malaria 
(35/43). Interviews of HWs and admitted patients (method 2) showed that 
96% (45/47) of documented signs were valid. HW interviews regarding 
discharged patients (method 3) showed that 35% (19/55) of non-
documented signs were not assessed by HWs. Malaria test results were 
documented in 65% of charts (41/63) (methods 1, 2, 3). Abstraction from 
inpatient charts was feasible, and documented data were valid. Despite 
poor documentation, data were sufficient to identify severe illness for 
three-quarters of patients. Charts contained moderate levels of testing 
and high levels of treatment information. This study was limited by small 
sample size and possible recall bias. We recommend chart abstraction 
for an inpatient survey and introducing a standard admission form as an 
intervention to improve documentation and quality of care.
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GENETIC DIVERSITY OF PLASMODIUM FALCIPARUM IN THE 
THREE MAJOR ECOLOGICAL ZONES OF GHANA
Anita Ghansah
Noguchi Memorial Institute for Medical Research, Legon, Ghana
Parasite genetic diversity information is useful for malaria control activities 
such as drug and vaccine failure rates. Parasite diversity varies with 
transmission intensity in varying geographical settings. Our objective was 
to describe the level of Plasmodium falciparum genetic diversity in the 
three ecological zones Ghana. A random selection of 379 baseline (Day 0) 
filter paper blood blots from children under five years, recruited between 
2005-2008 during the monitoring of the efficacy of antimalarial drugs for 
the treatment of uncomplicated malaria in Ghana were genotyped. DNA 
was extracted; allele frequency and genetic diversity were investigated 
by nested PCR of the block three of the MSP2. The samples were drawn 
from towns in the three major ecological settings of Ghana: Navrongo 
(Sudan Savannah), Begoro and Bekwai (forest zone) and Cape Coast 
(Coastal Savannah). Differences in clonal diversity were observed that 
can be explained by geographical location. In general FC27 was the 
dominant allele in the Ghanaian parasite isolates in comparison with the 
3D7 (Wilcoxcon sign rank z, 2.953: p=0.0031). There were significant 
differences in clonal diversity in the different ecological zones when 
the carriage of a single clone was compared with carrying two clones 
(Wilcoxcon sign rank z, 2.062:p=0,039 ), single clone vs. three clones 
(Wilcoxcon sign rank z, 2.717 p=0.007) and two clones vs. three clones 
(Wilcoxcon sign rank z, 2.953: p=0.003). This clonal diversity can be 
further explained by the differences in ecological zones, with the Sudan 
Savannah showing less diversity than the forest zone and the coastal 
savanna zone. Also, the forest zone showed more clonal diversity than the 
coastal Savanna and the two forest based towns did not show significant 
differences in clonal diversity. Greater genetic diversity was observed in the 
FC27 alleles than the 3D7 alleles which may translate into more diversity in 
the different ecological zones and population differentiations of the MSP2 
alleles probably due to differences in ecological zones resulting in varying 
transmission intensity and out-crossing of parasite isolates during sexual 
reproduction.
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ADOLESCENT PREGNANCY AND THE RISK OF PLASMODIUM 
FALCIPARUM MALARIA AND ANEMIA - A PILOT STUDY 
FROM SEKONDI-TAKORADI METROPOLIS, GHANA
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The problem of malaria in adolescence has been surpassed by the 
immense burden of malaria in children, most especially less than 5. A 
substantial amount of work done on malaria in pregnancy in endemic 
regions has not properly considered the adolescence. The present study 
therefore aimed at evaluating the prevalence of Plasmodium falciparum 
and anaemia infection in adolescent pregnant girls in the Sekondi-
Takoradi metropolis, Ghana. The study was carried out at four hospitals 
in the Sekondi-Takoradi metropolis of the western region of Ghana 
from January 2010 to October 2010. Structured questionnaires were 
administered to the consenting pregnant women during their antenatal 
care visits. Information on education, age, gravidae, occupation and socio-
demographic characteristics were recorded. Venous bloods were screened 
for malaria using RAPID response antibody kit and Geimsa staining while 
haemoglobin estimations were done by cyanmethemoglobin method. The 
results revealed that adolescent pregnant girls were more likely to have 
malaria infection than the adult pregnant women (34.6% verse 21.3%, 
adjusted OR 1.65, 95% CI, 1.03-2.65, P = 0.039). In addition, adolescent 
pregnant girls had higher odds of anaemia than their adult pregnant 
women equivalent (43.9% versus 33.2%; adjusted OR 1.63, 95% CI, 
1.01-2.62, P = 0.046). Taken together, these data suggest that adolescent 
pregnant girls were more likely to have malaria and anaemia compared 
to their adult pregnant counterpart. Results from this study shows that 
proactive adolescent friendly policies and control programmes for malaria 
and anaemia are needed in this region in order to protect this vulnerable 




INTERMITTENT PREVENTIVE TREATMENT OF MALARIA IN 
PREGNANCY (IPTP): EMPHASIS ON ADEQUATE DOSAGE AND 
TRIMESTER UPTAKE
Verner N. Orish1, Onyekachi S. Onyeabor2, Nnaemeka C. 
Iriemenam3
1Effia Nkwanta Regional Hospital Sekondi, Western Region, Sekondi, 
Ghana, 2The Satcher Health Leadership Institute, Department of 
Community Health and Preventive Medicine, Morehouse School 
of Medicine, Atlanta, GA, United States, 3Department of Medical 
Microbiology and Parasitology, College of Medicine of the University of 
Lagos, Idi-araba, Lagos, Nigeria
Intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-
pyrimethamine (SP) has been adopted as policy by all countries in sub-
Saharan Africa. However, studies on the post-implementation effectiveness 
and coverage of the therapy are being evaluated upon possible resistance 
that has been reported. This study assessed the effectiveness and uptake 
of the therapy by pregnant women attending antenatal care with some 
emphasis on trimesters and supposed doses taken. This cross-sectional 
study compared malaria and anaemia prevalence among 754 pregnant 
women using IPTp-SP with non-IPTp-SP users. The results showed that 
57.8% (436/754) used IPTp-SP while 42.2% (318/754) did not. In 
general, 81.4% of the IPTp-SP users were malaria negative while 18.6% 
were malaria positive and those who received ≥2 doses had significantly 
reduced prevalence of malaria. Furthermore, of those that received IPTp-
SP, 20.4% were in their 3rd trimester while 71.3% were in their 2nd 
trimester. However, only 3% of the pregnant women completed 3 doses 
while 30% completed the full ≥2 doses of IPTp-SP. In multivariate analysis, 
malaria infection in 3rd trimester was associated with increased odds of 
anaemia (adjusted OR 6.81, 95% CI, 1.19-38.94). IPTp-SP usage among 
pregnant women reduces malaria and its efficacy must be strengthened by 
proper dosage completion.
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DEVELOPING A MALARIA ENDEMICITY MAP FOR ETHIOPIA 
USING SEROLOGICAL INDICATORS OF PRIOR EXPOSURE TO 
PLASMODIUM FALCIPARUM AND P. VIVAX
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1Malaria Consortium, Kampala, Uganda, 2Malaria Consortium, Addis 
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Institute, Addis Ababa, Ethiopia, 5Oromia Regional Health Bureau, Addis 
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Ethiopia has a diverse ecology and geography that results in spatial and 
temporal variation in malaria transmission. Using evidence-based strategies 
to allocate the most appropriate interventions to different populations and 
transmission settings is crucial to sustaining reductions in malaria burden 
in Ethiopia, minimising epidemic risk, and eventually attaining elimination. 
Defining endemicity based on the detection of infection through 
light microscopy or antigen-detecting rapid diagnostic tests to define 
endemicity has limitations, due to highly seasonal transmission in many 
areas and presence of low density infections. Detection of Plasmodium 
falciparum and P. vivax antibodies was used to examine previous exposure 
to infection, a proxy to assess local transmission over a period of years. 
197 cross-sectional school-based surveys among children aged five to 
18 years were conducted in Oromia Regional State during the main 
transmission season. Key indicators were detection of parasites by light 
microscopy, and enzyme-linked immunosorbent assay (ELISA) to detect 
IgG against four antigens: P. falciparum glutamate rich protein (PfGLURP), 
P. falciparum merezoite surface protein (PfMSP), P. vivax merezoite 
surface protein (PvMSP) and P. vivax apical membrane antigen (PvAMA). 
Few schools (30/197) were found to have any Plasmodium infections 
by microscopy (prevalence range 0-15%), but a wide variation (range 
0-56%) in school sero-prevalence was identified. Among 30 schools with 
0% prevalence by microscopy also examined by ELISA, sero-prevalence 
range was 0-24%, demonstrating the ability of serologic markers to 
identify heterogeneity in recent transmission intensity at sites with few 
or no current Plasmodium infections among sampled individuals. The 
distributions of P. falciparum and P. vivax seropositivity across Oromia are 
described, together with development of geostatistical Bayesian models 
linking school seropositivity with meteorological and remotely-sensed 
environmental correlates to create a predictive endemicity map.
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Epidemics of malaria occur periodically in Ethiopia, often resulting in 
substantial morbidity and mortality. Effective surveillance and response 
systems are required to allow early identification of epidemics and 
minimise the impact on health of the population. The current strategy 
for epidemic detection in Ethiopia relies upon charting weekly malaria 
cases against a ‘normal’ calculated using the third quartile method from 
the previous five years of data. However, there are limitations to the 
quality and frequency of reporting and analysis of these data. The current 
study explores the use of simple, easy to measure indicators of malaria 
morbidity and infection at school level, including school absenteeism, 
with a view to identifying an indicator which can be used for an epidemic 
early warning system. It is expected that this approach will allow the 
community to notice unusual increases in malaria morbidity, prompting 
an in-depth investigation by district health officials. In locations with 
limited accessibility to district towns, this may overcome some of the 
challenges of the current health facility based epidemic detection system. 
A series of eight repeated cross-sectional school surveys were conducted 
at six sites in southern Ethiopia over the short malaria transmission 
season (April to June 2012), randomly selecting 110 children for each 
survey. Indicators collected were multi-species rapid diagnostic test result, 
microscopy examination of blood film, reported fever on survey day 
and in prior two weeks and measured axillary temperature. Participants 
were asked their normal frequency of school attendance and number of 
absences from school in the previous two weeks. School records of pupil 
absenteeism were collected on completion of the study, as well as routine 
data on clinical and confirmed malaria from health facilities serving the 
study population. Survey indicators and school absenteeism rates were 
compared to health facility data, in order to identify indicators which 





A NOVEL METHOD TO ASSESS THE SAFETY OF 
SULFADOXINE-PYRIMETHAMINE FOR INTERMITTENT 
PREVENTIVE TREATMENT IN INFANTS USING ROUTINE 
HEALTH FACILITY DATA FROM SOUTHERN TANZANIA
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Intermittent preventive treatment with sulfadoxine-pyrimethamine is 
recommended for malaria prevention in infants (IPTi-SP) in areas of 
moderate to high malaria transmission and where parasite resistance to SP 
is not high. Serious adverse events, including Stevens-Johnson syndrome 
(SJS), have been reported following SP exposure, but few infant-specific 
data exist. Within the context of a cluster randomized controlled trial 
of IPTi-SP in southern Tanzania, we captured routine health facility data 
on infant outpatient attendance from all health centres. Data included 
diagnosis, allowing classification of attendance for a non-scabies skin 
condition. We investigated the association of IPTi-SP with attendance for 
skin conditions using a number of methods, including the self-controlled 
case series method. This novel methodology allowed estimation of 
the relative incidence of attendance among infants presenting with a 
skin condition who had received SP for IPT-SP or for malaria treatment. 
Among these infants, the rates of attendance were compared between 
‘unexposed’ and ‘exposed’ periods of time, using infants as their own 
comparison- thus adjusting for all measured and unmeasured time-fixed 
confounders. Based on previous studies and the half life of SP active 
ingredients, we defined an ‘exposed’ period as the 42 days following an 
SP dose, and compared whether rates during this period differed to those 
during an infant’s ‘unexposed’ time. Data were available for 9880 infants 
over 12 months, with >8000 doses of SP received. No diagnoses of SJS 
were recorded. The incidence of attendance with a skin condition was 
0.062/year among all infants, and 0.071/year among the 3983 infants 
who had received >=1 dose of SP for IPT-SP or malaria treatment. In total 
239 infants attended for a skin condition and received at least one dose of 
SP, and these were included in the self-controlled cases series analysis. In 
comparison to the rate during ‘unexposed’ periods, the age-adjusted rate 
of attendance among these 239 infants during the 42 days after exposure 
was almost 50% lower suggesting no detectable increased rate of 
attendance for skin condition during the six weeks following an SP dose. 
These results provide reassurance about the safety of SP in infants from 
this setting, and provide a worked example of how the self-controlled case 
series method may be used to assess safety of interventions in developing 
countries using routine health facility data
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A PROSPECTIVE ANALYSIS OF PLASMODIUM FALCIPARUM 
INFECTION RISK FROM INFANCY TO ADULTHOOD IN AN 
AREA OF INTENSE, SEASONAL TRANSMISSION IN MALI
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Time to first malaria episode is often used as a measure of clinical 
immunity to Plasmodium falciparum. In contrast, the risk of P. falciparum 
infection irrespective of clinical disease can be measured by the time 
required to detect parasites in the blood by sensitive methods such as 
polymerase chain reaction (PCR). Pre-erythrocytic malaria vaccines aim to 
elicit a protective immune response against the sporozoite or liver stage 
of P. falciparum to prevent infection, but little is known about naturally 
acquired pre-erythrocytic immunity in endemic areas. Prospective studies 
that have assessed the risk of P. falciparum infection in endemic settings 
have failed to show correlations between antibodies to pre-erythrocytic 
antigens and infection, and evidence for age-dependent acquisition of 
protective immunity to infection is limited. To evaluate for evidence of 
naturally acquired pre-erythrocytic immunity, we conducted a prospective 
analysis of P. falciparum infection during a single malaria season from May 
to December 2011 in Kalifabougou, Mali. Of the 695 subjects enrolled in 
this study, 372 were uninfected by PCR at enrollment before the malaria 
season. Of these, we determined time to P. falciparum PCR positivity using 
dried blood spots collected at two-week intervals over the entire study 
period. We found no evidence that pre-erythrocytic immunity is acquired 
with increasing age/exposure. Unexpectedly, younger children (<4 years 
old) showed decreased risk of infection compared to older children (4-17 
years old) when adjusted for sex, hematocrit, Schistosoma co-infection, 
sickle cell trait, and spleen size (hazard ratio 0.44; 95% CI, 0.32-0.60; 
p<0.0001). Based on these data, antibody responses to Anopheles 
gambiae salivary gland extract, pre-erythrocytic antigens, and blood-stage 
antigens are being measured before and after the malaria season in an 
attempt to determine if the observed decreased risk in younger children is 
due to differences in vector/parasite exposure versus other factors.
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MALARIA IN THE KINGDOM OF SAUDI ARABIA - IS 
ELIMINATION A REALISTIC GOAL?
Michael Coleman1, Mohammed H. Al-Zahrani2, Marlize 
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In 1998, after two exceptional years of heavy rain, the Kingdom of 
Saudi Arabia (KSA) suffered its worst epidemic of malaria, with total 
cases reaching 40,796. Almost 90% of these were locally acquired, and 
incidence reached 11/1000 in the main malarious areas of Asser and 
Jazan, in Southern KSA. Since then, KSA has scaled up vector control 
with IRS, ITNs and larviciding and improved on case management. Today’s 
data tells a very different story: the number of autochthonous cases since 
2008 has been less than 100 per year, just 4% of total cases and an 
incidence rate of <0.05/1000, far lower than the rate of 5/1000 that WHO 
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recommends a country should achieve before considering elimination. 
On this basis alone, the goal of malaria elimination is considered realistic. 
Moreover, transmission is now limited to the southern regions of 
Asser and Jazan, bordering the Republic of Yemen, where Plasmodium 
falciparum is the main cause of malaria and Anopheles arabiensis the main 
vector. However, moving from a control to an elimination programme 
requires a considerable effort to scale up monitoring and evaluation 
efforts. KSA is adopting state of the art tools to support M&E and 
decision-making, developed by the IVCC with financial support from the 
Bill and Melinda Gates Foundation. Using annual data records, we show 
how trends in malaria in KSA have changed over time due to the impact 
of vector control as well as climate. Case data for malaria areas are utilised 
to generate focal risk maps of disease and to determine outbreak alert 
thresholds. The prospects for malaria elimination in KSA and the relevance 
of the model being applied will be discussed objectively in relation to other 
countries pursuing or considering malaria elimination, both in the region 
and globally.
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Malaria is dispersed from place to place by movements of either 
mosquitoes or humans. A better understanding of the patterns of 
dispersion will aid in preventing its geographical spread. Using landscape 
genetics, which combines population genetics and spatial epidemiology, 
we studied the population and spatial structure of Plasmodium falciparum 
in the Democratic Republic of the Congo (DRC). The population structure 
of P. falciparum parasites was characterized among 117 isolates from 
the DRC, 40 isolates from Guatemala and 12 from Guatemalan United 
Nations peacekeeping soldiers who visited DRC in 2010 and were found 
to have P. falciparum parasitemia by either slide microscopy or polymerase 
chain reaction (PCR) analysis. Seven neutral microsatellite markers were 
characterized and genetic relatedness was calculated using Nei’s genetic 
distance (GD) and Slatkin’s RST. Among the seven DRC sites Nei’s GD 
ranged from 0.26 to 0.92 and RST varied from -0.06 to 0.13. While 
genetic relatedness largely varied with distance, some geographic barriers 
to dispersion were noted. Parasites from the Guatemalan soldiers were 
closely related to parasites found in the DRC (Nei’s GD=0.28) but very 
different from those found in Guatemala (Nei’s GD=2.02). Similar results 
were found using Slatkin’s RST (0.07 to 0.20). Clustering of isolates 
from soldiers and DRC was confirmed by principle coordinate analysis. 
The results from the study support the epidemiologic findings that the 
soldiers acquired malaria while they were in northeastern DRC. Molecular 
tools and population genetics analysis can allow us the opportunity to 
study the spread of malaria within and between countries. By integrating 
genetic and spatial information, better models of disease spread can be 
developed.
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EFFECTIVENESS OF MALARIA CONTROL INTERVENTIONS 
AMONG PREGNANT WOMEN AND CHILDREN UNDER FIVE 
YEARS IN A RURAL AREA OF BURKINA FASO: A RESULT 
FROM NOUNA HEALTH AND DEMOGRAPHIC SURVEILLANCE 
SITE (NHDSS) SURVEY
Maurice YE
Nouna Health Research Center, Nouna, Burkina Faso
Malaria remains a major cause of global morbidity and mortality, with 
most of the burden being in sub-Saharan Africa though Insecticide-Treated 
mosquito nets (ITN) have been proved to be one of the most effective 
intervention to prevent malaria.The 2000 Abuja summit put emphasis on 
promoting effective prevention methods and management of case for 
vulnerable groups such as pregnant women and children under five. In 
this study we aimed to assess the ownership and use of ITNs and access 
of children under five to artemisinin based combination therapy (ACT).The 
study took place in a rural area of north-western Burkina Faso, which was 
characterized as holoendemic. A cross sectional surveys were undertaken 
in a two samples of population derived from the Nouna Health and 
Demographic Surveillance Site in 2010. The first was constituted by 
a sample of 2850 households and the second with a sample of 409 
children. Our results were compared to the Abuja indicators agreed upon 
by the Head of Africa States as target goals to achieve. Overall 89% of 
households revealed a possession of at least two bed nets among which 
47.96% were insecticide treated bed nets. 24.5% of children have slept 
under ITNs the last night whereas it was 28.4% for pregnant women. 
49.7% of children have presented a fever and 32.5% were tested positive 
for malaria among which 13.7% have been treated adequately with ACT. 
Malaria was the first cause of death (32.7%). Overall reduction of 22.8% 
of falciparum malaria prevalence was observed compared to 2006 survey 
data. In conclusion, many effort remains to achieve universal coverage 
with ITNs and clinical malaria cases management among vulnerable group 
so that to reach the Abuja targets and MDGs goals.
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The shift from targeted groups to universal coverage of Insecticide Treated 
Net (ITN) raises issues of gender equity and equality in access and use. 
There is a need for gender-based analysis to assess the effects of gender 
on the uptake of this key intervention for malaria control. The recent 
post-campaign survey in Northern Nigeria offers an opportunity to look at 
gender differences in ITN use. The post-campaign survey was conducted 
October 19-November 4, 2009 and included a random sample of 4,638 
individuals in Kano State. The survey was carried out using a questionnaire 
adapted from the Malaria Indicator Survey. Using binary logistic regression 
and controlling for several covariates, we assessed the effect of gender 
on ITN use among all the individuals living in households with at least one 
ITN. ITN ownership increased more than tenfold, from 6% to 71% before 
and after the campaigns. There was no significant difference between the 
proportion of females and males living in a household with at least one 
ITN. However, a higher percentage of females used ITN compared to males 
(56% vs. 46%). After controlling for several covariates, females remained 
more likely to use ITNs compared to males (OR: 1.5, 95%CI: 1.3-1.7). In 
conclusion, this study reveals gender inequality in ITN use with men less 
likely to use ITN. Notably, the uptake of the intervention among the most-
at-risk group (females) is higher. However, there is a need to also ensure 




TRANSMISSION BLOCKING EFFICACY OF ANTI-MALARIAL 
PLANT EXTRACTS ON PLASMODIUM FALCIPARUM 
GAMETOCYTES FIELD ISOLATES
Rakiswendé S. Yerbanga
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l’Ouest (IRSS-DRO), Bobo Dioulasso, Burkina Faso
Targeting gametocytes, gametes and/or ookinetes; i.e. the stages of the 
malaria parasite responsible for its transmission from the human host 
to the Anopheles vectors, is key for pharmacological malaria control 
strategies. Research efforts to identify such compounds have significantly 
increased over the last years. However, at present, only two drugs are 
available, namely primaquine and artesunate, that are acting on late stage 
gametocytes (stage IV-V). In this study, we assessed the antiplasmodial 
effects of 5 extracts from 2 plants against gametocyte to ookinete stages 
of Plasmodium falciparum field isolates in an ex vivo assay; Anopheles 
gambiae females were membrane fed on gametocytaemic blood, treated 
with the plant extracts and transmission blocking activity evaluated on 
day 7 by assessing oocyst prevalence and density. Two of the 5 tested 
extracts showed significant transmission blocking activity: the commercial 
neem (Azadiracta indica) extract NeemAzal®, completely blocked oocyst 
development at 500, 250 and 70 µg/ml. A 90% inhibition was still 
found at a dosage of 50µg/ml of this seed kernel extract. Transmission 
blocking activity was also found with an ethyl acetate leave extract from 
the same plant species, inhibiting oocyst development completely at 500 
µg/ml and by 80% at 250 µg/ml. The results of this study highlight the 
potential of anti-malarial plants for the discovery of novel transmission 
blocking molecules, but open also the challenging perspective of using 
standardized, transmission blocking herbal formulations as a complement 
to artemisinin combination therapy in the management of malaria and the 
control of the parasite’s transmission.
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Indoor residual spraying (IRS) has become an increasingly popular 
method of insecticide use for malaria control and many recent studies 
have reported on its effectiveness in reducing malaria burden in a 
single community or region. There is a need for systematic review 
and integration of the published literature on IRS and the contextual 
determining factors of its success in controlling malaria. This study reports 
the findings of a meta-regression analysis based on 13 published studies 
which were chosen from over 400 articles through a systematic search 
and selection process. The summary relative risk for reducing malaria 
prevalence was 0.38 (95% CI = 0.31-0.46) meaning a risk reduction of 
62%; however, an excessive degree of heterogeneity was found between 
the studies. The meta-regression analysis indicates that IRS is more 
effective with high initial prevalence, multiple rounds of spraying, use of 
DDT, and in regions with a combination of Plasmodium falciparum and P. 
vivax.
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A NEW DEVICE FOR SURVEILLANCE AND CONTROL OF 
OUTDOOR BITING MOSQUITOES: ITS DESIGN, FIELD TESTING 
AND APPLICATIONS FOR PREVENTION OF MOSQUITO 
BORNE INFECTIONS IN AFRICA
Nancy Stephen Matowo, Fredros Oketch Okumu
Ifakara Health Institute, Morogoro, United Republic of Tanzania
Mosquitoes that seek blood outdoors continue to contribute significantly 
to transmission of diseases such as malaria, filariasis and viral infections. 
To achieve the goals of eliminating mosquito-borne diseases, new tools 
that can be used outdoors are required to complement existing indoor 
interventions, such as insecticide-treated bed nets. We developed an 
odor-baited device called the Mosquito Landing Box (MLB), which can be 
used to control and monitor mosquitoes biting outdoors. The MLBs were 
baited with smelly socks and carbon dioxide gas. Field experiments were 
conducted in rural Tanzania to assess: a) the number of wild host-seeking 
mosquitoes visiting the MLBs, b) whether the mosquitoes stayed long or 
left shortly after arrival, c) the time of night when the mosquitoes were 
most active and d) whether the visiting mosquitoes could be contaminated 
and killed. There were significantly more mosquito vectors, Anopheles 
arabiensis (df=1, P<0.001), An. funestus (df=1, P<0.001), Culex species 
(P=0.028) and Mansonia species (P<0.001) visiting baited MLB than 
unbaited controls. Increasing sampling frequency from 2-hourly to either 
1-hourly or half-hourly was associated with an increase in number of 
mosquitoes caught (df=2, P<0.002), suggesting that many mosquitoes 
visited the device but left shortly afterwards. Outdoor host-seeking activity 
was highest from 2000hours to 2200hours and from 0400hrs to 0600hrs. 
Adding a partially open screen-cage around the MLB did not affect catches 
of An. arabiensis (df=1, P=0.986), An. funestus (df=1, P=0.776) or the 
culicines (df=1, P>0.681). Nearly half (47.1%) of the An. funestus caught 
visiting an insecticide-treated MLBs died compared to 1.2% in controls. 
Further studies are underway to identify more effective and long-lasting 
mosquito killing agents to apply on the MLBs. These findings indicate that 
the MLB might be useful for sampling and possibly controlling outdoor-
biting mosquitoes; by attracting, contaminating and ultimately killing the 
mosquitoes, hence potentially reducing disease transmission.
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VIRTUAL SCREENING FOR POTENTIAL LIGANDS OF 
G-PROTEIN COUPLED RECEPTORS (GPCRS): GATEWAY TO 
IDENTIFICATION OF NOVEL SCAFFOLDS FOR POTENTIAL 
TREATMENT OF NEGLECTED DISEASES
Grace Mugumbate, Stephen Fienberg, Kelly Chibale, Graham E. 
Jackson
University of Cape Town, Cape Town, South Africa
Helmintic diseases caused by parasitic nematodes affect about 550-750 
million people global. Also, malaria, caused by Plasmodium falciparum, 
was responsible for about 200 million cases and 650 000 deaths in 2010. 
Yet, little work has been done to discover new drugs that curb helmintic 
diseases. Also, the mosquito which transmits the malaria parasite has 
become resistant towards currently used insecticides. So, there is need to 
constantly search for new anti-parasitic drugs. Nematode FMRFamide-like 
peptides (FLPs) and the mosquito adipokinetic hormones (AKHs) alongside 
their G-protein coupled receptors (GPCRs) have been identified. GPCRs 
are known drug targets; hence intervention of the signalling pathway 
of FLPs and AKHs would lead to a reduction in nematode infections 
and the spread of malaria. Here, structure-based virtual screening of the 
ZINC database was performed using a previously modelled structure of 
a mosquito GPCR, AKHR to identify potential GPCR ligands. Docking 
calculations to study binding modes and affinities of a mosquito AKH 
(AKH-1) were done. ZINC compounds were then docked to AKHR and 
those with higher binding affinities for the receptor were selected for 
insecticidal evaluations and tested for activity towards nematode GPCRs. 
Docking results showed that AKH-1 had binding affinities of ∆Gb = 
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-10.7 kcal/mol for the receptor. The AKH interacted with Tyr110, Thr129, 
Gln209, Lys307 and Tyr285 in the receptor binding site. From the ZINC 
database, about 120 compounds, containing a variety of scaffolds, 
showed higher binding affinities (highest affinity: ∆Gb = -12.5 kcal/) for 
the receptor than AKH-1. These results provide novel scaffolds that could 
be used for potential treatment of neglected diseases.
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FINDINGS FROM A RAPID QUALITATIVE ASSESSMENT 
OF ACCESS TO MALARIA PREVENTION AND TREATMENT 
RESOURCES AMONG BURMESE MIGRANTS IN TAK 
PROVINCE, THAILAND
Denise Roth Allen1, Eugenie Poirot1, Piyaporn Wangroongsarb2, 
Muhammed Shafique3, Jimee Hwang1, David Sintasath3, Sylivia 
Meek4, S. Patrick Kachur1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Bureau of Vector Borne Diseases, Ministry of Public Health, Bangkok, 
Thailand, 3Malaria Consortium Asia, Bangkok, Thailand, 4Malaria 
Consortium, London, United Kingdom
Recent evidence of the declining efficacy of Thailand’s first line artemisinin-
based combination therapy (ACT), mefloquine-artesunate, in western 
Thailand has raised concerns that artemisinin resistance is already present 
on the Thai-Burma border. In Thailand, malaria occurs mainly in the 
border provinces, with the highest incidence occurring among Burmese 
migrants in Tak Province. Strategies to ensure migrants’ timely access 
to effective malaria treatment and prevention resources are therefore 
of utmost importance. Although malaria case management and vector 
control interventions in Tak Province should be targeted to Thai nationals, 
refugees, and migrant workers alike, little is known about how Burmese 
migrants who live or work in non-refugee camp settings actually access 
and use malaria resources. This dearth of information on migrant malaria 
care-seeking behaviors has hampered Thailand’s ability to assess how 
well malaria interventions are reaching these populations. To address 
this gap, in February 2012 we conducted a rapid qualitative assessment 
of community- and provider- level factors that affect migrants’ use of 
malaria prevention and treatment resources in Tak Province, Thailand. 
Qualitative data were collected in 4 villages and 2 commercial farm 
settings in two districts and included 8 focus group discussions, 11 key 
informant interviews, 10 health provider- and 31 community- in-depth 
interviews, and 7 seasonal calendars. Interviews were conducted in Karen, 
Burmese, and Thai, digitally recorded, and transcribed in the language of 
interview. Interview transcripts were translated into English and content 
analysis conducted. Preliminary results indicate that several community 
and health facility factors interact to limit migrants’ access to effective 
malaria prevention and treatment resources, particularly among non-
registered migrants. These include misunderstandings about the causes 
of malaria, the limited availability of insecticide-treated nets for migrants, 
delays in reaching health facilities due to financial and legal barriers, ACT 
procurement and distribution delays, and language barriers between 
providers and their migrant patients. To minimize malaria transmission and 
the spread of artemisinin resistance, additional measures should be put in 
place to help achieve better access to malaria resources among displaced 
populations living in Thailand’s border areas.
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STOCHASTIC MODELS FOR THE AUTODISSEMINATION OF 
INSECTICIDES BY MOSQUITOES
Samson S. Kiware
Ifakara Health Institute, Dar es salaam, United Republic of Tanzania
Vector control techniques that complement indoor residual spraying 
(IRS) and long-lasting insecticidal nets (LLINs) may be needed to achieve 
malaria elimination. Semi field system (SFS) experiments were conducted 
to evaluate the potential for the autodissemination of pyriproxyfen 
(PPF) by adult mosquitoes into their breeding sites and its impact 
on adult mosquito emergence. We present stochastic mathematical 
models parameterized using SFS data to help design field trials for the 
autodissemination of PPF by adult mosquitoes. We incorporate stochastic 
characteristics of the autodissemination technique into mosquito life 
cycle: (1) To show how the fit between simulated and experimental data 
may be used to design field trials. (2) To run the model using parameters 
derived from mosquitoes innate life cycle characteristics such as blood-
feeding, resting, flight range, and oviposition behaviour. (3) To guide field 
trial strategies that achieve effective insecticide coverage of breeding 
sites using optimal dissemination stations. Our models developed using 
experimental data may help design field trials for the autodissemination 
technique by exploiting different parameters of mosquitoes’ life cycle. The 
model outputs suggest the design of dissemination stations, the distance 
between them, PPF treatment proportions and intervals necessary to 
achieve high coverage of breeding sites that may reduce adult mosquito 
density up to 40%. Mathematical models parameterized using semi-field 
experimental data are used to design field trials for the autodissemination 
of insecticides by mosquitoes.
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ISOLATION AND CHARACTERIZATION OF GRAM POSITIVE 
ENDOSPORE FORMING BACTERIA WITH BIO-LARVACIDAL 
EFFECT AGAINST MAJOR MALARIA VECTORS IN UGANDA
Matthew Lukenge1, Josephine Birungi2, Jonathan Kayondo2, 
Charles Masembe1, Louis Mukwaya2
1Makerere University Kampala, Kampala, Uganda, 2Uganda Virus Research 
Institute, Entebbe, Uganda
Mosquito borne diseases are major causes of mortality and morbidity 
in the tropics. Over 20 Anophilines are of medical importance but in 
Uganda, Anopheles gambiae and An. funestus are the major malaria 
vectors. Globally, Malaria accounts for closely 1 million annual deaths, 
over 90% of which is from Africa. In Uganda 12.3 million cases occur 
with over 100,000 annual deaths and an estimated 384 child deaths per 
day. The comprehensive approach for malaria control includes indoor 
residual sprays (IRS), insecticide treated bed net distribution and malaria 
treatment with ACTs as well as fansidar prophylaxis in pregnant women. 
Despite these interventions, the malaria scourge prevails mainly due 
to resistance in both the parasite and the vector. There are promising 
results for a malaria vaccine but extensive trials are still needed before it’s 
operationalised. Proper vector management emphasizes a multifaceted 
bio-rational approach where bacterial agents have been handy. Bacillus 
thuringiensis and B. sphaericus are the most widely studied and advanced 
biological agents but the spreading wave of resistance is their major 
setback. Their virulence has been noted to vary according to species 
variant and the region the agent is isolated. Therefore, there is a need 
to search for alternatives but none of such studies have been done in 
Uganda. Tree holes and water pond soil samples were pasteurized and 
isolates were identified microscopically for Gram and endospore reactions. 
They were exposed to 3rd instars of Aedes aegypti and mortality was 
observed from 3 hrs to 72 hrs. 39 isolates (9.4%) were larvacidal against 
Ae. aegypti, 80% of which were from tree holes. 1 unique isolate had 
terminal endospores with a drumstick appearance and produced 60% 
mortality within 3 hrs while the other 38 were within 24 hrs. Biochemical, 
molecular characterization, optimal lethal doses and Anopheles 
comparative assays are to follow. In conclusion, 39 isolates have potential 
of being incorporated in biological control and thus recommending their 




BUILDING ON SUCCESS IN THE FIGHT AGAINST MALARIA: 
COMMUNITY INVOLVEMENT IN THE INSECTICIDE TREATED 
NETS HOUSEHOLD DISTRIBUTION AND HANG-UP CAMPAIGN 
IN GHANA
Eunice A. Adjei1, Keziah L. Malm1, Samuel Oppong1, Lily B. 
Sampong1, Aba Baffoe-Wilmot1, Constance Bart-Plange2
1National Malaria Control Programme/Ghana Health Service, Accra, 
Ghana, 2National Malaria Control Programme, Accra, Ghana
Malaria accounted for 38.2% of Out Patient Department (OPD) 
attendance and 43.9% of admissions in Ghana. Insecticide treated 
nets (ITNs) is part of the control strategies in the country. Distribution 
had been through antenatal clinics with occasional mass campaigns 
targeting pregnant women and children under five years. Despite these 
efforts, ownership and usage in the country remained low. Only 33 % of 
households owned at least one ITN nationwide in 2008. Usage of ITNs 
among children and pregnant women was 28% and 20% respectively 
in the same year with the lowest coverage in the northern part of the 
country. Prominent among the reasons for the low usage was difficulty in 
hanging the net. To address this, a household distribution and hang up 
of ITNs was adopted. Community members and leaders were involved in 
implementing the campaign. This paper appraises the role of community 
members and leaders in the successful implementation of the campaign. 
Community leaders and chiefs supported by providing vehicles and funds 
to cart logistics to communities. Some chiefs and assembly members 
provided storage for the logistics. Chiefs and elders resolved conflicts and 
misunderstandings, volunteers were identified by community members 
and trained to move from one household to another to hang nets using 
their prior registration data. In some communities, members motivated 
these volunteers by paying a token which they had agreed on during 
durbars or gave them food stuff whilst in others the community leaders 
gave them the tokens. Through these efforts, community members 
received free insecticide treated nets hanged over their sleeping places. 
They were also taught how to maintain the net properly. In the northern 
region of the country six months after the campaign, household 
ownership of ITNs increased from 26.7% to 81.8%. ITN usage among 
children under five increased from 11.2% to 52.0% and from 7.0% to 
39.5% in pregnant women. Community involvement is important in 
ensuring the success of implementation of health interventions.
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MALARIA PREVENTION MEASURES EXPENDITURES 
IN BURKINA FASO: HOW MUCH DO THEY COST TO 
HOUSEHOLDS?
Fadima I. Yaya Bocoum1, Danielle Belemsaga1, Seni Kouanda1, 
Halidou Tinto1, Alex Adjagba2
1institut de recherche en science de la santé, Ouagadougou, Burkina Faso, 
2PATH, Ferney voltaire, France
The efficacy of insecticide-treated nets (ITNs) has demonstrated in the 
protection from mosquito bites. The provision of insecticide-treated 
nets (ITNs) is widely accepted in Burkina Faso. However, other methods 
of prevention are used by the households. In the perspective of the 
introduction of the vaccine, it is important to know more about the 
household expenditure on the non-net products and practices. This paper 
aims to estimate the amounts spent on different malaria prevention 
measures in Burkina Faso. A cross sectional survey was conducted during 
the high transmission season in 2010. Simple random sampling was 
used to select villages and households. Data collection was carried out 
among 506 households in Nanoro district in Burkina Faso. Households 
were asked about expenditures on other forms of malaria prevention 
over the previous month including expenditure on coils, indoor spraying, 
aerosols, repellents, herbs, cleaning surrounding, environment and 
clearing vegetation; and any other forms of prevention. More than 50% 
of households used at least one malaria prevention measure. Around 98% 
of households owned at least one bed net. Bed nets were used by 94% of 
household head, 88% of under five children, 85% of husband or wife and 
83% of children up to 5 years. 32% of households use smoke, 20% clean 
outside environment, 16% cultivate specific plants, 8% use coils, and 
3% indoor spraying. The majority of households did not spend money on 
malaria prevention measures. Households spent an average of 2450FCFA 
on bed net, but only 6% of bed net were bought. Households spent an 
average of 910 FCFA on coils and 1768 FCFA on indoor spraying in the 
previous month. Household wealth was associated with coils (p=0,008), 
indoor spraying (p=0,04) and cleaning surrounding (p=0,009). Most 
of households received bed nets with the implementation of the new 
program of distribution of bed nets. They used more than one prevention 
measure. The introduction of the vaccine will affect the households’ 
practices and it is important that it doesn’t affect the utilization of the 
other malaria prevention practices.
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ASSESSING THE EFFICACY OF TWO TYPES OF LONG-LASTING 
INSECTICIDAL NETS (LLINS) TESTED IN NAMPULA PROVINCE, 
MOZAMBIQUE
Ana Paula Abilio1, Julliet Morgan2, Samira Sibindy1, Jacinta 
Luciano1, Ayubo Kampango1, Júlio Matusse1, Elias Machoe1, Maria 
Pondja3, Dulcisaria Marenjo3, Adeline Chan4
1National Institute of Health-Ministry of Health, Maputo, Mozambique, 
2President’s Malaria Initiative, Centers for Disease Control and Prevention, 
Maputo, Mozambique, 3Malaria Control Program-Ministry of Health, 
Maputo, Mozambique, 4Malaria Branch, Centers for Disease Control and 
Prevention, Atlanta, Georgia
Long-lasting insecticidal nets (LLINs) are an important tool to prevent 
malaria in sub-Saharan Africa by reducing human-vector contact. In 
line with the new WHOPES LLIN evaluation guidelines we prospectively 
evaluated LLIN efficacy, including physical durability and insecticidal 
efficacy, on LLINs distributed during a campaign in October 2008 in 
Nampula Province, Mozambique. We present here the insecticidal 
efficacy of Olyset® and PermaNet® LLINs from the first year of follow-
up. We tagged 2000 Olyset® and 4000 PermaNet® LLINs and randomly 
distributed them during the 2008 campaign. The tagged LLINs were then 
located using GPS during a house-to-house survey one month after the 
distribution campaign. A random sample of the households (HHs) found 
to have a tagged LLIN was selected for a three year follow-up evaluation. 
At one, two and three years after the distribution campaign, the selected 
HHs were surveyed and tagged LLINs were collected and transported to 
the Instituto Nacional de Saúde (INS) in Maputo for further evaluation. 
We assessed unused LLINs as the baseline. We took two day-old non 
blood-fed female mosquitoes from an insectary susceptible colony of An. 
Arabiensis to conduct cone bioassay tests on the baseline LLINs and LLINs 
collected during the first year of follow-up for both brands. Untreated 
polyester netting (25 cm x 25 cm) was used as negative control. A total of 
49 Olyset® and 83 PermaNet® LLINs were collected during the first year 
of follow up. The knockdown effect was recorded after three minutes of 
exposure, and mortality was recorded after 24 hours post-exposure. The 
mortality on the baseline LLINs exposed to An. arabiensis was 100% for 
both brands. We found 96.9% and 99.7% An. arabiensis mortality after 
exposure to Olyset® and PermaNet® respectively on the LLIN collected 
during the first year of follow-up. Our findings show that LLINs retain 
their insecticidal efficacy after one year in rural Mozambique, although 
this starts dropping: Olyset® more rapidly compared with PermaNet® but 
not statistically significantly (P= 0,097). Further assessment after two and 
three years is on-going and results available later in 2012. These will give 




EFFECTS OF INSECTICIDE RESISTANCE AND CREPUSCULAR 
BITING BEHAVIOR ON THE COST EFFECTIVENESS OF A 
MASS, LONG-LASTING, INSECTICIDAL NET DISTRIBUTION: A 
MODELING STUDY
Olivier J. Briet, Nakul Chitnis
Swiss Tropical and Public Health Institute, Basel, Switzerland
The effectiveness of insecticide treated nets (ITNs) in preventing malaria 
is threatened by developing insecticide resistance and changing biting 
behavior. Data from experimental hut studies on the effects of a third 
generation long lasting ITN on eight anopheline mosquito populations 
with varying levels of insecticide resistance (from less than 10.6 % 
mortality in 0.05% deltamethrin WHO cylinder tests to fully susceptible) 
were used to parameterize malaria models. The effectiveness of a mass 
distribution of ITNs against malaria, in terms of episodes averted during 
the effective lifetime of the batch, and in terms of net health benefits 
expressed in disability adjusted life years (DALYs) averted, depending on 
resistance, biting behavior, and pre-intervention transmission level, was 
studied using an ensemble of 14 model variants in OpenMalaria. With 
the most resistant mosquito population, at the transmission level where 
ITNs were most effective (4 infectious bites per adult per annum (ibpapa) 
pre-intervention), the ITN mass distribution averted up to about 35% less 
episodes and DALYs than with susceptible populations. This was similar to 
the loss of effectiveness if 40% instead of 10% of the mosquitoes always 
bit during times when people are not under an ITN. Over the ranges 
studied, effectiveness of ITNs was more sensitive to the pre-intervention 
transmission level than to the level of insecticide and behavioral resistance. 
ITNs had positive net health benefits in most scenarios. Only at pre-
intervention transmission levels above 128 ibpapa, a minority of variants 
of the model ensemble showed (slightly) negative net health benefits. ITNs 
are likely to be cost effective against malaria even in areas with strong 
pyrethroid resistance and where a large proportion of host-mosquito 
contact occurs during times when ITN users are not under their nets.
406
THE ASSESSMENT OF IEC/BCC MATERIALS AND DELIVERY 
CHANNELS IMPLEMENTED ALONG THE THAI-CAMBODIAN 
BORDER
Rungrawee Tipmontree1, Nardlada Khantikul2, Wichai Satimai1, 
Muhammad Shafique3
1Bureau of Vector Borne Diseases, Nonthaburi, Thailand, 2Office of Disease 
Prevention and Control No.10, ChinagMai, Thailand, 3Malaria Consortium 
Asia, Bangkok, Thailand
The assessment of information, education and communication (IEC) 
products and communication channels was carried out in Chanthaburi and 
Si Sa Ket Provinces, eastern Thailand in February, 2010. The assessment 
was conducted to determine the acceptance, cultural appropriateness, 
and effectiveness of IEC materials produced to promote the behavior 
changes in the project “A strategy for the containment of artemisinin 
tolerant malaria parasites in South-East Asia”. The main objective of the 
assessment was to understand the interim effects of IEC materials on 
the target audience and to find out the most effective communication 
channels or media to reach out to the targeted mobile and migrant 
population in the project. The assessment used both qualitative and 
quantitative methods including interviews and focus group discussions. 
The qualitative component helped triangulate the quantitative findings. A 
total of 81 respondents were interviewed in the survey. Two focus group 
discussions were conducted with the target audience in both provinces. 
The results were encouraging and showed that the coverage of IEC 
materials was high (80.2-83.9%) in both areas. Overall, the pamphlets 
were highly received among the respondents in all aspects, i.e. contents, 
colours, sizes, and illustrations. It was found that most of the respondents 
could comply with key messages appeared on the pamphlets. The findings 
of FGD showed similar outcomes as compared with the quantitative 
survey. Majority of the respondents highly accepted the posters as shown 
by survey. The results showed that the IEC materials were culturally 
appropriate and very well received by the target population. More 
importantly, we found that the interpersonal communication was the 
highly preferred communication channel for health education. These 
findings should be utilized as an evidence for enhancing the capacity of 
our field staff and volunteers to effectively deliver the health education 
program to the target population, as the aim set to change people’s 
behaviors and finally to save people’s health from malaria.
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FIELD EFFICACY AND PERSISTENCE OF LONG LASTING 
INSECTICIDE TREATED MOSQUITO NETS (LLINS) IN 
COMPARISON WITH CONVENTIONAL INSECTICIDE TREATED 
MOSQUITO NETS (ITN) AGAINST MALARIA VECTOR IN 
THAILAND
Suchart Patipong, Siriporn Yongchaitrakul, Wichai Satimai
Bureau of Vector Borne Disease, Nonthaburi, Thailand
In Thailand, the conventional Insecticide Treated mosquito Nets or ITN 
have been used over the years by the villagers. These mosquito nets are 
treated with permethrin 10%w/w EC manually as under the guidance 
of the health workers. These treated nets have efficacy for 6 months 
and need re-treated again. Long Lasting Insecticide treated mosquito 
Nets or LLINs, which can retain persistence for at least 3 years, are being 
considered to replace the conventional ITN. This study is intended to 
monitor the bioefficacy of two products of LLINs under field conditions in 
Thailand. These nets are PermaNet® and OlysetNet® The study was carried 
out in a malaria endemic area of Kanchanaburi province. PermeNet®, 
OlysetNet® and conventional ITN were distributed to the households were 
allowed to use the bed nets. The nets were washed at every 6 months 
intervals and only conventional ITN were re-treated after washings. WHO 
standard procedures for cone bioassay tests were conducted with the 
bed net samples collected from the households that were using the nets 
and laboratory reared Anopheles minimus were use in cone bioassay tests 
to access the efficiency of mosquitoes nets. Results of the study showed 
that both LLINs (PermaNet®and OlysetNet®) offered > 80% mortality on 
Anopheles minimus over the entire 3 years period of field evaluation. The 
conventional ITN performed similar to LLINs except the fact that ITN were 
re-treated at 6 months intervals. Interestingly the ITN offered only 15% 
mortality after 6 months use and were washed without re-treatment.
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ISOLATION OF ANTIPOLIOVIRUS AGENTS FROM 
ZEPHYRANTHES CANDIDA LINDL AND CASSIA SIAMEA LAM
Omonike O. Ogbole1, Johnson A. Adeniji2, Ramsay S. Kamdem3, 
Edith O. Ajaiyeoba1, Muhammad I. Choudhary4, Festus D. Adu2
1Department of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, 
Ibadan, Nigeria, 2WHO Polio Laboratory, Department of Virology, College 
of Medicine, University of Ibadan, Ibadan, Nigeria, 3Department of Organic 
Chemistry, Higher Teachers’ Training College, University of Yaounde I, 
Yaounde, Cameroon, 4HEJ Reseach Institute of Chemistry, International 
Center for Chemistry and Biological Sciences, University of Karachi, 
Karachi, Pakistan
Polio eradication by vaccination of children in Nigeria has been largely 
unsuccessful due to the characteristic problems of accessibility, limited 
supervision, cultural hindrances and occasional vaccine-associated paralytic 
poliomyelitis. The need to consider alternative ways of managing the 
infection becomes imperative. This led to the ethnobotanical study of 
plants used for control of viral infection in South-Western Nigeria. The 
objective of this study was to screen for efficacy, isolate and characterize 
antiviral agents from these plants.Fourteen medicinal plant samples were 
extracted by maceration into absolute methanol at room temperature 
and subjected to antiviral assay. Ability of extracts to inhibit viral-induced 
cell death in tissue culture was evaluated three days post-infection by 
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MTT colorimetric assay. Linear regression was used to determine IC50 and 
CC50, from which Selectivity Index (SI) was calculated. Bioassay-guided 
fractionation of extracts, repeated column and preparative thin layer 
chromatography of active fractions led to isolation of active compounds. 
Chemical structures of compounds were elucidated using spectroscopic 
techniques. The crude extracts of whole plant Zephyranthes candida and 
stem bark Cassia siamea were the most active of the extracts with IC50 
of 1.85×10-3µg/mL and 1.21×10-1µg/mL respectively. Activities were 
retained in the chloroform fractions of Z. candida and C. siamea with 
IC50 of 1.2×10-3µg/mL and 2.3×10-1µg/mL respectively. Hexane fraction 
of C. siamea was also comparatively active with IC50 of 5.1×10-1µg/mL. 
Five compounds were isolated from Z. candida, namely; 7-hydroxy-3’,4’-
methylenedioxyflavan, lycorine, trisphaeridine, β- sitosterol glucoside and 
stigmasterol. Lupeol, lupenone, betulinic acid, emodin, chrysophanol, 
psycion and β- sitosterol glucoside were obtained from C. siamea. 
Lupeol was the most active compound from C. siamea with IC50 value of 
1.4×10-2µg/mL Lycorine was the most active compound from Z. candida 
with IC50 value of 5.8×10-2µg/mL . Two compounds; 7-hydroxy-3’, 
4’-methylenedioxyflavan and trisphaeridine are reported from Z. candida 
and their anti-poliovirus properties are established. This study provides 
chemical entities that may be lead for development of antiviral agents.
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STUDY OF ARBOVIRUSES IN ARCHIVED SPECIMENS FROM 
ACUTE FEBRILE ILLNESS STUDIES IN BANDUNG, INDONESIA
Ungke Antonjaya
Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia
Numerous recent arboviral outbreaks have demonstrated that arthropod-
borne pathogens continue to be significant public health threats. These 
outbreaks have not been limited to tropical or developing countries as 
people and goods can be moved anywhere in the world within days. 
Indonesia might be a very important country for emerging viruses having 
several endemic arboviruses including dengue, chikungunya, and Japanese 
encephalitis viruses. Outbreaks due to these viruses have occurred 
several times in Indonesia but to date studies on the existence of other 
arboviruses in Indonesia are scarce. Therefore, a study to detect evidence 
of arboviral pathogens in archived samples is currently in progress. The 
main purpose of this project is to identify the presence of emerging 
arboviruses of pandemic risk in Indonesia. We have identified archived 
samples from prior acute febrile infection studies that enrolled patients 
in two hospitals in Bandung, West Java, Indonesia from 2004-2005. The 
original study enrolled a total of 406 hospitalized suspect-dengue cases; 
the majority (311) had evidence of recent dengue infection. However, 
infecting etiologies on the remaining samples had not been determined. 
The current study includes testing for other specific endemic arboviruses 
as well as unknown arboviruses in the dengue negative samples. Initially, 
samples are tested against panels of several arboviruses including 
flaviviruses, alphaviruses, and bunyaviruses employing RT-PCR and IgM 
detection assays. Suspect positive samples are further tested with virus 
specific RT-PCR, viral isolation, and DNA sequencing targeting several 
viruses including Japanese encephalitis virus, West Nile virus, Zika virus, 
Chikungunya virus, Ross River virus, and hantaviruses. Our study is the 
first systemic survey on emerging viruses in Indonesia with gold standard 
molecular, serological, and virus isolation assays to estimate the magnitude 
of circulation of arboviruses.
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HBSAG PREVALENCE AMONG PRE-VACCINE AND VACCINE 
ERA CHILDREN IN BANGLADESH: PRELIMINARY RESULTS
Repon C. Paul1, Mahmudur Rahman2, Eric Mast3, Eric Wiesen3, 
Trudy Murphy3, Minal Patel3, Mizanur Rahman4, Jayantha 
Liyanage4, Nihal Abeysinghe5, Stephen Luby1
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Bangladesh, 3Centers for Disease Control and Prevention, Atlanta, GA, 
United States, 4World Health Organization, Dhaka, Bangladesh, 5World 
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Hepatitis B virus infection is a leading cause of morbidity and mortality due 
to hepatocellular carcinoma and liver cirrhosis worldwide. Some previous 
small scale studies in Bangladesh observed hepatitis B surface antigen 
(HBsAg) prevalence as 3%-7%. During 2003-2005 Bangladesh introduced 
hepatitis B (HepB) vaccine into the routine childhood vaccination schedule 
provided at 6, 10 and 14 weeks of age. While a birth dose of HepB 
vaccine is widely recommended, the country’s high prevalence of home 
births (85%) presents logistical difficulties to timely administration of a 
birth dose. This study evaluated the impact of HepB vaccine introduction 
in Bangladesh in the absence of a birth dose by comparing HBsAg 
prevalence among children born before and children born after HepB 
introduction. Using probability proportional to size cluster sampling, 
we selected a nationally representative sample of 2,100 pre-vaccine era 
children born from April 1, 2001 to March 31, 2002 and 2,100 vaccine-
era children born from November 1, 2005 to October 31, 2006 from 105 
clusters. In each cluster, starting from the center to a randomly chosen 
direction, we visited all households until we found 20 pre-vaccine era and 
20 vaccine-era children. After taking written consent from their guardians, 
we collected a blood sample from each child along with vaccination and 
demographic information. We performed a rapid test of HBsAg in the 
field (Abbot Determine; sensitivity: 95%-100% and specificity: 96%-
100%). Confirmatory testing will use standard serologic assays. To enroll 
2,100 children from each group, we approached 2,203 pre-vaccine era 
children (refusal rate 5%) and 2,270 vaccine-era children (refusal rate 
8%). Among the enrollees, 97% of vaccine-era children received HepB 
from national childhood vaccination program and 2.7% of pre-vaccine era 
children received HepB from private sources. None of 2,100 vaccine-era 
children were HBsAg-positive; by comparison, 24 (1.1%; 95% CI=0.7-
1.7) of 2,100 pre-vaccine era children were HBsAg positive. Preliminary 
results suggest that even without a birth dose, the HepB vaccine program 
was highly effective in Bangladesh. Considering the long term efficacy of 
HepB, childhood HepB vaccination will continue to reduce the national 
hepatitis B burden. These findings support continued investment in 
HepB in other countries who introduced HepB vaccine into childhood 
immunization programs but have not yet evaluated impact.
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SEROPREVALENCE OF CYTOMEGALOVIRUS INFECTION IN 
A COHORT OF CHILDREN EXPERIENCING DIFFERENTIAL 
MALARIA TRANSMISSION DYNAMICS IN WESTERN KENYA
Sidney Ogolla1, Erwan Piriou1, Asito S. Amolo1, Peter O. Sumba1, 
Nancy Fiore2, Rosemary Rochford2
1KEMRI, Kisumu, Kenya, 2SUNY Upstate Medical University, Syracuse, NY, 
United States
Cytomegalovirus infection is a serious cause of congenital disease 
in western countries where it causes sensoneural hearing loss and 
neurodevelopmental disorders and is one of the main viruses associated 
with transfusion related infections. The virus can be reactivated and causes 
fatal infection in immunosuppressed individuals. The prevalence of CMV 
infection in American adults is approximately 54% while approximately 
85% of Gambian children acquire CMV infection by their first birthday. 
However, little is known about the prevalence of CMV in Kenyan children. 
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Our aim was to determine the CMV seroprevalence in a cohort of children 
from western Kenya. Infants were enrolled from two rural sites in Western 
Kenya: Kisumu District where malaria transmission is holoendemic and 
Nandi District where malaria transmission is sporadic. Blood samples 
from infants born to HIV-seronegative mothers were taken from 1 month 
through 24 months of age to measure CMV viral load in peripheral blood 
and CMV antibodies. CMV-specific IgG was assessed using a luminex bead 
based array assay and viral loads were measured in DNA extracted from 
whole blood using quantitative PCR. Preliminary results shows that CMV 
seroprevalence increases with age with a seroprevalence of 60% versus 
22% at three months, 80% versus 52% at 6 months, 91% versus 83% at 
12 months and 100% versus 92% at 24 months in malaria holoendemic 
and sporadic areas respectively. Studies are ongoing to analyze CMV IgM 
to confirm whether there is primary infection by 3 or 6 months of age. 
These preliminary results show higher seroprevalence of CMV in infants 
living in a malaria endemic area within the first year of life compared to 
infants from a region with sporadic malaria transmission. Further studies 
are needed to understand why seroprevalence of CMV in a malaria 
endemic region is so high early in infancy.
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A SURVEY OF ARBOVIRUSES CIRCULATING IN KENYA 2007-
2010
Hellen S. Koka1, Caroline Ochieng1, Albina Makio1, James 
Mutisya1, Lillian Musila1, Edith Chepkorir2, Joel Lutomiah3, 
Rosemary Sang3
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Arbovirus surveillance in mosquitoes during the inter-epidemic period 
of 2007-2010 in six sites in Kenya indicated that several viruses were in 
circulation. The sites Garissa ,Magadi ,Turkana , Tanadelta , Budalangi 
and Naivasha are well spread across the country .A total of 25 isolates 
were made comprising of 4 viruses from three arbovirus families.11 of 
the isolates have not yet been fully characterized. The mosquitoes were 
collected using CO2-baited CDC light traps from December 2009 to 
June 2010 in the selected sites during wet seasons. Mosquitoes were 
identified to specie and pooled (≤ 25 mosquitoes per pool).Consequently, 
the mosquitoes were homogenized in 1.5ml eppendorf tubes containing 
one 4.5mm copper bead and 750µl of minimum essential medium 
supplemented with 15% FBS, 2% L-Glutamine and 2% Antibiotics 
mixture. The homogenates were centrifuged at 10,000 rpm at 40C for 
15min and the resultant supernatants inoculated in monolayers of VERO 
cells in 24 well plates. The cultures were incubated at 37°C and monitored 
for cytopathogenic effects (CPE) daily upto 14 days. Cultures showing 
CPE were harvested and viruses identified by RT-PCR and sequencing. 
Bunyavirus isolates were obtained from pools of Aedes mcintoshi (4), 
Anopholes funestus (3) and Ae. tricholabis (1).Five of these mosquitoes 
were collected from Garissa, two from Magadi and One from Tanadelta. 
Alphaviruses were isolated from pools of Cx. univittatus(3), Culex spp(1) , 
Ae. luridus pools(2) , Ae. tricholabis(2), Ae. mcintoshi(2) and Aedes spp(1). 
Six of these isolates were collected Garissa ,two from Naivasha ,one from 
Budalangi and three from Tanadelta .All Flavivirus isolates were isolated 
from Cx.univittatus mosquitoes ,five of which were from Garissa and 
one from Turkana. Eight Bunyaviruses (4 Bunyamwera, 1 Pongola), 11 
Alphaviruses (4 Ndumu, 3 Babanki) and 6 Flaviviruses (6 West Nile viruses) 
were isolated. Four of the Alphaviruses and three of the Bunyaviruses 
have not yet been fully characterized.This results indicate that continued 
arbovirus surveillance in this region is important to avert future arbovirus 
outbreaks,map out risk zones and direct correct diagnosis of febrile 
illnesses in the human population.
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SEROLOGICAL EVIDENCE OF NIPAH LIKE VIRAL INFECTION IN 
PIGS IN BANGLADESH
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Nipah virus (NiV) causes fatal encephalitis in humans; Pteropus bats are 
their natural reservoir. Pigs may act as a potential amplifier of NiV and 
transmit the disease to humans as in Malaysia 1998-99. We looked 
for serological evidence of NiV infection in pigs in three North-western 
Districts in Bangladesh where human NiV infections were repeatedly 
identified. From May to September 2009 we collected blood samples from 
312 pigs (Sas scrofa) (Rajshahi, n=100; Nawabganj, n=102; and Naogaon, 
n=110) from backyard and nomadic herds over six months of age. We 
tested the serum samples for antibody binding to a NiV recombinant G 
glycoprotein using a Luminex assay. Samples having median fluorescence 
intensity over 1000 were considered positive. Samples tested positive for 
antibody were further tested by serum neutralization test against the NiV 
N protein. To understand the difference between exposure (age, sex, pig 
raising pattern) and outcome (NiV antibody) we performed Wilcoxon rank-
sum test and chi-squared. Of the 312 pigs, 60 had antibody against NiV G 
protein by luminex testing [19%, 95% Confidence Interval (CI): 14 - 24]. 
However, none of the serum samples demonstrated serum neutralization. 
The prevalence of NiV G protein antibody in pigs was higher in Rajshahi 
26% [95% CI 17 - 38] and Nawabganj 23% [95% CI 16 - 33] than in 
Naogaon district 9% [95% CI 4 - 16]. Compared with the pigs that lacked 
NiV G antibody, pigs with NiV G antibody did not differ by age (median 23 
months vs. 22.8 months, P=0.9); sex (21% female vs. 18% male, P=0.5); 
and raising pattern (pigs with NiV antibody: 20% raised in backyard vs. 
15% raised in nomadic herds, P=0.4). In conclusion, this study identified 
serological evidence of Nipah or perhaps a closely related virus infecting 
pigs in Bangladesh. The difference in prevalence by geography suggests 
that the positive antibody tests did not result from nonspecific binding 
with porcine antigens. Actively screening pigs to identify henipavirus 
infections, may identify viruses of public health importance.
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SEROLOGICAL AND MOLECULAR CHARACTERIZATION OF 
SUSPECTED CASES OF HEMORRHAGIC FEVER AND HEPATITIS 
VIRUSES IN NORTHERN GHANA
Joseph Humphrey Bonney1, Mubarak Osei-Kwasi1, Theophilus 
Adiku2, Jacob Samsom Barnor1, Meike Hass3, Robert Amesiya4, 
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Ahadzie6, Stephan Guenther3
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Haemorrhagic Fever (HF) viruses are prevalent in West Africa and have led 
to outbreaks with considerable morbidity and mortality. Evidence abounds 
for HFs but the causative agents are not fully discerned. Molecular and 
serological tools to diagnose Lassa fever, Yellow fever and other viral 
haemorrhagic fevers (VHFs) and research programmes identifying VHF 
agents, as well as estimating their public health relevance rarely exist in 
Ghana. Reports on the prevalence ratio of viral hepatitis (VH) in Ghana 
is one in six and this was consistent with a recent data in a study. There 
are no guidelines for the screening of viral markers for viral hepatitis; 
testing is left to the local health institutions to implement based on 
high index of suspicion. Routine screening for HAV and/or HEV are not 
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performed. However, reported fatal cases of HEV in pregnant women in 
southern Ghana have been documented. This study sought to establish 
the prevalence of VHFs and VH in Northern Ghana. Base on reports and 
geographical locations of border countries with confirmed VHF cases, 
16 health facilities were chosen as sentinel sites. Patient consenting and 
meeting the case definition were recruited and sampled. Virus detection 
and characterization by serological and molecular techniques was done 
for viral agents associated with VHF. Laboratory analyses were conducted 
on 276 serum samples. Investigations with RT-PCR assays for all the 
clinical specimens were found negative for VHF virus types, Lassa, Crimean 
Congo, Yellow fever, Dengue, Ebola, Marburg, and Rift Valley. Anti-Lassa 
fever IgG antibody titers were recorded for one case (titer ≥ 1:20) and 
8 cases of anti-Dengue type-2 IgG (titer ≥ 1:80). Two cases exhibiting 
specific IgG (titers 1:1280 and 1:1280) and IgM (titers 1:20 and 1:20) 
against Chikungunya virus were found. Viral nucleic acid were however 
detected for viral hepatitis agents including; 21 (7.6%) for Hepatitis A; 
58 (21.0%) for Hepatitis B, and 23 (8.3%) for Hepatitis C viruses. Anti-
HEV IgM antibodies in all serum samples evaluated were 62 (22.5%). Our 
findings do not indicate a significant presence of VHF agents in Northern 
Ghana. However, the data generated suggest that VH infections, which 
often share clinical symptoms with VHFs are widespread, illustrating the 
need for differential diagnosis to be implemented.
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RESPIRATORY INFECTIONS IN PERU (2005-2010)
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Human enteroviruses (HEVs) are known to cause respiratory tract 
infections and are classified into four groups (A-D) and 106 different 
serotypes. Little is known about the various HEVs’ role in respiratory 
infections in South America. This study describes the epidemiology and 
phylogenetic characterization of non-polio HEV respiratory infections 
in patients with influenza-like illness enrolled in a passive surveillance 
network in various regions of Peru. Oropharyngeal swabs and 
epidemiological data were collected from participants after obtaining 
verbal consent. Viral isolation was performed in cell culture and identified 
by immunofluorescence assay. Serotype identification of HEV isolations 
was performed using commercial monoclonal antibodies. Identification of 
non-serotypeable isolations was carried out by reverse transcriptase-PCR, 
followed by sequencing for genotype determination. Between 2005 and 
2010, we analyzed a total of 24,240 samples. We identified at least one 
respiratory virus in 41.1% of samples (9971/24240); of those, HEV was 
found in 173, for a prevalence of 0.7% (173/24240). Our results revealed 
a clear predominance of HEV-B species, 92.5% (160/173). No isolations of 
HEV-C and HEV-D were found. The mean age and standard deviation for 
HEV-positive subjects were 9.2 and 12.5 years, respectively, much lower 
than the population sampled (17.6 and 17.5 years, respectively). A total 
of 15 different serotypes were identified, with the most common being 
coxsackievirus B1, coxsackievirus B2, coxsackievirus A16, and enterovirus 
71. This study is the first to report HEV isolation from respiratory 
specimens in Peru. Compared with other countries in South America, our 
HEV prevalence in ILI was similar to those from Ecuador and Brazil, and 
our HEV-group breakdown was similar to that found in Brazil.
416
SEROLOGICAL CHARACTERIZATION OF GROUP C VIRUSES 
ASSOCIATED WITH FEBRILE ILLNESS IN PERU, 1999 - 2011
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Group C viruses are arthropod-borne viruses with tri-segmented RNA 
genomes belonging to the genus Orthobunyavirus, family Bunyaviridae. 
Group C viruses were first identified near Belem, Brazil, in 1954 and 
have since been found across tropical and subtropical areas of the 
Americas. Group C viruses are common causes of sporadic, mild to 
severe, self-limiting febrile illnesses characterized by headache, vertigo, 
backache, muscle and joint pain, nausea, and photophobia. While Group 
C viruses have not been associated with epidemics or fatal infections, 
orthobunyaviruses have been shown to have potential for emergence in 
humans and livestock, underscoring the importance of understanding 
their epidemiology and ecology. To address this need, we conducted 
a serological characterization of Group C viruses isolated from febrile 
patients in Peru between 1999 and 2011. Patients with fever >38°C and 
signs and symptoms compatible with viral infection were enrolled in a 
clinic-based febrile surveillance study in sites across Peru (Cusco, Junin, 
Lima, Loreto, Madre de Dios, Piura, and Tumbes). The identification 
of Group C viruses was made initially by viral isolation using Group 
C hyperimmune ascitic fluid in an indirect immunofluorescence test. 
Microneutralization tests, considered the most specific serological assay 
available, were used to distinguish among closely related Group C 
viruses. Between 1999 and 2011, 61 Group C isolates were recovered 
from approximately 32,000 acute-phase febrile serum samples. All of the 
Group C viruses identified were isolated from participants in the jungle 
cities of Iquitos, Yurimaguas, and Puerto Maldonado. Isolates serologically 
consistent with Caraparu virus (62.3%), Murutucu /Marituba (34.4%) 
and Itaqui virus (3.3%) were identified. These results demonstrate the 
sustained transmission of and human exposure to distinct Group C viruses 
across Peru. Serological data will be paired with full-genome sequences to 
further explore the evolutionary relationships among Group C viral strains.
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FIELD TRIAL FOR RIFT VALLEY FEVER CLONE 13 VACCINE IN 
LIVESTOCK FARMS IN KENYA
Leonard M. Njagi
Ministry of Livestock Development, Kangemi-Nairobi, Kenya
We carried out a field trial of Rift Valley Fever (RVF) Clone 13 vaccine, 
produced by Onderstepoort Biological Products, South Africa, to 
determine its safety and efficacy in commercial livestock in Kenya. 
Experimental studies have suggested that Clone 13 is a superior RVF 
vaccine when compared to the currently available Smithburn strain 
vaccine, in terms of safety and efficacy, and Clone 13 has the potential 
for testing that can differentiate infected and vaccinated animals 
(DIVA). General health observations, injection site reactions, and rectal 
temperature were assessed by monitoring all animals for the first 3 days 
and on day 14 post-vaccination. Blood specimens were obtained on days 
0, 14, 28, 56, 183 and 366 after vaccination and sera tested for the 
presence of IgM and IgG antibodies against RVF virus. The individual farm 
animal husbandry and reproduction management system was maintained 
for the study animals. A total of 404 animals (cattle, sheep, goats) located 
at three commercial farms in Kenya were enrolled in the study. Of these, 
170 (42.1%) animals were not pregnant whereas 234 (57.9%) were at 
either early or late pregnancy. Of the 404 animals, 195(48.3%) were 
inoculated with RVF Clone 13 vaccine, and the remaining 209 (51.7%) 
animals inoculated with saline as placebo. Eleven (2.7%) study animals 
were lost to follow up after being sold following accidental trauma or lost 
to predation. Most animals maintained good health following vaccination 
with no adverse events except for 20 sheep (4.9%) that developed 
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uncomplicated mild nasal discharge 1 to 3 days post vaccination 
confirmed as bacterial infections; all recovered. One cow was treated for 
placenta after birth. Of 234 pregnant animals that delivered, 231 (98.7%) 
had live births including 31 cattle, 102 sheep (including 10 twins), and 
98 goats (including 26 twins); however, one (0.4%) abortion and two 
(0.8%) still births occurred in goats. No teratogenicity was observed in any 
offsprings. Both IgM and IgG antibodies were detected in vaccinated but 
not unvaccinated animals. In conclusion, the RVF Clone 13 vaccine was 
found to be safe for use in cattle, sheep, and goats including animals in 
early and late pregnancies. The vaccine also appears to have good efficacy 
as demonstrated by detection of antibodies against the virus.
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IDENTIFICATION OF A NOVEL ORTHOBUNYAVIRUS ISOLATED 
FROM CULEX (MELANOCONION) PORTESI MOSQUITOES 
FROM IQUITOS, PERU
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Vector-borne pathogens are among the most important emerging and 
re-emerging viruses that cause epidemics in humans and livestock. In 
this study, we describe the isolation and molecular characterization of 
a novel orthobunyavirus (genus Orthobunyavirus, family Bunyaviridae) 
isolated from Culex (Melanoconion) portesi during entomological 
surveillance for arboviruses in the city of Iquitos, located in the Amazon 
basin of northeastern Peru. Mosquitoes were collected by CO2-baited 
CDC light traps, identified to species, pooled, triturated, and inoculated 
onto mosquito (C6/36) and mammalian (Vero 76) cell cultures. In one 
pool of Culex (Mel) portesi collected in November 2009, evidence 
for orthobunyavirus infection was detected by cytopathic effect and 
indirect immunofluorescent assay in inoculated Vero 76 cells using 
polyclonal antibodies against Group C orthobunyaviruses. Hyperimmune 
ascitic fluid against a range of Group C viruses, including Apeu, Itaqui, 
Murutucu, Marituba, Oriboca, and Caraparu viruses, were unable to 
neutralize the virus isolate in microneutralization assays. Full genome 
sequence was generated by random amplification and pyrosequencing 
and compared with sequences available in GenBank. While the highest 
sequence similarity was with Group C viruses, nucleotide (<75%) and 
amino acid identity (<70%) was low for S, M, and L segments compared 
with previously reported viruses. Based on serological and molecular 
results, we conclude that this isolate is a novel member of the Group 
C orthobunyaviruses. Future studies will be necessary to determine the 
prevalence and possible human health impact of this newly-identified 
virus.
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IMMUNE RESTORATION DISEASE AND CHANGES IN CD4+ 
T-CELL COUNT IN HIV-INFECTED PATIENTS DURING HIGHLY 
ACTIVE ANTIRETROVIRAL THERAPY AT ZEWDITU MEMORIAL 
HOSPITAL, ADDIS ABABA, ETHIOPIA
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Highly active antiretroviral therapy (HAART) improves the immune 
function and decreases morbidity, mortality and opportunistic infections 
(OIs) in HIV-infected patients. However, since the use of HAART, immune 
restoration disease (IRD) has been described in association with many OIs. 
Our objective was to determine the proportion of IRD, changes in CD4+ 
T-cell count and possible risk factors of IRD in HIV-infected patients. A 
retrospective study of all HIV- infected patients starting HAART between 
September 1, 2005 and August 31, 2006 at Zewditu memorial hospital 
HIV clinic, Addis Ababa, Ethiopia was conducted. All laboratory and 
clinical data were extracted from computerized clinic records and patient 
charts. A total of 1166 HIV- infected patients with mean ± SD age of 36 
± 9.3 years were on HAART. IRD was identified in 170 (14.6%) patients. 
OIs diagnosed in the IRD patients were tuberculosis (66.5%, 113/170), 
toxoplasmosis (12.9%, 22/170), herpes zoster rash (12.9%, 22/170), 
Pneumocystis jirovecii pneumonia (4.1%, 7/170), and cryptococcosis 
(3.5%, 6/170). Of the 170 patients with IRD, 124 (72.9%) patients 
developed IRD within the first 3 months of HAART initiation. Low baseline 
CD4+ T-cell count (odds ratio [OR], 3.16, 95% confidence interval [CI], 
2.19-4.58) and baseline extra pulmonary tuberculosis (OR, 7.7, 95% 
CI, 3.36-17.65) were associated with development of IRD. Twenty nine 
(17.1%) of the IRD patients needed to use systemic anti-inflammatory 
treatment where as 19(11.2%) patients required hospitalization associated 
to the IRD occurrence. There was a total of 8 (4.7%) deaths attributable to 
IRD. In conclusion, the proportion and risk factors of IRD and the pattern 
of OIs mirrored reports from other countries. Close monitoring of patients 
during the first three months of HAART initiation is important to minimize 
clinical deterioration related to IRD.
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DISTRIBUTION OF KILLER CELL IMMUNOGLOBULIN-LIKE 
RECEPTORS (KIR) GENES IN AN ADMIXED PERUVIAN 
POPULATION
Sandra S. Morales Ruiz, Daniel D. Clark, Elsa E. González, 
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Killer cell immunoglobulin-like receptors (KIR) are glycoproteins located 
on the surface of NK cells. These receptors are classified into two groups 
according to their cytoplasmic domain, which transduces inhibitory or 
activating signals, and consequently modulates NK cell function and 
most likely the susceptibility to diseases or infections. We studied the 
distribution of KIR genes in 363 Peruvian HTLV-1-infected individuals 
using two ethnic classification methods: 1) a questionnaire, which defined 
the participants as Andean (both parents born in the Andes) or Mestizo 
(only one parent born in the Andes); and b) ancestry informative markers 
(AIM), which allowed classifying the whole population into three groups 
according to their ethnic admixture proportions. DNA was obtained from 
blood samples of each individual and KIR genotyping was carried out 
using PCR-SSP. No significant differences were observed in gender and 
age according to the Andean/Mestizo classification, whereas significant 
differences were found when the ethnic admixture proportion criterion 
was applied. The frequency of KIR2DS3, KIR2DS4 and KIR2DL3 were 
statistically different between Andeans and Mestizos. When using ethnic 
admixture proportion, significant differences were observed for KIR3DL1 
and KIR2DS4s in addition to those genes, among the three groups 
defined. No significant differences were detected in haplotypes and 
inhibitory-activating KIR genes using either the questionnaire or AIM-
based classification. AIM helps minimizing both the bias in ethnic group 
definition and the effects of population stratification, and therefore should 
be used in order to avoid false results when searching for gene-disease 
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Arboviruses are transmitted by arthropods; humans become infected 
during blood meal by infected mosquitoes, ticks and sandflies. Arboviruses 
have been well characterized in many industrialized countries, but 
there are many knowledge gaps in developing nations. Entomological 
surveys conducted so far have demonstrated circulation of arboviruses 
of significant public health importance in Aedes, Anopheles and 
Culex species in vast populations in Kenya, suggesting the presence 
of competent vector systems for many of the arboviruses. The human 
population involvement in the transmission of these viruses has however 
not been demonstrated. This study sought to determine the sero-
prevalence of a range of arboviruses including Chikungunya, Dengue, 
Sindbis, Sandfly Naples, Sandfly Sicilian, Uganda S, West Nile and Zika 
viruses in Ijara and Marigat. About 5µl of patients’ serum samples was 
used to test for antibodies to each of the viruses listed. All the samples 
were tested by IgG ELISA.A total of 351 patient serum samples were 
analyzed, of these 193 (54.9%) were male while female were 158 
(45.1%), and age range was between 3 and 73. The overall positivity 
for the arboviruses was 53/351 (15.1%). The arboviruses prevalence 
in Marigat was 7% (10/143) while Ijara was 21% (43/208). Uganda S 
virus was the most prevalent with 10%, followed by West Nile virus 6%, 
Sindbis 5%, Dengue 2%, Chikungunya 1.1%, Sandfly Naples 0.2%. 
Antibodies against Sandfly Sicilian and Zika viruses were not detected. This 
is the first documentation of antibodies against Sandfly Naples virus in the 
sub-Sahara Africa. This study has shown the evidence of past exposure 
of the selected arboviruses in human population in the two sites. This 
information together with vectors data will strengthen efforts to develop 
focused preventive actions to stop transmission and create awareness 
among clinicians to help improve patients’ management in the region.
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LONG-TERM CLINICAL, IMMUNOLOGIC AND VIROLOGIC 
FOLLOW-UP IN A COHORT INFECTED WITH MAYARO VIRUS
Eric S. Halsey1, Carolina Guevara1, Crystyan Siles2, Stalin 
Vilcarromero2, Erik J. Jhonston3, Victor Fiestas4, Patricia Aguilar5, 
Julia S. Ampuero1
1U.S. Naval Medical Research Unit No. 6, Lima, Peru, 2U.S. Naval Medical 
Research Unit No. 6, Iquitos, Peru, 3Universidad Nacional de la Amazonia 
Peruana, Iquitos, Peru, 4Instituto Nacional de Salud, Lima, Peru, 5University 
of Texas Medical Branch, Galveston, TX, United States
Alphaviruses, such as Venezuelan equine encephalitis virus and 
chikungunya virus, are mosquito-borne pathogens possessing the 
potential of causing explosive epidemics with chronic sequelae in those 
infected. Much less is known about Mayaro virus (MAYV), an alphavirus 
endemic to the Amazon basin that causes fever, malaise, and joint pain 
in the acute setting. Long-term studies of this virus are rare and limited 
to case reports. Starting in January 2011, as part of a collaborative febrile 
surveillance project with the Peruvian Ministry of Health in the Amazon 
cities of Iquitos and Yurimaguas, we enrolled 17 patients with acute 
MAYV infection confirmed by isolation (11), PCR (6), or ≥ 4-fold change 
in IgM titer (17)_most patients had more than one positive assay. In 
addition to their acute visit, patients were also evaluated at 20 days (±10 
days), 3 months (±10 days), and 6 months (±15 days). At each follow-up 
visit, a detailed interim history was taken and a physical examination was 
performed. In addition, serum was obtained in order to evaluate IgM 
and IgG titers and urine was collected and will be evaluated with PCR. 
Preliminary results show that while IgG levels persist at high levels at 6 
months, IgM titers remain elevated in most patients at 3 months, but 
return to zero in the majority at 6 months. Fourteen of seventeen patients 
had arthralgias at the acute visit, 3 of 17 (18%) at 20 days, 7 of 16 (44%) 
at 3 months, and 6 of 12 (50%) at 6 months. Distal joints, specifically of 
the hand and ankle, were the most commonly affected. Malaise, present 
in 17 of 17 (100%) at the acute visit, persisted in 2 of 17 (12%) patients 
at 20 days, 2 of 16 (13%) at 3 months, and 0 of 12 (0%) at 6 months. 
Our investigation will continue to follow these patients at one and two 
year visits, and we will also investigate immunologic and virologic findings 
that correlate with long-term morbidity.
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POST-EPIDEMIC SEROPREVALENCE OF RIFT VALLEY FEVER 
VIRUS AMONG SOMALI VILLAGES IN NORTHEASTERN 
KENYA
A. Desiree LaBeaud1, Laura J. Sutherland2, Samuel Muiruri3, 
Saidi Dahir3, Zach Traylor2, Eric Muchiri3, Amy G. Hise2, James W. 
Kazura2, Charles H. King2
1Children’s Hospital Oakland Research Institute, Oakland, CA, United 
States, 2Case Western Reserve University, Cleveland, OH, United States, 
3Division of Vector-borne and Neglected Tropical Diseases, Ministry of 
Health, Nairobi, Kenya
In endemic areas, Rift Valley fever virus (RVFV) is a significant threat to 
both human and animal health. Goals of this study were to measure 
human anti-RVFV seroprevalence in a high-risk area following the 2006-
2007 Kenyan Rift Valley Fever (RVF) epidemic, to identify risk factors 
for RVFV exposure, and to monitor for sequelae of RVFV disease. We 
conducted a large cross-sectional village cluster survey among residents 
aged 1-85 years in 6 villages in Ijara District, Northeastern Province, Kenya: 
Tumtish (N=190, 47 households), Matarba (N=242, 70 households), 
Korahindi (N=289, 86 households), Gedilun (N=237, 63 households), 
Golalbele (N=85, 27 households), and Sabenale (N=64, 20 households). 
Participants underwent questionnaire administration, physical exam, vision 
testing, and blood collection for RVFV testing. One thousand one hundred 
seven individuals were tested for RVFV exposure via RVFV IgG ELISA; 667 
or 60% were women and 631 or 57% were children aged 1- 15 years. 
Overall, 173/1111 or 16% (CI95% 13.78-18.42) of local residents were 
RVFV seropositive. Seroprevalence varied by village: Tumtish (27/190, 
14%, CI95% 9.59-20.02), Matarba (37/242, 15%, CI95% 11.00-20.27), 
Korahindi (53/291, 18%, CI95% 15.63-24.99), Gedilun (32/237, 13.5%, 
CI95% 9.27-18.05), Golalbele (15/87, 17%, CI95% 9.98-26.84), and 
Sabenale (10/64, 15.6%, CI95% 7.76-26.86). Visual impairment (defined 
as ≤20/20) was much more likely in the RVFV-seropositive group (P= 
0.0001). Our results highlight significant variability in RVFV exposure in 
six neighboring villages having very similar climate, terrain, and Somali 
populations. In concordance with previous studies, RVFV seropositivity was 
associated with poor visual acuity. Further analysis of questionnaire data 
will elucidate primary risk factors for RVFV exposure.
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REVISITING ALBERT SABIN’S RESEARCH ON HUMAN 
DENGUE INFECTION
Grace E. Snow1, Benjamin Haaland2, Eng Eong Ooi2, Duane J. 
Gubler2
1Duke University, Durham, NC, United States, 2Duke-NUS Graduate 
Medical School, Singapore, Singapore
There is no good animal model for dengue, one of the most important 
emerging tropical infectious diseases. As a result, we have relied on 
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human studies done by the US Army in the 1920s and 1940s for basic 
information on incubation period, cross protective immunity and early 
clinical presentation. One study was conducted by Albert Sabin, who 
infected 118 volunteers with DENV-1 and -2 isolated in Hawaii, New 
Guinea and India. Sabin presented a broad overview of these studies 
in his oft-cited 1952 paper, but the details were never published. His 
original laboratory records, which were bequeathed to one of us (DJG), 
provided the opportunity to re-visit these seminal studies. Of 118 primary 
infections (104 DENV-1 and 14 DENV-2), 20 subjects were reinfected 
with the heterologous serotype at intervals of 1.5 - 9 months to evaluate 
the duration of cross-protective immunity between serotypes. Median 
fever duration for primary DENV-2 infections was 2.2 days compared to 
3.3 days for primary DENV-1 (p < 0.05), although maximum temperature 
and severity of illness were comparable. Of 7 secondary infections at 
6-8 weeks, all but one had temperature <38°C; one with a maximum 
temperature of 38°C on day 8, was viremic. At 8-10 weeks post 
primary infection, 4 out of 5 (80%) subjects became ill with maximum 
temperature between 38.1 and 38.8°C. At 4-9 months post primary 
infection, 7 out of 8 (88%) subjects with secondary infection developed 
fever and 3 (38%) had a maximum temperature >39°C. There was a trend 
towards a shorter incubation period in secondary infections at 4-9 months 
(median 4.2 days) compared to primary infections (median 6.9 days), and 
illness was generally milder in secondary infections. The data suggest 
that the DENV serotype and/or strain may influence the duration of fever 
in primary infection, and the time elapsed from the primary infection 
influences the symptoms, duration and severity of fever and leukopenia in 
secondary infections. A detailed analysis of the Sabin experiments will be 
presented.
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DENGUE VIRUS INFECTION IN THE SKIN: DENDRITIC CELLS 
AND THE ROLE OF MOSQUITO SALIVA
Michael A. Schmid1, Karla N. Gonzalez2, Matthew T. Aliota3, 
Laura Kramer3, Eva Harris1
1Division of Infectious Diseases and Vaccinology, School of Public Health, 
University of California, Berkeley, Berkeley, CA, United States, 2Laboratorio 
Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, 
Ministerio de Salud, Managua, Nicaragua, 3Wadsworth Center, New York 
State Department of Health, Slingerlands, NY, United States
Dendritic cells (DCs) that reside in the skin serve as sentinels of the 
immune system. The 4 dengue virus serotypes (DENV1-4) are transmitted 
when infected Aedes aegypti or Ae. albopictus mosquitoes bite humans, 
and may result in dengue, the most prevalent arthropod-borne human 
viral disease. Primary DENV infection confers life-long protection to the 
same serotype, while secondary infection with a distinct DENV serotype is 
a major risk factor for severe disease via serotype cross-reactive enhancing 
antibodies (ADE) or T cells. DCs, monocytes, and macrophages are targets 
of DENV in humans, yet little is known about initial DENV infection in the 
skin after the bite of an infected mosquito or about subsequent systemic 
viral spread. Here, we report a novel intradermal (i.d.) infection model 
with DENV2 strain D220 in the ears of C57BL/6 mice deficient in the IFN-
α/β receptor (IFNAR-/-), under primary and ADE infection conditions. Ear 
skin is digested to separate epidermal from dermal sheets and to prepare 
single cell suspensions, which are stained with monoclonal antibodies 
(MAbs) against surface markers to distinguish cell populations and MAbs 
against intracellular DENV nonstructural protein 3 and envelope to identify 
DENV-infected cells by flow cytometry. 24 and 48 hours after infection, 
replicating DENV was detected in epidermal Langerhans cells, dermal 
CD11b+ DC and CD103+ DC subsets, and CD45- non-hematopoietic cells 
in both the epidermis and dermis. Inoculation of sub-neutralizing levels 
of DENV-specific MAbs resulted in increased morbidity and mortality 
of IFNAR-/- mice after i.d. DENV infection; we are now analyzing DENV-
infected skin cell populations under ADE conditions. While probing for 
blood vessels, mosquitoes eject saliva, which contains pharmacologically 
active substances, into the skin. When mice were pre-sensitized to salivary 
gland extracts (SGE) from female Ae. aegypti mosquitoes by repeated i.d. 
inoculation of SGE 4 and 2 weeks prior to co-injection of DENV2 D220 
and SGE, preliminary results revealed reduced numbers of DENV+ cells 
in the dermis compared to naïve mice that were not pre-sensitized to 
SGE. We are currently expanding the investigation of the role of vector 
saliva and ADE on DENV replication in the skin, spread of infection, 
and induction of the immune response. These findings will improve 
understanding of the initial events following DENV infection and will 
inform future vaccine development.
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ANALYSIS OF EARLY DENGUE VIRAL INFECTION IN MICE AS 
MODULATED BY AEDES AEGYPTI PROBING
Michael K. McCracken, Rebecca C. Christofferson, Christopher 
N. Mores
Louisiana State University, Baton Rouge, LA, United States
Mosquito saliva contains proteins with anti-inflammatory, anti-hemostatic, 
and immuno-modulatory capabilities. Arbovirus-infected mosquitoes 
expectorate saliva and virus immediately prior to blood feeding and this 
saliva has been shown to aid the establishment of arboviruses such as 
Sindbis and West Nile within the vertebrate host. Limited work exists on 
the functional relationship between Aedes aegypti salivary proteins and 
vertebrate infection with dengue virus. Most studies have focused on 
associations between disease severity and changes observed in the early 
days post exposure rather than interactions that could affect establishment 
of dengue virus within a vertebrate host. Here, we examine in vivo 
transcriptional changes of critical innate immune pathways three hours 
post exposure at inoculation sites of IRF3/7 -/--/- (C57BL/6) mice. Mice 
received dengue serotype 2, strain 1232 intradermal needle-inoculation 
where field collected Ae. aegypti mosquitoes 1) had and 2) had not 
recently probed. At inoculation sites where mosquitoes had probed, we 
observed a generalized up-regulation of the transcripts for transcription 
factors, such as relA, and transcription factor associated proteins. We 
found substantial down-regulation of various cytokines including the 
interferon γ transcript and the transcript of a monocyte chemotactic 
molecule, IP-10. Additionally, we found an approximately 45-fold down-
regulation of the transcript for toll-like receptor 7, an endosomal pattern 
recognition receptor for single-stranded RNA. The down-regulation of 
these transcripts early in the infection process could indicate important 
mechanisms by which mosquito salivary proteins serve to enhance the 
establishment of dengue viral infections in the vertebrate host.
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DENGUE VIRUS-SPECIFIC HUMORAL AND T CELL RESPONSES 
IN NOVEL HUMANIZED MICE
Smita Jaiswal1, Marcia Woda1, Pamela Pazoles1, Leonard Shultz2, 
Dale Greiner1, Michael Brehm1, Anuja Mathew1
1University of Massachusetts Medical School, Worcester, MA, United 
States, 2Jackson Labs, Bar Harbor, ME, United States
Dengue is a mosquito borne viral disease of humans, and animal models 
that recapitulate human immune responses and/or dengue pathogenesis 
are needed to understand the pathogenesis of the disease. We recently 
described an animal model for dengue virus (DENV) infection using 
humanized NOD-scid IL2rγnull mice (NSG) engrafted with cord blood 
hematopoietic stem cells (HSC). We sought to further improve this model 
by co-transplantation of human fetal thymus and liver tissues into NSG 
(BLT-NSG) mice. Enhanced DENV-specific antibody titers were found in 
the sera of BLT-NSG mice compared to human cord blood HSC-engrafted 
NSG mice. Furthermore, B cells generated during the acute phase and in 
memory from splenocytes of immunized BLT-NSG mice secreted DENV-
specific IgM antibodies with neutralizing activity. We have generated and 
characterized a panel of human monoclonal antibodies (MAbs) from B 
cells in BLT-NSG mice during acute DENV infection and in convalescence. 
Human T cells in engrafted BLT-NSG mice secreted IFN-gamma in response 
to overlapping DENV peptide pools and HLA-A2 restricted peptides. 
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BLT-NSG mice will provide a much-needed platform to assess human 
immune responses to DENV vaccines and the effects of prior immunity on 
subsequent DENV infections.
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TRANSMISSION OF DENGUE TO MOSQUITOES DURING 
PERIODS OF LOW VIREMIA
Rebecca C. Christofferson, Christopher N. Mores
Louisiana State University, Baton Rouge, LA, United States
Our understanding of dengue transmission dynamics is largely driven by 
hospital and/or symptomatic case data. It has been suggested that higher 
viremia levels, as observed in patients with more severe disease, may result 
in a higher probability of uptake by a vector, thus enhancing transmission. 
Comparatively little attention has been paid to the role of lower level 
viremic and possibly asymptomatic cases in dengue transmission. Such 
inapparent infections may account for the majority of dengue infections. 
Additionally, as dengue transmission occurs at a highly focally spatial level 
(households, schools, workplaces), the transmission to mosquitoes from 
such low viremias has not been sufficiently investigated. Accordingly, 
we investigated the rate of acquisition, subsequent dissemination and 
transmission of dengue virus serotype 2, strain 1232 at low viremia levels 
by Aedes aegypti (Rockefeller) mosquitoes from a permissive mouse 
model. Cohorts of mosquitoes kept for up to fifteen days post exposure to 
viremic mice were allowed to refeed on naïve mice, and were then tested 
for virus infection and dissemination. Critically, at viremias as low as 1x101 
and 1x102 pfu/ml, mosquitoes acquired virus infections, with predicted 
transmission rates of 7-18%. Our findings suggest that during lower 
viremia levels, asymptomatic (or prepatent) cases may account for an 
important proportion of the transmission potential to mosquito vectors.
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GENOME-WIDE PATTERNS OF INTRA-HUMAN DENGUE 
VIRUS DIVERSITY REVEAL ASSOCIATIONS WITH VIRAL 
PHYLOGENETIC CLADE AND INTER-HOST DIVERSITY
Poornima Parameswasan1, Patrick Charlebois2, Yolanda Tellez3, 
Andrea Nuñez3, Elizanbeth M. Ryan2, Christine M. Malboeuf2, 
Joshua Z. Levin2, Niall J. Lennon2, Angel Balmaseda3, Matthew R. 
Henn2, Eva Harris1
1Division of Infectious Diseases and Vaccinology, School of Public 
Health, University of California, Berkeley, Berkeley, CA, United States, 
2Broad Institute of Massachusetts Institute of Technology and Harvard, 
Cambridge, MA, United States, 3Laboratorio Nacional de Virología, Centro 
Nacional de Diagnóstico y Referencia, Ministerio de Salud, Managua, 
Nicaragua
Analogous to observations in RNA viruses such as Human 
Immunodeficiency Virus, genetic variation associated with intra-host 
dengue virus (DENV) populations has been postulated to influence 
viral fitness and disease pathogenesis. Previous attempts to investigate 
intra-host genetic variation in DENV characterized only a handful of 
viral genes or limited numbers of full-length genomes. We developed a 
whole-genome amplification approach coupled with deep sequencing 
to capture intra-host diversity across the entire coding region of DENV-2. 
Using this approach, we sequenced DENV-2 genomes from the serum of 
22 Nicaraguan individuals with secondary infection and captured ~75% 
of the DENV genome in each sample (range 40-98%). We identified 
and quantified variants using a highly sensitive and specific method, 
and determined that the extent of diversity was considerably lower than 
previous estimates. Significant differences in intra-host diversity were 
detected between genes and also between immunogenically-distinct 
domains of the Envelope gene. Interestingly, a strong association was 
discerned between the extent of intra-host diversity in a handful of genes 
and viral clade identity. Additionally, the abundance of viral variants within 
a host, as well as the impact of viral mutations on amino acid encoding 
and predicted protein function, determined whether intra-host variants 
were observed at the inter-host level in circulating Nicaraguan DENV-2 
populations, strongly suggestive of purifying selection across transmission 
events. Our data illustrate the value of high-coverage genome-wide 
analysis of intra-host diversity for high-resolution mapping of the 
relationship between intra-host diversity and clinical, epidemiological and 
virological parameters of viral infection.
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DAILY HANDHELD ULTRASONOGRAPHY PERFORMED BY 
CLINICIANS CAN DETECT SUBCLINICAL PLASMA LEAKAGE 
AND IDENTIFY DENGUE PATIENTS AT RISK FOR DENGUE 
SHOCK SYNDROME
Meta Michels1, Quirijn de Mast1, Uun Sumardi2, André J. van der 
Ven1, Bachti Alisjahbana2
1Radboud University Nijmegen Medical Centre, Nijmegen, The 
Netherlands, 2Faculty of Medicine, University of Padjadjaran, Hasan Sadikin 
Hospital, Bandung, Indonesia
Plasma leakage is the critical feature of severe dengue infection. Timely 
detection of plasma leakage is important to identify those at risk 
for dengue shock syndrome (DSS). While presently available clinical 
and laboratory (e.g. hematocrit) markers have only low sensitivity , 
ultrasonography may improve timely detection of plasma leakage. 
Unfortunately, limited availability in resource poor settings and costs 
are hurdles for widespread implementation. In recent years, however, 
affordable handheld ultrasound devices have become available that can be 
operated by non-radiologists. We studied the possibility to detect plasma 
leakage and to identify patients at risk for DSS by non-radiologists using 
serial handheld ultrasonography in a prospective cohort of Indonesian 
patients with laboratory proven dengue. A total number of 66 patients 
were enrolled, of whom 44 were classified as non-DSS and 11 as DSS. At 
enrollment, subclinical plasma leakage in the form of ascites or pleural 
effusion was already detected in 26% of the patients. Presence of ascites 
or pleural effusion at enrollment had a positive predictive value of 35% 
for the development of DSS, and a negative predictive value of 90%. At 
enrollment, 55% of DSS cases already had detectable plasma leakage 
and this increased to 91% during the subsequent days. Gallbladder 
wall edema was most pronounced in DSS patients and often preceded 
ascites and/or pleural effusion. The findings of handheld ultrasonography 
corresponded well with conventional ultrasonography made by a certified 
radiologist during the critical phase of the infection. Serial hematocrit and 
albumin measurements, as recommended by WHO guidelines, failed to 
identify plasma leakage. In conclusion, serial handheld ultrasonography 
performed by clinicians is a sensitive tool to detect plasma leakage in 
dengue, in contrast to existing markers such as albumin and hematocrit. 
Detection of subclinical plasma leakage and/or an edematous gallbladder 
wall can identify patients at risk for DSS, and these patients merit more 
intensive monitoring of circulatory status and intravenous treatment. The 
introduction of more affordable handheld ultrasound devices, operated 
by shortly trained clinicians, can increase the clinical implementation of 
ultrasonography in dengue, especially in resource poor countries which are 




ELQ-300 FOR TREATMENT AND PREVENTION OF MALARIA
Michael K. Riscoe1, Roman Manetsch2, Dennis E. Kyle2, Aaron 
Nilsen1, Alexis N. LaCrue2, Fabian Saenz2, Akhil Vaidya3, Isaac 
Forquer1, R. Matthew Cross2, Susan Charman4, Jeremy Burrows5, 
R. Kip Guy6, Wil Milhous2, Rolf Winter1, Peter Siegl7, Joanne M. 
Morrisey3, Michael W. Mather3, Jane X. Kelly1, Tina S. Mutka2, 
Karen White4
1Veterans Affairs Medical Center/Oregon Health Sciences University, 
Portland, OR, United States, 2University of South Florida, Tampa, FL, 
United States, 3Drexel University, Philadelphia, PA, United States, 4Monash 
University, Melbourne, Australia, 5Medicines for Malaria Venture, Geneva, 
Switzerland, 6St. Jude Children’s Research Center, Memphis, TN, United 
States, 7Siegl Pharma Consulting, Blue Bell, PA, United States
ELQ-300 is a novel antirespiratory compound with low nanomolar IC50 
values against blood stages of Plasmodium falciparum and P. vivax, 
including drug resistant laboratory strains and field isolates. It has, so far, 
proven impossible to generate ELQ-300 resistant mutants using single 
step methodology, with a demonstrated resistance frequency far improved 
over atovaquone. The in vitro potency, combined with the high metabolic 
stability, results in spectacular oral efficacy with a curative blood stage 
dose of 1 mg/kg against P. berghei or P. yoelii infected mice in standard 
3 and 4 day tests. Interestingly, the molecule is also exquisitely potent 
against exo-erythrocytic stages and impacts not only liver schizonts, 
but also blocks stage V gametocyte development and inhibits ookinete 
formation in the mosquito midgut. Although its aqueous solubility is 
limited, ELQ-300 exhibits high oral bioavailability at therapeutically 
relevant doses with extended half-lives in rodents and dogs. Impressively, 
in vivo doses of 0.03mg/kg result in formal causal prophylaxis and killing 
of all P. berghei liver schizonts; furthermore this same dose results in 
complete inhibition of P. berghei oocyst formation in a mouse feeding 
study thus totally inhibiting sporogony and demonstrating a 100% 
block of transmission. ELQ-300 has high in vitro selectivity over human 
cytochrome bc1 and it is without cytotoxicity (10µM) against a panel of 
mammalian cell types. It was not inhibitory against a large safety and 
selectivity target panel of receptors, amine transporters and ion channels, 
including the hERG channel, nor is the compound genotoxic as assessed in 
a 5-strain Ames and in vitro micronucleus assays. Given the low predicted 
dose in patients, a long predicted human half-life, and potent activity 
against blood and exo-erythrocytic stages of parasite development, ELQ-
300 offers the hope of a new molecule for the treatment, prevention and, 
ultimately, eradication of malaria.
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POTENTIAL EFFICACY OF CITICOLINE AS ADJUNCT THERAPY 
FOR CEREBRAL MALARIA
Fatima El-Assaad1, Valery Combes1, Georges E. Grau1, Ronan 
Jambou2
1Vascular Immunology Unit, Faculty of Medicine, University of Sydney, 
Sydney, Australia, 2Institut Pasteur de Madagascar, Antananarivo, 
Madagascar
During cerebral malaria (CM), sequestration of parasitised erythrocytes, 
platelets and leucocytes within the cerebral microvessels, coupled with 
cytokine overproduction leads and/or blood brain barrier (BBB) disruption 
and/or intercellular junction opening. We evaluated the efficacy of 
citicoline (CTC), a membrane stabilising agent already registered for use 
in ischemic stroke and anti-histamine as adjunct therapy to enhance the 
recovery from CM. Initial trials in Plasmodium berghei ANKA-infected 
mice (which develop a lethal syndrome 7 days post-infection) showed that 
treatment with CTC alone (1g/kg, from day-4 to day-7) doesn’t enhanced 
survival after day-7. After day-14, CTC in combination with a sub-effective 
dose of artemisinin (40 mg/kg) enhanced survival from 20% (artemisinin 
alone) to 75% (art+CTC). CTC is a very well tolerate compound, registered 
by the FDA as a nutritional supplement for children. It could be thus very 
easy to use in public health structures. These data support development 
of studies in human to address interest of membrane protector as adjunct 
therapy during Malaria.
433
PATHWAYS TO HEMOLYTIC TOXICITY OF PRIMAQUINE: 
EVALUATION OF POTENTIAL HEMOTOXIC METABOLITES OF 
PRIMAQUINE AND AMINOPHENOL ANALOGS IN VITRO ON 
NORMAL AND GLUCOSE 6-PHOSPHATE DEHYDROGENASE 
DEFICIENT HUMAN ERYTHROCYTES
Narayan D. Chaurasiya1, Rajnish Sahu1, Vijender Adelli1, N.P. 
Dhammika Nanayakkara1, Colin Ohrt2, Larry A. Walker1, Babu L. 
Tekwani1
1School of Pharmacy, University of Mississippi, University, MS, United 
States, 2Walter Reed Army Institute of Research, Silver Spring, MD, United 
States
Recent malaria treatment measures have resulted into significant decrease 
in cases of Plasmodium falciparum, but P. vivax cases are steadily rising. 
Primaquine (PQ) is the drug of choice for radical cure of relapsing P. 
vivax malaria. However, utility of PQ has been limited primarily due to 
hemolytic toxicity in the G6PD deficient populations. The redox active 
metabolites generated through CYP mediated pathways are responsible 
for hemolytic toxicity of PQ, but the identity of these metabolites has still 
remained elusive. The phenolic metabolites reported in in vitro metabolism 
and experimental animal studies have been suggested as the potential 
hemotoxic metabolites. In view of these, 5-hydroxy primaquine (5-HPQ), 
8-N hydroxyl 6-methoxyaminoquinoline (NHMAQ) and some aminophenol 
analogs were evaluated in vitro on normal and G6PD deficient human 
erythrocytes. Hemolytic response was monitored with multiple 
biochemical markers namely, methemoglobin, reactive oxygen species 
(ROS) and depletion of reduced glutathione (GSH). The PQ metabolites 
and aminophenol analogs produced differential hemotoxic response on 
normal and G6PD deficient human erythrocytes. 5-HPQ and NHMAQ 
produced a robust increase in methemoglobin and ROS, and the responses 
were similar in normal and G6PD deficient erythrocytes. However, the 
metabolites depleted GSH only in G6PD deficient erythrocytes. This 
differential response may explain selective susceptibility of G6PD deficient 
individuals to hemolysis during treatment with PQ. 5HPQ produced 
about 3 fold higher methemoglobin accumulation and more prominent 
depletion of GSH than NHMAQ. However, NHMAQ generated about 
three-fold higher ROS signal compared to 5-HPQ. The 2-aminophenols 
generated more prominent hemotoxic responses than 4-aminophenols, 
while 3-aminophenols were non-toxic. 4-Methyl and chloro substitutions 
potentiated the toxicity, while 4- and 5-nitro substitutions attenuated 
the toxicity of 2-aminophenols. A pattern of structure toxicity relation 
observed in hemotoxic response of aminophenols may be useful for 
designing PQ analogs with better therapeutic index.
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AN IN VIVO GLUCOSE-6-PHOSPHATE DEHYDROGENASE 
(G6PD)-DEFICIENT MOUSE MODEL TO PREDICT HEMOLYTIC 
TOXICITY OF CANDIDATE 8-AMINOQUINOLINE (8-AQ) ANTI-
MALARIAL DRUGS
Prabhati Ray, Peng Zhang, Jack Amnuaysirikul, Max Grogl, Colin 
Ohrt, Mike O’Neil, Mark Hickman
Walter Reed Army Institute of Research, Silver Spring, MD, United States
Many of 8-aminoquinoline (8-AQ) compounds investigated to treat 
relapsing malaria are hemolytic in subjects with glucose-6-phosphate 
dehydrogenase deficiency (G6PDD). As 8-AQ drugs are the only treatment 
for relapsing Plasmodium vivax malaria, research studies to develop non-
hemolytic 8-AQs are very important, and an in vivo model is desperately 
needed to test the hemolytic potential of newly developed 8-AQ drugs. 
We have “proof of concept” for a G6PD-deficient (G6PDD) mouse model 
with a similar degree of G6PD deficiency as in the human African type 
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A- population (10-15% of normal G6PD activity); this model mimics the 
8-AQ drug-induced hemolysis in human G6PDD individual. This mouse 
model was validated using two known hemolytic 8-AQs, i.e., primaquine 
and pamaquine, and two known non-hemolytic drugs, chloroquine and 
mefloquine. Major hemolytic parameters evaluated were decreased red 
blood cell counts; increased reticulocyte counts; Heinz body formation; 
and decreased haptoglobin level in serum. Mice given the hemolytic drugs 
consistently displayed a hemolytic response, whereas those treated with 
chloroquine and mefloquine showed no significant hemolytic response. 
In this study, we assessed the effects of various dose levels of tafenoquine 
using this G6PDD mouse model. Tafenoquine was given orally at several 
doses (13.3, 7.5 or 2.5 mg/kg/d) for 3 days; or (40, 30, 20, or 10 mg/kg/
day) for 1 day. A known hemolytic drug, primaquine, was dosed at 8.8 
mg/kg/day for 3 days, as the positive control. Tafenoquine at the 100% 
causal prophylaxis efficacy dose (CP-ED100, 2.5 mg/kg/day for 3 days, or 
10 mg/kg for one day) demonstrated no hemolytic toxicity in our G6PDD 
mouse model, whereas primaquine at ½ ED100 (8.8 mg/kg/day for 3 days) 
displayed a hemolytic response . Higher doses of tafenoquine, above 
the ED100 (e.g. 13.3 mg/kg/d for 3 days, or 40 mg/kg for 1 day), were 
shown to induc hemolysis in G6PDD mice. We conclude that tafenoquine 
treatment at the ED100 dose is safer than treatment with PQ at the ED100 
dose.
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A PHASE I STUDY TO INVESTIGATE THE HAEMOLYTIC 
POTENTIAL OF TAFENOQUINE IN HEALTHY SUBJECTS WITH 
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 
(TAF110027)
Ronnatrai Rueangweerayut1, Germana Bancone2, Andrew P. 
Beelen3, Nick Carter4, Stephan Duparc5, Justin A. Green4, Emma J. 
Harrell4, Jörg-Peter Kleim4, Ann K. Miller6, Jörg Möhrle5, Ammar 
Qureshi4, Nushara Yubon7, Lucio Luzzatto8, Francois H. Nosten2, 
Supornchai Kongpatanakul9
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Unit, Mae Sot, Thailand, 3formerly GlaxoSmithKline; currently with 
Myrexis Inc., Salt Lake City, UT, United States, 4GlaxoSmithKline, Uxbridge, 
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6GlaxoSmithKline, King of Prussia, PA, United States, 7GlaxoSmithKline, 
Bangkok, Thailand, 8Istituto Toscano Tumori (ITT), Firenze, Italy, 
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Tafenoquine (TQ) is an 8-aminoquinoline (8-AQ) with a half life of 2-3 
weeks currently in development as a single dose treatment for the radical 
cure of Plasmodium vivax malaria. 8-AQs cause haemolysis in glucose-
6-phosphate dehydrogenase (G6PD) deficient individuals; common in 
malarious regions. As a first step to investigate TQ’s haemolytic potential 
quantitatively we have commenced a dose escalation Phase I safety 
study. We recruited healthy female volunteers (Hb >12 g/dL) who were 
heterozygous for the G6PD Mahidol mutation assessed by PCR-RFLP with 
red cell G6PD enzyme activity 40-60% of normal (based upon testing 
n=39 males defining a local median value of 11.5 IU/gHb, as reported 
previously. G6PD normal control subjects were Mahidol negative with 
>80% G6PD activity. A priori we defined a dose escalation strategy 
based upon the number of subjects reaching a dose limiting toxicity (DLT) 
defined as an absolute decline of ≥2.5 g/dL Hb or ≥7.5% in haematocrit: 
should 3 or more subjects reach DLT in any given cohort dose escalation 
will stop. We have completed dosing cohorts of 6 normal and 6 deficient 
subjects with single 100 mg and 200 mg doses. 1/6 of the heterozygote 
subjects in the 100 mg cohort, and 2/6 in the 200 mg cohort reached DLT. 
Median maximum fall in Hb in both cohorts was 1.6 g/dL (range 0.9 - 2.4 
in the 100 mg cohort, range 1.3 g/dL - 3.1 g/dL in the 200 mg cohort). 
An increase in bilirubin was common (5/6 in 100 mg cohort, 3/6 in 200 
mg cohort) and by day 12 all subjects had exhibited a reticulocyte level 
of at least 2.2%. In G6PD normal subjects smaller Hb falls were observed 
(range 0.6 to 2.1 g/dL) but were not attributed to hemolysis. Additional 
relevant clinical and laboratory data will be presented. TQ is a promising 
new therapy for radical cure of P. vivax in G6PD normal subjects. Our data 
demonstrate that in non-anaemic G6PD deficient heterozygotes with 
40-60% G6PD enzyme activity TQ regularly causes haemolytic anaemia, 
which appears to be dose-related, and has been of mild to moderate 
degree with a dose of 100-200 mg.
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USING HUMAN BLOOD STAGE PLASMODIUM FALCIPARUM 
INFECTION TO DEFINE THE ACTIVITY OF LICENSED AND 
EXPERIMENTAL ANTIMALARIAL DRUGS
James S. McCarthy1, Silvana Sekulsoki2, Katharine Trenholme1, 
Suzanne Elliott2, Paul Griffin1, Jane Gaydon3, Louise Marquart2, 
Peter O’Rourke2, Andrew Humberstone4, Joerg Moehrle4, Theo 
Sloots3, Stephan DuParc4, Mark Baker4
1Queensland Institute of Medical Research, University of Queensland, 
Herston, Australia, 2Queensland Institute of Medical Research, Herston, 
Australia, 3QPID, University of Queensland, Herston, Australia, 4Medicines 
for Malaria, Geneva, Switzerland
The growing awareness of slow clearance as a potential marker of 
incipient failure of artemisinin antimalarials has highlighted the need 
for better defining the clearance kinetics of parasitemia following drug 
therapy. Most previous studies have used parasite counts as determined 
by slide estimation to determine clearance. Such data are of suboptimal 
quality to precisely define the inherent activity of various antimalarials. 
We have undertaken a series of four studies in human volunteers 
experimentally infected with blood stage parasites of Plasmodium 
falciparum where the clearance kinetics of parasitemia have been 
closely monitored by serial quantitative PCR. Data will be presented 
on the kinetics of clearance, presented as the parasite reduction ration 
(PRR) in these four cohorts following treatment with artemether-
lumefantrine, atovaquone-proguanil, pyrimethamine-sulfadoxine and 
mefloquine. Benchmarking the pharmacodynamic activity of both licensed 
and experimental antimalarials and correlating these data with the 
pharmacokinetic profile of the drugs will provide a much needed evidence 
base for the development of new antimalarials as well as improving 
understanding drug activity and the development of drug resistance.
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A POPULATION PHARMACOKINETICS ANALYSIS OF OZ439 
DISPOSITION IN PATIENTS
Mark B. Baker, Fiona Macintyre, Joerg Moehrle
Medicines for Malaria Venture, Geneva, Switzerland
OZ439 is a synthetic trioxolane undergoing clinical investigation and 
being developed by MMV as a potential anti-malarial therapy. OZ439 has 
shown in vivo a potential for a single dose cure in Plasmodium falciparum 
malaria while showing in in vitro and in vivo models marked prophylactic 
potential, extended half-life and oral bioavailability, and increased 
metabolic stability. Data from Phase I study in healthy volunteers and 
the on-going Phase IIa have confirmed OZ439 to be safe and tolerable. 
The pharmacokinetics (PK) of OZ439 will help determine its potential as 
a single dose cure. PK data from the on-going Phase IIa investigation in 
patients was analysed using a non-linear mixed effects approach. In this 
study single doses of OZ439 have been orally administered to patients. 
The optimal structural model was a 2 compartment model with oral 
absorption. The oral absorption had a lag time associated with it. Inter-
individual variability was attributed to the central volume of distribution, 
clearance and lag time. The observed PK was linear with a clearance of 
65.7 L/hr and an elimination half-life of 53 hours; thus the PK supported 
OZ439’s potential as a single dose cure. This population PK model will 
aid in predicting the time course of OZ439 at different doses and will 
be updated as more data is collected. This will include determining the 
covariates of the PK parameters in order to characterise the effects of 
age, co-administered drugs, and ethnopharmacology. A major benefit of 
characterising the PK in this manner is the ability to use these parameters 
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in PK/PD models, to make population predictions of OZ439’s efficacy as an 
anti-malarial, to confirm the suitability of OZ439’s PK for a single dose cure 
and to design future clinical trials.
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A CONSERVED PLASMODIUM PROTEIN REGULATES 
MEROZOITE PRODUCTION DURING INTRAERYTHROCYTIC 
SCHIZOGONY
Bareza A. Rasoul1, Marcus Skaflen2, Steven P. Maher3, Anatoli 
Naumov3, Chris Lantz2, John H. Adams3, Bharath Balu1
1SRI International, Harrisonburg, VA, United States, 2James Madison 
University, Harrisonburg, VA, United States, 3University of South Florida, 
Tampa, FL, United States
A critical aspect of Plasmodium biology is its ability to multiply 
exponentially during different stages of its life cycle. Both within the 
vertebrate and invertebrate hosts, the parasite undergoes a rapid 
increase in population through asexual reproduction, which is critical 
for its transmission and disease pathogenesis. In the human blood 
stages, P. falciparum typically produces an average 20 merozoites per 
schizont, which upon release, infect new host erythrocytes and continue 
to exponentially increase in numbers. Although this is a crucial step 
in maintaining infection in the human host, mechanisms controlling 
merozoite production are still poorly understood in Plasmodium. Here, 
we report the identification of a conserved Plasmodium protein, critical 
for regulating merozoite production in the intraerythrocytic stages of P. 
falciparum. piggyBac insertion into the coding sequence of this protein 
results in approximately 40% reduction in merozoite numbers and severely 
attenuates the parasite intraerythrocytic growth rate. Understanding 
the functions of this protein will provide novel insights into a crucial 
component of parasite biology.
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GENOME-EDITING THE MALARIA PARASITE PLASMODIUM 
FALCIPARUM
Judith Straimer1, Marcus C. Lee1, Bryan Zeitler2, Andrew H. Lee1, 
Jocelynn R. Pearl2, Lei Zhang2, Edward J. Rebar2, April Williams3, 
Manuel Llinás3, Philip D. Gregory2, Fyodor D. Urnov2, David A. 
Fidock1
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Malaria afflicts 225 million people worldwide and its most lethal etiologic 
agent, Plasmodium falciparum, is evolving to resist the latest-generation 
therapeutics. Tools for genome-directed study of such resistance and ways 
to overcome it, however, are sorely lacking. Here we report rapid and 
targeted genetic engineering of this parasite, using zinc-finger nucleases 
that produce double-strand breaks in a user-specified locus and trigger 
homology-directed repair. Targeting an integrated gfp locus, we obtained 
a homogeneous population of knockout parasites in an unprecedented 
15 days. Moreover, ZFNs engineered against pfcrt produced parasites 
that carry a panel of investigator-defined point mutations and acquired 
antimalarial drug resistance. The efficiency, versatility and precision of this 
approach enable genome editing of this human pathogen to meet the 
challenge of substantially reducing the burden of disease.
440
GLOBAL IDENTIFICATION OF PALMITOYLATION SITES IN 
PLASMODIUM FALCIPARUM SCHIZONTS
Chwen Tay, Mark O. Collins, Matthew L. Jones, Jyoti S. 
Choudhary, Julian C. Rayner
Welcome Trust Sanger Institute, Cambridge, United Kingdom
Protein palmitoylation, the addition of a 16-carbon saturated fatty acid 
to cysteine residues, is a major post-translation modification that is used 
in all eukaryotes to regulate protein function. Like phosphorylation, 
palmitoylation is a reversible event, and can serve to regulate protein 
localisation, stability, and activity either stably or in response to specific 
stimuli. Previously only three Plasmodium falciparum proteins were 
known to be palmitoylated, but by combining two established and 
orthogonal purification approaches we have recently identified more than 
300 palmitoylated proteins in late blood-stage P. falciparum parasites, 
including palmitoyl-proteins involved in protein secretion, drug resistance, 
signalling, development, cytoadherence and invasion. This suggests that 
palmitoylation is likely to regulate multiple Plasmodium-specific biological 
processes, but in order to drive specific biological hypotheses it is critical 
that we identify which specific sites within each palmitoyl-protein are 
modified. Like phosphorylation, palmitoylation sites can largely not be 
predicted using primary sequence data alone, with the exception of 
cysteines immediately downstream of myristoylation sites. We have now 
developed a novel protocol that can identify specific palmitoylation sites, 
and have used it to identify more than 1000 palmitoylation sites in P. 
falciparum blood stage proteins, some of which are now being followed 
in functional studies. Given the scale at which this modification is used 
in blood stage parasites, palmitoylation should be considered alongside 
phosphorylation as a major regulatory mechanism and potential target for 
intervention.
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DISCOVERY OF CONSERVED PLASMODIUM ANTIGENS ON 
THE SURFACE OF RED BLOOD CELLS USING DNA APTAMERS
Eugene K. Oteng1, Chris Newbold1, Carole Long2
1University of Oxford, Oxford, United Kingdom, 2National Institutes of 
Health, Rockville, MD, United States
During its intraerythrocytic cycle, the human malaria parasite Plasmodium 
falciparum remodels the host red blood cell (RBC) plasma membrane 
with a poorly defined collection of antigenically diverse proteins. While 
these proteins play roles important for parasite survival and virulence they 
are exposed to potential drugs and immune effectors in blood for ~24 
hours as parasites develop. It is not clear, however, whether any of these 
proteins are structurally conserved enough to provide a novel target for 
vaccine or drug development. Here we describe a novel DNA aptamer 
selection scheme to probe for epitopes on the parasitized RBC surface 
that are conserved between geographically distinct parasite isolates. Our 
scheme isolated 14 aptamers that tightly bind parasitized RBCs (with 
low-nanomolar dissociation constants) and possess no affinity for non-
parasitized RBCs. Three aptamers recognize all laboratory-adapted clones 
and field isolates of P. falciparum, P. vivax and P. knowlesi tested yet show 
no affinity for the murine malaria parasites, P. berghei and P. chabaudi. 
Moreover, some of these aptamers efficiently kill blood-stage parasites in 
vitro in a dose-dependent and sequence-specific manner. Current work is 
focused on identifying the aptamer binding to membrane extract targets 
and elucidating their role in parasite survival. Discovery of a protein or 
epitope conserved between the major species of human malaria parasites 
may have implications for drug and vaccine development and validates our 




TOWARD RNA-BASED APPROACHES FOR STUDYING 
MALARIA PARASITE BIOLOGY
Jeffrey C. Wagner, Jacquin C. Niles
Massachusetts Institute of Technology, Cambridge, MA, United States
Malaria caused an estimated 655,000 deaths in 2010, mostly in children 
under the age of five years. Plasmodium falciparum is responsible for 
the majority of malaria morbidity and mortality. Research efforts aimed 
at gaining biological insights into this parasite are hampered by a lack of 
gene regulatory technologies that permit elucidation of genetic pathways 
in situ. Inducible expression is an important strategy for establishing 
how genes function, and for determining their interactions in biological 
pathways. Pathways that are both essential and unique to the parasite 
can then be targeted in drug development efforts. Based on this need, 
we have reconstituted an inducible T7 RNA polymerase (T7 RNAP) 
transcriptional system in P. falciparum. We have demonstrated T7 RNAP-
directed, IPTG-inducible target transcript production in situ at levels similar 
to or greater than those generated by characterized native polymerase II 
promoters. In the repressed state, target transcript levels are reduced by 
more than ten-fold. With this new tool, we envision using RNA-based 
approaches, such as conditionally expressing aptamers that can disrupt 
protein function, to complement the characterization and validation of 
potential parasite drug targets.
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BASELINE AND EARLY POST-ANTIPARASITIC TREATMENT 
URINE ANTIGEN LEVELS IN NEUROCYSTICERCOSIS
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Sarah Gabriel2, Yesenia Castillo3, Pierre Dorny2, Hector H. Garcia3, 
For the Cysticercosis Working Group in Peru3
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Circulating antigen levels may provide a monitoring tool for human 
neurocysticercosis (NCC). Experience with serum levels shows that 
they correlate with parasite burden and evolution, and that they drop 
in a few months after successful antiparasitic treatment. Also, under 
clinical circumstances, urine levels have been shown to correlate with 
serum levels. Urine being a non-invasive sample, we wanted to evaluate 
whether it could be used as a follow up tool to determine early changes 
in levels of circulating antigen, during the initial two weeks of therapy. 
Thirty-one patients, 18 men and 13 women, aged 18 to 80 years, with 
neurocysticercosis demonstrated by MRI and confirmed by antibody 
serology on EITB, had urine samples collected at baseline and at days 1, 
3, 5, 7, 9 11, and 13. These samples were processed using a monoclonal 
antibody-based AgELISA (B158/B60). Sensitivity of the AgELISA was 81% 
(25/31) both in serum and in urine. There was a very high correlation 
between baseline serum and urine levels. Antigen levels did not become 
negative in this short period and had different trends, mostly stable, or 
decreasing. In some patients, antigen levels decrease by more than 10 
times along two weeks. Patients who were later shown as treatment 
failures had persistent or increasing antigen levels. Urine antigen detection 
may serve to monitor NCC patients after antiparasitic treatment, 
particularly in those who are antigen positive at baseline.
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IMMUNE RESPONSE DURING NEUROCYSTICERCOSIS IN 
MADAGASCAR
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Neurocysticercosis (NCC) is the most important cause of seizure in tropical 
countries. In Madagascar seroprevalence of cysticercosis (in blood) can 
reach 20% in population of the highlands. However biological methods 
used in blood can give high level of false positivity due to extra-cerebral 
localisation of the cysts, and can be in same time poorly sensitive when 
a single cyst is located in brain. Scanners are also poorly available in 
tropical countries leading treatment of the patients with anti-helminths 
on behalf of ELISA anti-Taenia solium results. We thus urgently need to 
improve diagnostic of NCC. We analysed cellular and serological immune 
response in adult patients suffering from recent seizures, with or without 
images of NCC on CT-Scan. We used both reference glycosylated proteins 
and liquid of cysts (LC) as antigen for lymphocyte proliferation tests (LPT) 
and for serological analysis. In the same time we compared anti-Tsolium 
isotypes (IgE, IgA, IgD, IgG) in blood and in cerebrospinal fluid (CSF). 
LPT using LC but not glycosylated protein was found to be an accurate 
method to detect cysticercosis which pave the was to the development 
of new strategy of test for this disease. In the same time isotype analysis 
enlightened clearly local secretion of antibodies in CSF and IgD was more 
accurate to detect this proliferation than IgA or IgE. An overall analysis of 
these data will be presented.
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ENHANCED CORTICOSTEROID USE IN THE TREATMENT OF 
PARENCHYMAL NEUROCYSTICERCOSIS REDUCES SEIZURE 
OCCURRENCES WITHOUT A REDUCTION IN EFFICACY OR AN 
INCREASE IN SIDE EFFECTS
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Group in Peru, Lima, Peru
Although corticosteroids are commonly employed to reduce treatment 
induced seizures in the treatment of parenchymal neurocysticercosis 
(NCC), the benefits of their use and exactly how and when to use 
them has not been rigorously studied. In an open randomized trial, two 
groups of 31 patients with one or more viable parenchymal cysts were 
treated with 15 mg/kg albendazole for 14 days and either the standard 
dexamethasone regimen at 6 mg/day for 10 days, (Arm 1) or for 28 days 
at 8 mg/day with a 14 day taper (Arm 2). Subjects were required to be on 
antiseizure medication with proven effective blood levels. The number of 
seizures and persons with seizures were compared from 1-360 days with 
the interval of 11-42 days as the primary outcome, efficacy at 180 days by 
MRI and side effects from 1-360 days. Number of seizures (mostly partial 
seizures) and people with seizures were increased in Arm 1 compared 
to Arm 2 during the trial but did not reach significance for the primary 
outcome 11-42 day interval (p=0.623). There was a similar increase of 
generalized seizures in Arm1 but too few occurred in either Arm to be 
analyzable. However, from days 1-10 and 11-21 the number of partial 
seizures (p=0.016 and p=0.016 respectively) and people with seizures 
(p=0.013 and p=0.020 respectively) were significantly increased in Arm 
1 compared to Arm 2. There was also a significant increase of partial 
133
www.astmh.org
seizures (p=0.036) and persons with seizures (p=0.041) in Arm 1 during 
the entire course of the trial, mostly due to early events. By a number 
of measures efficacy including percent reduction in cysts cure rates, and 
subjects requiring retreatment, was similar between the Arms. Although 
there were more adverse events in Arm 1, mostly due to neurologically 
based changes, none of the events reached significance. Enhanced 
corticosteroids significantly decreased treatment induced seizures 
compared to a standard regimen without a decrease in efficacy or undo 
increase in side effects. Effects were due predominately to a decrease in 
seizures within the first 21 days.
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TWO LARGE EPILEPSY SURVEYS IN A CYSTICERCOSIS-
ENDEMIC REGION IN TUMBES, PERU
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Epilepsy is one of the older diseases of mankind. The prevalence of 
epilepsy worldwide added to inadequate treatment and late intervention 
results in chronic morbidity and considerable mortality in poor populations. 
Neurocysticercosis (NCC), a helminthic disease of the central nervous 
system, is one of the leading causes of seizures and epilepsy. Taking 
advantage of a large cysticercosis elimination program, we performed two 
wide scale cross-sectional studies in 58 rural communities of the Northern 
coast of Peru to assess the prevalence and characteristics of epilepsy 
and epileptic seizures in this cysticercosis-endemic region. Two studies 
were conducted between 2006 and 2007, involving 20,610 individuals. 
An initial epilepsy screening survey was followed by a phase of medical 
evaluation, followed by interview with a neurology specialist. A total of 
17,452 individuals older than 2 years (86.41%) consented to participate. 
The overall prevalence of epilepsy was 17.25/1000, and that of active 
epilepsy was 10.8/1000 inhabitants, without marked differences between 
surveys.The prevalence of epilepsy by age increased after age 25 years 
and dropped after age 45. Only 45 out of 188 (23.94 %) patients with 
active epilepsy (30/107 and 15/81 from 2006 and 2007 respectively) were 
taking antiepileptic drugs. All of them were receiving sub-therapeutic 
doses. The seroprevalence of antibody against T. solium in individuals with 
epilepsy was approximately 40% in both studies. In the first survey there 
was no statistically significant difference in overall seroprevalence between 
individuals with and without epilepsy. The proportion presenting strong 
antibody reactions (4-7 bands by EITB) was however five times higher in 
individuals with epilepsy than that in individuals without epilepsy. In the 
second survey, the seroprevalence as well as the proportion presenting 
strong antibody reactions were significantly higher in individuals with 
epilepsy. Brain CT showed NCC-compatible images in 109/282 individuals 
with epilepsy (39%). All individuals with viable parasites on CT were 
seropositive. Prevalence of epilepsy in this cysticercosis endemic region is 
high and NCC is an important contributor to it.
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PROVINCES OF BURKINA FASO
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Taenia solium cysticercosis is considered as an emerging infection in 
Sub-Saharan Africa. Results from a previous pilot study in Burkina Faso 
showed that half of people with epilepsy in two villages where pigs were 
raised had neurocysticercosis. The aim of this study was to estimate the 
lifetime prevalence of epilepsy in 60 villages located in three Provinces of 
Burkina Faso. This is the baseline cross-sectional component of a large 
community randomized-control trial which took place between February 
2011 and January 2012. The provinces of Nayala (10 villages), Boulkiemdé 
(30 villages) and Sanguié (20 villages) were selected for inclusion in the 
study. In each province, all departments where pigs were raised (30 of 
31) were selected. Within each department, two villages meeting the 
eligibility criteria were selected at random. In each village, one person 
was selected at random from each of 10 (with sows), 30 (with piglets) 
and 40 (with or without pigs) randomly-selected concessions (a grouping 
of several households). A total of 60 of 80 participants in each village 
were asked for their consent to provide a blood sample to test for the 
presence of antigens to the larval stages of T. solium using an ELISA test. 
A total of 4,970 individuals, aged 6 to 99 years (median of 30 years), were 
interviewed with a screening questionnaire for epilepsy. Screened positive 
participants were examined by a physician to confirm the diagnosis of 
epilepsy. Preliminary estimates of the unweighted lifetime prevalence of 
confirmed epilepsy were 3.0%, 1.0% and 3.4% in Boulkiemdé, Nayala 
and Sanguié, respectively. At the village-level, the lifetime prevalence 
showed important variation, ranging from 0% (in 7 villages, including 4 
villages in Nayala Province) to 8.8% in one village of Sanguié. Although 
these data are being analysed to account for the clustered nature of the 
sampling strategy, they provide evidence that the prevalence of epilepsy 
varies spatially in rural Burkina Faso.  
448
CYST STAGE AND DIMENSION INFLUENCE SEROLOGICAL 
RESPONSE IN HEPATIC ECHINOCOCCUS GRANULOSUS 
INFECTION
Enrico Brunetti1, Raffaella Lissandrin2, Luca Piccoli2, Carmine 
Tinelli2, Claudia Cevini2, Roberta Maserati2, Antonella Bruno2, Sam 
R. Goblirsch3, Simona Gatti2
1University of Pavia, Pavia, Italy, 2IRCCS Policlinico San Matteo, Pavia, Italy, 
3University of Minnesota, Minneapolis, MN, United States
Diagnosis of hepatic cystic echinococcosis (CE) is based primarily on 
ultrasound (US) and serology. The latter has a minor role as it cannot 
distinguish between active and inactive cysts and its sensitivity and 
specificity are poor and influenced by many variables. Furthermore, 
most clinical studies on serology of CE do not take into account the cyst 
stage and this impairs their usefulness in clinical decision making. We 
investigated retroactively a cohort of patients diagnosed with CE who 
were seen in our clinic from May 2000-June 2012, by looking at the 
correlation, if any, of their cyst stage as seen on US and their serological 
test (IHA and ELISA) results. Cysts were stratified by stages (active, 
transitional and inactive cysts, WHO IWGE) and by dimension (S≤ 5 cm, M 
5-10 cm and L≥ 10 cm). Of the 339 patients evaluated in 812 visits, 249 
had 1 parasitic cyst and 90 had a non parasitic cyst. IHA and ELISA were 
positive in 87 and 83% of active cysts, 90 and 93% of transitional and 60 
and 50% of inactive cysts and post-surgical residual cavities, respectively. 
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Specificity of both tests was 99 %. A statistically significant difference (p< 
0,0001) for median values of IHA and ELISA was found between active 
and inactive cysts, active and residual cavities and transitional and inactive 
cysts. Both tests were positive in 58% of examinations, specifically in 81% 
of active cysts, 90% of transitional cysts and 51% of inactive cysts. Both 
tests were negative in 99% of non parasitic cysts. Serological response is 
also influenced by cyst dimensions. Both tests were positive in 76% of L 
, 62 and 48% of M and S cysts respectively, with statistically significant 
differences between serological response among L and S cysts and M and 
S cysts. Serological response to hepatic CE with routinely used tests is 
influenced by dimension and biological activity of the cyst. Future clinical 
studies on the use of serology in CE should take this into account.
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Shan2, Qin-Wen Tai3, Tao Li3, Jin-Hui Zhang3, Jin-Ming Zhao3, Hao 
Wen2
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Xinjiang Medical University, Urumqi, Urumqi, China, 2State Key Laboratory 
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Laboratory of Echinococcosis, 1st Affiliated Hospital of Xinjiang Medical 
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University, Urumqi, China
Echinococcosis is a chronic parasitic infectious disease regulated by T 
cell subsets. CD4+CD25+FoxP3+ regulatory T (Treg) cells and Th17 cells 
have been described as two distinct subsets and have the opposite effect 
on inflammation. Th17/Treg balance controls inflammation and may 
play important role in the pathogenesis of immune evasion. To assess 
whether this balance was broken, we detected Th17/Treg functions in 
different levels including cell frequencies, related cytokines secretion and 
key transcription factors in patients with cystic echincoccosis and healthy 
controls. The results demonstrated that patients with cystic ehinococcosis 
revealed significant increase in peripheral Treg number, related cytokines 
(IL-10 and TGF-β1) and transcripition factor (Foxp3) levels and moderate 
decrease in Th17 number, related cytokines (IL-17 and IL-23) and 
transcription factor (RORγt) levels as compared with controls. Results 
indicated that Th17/Treg functional imbalance exsists in patients with 
choronic cystic ehinococcosis, sugessting a potential role for Th17/Treg 
imbalance in the pathogenesis of immunue evasion in echinococcosis.
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USE OF SMARTPHONES IN HEALTH AND DEMOGRAPHIC 
SURVEILLANCE
Aurelio Di Pasquale1, Bruce MacLeod2, Willem Takken3, 
Alexandra Hiscox3, Richard W. Mukabana4, Henry Mwanyika1, 
Nicolas Maire1
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Health and Demographic surveillance systems (HDSS) can provide 
essential information in areas where routine vital registration is absent or 
incomplete. HDSSs also play an essential role in health intervention studies 
in such areas. Setting up and running an HDSS poses an operational 
challenge, and a reliable and efficient platform for data collection and 
management is a key prerequisite. openHDS is an HDSS data system 
that provides data entry, quality control, and reporting to support demo-
graphic and health surveillance. openHDS has recently been integrated 
with the Open Data Kit (ODK) software platform for data collection using 
mobile devices running the Android operating system. The use of direct 
data entry using smartphones offers a number of advantages: it reduces 
the workload of the data management team, allows for near real-time 
quality control, and can provide guidance for the project logistics. 
Here we present an overview of the openHDS/ODK software platform, 
and report on the experience of using this platform to set up a HDSS to 
support a malaria intervention study in Kenya, in the Rusinga Island during 
the Solarmal Project in collaboration with the ICIPE research center in 
Mbita, Nyanza (Kenya).
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ROLE OF POOR ENVIRONMENT AND SOCIAL STATUS ON 
LEPTOSPIRA TRANSMISSION IN THE URBAN SLUM SETTING: 
A PROSPECTIVE PROPENSITY SCORE-MATCHED COHORT 
STUDY
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Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil, 3Instituto de 
Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil, 4Secretária 
Estadual de Saúde da Bahia, Salvador, Brazil, 5Escola Nacional da Saúde 
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Leptospirosis is an important health problem in slum settlements 
worldwide, which have environmental and social conditions for rat-borne 
transmission. We performed a propensity score-matched analysis of 
longitudinal data from a cohort of urban slum residents to delineate the 
role of poor environment and social status on Leptospira infection risk. A 
prospective study identified Leptospira infections, potential environmental 
transmission sources, socioeconomic factors, and risk behaviors among 
slum residents during four annual serosurveys. We calculated a propensity 
score to estimate the probability of an individual residing in proximity 
to environmental transmission sources, based on 13 socioeconomic 
variables, and a second score to estimate the probability of having a per 
capita daily household income below the median of $1.32, based on 16 
environmental variables. We then created two matched cohorts based 
on these propensity scores in order to evaluate the isolated infection risk 
due to slum environment and social status, respectively, in Generalized 
Estimation Equation models. Among 1224 pairs of person-years of follow-
up, matched according to propensity for environmental exposures, we 
found the 15-24 year (RR, 2.60, 95% CI, 1.29 - 5.23) and 25-34 year 
(RR, 3.29; 95% CI, 1.61 - 6.72) age groups, male gender (RR, 2.15; 95% 
CI,1.31 - 3.52), illiteracy (RR, 2.94; 95% CI, 1.68 - 5.17), and household 
proximity to open waste sewers and flood risk areas (RR, 1.90; 95% 
CI, 1.03 - 3.50) to be independent risk factors. Among 1315 pairs of 
person-years of follow-up, matched according to propensity for low 
income, we found belonging to 25-34 year age group (RR, 3.13; 95% CI, 
1.53 - 6.42), male gender (RR, 2.17; 95% CI, 1.34 - 3.50), illiteracy (RR, 
1.91; 95% CI, 3.47 - 1.05), and household proximity to open sewers and 
flood risk areas (RR, 2.06; 1.16 - 3.66) to be independent risk factors for 
infection. We found that poor environmental conditions associated with 
inadequate sewage and rainwater drainage significantly increase the risk 
of leptospirosis transmission, independent of economic status. Young 
adult male and illiterate participants were also at greater risk. Prevention 
of urban leptospirosis will therefore require improving infrastructure in 
slum communities. Furthermore, the specific exposures and risk behaviors 
of young males and individuals with low social status need to be identified 




LESSONS LEARNED IN IMPLEMENTING LOW-COST EHEALTH 
TOOLS IN NICARAGUA: SUPPORTING INFORMATION 
COLLECTION, MANAGEMENT AND USE IN HEALTH CARE 
DELIVERY AND PUBLIC HEALTH RESEARCH IN LIMITED-
RESOURCE SETTINGS
William Avilés, Heather Zornetzer
Sustainable Sciences Institute, Managua, Nicaragua
This is a critical time in the global dialogue about “eHealth”. Investing in 
efficient, accessible, and cost-effective information and communication 
technology (ICT) tools can help to improve health outcomes and prevent 
diseases in low-resource settings. Since 2004, the Sustainable Sciences 
Institute has been working with various eHealth and mHealth tools to 
support clinical and epidemiological data management needs for the 
Pediatric Dengue Vaccine Initiative cohort study, in collaboration with 
the University of California, Berkeley, and the Nicaraguan Ministry of 
Health. Beginning in 2009, several collaborative projects were launched 
in Nicaragua with local partners to adapt, test and implement various 
ICT tools to improve timely and efficient access to information for key 
healthcare actors at the primary care level. Work includes implementation 
at various scales of a web-based electronic medical record system 
(OpenMRS) for pediatric immunization tracking and prenatal health 
monitoring and follow-up. In 2010, an open-source web-based Laboratory 
Information Management System (LIMS) was developed for the National 
Diagnostic and Reference Laboratory and its regional centers, which is 
currently in the implementation phase. In 2011, a primary care blood 
transfusion recipient tracking system was developed, linking the Red 
Cross blood donation information system with that of the national blood 
bank commission. In parallel, work with OpenROSA-compliant open-
source mobile health technologies including OpenXData, OpenDataKit, 
CommCare, EpiSurveyor, and FrontlineSMS is ongoing and aims to extend 
the reach of data collection and reporting tools at both the clinic and 
community levels. These applications include support of the Behavior 
Change Communication project working with men in rural areas, 
pregnancy and child emergency notification systems, rapid notification of 
communicable diseases, and decision support for community surveillance, 
all using phones as primary data collection instruments. Critical lessons 
learned include engaging primary stakeholders early and often in the 
iterative processes of design, implementation and evaluation of these 
interventions. This helps to ensure that changes in work flow and 
information flow facilitated by ICTs are incorporated in a sustainable way 
to support health system strengthening.
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Targeted global efforts to improve survival of young adults need 
information on mortality trends; contributions from health and 
demographic surveillance system (HDSS) are required. Retrospective 
analysis of deaths among adolescents (15-19 years) and young adults 
(20-24 years) was conducted using census and verbal autopsy data in 
rural western Kenya under HDSS. Mid-year population estimates were 
used to generate all-cause mortality rates per 100,000 population by 
age and gender, by communicable (CD) and non-communicable (NCD) 
causes. Linear trends from 2003 to 2009 were examined. In 2003, all-
cause mortality rates of adolescents and young adults were 403 and 
1,613 per 100,000 population among females, and 217 and 716 per 
100,000 among males, respectively. CD mortality rates among females 
and males 15-24 years were 500 and 191 per 100,000 (relative risk [RR] 
2.6; 95% confidence intervals [CI] 1.7-4.0; p<0.001). NCD mortality rates 
in same aged females and males were similar (141 and 128 per 100,000, 
respectively; p=0.76). By 2009, young adult female all-cause mortality fell 
53% (χ2 for linear trend 30.4; p<0.001) and 61.5% among adolescent 
females (χ2 for linear trend 11.9; p<0.001). No significant CD mortality 
reductions occurred among males or for NCD mortality in either gender. 
By 2009, all-cause, CD, and NCD mortality rates were not significantly 
different between males and females, and among males, injuries equalled 
HIV as the top cause of death. Significant reductions in adolescent and 
young adult female mortality rates evidence the effects of targeted public 
health programmes, however, all-cause and CD mortality rates among 
females remain alarmingly high. Data underscore the need to strengthen 
programmes and target strategies to reach both males and females, and 
to promote NCD as well as CD initiatives to reduce the mortality burden 
among both genders.
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MALARIA RAPID DIAGNOSTIC TESTS IN CONTEXT: INSIGHTS 
FROM THE ACT CONSORTIUM
Shunmay Yeung, Toby Leslie, Clare Chandler, RDTs in Context 
Working Group
London School of Hygiene and Tropical Medicine, London, United 
Kingdom
The availability of affordable, accurate Rapid Diagnostic Tests (RDTs) for 
malaria is enabling a shift from presumptive treatment to parasitological 
confirmation. Questions remain as to where RDTs should be deployed, 
best practice to support their effective deployment and their potential 
impact and cost under real-life conditions. Key determinants have been 
proposed to include the epidemiological setting, prior provider and 
community experiences and practices and the presence and effectiveness 
of supporting interventions. This paper will present a framework for 
considering the complex issues of RDTs as they are implemented in 
context, focusing on steps along a pathway from initial diagnostic policy 
choice through uptake and provider “adherence” to test results and on 
into public health impact and cost-effectiveness. The presentation will 
draw on the multidisciplinary work of projects within the ACT Consortium 
from 9 countries in Africa and Asia and present empirical data from these 
studies and others from the literature. This will include experiences from 
the introduction of RDTs through public and private sector providers, and 





DETECTION OF HUMAN MONKEYPOX IN THE REPUBLIC 
OF THE CONGO FOLLOWING INTENSIVE COMMUNITY 
EDUCATION
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In October, 2009, interethnic violence in northwestern Democratic 
Republic of the Congo (DRC) precipitated the movement of refugees 
across the Ubangi River into neighboring Republic of the Congo (ROC). By 
the end of January 2010, approximately 114,000 refugees had relocated 
to cities and villages along the river in ROC, concentrating mainly in 
areas north of the city of Impfondo, where medical resources are scarce. 
Monkeypox is an acute viral infection with a clinical course resembling 
smallpox. It is endemic in northwestern DRC, but appears to occur only 
sporadically in ROC. The influx of refugees to ROC heightened concerns 
about monkeypox in the area, owing to the possibility that virus could 
be imported, or that incidence could increase due to food insecurity 
and over reliance on bush meat. As part of a broad-based campaign to 
improve health standards in refugee settlement areas, UNICEF sponsored 
a program of intensive community education which included modules on 
monkeypox recognition and prevention. In April and May, 2010, INCEF, 
the implementation partner for the program, performed outreach in 25 
cities and villages where refugees had congregated. Approximately 65,000 
people attended the outreach sessions. In the six months immediately 
following the outreach, ten suspected cases of monkeypox were reported 
to health authorities. Skin lesion specimens were collected from 5 of the 
suspected cases. Laboratory testing confirmed monkeypox virus infection 
in 2 individuals (one of whom was in a cluster of 4 suspected cases), and 
one individual was positive for yaws. Analysis of the viral genome of an 
isolate recovered from 1 of the 2 confirmed cases is highly similar (but 
not identical) to the virus implicated in a hospital-associated outbreak of 
monkeypox that occurred in Impfondo, ROC in 2003. It is less similar to a 
strain isolated from northwest DRC in 2009. Anecdotes collected at the 
time of case reporting suggest that the outreach campaign contributed 
to detection of suspected cases by generating a heightened awareness of 
monkeypox in refugee settlement areas.
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We examined the household incidence of burn-related injuries using 
a prospective, population-based infectious disease surveillance system 
consisting of approximately 28,000 individuals living in 6,000 households 
in the urban slum of Kibera, in Nairobi, Kenya. The study period was 5 
years, July 2006-June 2011. A total of 3,072 cases (2,723 individuals) of 
burn injury were identified with an incidence of 27.9/1000 person years 
of observation (PYO). Burn incidence among children <5 years of age 
was 81.5/1000 PYO compared to 21.2/1000 PYO in those ≥ 5 (p<0.001). 
Females ≥ 5 sustained burn injuries at a rate 1.4-fold greater than males 
≥ 5 (24.5 vs. 18.1/1000 PYO; p<0.001). The disparity was greatest for 
women 18-34 and 35-49 years age, who were 1.9-fold (p<0.001) and 2.1-
fold (p<0.001), respectively, more likely to incur a burn injury compared 
to men of the same age group. Clinical data from a small proportion 
of all burn cases showed that 82% of burns were due to cooking, the 
remaining 18% was due to various non-cooking related accidents and 
other causes (i.e., electrical burns, assault, etc.). Overall burn injury rates 
from Kibera were 5-fold and 10-fold higher than rates from an urban 
regional study in Ghana and a national survey in Bangladesh, respectively. 
Burn injuries may contribute more significantly to increased morbity in the 
developing world than previously thought and are potentially impacted by 
urbanization where dense population and unsafe cooking environments 
may increase the risk.
457
THE MARKET IMPACT OF AN INTERNATIONAL 
COLLABORATION FOR QUALITY CONTROL OF RAPID 
DIAGNOSTIC TESTS FOR MALARIA
Jane A. Cunningham1, Sandra Incardona2, Michelle Gatton3, 
Didier Menard4, Jenny Luchavez5, Nora Champouillon2, Kerim 
Trigg2, Silvia Schwarte6, Andrea Bosman6, John Barnwell7, Qin 
Cheng8, Peter Chiodini9, Mark D. Perkins2, David Bell2
1UNICEF/UNDP/World Bank/WHO Special Programme for Research and 
Training in Tropical Diseases (TDR), Geneva, Switzerland, 2Foundation for 
Innovative New Diagnostics, Geneva, Switzerland, 3Queensland Institute 
of Medical Research, Brisbane, Australia, 4Institut Pasteur du Cambodge, 
Phnom Penh, Cambodia, 5Research Institute for Tropical Medicine, Manila, 
Philippines, 6World Health Organization/Global Malaria Programme (GMP), 
Geneva, Switzerland, 7Centers for Disease Control and Prevention/National 
Center for Global Health/Division of Malaria and Parasitic Diseases, 
Atlanta, GA, United States, 8Army Malaria Institute, Brisbane, Australia, 
9Hospital Tropical Diseases, London, United Kingdom
The number of commercial malaria rapid diagnostic tests (RDT) has 
expanded over the past decade. The dynamic flux of products, together 
with weak regulation and a lack of consistent data on quality, has made 
quality-based procurement difficult. Over several years, WHO, TDR, FIND, 
US CDC, and other partners developed and operationalized malaria RDT 
Product Testing (PT) and Lot Testing (LT) programmes. Data collected 
since 2008 provides unique insight into the impact of such a programme 
on RDT quality and markets. Through open calls for expression of 
interest (2008-2011) to ISO13485-certified manufacturers, RDTs were 
submitted for evaluation against panels of low and high density cultured 
P. falciparum (Pf) parasites, wild-type Pf and P. vivax (Pv) parasites, and 
parasite-negative samples. Similarly, lot testing open to manufacturers and 
procurers uses the same, though much smaller, sets of Pf, Pv and malaria-
negative samples. In 2011, surveys of manufacturer sales (2007-2010) 
were conducted. To date, three rounds of PT have been performed on 120 
products, including 24 resubmissions. The average panel detection score 
(PDS) against low density samples increased between Rounds 1 and 3, by 
9.6% for Pf and 11% for Pv. The average change in PDS at low parasite 
density for resubmitted products was greater, at 12.7% for Pf and 27.4% 
for Pv. Based on sales information from 31 manufacturers, the RDT market 
has increased from 45M in 2008 to 88M in 2010. Sales have shifted 
towards products with a higher PDS, a surrogate for analytic sensitivity. 
Lot testing requests have increased by 258%, from 139 in 2008 to 360 in 
2011, representing ~50% of lots sold into the public sector; furthermore, 
LT failure rates have decreased. The malaria RDT evaluation scheme 
provides data to distinguish between well and poorly performing tests, 
which in turn informs procurement decisions and enables manufacturers 
with better tests to expand their markets. The dramatic improvement 
of resubmitted RDTs indicates that manufacturers can improve product 




VALIDATION OF AN AUTOMATED RDT READER AND DATA 
MANAGEMENT DEVICE IN TANZANIA
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Lack of proper quality assurance is perceived as a significant obstacle 
to the widespread implementation of RDT-based malaria management 
strategy, as recommended by WHO. Previous experience has shown that 
continuous training and/or job aids can abate reduction in diagnostic 
accuracy of RDT based diagnosis over time resulting from human error. As 
well, reporting of diagnostic events is very limited, imprecise and slow in 
most remote areas, impeding proper decision making by control program 
managers. Fio Corporation has developed a system to address both 
problems: improving quality of RDT based diagnosis by providing job aids 
for RDT processing, automated interpretation through digital technology 
and optimal case real time reporting using transmission over cell phone 
network. A fully blinded study was conducted in Bagamoyo district of 
Tanzania to test the diagnostic accuracy of the Fio system using SD Bioline 
malaria Pf/Pan RDT. Patient population consisted of males and females 
> 1 y. o., with symptoms of acute malaria. Main statistical analysis by a 
third party included dx performance of RDT interpreted by device (DEV), 
dx performance of RDT interpreted by experts visual (VIS), and comparison 
of DEV and VIS. Reference standard: expert microscopy performed at 
a central location. RT-PCR was used as tie-breaker in discrepant results. 
1346 patients were enrolled over a 6 week period. Overall Pf infection 
prevalence was 11.1%. DEV Sens: 95.3; Spec: 94.9; PPV:70.3, NPV:99.4. 
VIS Sens: 94.7; Spec: 95.6; PPV: 72.8; 99.3. Percentage concordance 
between DEV and VIS was 97.8. User errors were documented in17/29 
(59%) of discrepant results. Data from devices reached the Fio Cloud in 
real-time and could be accessed by PI & study coordinator. The Sens and 
Spec obtained are similar to other publications. Fio System was shown 
to deliver an automated high diagnostic performance, as good as expert 
visual interpretation. The system was found to be user friendly, practical, 
reliable and accurate. DEV false positives represented <1% of results.
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In West Africa Plasmodium falciparum (Pf) predominates, accompanied 
by non-Pf species in mixed infections that can account up to 20% of all 
malaria cases, with relatively few non-Pf monoinfections. Mixed infections 
have led some countries to select combo RDTs for routine use. In countries 
where non-Pf monoinfections account for less than 5% of all malaria 
cases, pf-only RDTs are preferable as interpretation of tests results is 
simpler and cost is lower. In 2011 Liberia’s NMCP with support from PMI/
IMaD proposed monitoring malaria parasite species to respond to claims 
from providers saying Pf-only RDTs fail to detect malaria because non-Pf 
monoinfections were on the rise. To contain cost and ensure sample was 
representative of the population, parasite species identification (ID) was 
done on biological material collected during MIS 2011, and owned by the 
NMCP. Species ID based on MMEQA slides -excluding heavy parasitemias- 
were assumed to introduce selection bias, overestimating non-Pf. During 
MIS household parasitemia surveys, in addition to mRDTs, slides for MM 
and blotted blood for PCR were collected. Blind species identification was 
done at Liberia’s National PH Reference Laboratory and IMaD Office, with 
participation of three expert microscopists (Level 1). MIS 2011 collected 
blood from 3841 children. A random subsample of 476 slides (15%) 
were selected for MMQA and preliminary analysis of species ID based 
on thick blood films (thin films are better for species ID, but were not 
available). 70 contained malaria parasites. Two slides out of 70 had mixed 
infections (Pf+Pm) and 13 had only Pm, the rest were Pf exclusively. If 
these preliminary results are confirmed by the analysis of species in the 
whole set of positive and readable slides, this will signify that about one 
fifth of malaria cases have non-Pf monoinfection. Those are not detectable 
by Pf-only mRDTs, and there will be need -after using up existing stocks- to 
switch to a combo mRDT with the added cost of retraining, and printing 
job aids. Decisions such as switching from Pf-only to combo RDTs or from 
ACT to a different medication is expected to be done on an annual basis 
or less frequently. A sample size of 750 individuals per stratum (i.e. health 
region) is easily attainable with biennial parasitemia surveys that reach 
about 4000 children.
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Over-treatment of malaria is a common problem in many malaria-endemic 
countries, with parasite-negative patients often receiving an artemisinin-
based combination therapy (ACT) or other antimalarials, leading to 
over-use of ACT, and potentially delaying appropriate treatment, which 
may have severe consequences. Understanding factors associated 
with antimalarial treatment of malaria-negative patients is crucial to 
addressing this problem, and will be of even greater importance if 
malaria transmission decreases and the fraction of fevers attributable 
to malaria is reduced further. To understand current treatment practices 
and identify factors associated with antimalarial treatment of parasite-
negative patients, we conducted surveys at 320 health facilities in three 
regions in Tanzania with varying malaria epidemiology (Mwanza, Mbeya, 
and Mtwara). Surveys were undertaken in 2010 and 2012 before and 
after nationwide roll-out of rapid diagnostic tests for malaria (mRDTs). 
Patients with fever in the previous 48 hours were interviewed following 
their consultation at the facility. Finger prick blood samples were taken by 
the study team to test for malaria parasitemia, allowing cross-referencing 
with any diagnostic test used by facility staff. Data were collected on 
patient characteristics, previous treatment for fever, and care received at 
the facility. Health workers were interviewed about their qualifications, 
training and supervision, knowledge, and facility stocks of antimalarials 
and mRDTs. At baseline, data was collected on 1739 patients (follow-up 
data collection ongoing). By study blood slides, 93% tested negative for 
malaria in Mwanza, 98% in Mbeya, and 79% in Mtwara. Overall, 42% of 
malaria-negative patients were treated with antimalarials by health facility 
workers. We will report the results of multivariate regression analyses 
accounting for the complex sample design to identify patient, health 
worker and facility-level factors associated with correct management 
of malaria-negative patients before and after widespread availability of 
mRDTs to support health worker decision-making. These results will be 
relevant to the success of mRDT roll-out and the design of interventions to 




COMMUNITY LEVEL MANAGEMENT OF FEVER IN 
AFGHANISTAN - THE ROLE OF MALARIA RAPID DIAGNOSTIC 
TESTS
Toby Leslie1, Amy Mikhail1, Ismail Mayan2, Asif Alokozai2, Nader 
Mohammed2, Anwar Hasanzai3, Habib Bakhtash4, Bonnie Cundill1, 
Christopher J. Whitty1, Mark Rowland1
1London School of Hygiene and Tropical Medicine, London, United 
Kingdom, 2Health Protection and Research Organisation, Kabul, 
Afghanistan, 3HealthNet TPO, Jalalabad, Afghanistan, 4MERLIN, Kunduz, 
Afghanistan
In areas of low and seasonal malaria transmission, differential diagnosis 
of non-specific fever is important for patient care, control of malaria and 
in treatment and control of non-malarial causes of fever. Afghanistan is 
endemic for both vivax and falciparum malaria but with a low transmission 
intensity and dominated by vivax which accounts for 80-90% of cases. 
Our previous research has shown that malaria is consistently over-
diagnosed and treated at the clinic level, but little is known about how 
community health workers (CHW) treat patients in the community. 
A cluster randomised trial of malaria rapid diagnostic tests (RDT) was 
undertaken using 400 CHWs to recruit 2600 patients in two transmission 
areas of Afghanistan. All CHWs administratively attached to 22 clinics 
(clusters) received training on management of malaria according to 
Government and WHO guidelines. Half of the clinics were randomly 
assigned to the intervention (RDTs), while half used clinical signs and 
symptoms for diagnosis and treatment. The primary outcome was the 
proportion of patients appropriately treated and aimed to evaluate 
whether the intervention resulted in improved targeting of treatment for 
patients with and without malaria. This included the use of artemisinin 
combination therapy for the rarely encountered cases of falciparum 
malaria. The outcome was measured against PCR based diagnosis of 
malaria to give a gold-standard diagnosis. The accuracy of the RDT and 
the prescribers’ response to the results was assessed. This presentation 
will outline the results of the study and discuss implications for policy 
and practice of fever treatment at community and clinic level in malaria 
endemic areas outside Africa.
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ASSOCIATIONS BETWEEN FIVE DIAGNOSTIC METHODS OF 
PLACENTAL MALARIA AND LOW BIRTH WEIGHT IN AN AREA 
OF HIGH MALARIA TRANSMISSION IN TORORO, UGANDA
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6The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, 
Switzerland
The adverse consequences of placental malaria (PM) have been well 
established. Most studies rely on measures of PM as a surrogate marker 
of adverse birth outcomes such as low birth weight (LBW). However, 
there are no consistent standards for defining PM. Determination of a 
diagnostic standard is essential in order to compare studies using PM as 
the outcome of interest. This study compared the associations between 
5 different definitions of PM and LBW. A total of 565 HIV-uninfected 
pregnant women were enrolled at delivery and infants were weighed at 
birth. LBW was defined as less than 2500 grams. Specimens collected 
included placental blood and tissue for histopathology. Placental blood 
was used for 3 definitions of PM: 1) positive blood smear (BS) for asexual 
parasites, 2) positive HRP2-based rapid diagnostic test (RDT), and 3) 
positive PCR. Placental histopathology was used for 2 definitions of PM: 
1) any evidence of asexual parasites or hemozoin pigment, and 2) a 
quantitative assessment of hemozoin pigment (present in > 50% of 50 
high powered fields examined.) The overall prevalence of PM defined 
by placental BS, placental RDT, placental blood PCR, conventional 
histopathology, and quantitative assessment of hemozoin pigment was 
17.5%, 23.4%, 28.1%, 65.8% and 16.9%, respectively. Placental BS 
and RDT were significantly associated with LBW (RR=1.72, CI=0.99-2.99 
and RR=1.97, CI=1.19-3.26, respectively) whereas placental PCR was not 
(RR=1.42, CI=0.72-4.18). Any evidence of PM by histopathology was not 
significantly associated with LBW (RR=1.73, CI=0.72-4.18); however, the 
quantitative assessment of hemozoin pigment was strongly associated 
with LBW (RR=3.60, CI=1.75-7.39). Placental histopathology was the most 
sensitive test for evidence of active or past placental malaria. Placental 
BS and RDT were also associated with LBW, while placental PCR was not. 
A definition of PM based on quantitative measure of hemozoin pigment 
from histopathology specimens may provide the best surrogate measure of 
adverse birth outcomes.
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DETECTION OF PLACENTAL MALARIA AND IMPACT OF RDT 
SCREENING AND TREATMENT ON PREGNANCY OUTCOMES 
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The negative effects of malaria infection in pregnancy have long been 
recognized. Intermittent preventive therapy (IPTp) with sulfadoxine-
pyrimethamine (SP) is becoming less effective as parasite resistance 
increases. New antimalarial medicines for IPTp are being considered, but 
have disadvantages. Therefore, screening with malaria rapid diagnostic 
tests (RDTs) may offer an accurate and practical way to identify pregnant 
women who will benefit from targeted antimalarial therapy. We assessed 
the association between antenatal (ANC) and intrapartum RDT results 
and pregnancy outcome in two African clinical settings (Uganda, 
hyperendemic, and Burkina Faso, seasonal transmission). We enrolled 
995 (345 Uganda, 650 Burkina Faso) HIV-negative women in the second 
or third trimester of pregnancy and followed them to delivery. On the 
standard IPTp schedule and at the time of delivery, participants’ blood 
was collected for RDTs, microscopy, PCR and hemoglobin measurement; 
placental tissue for histology was obtained at delivery. Participants with 
negative RDT results received SP; those with a positive RDT received 
artemether-lumefantrine or quinine, and SP. Preliminary data from Uganda 
show that 123 (45%) participants had positive RDT results at routine ANC 
visits. There was no significant difference in mean birth weight for mothers 
who had a positive RDT at time of usual IPTp dose and those who had 
all negative RDT results (3.10 kg versus 3.13 kg, t=0.93, p=0.35). There 
were 8 adverse pregnancy outcomes, 7 of which were among women 
whose RDT results were all negative and who received SP only. At time of 
delivery there was no difference in maternal hemoglobin (12.12 g/dL in 
those with RDT positive results and 12.35 g/dL in RDT negatives, t=1.03, 
p=0.31). Additional data will be presented from both sites on the accuracy 
of diagnostic testing for malaria during pregnancy and on the potential for 
malaria RDT screening and treatment of asymptomatic pregnant women 




TO ASSESS WHETHER INDOOR RESIDUAL SPRAYING CAN 
PROVIDE ADDITIONAL PROTECTION AGAINST CLINICAL 
MALARIA OVER CURRENT BEST PRACTICE OF LONG-LASTING 
INSECTICIDAL MOSQUITO NETS IN THE GAMBIA: A TWO-
ARMED CLUSTER-RANDOMIZED STUDY
Margaret Pinder1, Musa S. Jawara1, Lamin B. Jarju2, 
Ballah Kandeh2, David Jeffries1, Kalifa A. Bojang1, Umberto 
D’Alessandro1, David J. Conway3, Steve W. Lindsay4
1MRC Unit, The Gambia, Banjul, Gambia, 2National Malaria Control 
Programme, Banjul, Gambia, 3London School of Hygiene and Tropical 
Medicine, London, United Kingdom, 4Durham University, Durham, United 
Kingdom
Recently, there has been mounting interest in scaling-up vector control 
against malaria in Africa. It needs to be determined if indoor residual 
spraying (IRS with DDT) will provide significant marginal protection against 
malaria over current best practice of long-lasting insecticidal nets (LLINs) 
and prompt treatment in a controlled study, given that DDT is currently 
the most persistent insecticide for IRS. A two armed cluster-randomised 
controlled study was conducted to assess whether DDT IRS and LLINs 
combined provided better protection against clinical malaria in children 
than LLINs alone in rural Gambia. Each cluster was a village, or group of 
small adjacent villages. All clusters received LLINs and half received IRS 
in addition. 7,800 children, aged 6 months to 14 years, were enrolled 
and followed for clinical malaria using passive case detection to estimate 
malaria incidence, the primary endpoint, for two malaria transmission 
seasons in 2010 and 2011. Exposure to malaria parasites was assessed 
using light and exit traps followed by detection of Anopheles gambiae 
species and sporozoite infection rates. Children were surveyed at the 
start of the study and the end of each transmission season to determine 
Plasmodium falciparum parasite rates and prevalence of anaemia. Study 
findings will be discussed in relation to effective malaria control in the 
Sahel. 
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UNDERSTANDING THE LOCAL POPULATION STRUCTURE OF 
PLASMODIUM IN THE CONTEXT OF MALARIA CONTROL 
AND ELIMINATION
Stella Chenet1, Leopoldo Villegas2, Ananias A. Escalante1
1Center for Evolutionary Medicine and Informatics, Arizona State 
University, Tempe, AZ, United States, 2Centro de Investigación de 
Campo Francesco Vitanza, Tumeremo, Venezuela and ICF International, 
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There is always population structure and malarial parasites are not an 
exception. The meaning of such structures, however, would depend on 
the scale and focus of the research. In the context of malaria control, the 
evaluation of treatment efficacy requires genotyping parasites at the local 
or regional level to distinguish homologous from heterologous parasites in 
recurrent infections as well as to get a good knowledge of the haplotypes 
circulating in the area. Unveiling such dynamics requires a good 
understanding of the temporal population structure and the accuracy of 
the information will depend on the adequacy of the markers used. In this 
study, we determined the minimum number of microsatellites needed to 
differentiate Plasmodium population clusters and haplotypes pertaining to 
each cluster in sympatry by using 215 blood samples (107 infected with 
Plasmodium vivax and 108 infected with P. falciparum) from a population 
in Tumeremo (Bolivar State) in Venezuela collected between March 2003 
and November 2004. We found that malarial parasites undergo clonal 
expansions and that such dynamics needs to be taken into account during 
the onset of drug resistance at a local level. The use of this design could 
be easily applied in epidemiological studies to differentiate reinfection 
from recrudescence cases, describe gene flow and identify lineages that 
area stable in time. This information would be useful in determining 
specific geographic units of malaria treatment and control.
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EVALUATION OF THE EFFICACY AND SAFETY OF REDUCING 
DOSES OF PRIMAQUINE FOR CLEARANCE OF GAMETOCYTES 
IN UNCOMPLICATED FALCIPARUM MALARIA IN CHILDREN IN 
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Administration of the gametocytocidal drug primaquine (PQ) is a 
well-recognized tool to block transmission of malaria from humans to 
mosquitoes. The World Health Organization (WHO) has recommended 
adding a single dose of PQ to artemisinin-based combination 
treatment for falciparum malaria, particularly as a component of an 
elimination program. However, in individuals with glucose-6-phosphate 
dehydrogenase deficiency (G6PDd), PQ can cause life-threatening 
hemolysis, which has restricted its widespread use in regions where G6PDd 
is prevalent. This adverse effect is dose-dependent. We hypothesize 
that administration of PQ at a dose lower than that recommended by 
the WHO (0.75 mg/kg) will be safer than, yet as efficacious as, the 
WHO dose. We are currently conducting a randomized, double-blinded, 
placebo-controlled clinical trial to compare the efficacy and safety of three 
doses of PQ in Uganda. Children aged 1-10 years with uncomplicated 
falciparum malaria and normal G6PD status are recruited and treated 
with artemether-lumefantrine. On the third day of treatment, participants 
are randomized to receive 0.1mg/kg, 0.4mg/kg or 0.75mg/kg of PQ, or 
placebo. Participants are followed up for 28 days with repeated blood 
sampling. Efficacy outcomes include the number of days to gametocyte 
clearance (measured by quantitative real-time nucleic acid sequence-based 
amplification [QT-NASBA] on days 0-14, and the area under the curve of 
QT-NASBA-measured gametocyte density over time. Safety outcomes are 
the mean maximal change in hemoglobin on days 0-28, requirement for 
blood transfusion, evidence of hemolysis and incidence of adverse events. 
Efficacy analysis will be conducted for non-inferiority of each reduced dose 
of PQ treatment compared to the WHO-recommended dose. For safety, 
the superiority of test doses to standard dose will be assessed. Recruitment 
started end-December 2011 and 200 (42%) of the target sample size of 
480 participants have been recruited to date. Complete, un-blinded results 




CLUSTER-RANDOMIZED 12-MONTH STUDY INVESTIGATING 
THE EFFECT OF COMMUNITY SCREENING AND TREATMENT 
OF ASYMPTOMATIC CARRIERS OF PLASMODIUM 
FALCIPARUM MALARIA WITH ARTEMETHER-LUMEFANTRINE 
ON SYMPTOMATIC MALARIA EPISODES IN CHILDREN AGED 
<5 YEARS AND HEMOGLOBIN LEVELS IN SUB-SAHARAN 
AFRICA
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The systematic detection of asymptomatic carriers (ACs) of Plasmodium 
falciparum by rapid diagnostic test (RDT) and subsequent treatment with 
artemisinin-based combination therapy has the potential to impact disease 
transmission. A single-center, controlled, parallel, cluster-randomized 
study was conducted in Burkina Faso to evaluate the impact at the 
community level of detecting and treating ACs during 3 community 
screening campaigns (CSCs) conducted before the rainy season. The two 
primary endpoints were: the number of symptomatic malaria episodes 
with a parasite density >5000/µL (SMRC5000) per person-year in infants 
and children aged <5 years during the follow-up period, and hemoglobin 
(Hb) level change from day 1 to day 28 of CSC1 in treated vs. untreated 
ACs >6 months of age. 18 villages were randomized in a 1:1 ratio. In the 
intervention arm, ACs were identified by RDT and treated with artemether-
lumefantrine (AL) or an alternative (if AL was contraindicated). Blood 
was collected in the intervention arm from all subjects and in the control 
arm from a randomly selected subset, at CSC1 for Hb measurement 
and at each CSC for delayed microscopy reading so that subjects (and 
study personnel) remained unaware of their AC status. Symptomatic 
malaria episodes were treated with AL or alternative in both arms for 
the duration of the study. In total, 14,075 subjects entered the study. At 
study end, the cluster-level mean number of SMRC5000 per person-year in 
infants and children aged <5 years was similar between the intervention 
and the control arms (1.69 vs. 1.60; P=0.3482). The mean change in Hb 
levels from day 1 to day 28 of CSC1 in the intervention arm was 0.53 g/
dL vs. -0.21 g/dL in the control arm (P<0.0001). These results show that 
the systematic detection by RDT and treatment of ACs at the community 
level did not have a significant impact on disease transmission in the 
population. Although the change in Hb level between the two arms was 
statistically significant, it was not deemed to be clinically meaningful.
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THE EFFECTIVENESS OF A SINGLE ROUND OF MASS 
MALARIA SCREENING AND TREATMENT IN SOUTHERN 
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In Zambia the current interventions of insecticide-treated mosquito 
nets, indoor residual spraying and case management with artemisinin 
combination therapy are not likely to result in malaria elimination alone. 
As part of a pilot mass malaria screening and treatment intervention, 10 
health facilities in Gwembe and Sinazongwe districts, Southern Province, 
Zambia were randomly selected to receive a single round of mass malaria 
screening and treatment preceding the 2012 high malaria transmission 
season. In December 2011 and January 2012 approximately 50,000 
individuals, regardless of symptoms, were tested for malaria parasites 
by community health workers using ICT Mal Pf rapid diagnostic tests. 
Individuals testing positive were treated with artemether-lumefantrine, 
the national first line malaria treatment. The single round of mass malaria 
screening and treatment will be evaluated using a combination of study 
designs and analyses: 1) a randomized post-only comparison between 
intervention and control areas of parasite prevalence in children < 6 years 
of age measured through an oversampled malaria indicator survey in April 
2012; 2) a randomized post-only comparison between intervention and 
control areas of parasite prevalence in all individuals measured through 
the first round of the intervention in June 2012; 3) a pre-post comparison 
of parasite prevalence within intervention areas (follow-up June 2012); 
and 4) a randomized longitudinal comparison of monthly outpatient 
laboratory-confirmed malaria cases recorded from health facilities within 
the 2 districts. Each method of evaluation has limitations including the 
lack of a baseline in the randomized post-only comparisons, the lack of 
a counterfactual in the pre-post comparison, and known biases in health 
facility routine data. Preliminary results will be available in September 
2012.
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REACTIVE CASE DETECTION FOR MALARIA ELIMINATION: 
REAL-LIFE EXPERIENCE FROM AN ONGOING PROGRAM IN 
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Reactive case detection, whereby households and neighbors of passively 
detected cases are screened and treated, is being implemented in a 
number of Plasmodium falciparum malaria eliminating countries. This 
type of surveillance is designed to take advantage of the spatial clustering 
of infection and is primarily used to target the asymptomatic infectious 
pool. A crucial, yet not well understood, aspect of reactive case detection 
is the size of the screening radius employed around each index case. 
Using nationwide reactive case detection data from Swaziland, collected 
between December 2010 - March 2012, analyses were conducted to 
explore the relationship between the probability of detecting a case and 
distance to the passively detected index case. Results show that infection 
is highly clustered at the household level, with the odds of detecting a 
secondary case being six to seven times higher within the index household 
than in households located either up to 100m or over 100m away. The 
probability of detecting a case outside the index household did not appear 
to be associated with whether another case was detected inside the index 
household. From an operational perspective, the data suggest that using 
a screening radius of 1km is extremely challenging with high coverage 
unlikely to be achievable in resource constrained settings. Together, these 
results suggest that future reactive case detection in Swaziland could be 





ALLOCATIVE EFFICIENCY MODELING OF MALARIA 
TREATMENT AND PREVENTION: ANALYSIS OF INTERACTIONS 
TO IMPROVE INTERVENTIONS
Monique A. Smith1, Prashant Yadav1, Jenna Coalson2, Mark L. 
Wilson2
1University of Michigan William Davidson Institute, Ann Arbor, MI, United 
States, 2University of Michigan School of Public Health, Ann Arbor, MI, 
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The recent expansion of anti-malaria efforts and increased focus on local 
elimination have resulted in greater funding and enhanced distribution 
aimed at reducing disease burden. Both donors and public health 
agencies have become interested in how to maximize impacts of various 
kinds of interventions. Not surprisingly, allocation of resources toward 
different types of treatment and prevention may have complex effects on 
the dynamics of transmission and effectiveness of disease suppression. 
Despite the absence of a singular model for successful control, there is a 
need to understand how introduction of interventions that bundle into 
a given system results in observed outputs and outcomes to predict the 
optimal deployment of resources. We developed a system dynamics, 
compartmental, simulation model of population transition among states 
of parasitemic and/or symptomatic as well as susceptible and/or infectious. 
Age-specific survival and entomological inoculation rates were drawn from 
the literature. Different allocations of four interventions (prevention with 
ITNs, IRS and IPT, and treatment with ACT) produced very different impacts 
on population patterns of transmission, infection and disease across 
different transmission contexts. Exemplary results are presented in the 
context of algorithms that could be aimed at improving effectiveness of 
such large-scale intervention. The ultimate goal of our efforts is to produce 
a user-friendly program that will allow countries to better understand the 
complex interactions that malaria reduction efforts produce, and in so 
doing provide policy makers with the tools to improve resource allocation. 
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ON THE EARLY EVENTS OF LEISHMANIA BRAZILIENSIS 
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Oliveira2, Aldina Barral2, Fabienne Tacchini-Cottier1
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Leishmania parasites are transmitted to the mammalian hosts by the 
bite of phlebotomine sandflies. During this process, not only parasites 
but also sandfly salivary products are delivered to the host. Leishmania 
braziliensis is the etiological agent responsible for cutaneous and 
mucocutaneous leishmaniasis throughout Brazil and the parasite is 
transmitted by Lutzomyia genus of sandflies. The objective of this study 
was to investigate the influence of sandfly saliva on the development of 
the immune response to L. braziliensis infection. Previously, immunization 
with sandfly salivary gland extract (SGS) from L. longipalpis was shown 
to protect against infection while the opposite effect was observed 
following L. intermedia preimmunization. To understand the mechanisms 
involved in these differences, we analyzed the impact of L. intermedia 
preimmunization on the innate immune response. First, we characterized 
the cellular infiltrate in response to SGS inoculation in the presence or 
absence of parasites. Next, we examined the cellular recruitment and gene 
expression profiles in mice preimmunized with L. intermedia compared to 
mice given PBS as a control. The global effect of preimmunization with L. 
intermedia SGS on gene expression was subjected to microarray analysis, 
revealing a distinct set of IFN-inducible genes that were upregulated in 
response to immunization with SGS; however, these genes were silenced 
at the time analyzed in mice given L. braziliensis suggesting the parasite 
is modulating the dermal microenvironment creating a niche for parasite 
persistence.
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LEISHMANIA DONOVANI FOLLOWING TRANSMISSION BY 
SAND FLY BITES IN BALB/C MICE AND HAMSTERS
Ranadhir Dey1, Hamide Aslan2, Claudio Meneses2, Pradeep K. 
Dagur3, John Philip McCoy3, Robert Duncan1, Jesus G. Valenzuela2, 
Hira L. Nakhasi1, Shaden Kamhawi2
1Division of Emerging and Transfusion Transmitted Diseases, Center 
for Biologics Evaluation and Research, Food and Drug Administration, 
Bethesda, MD, United States, 2Vector Molecular Biology Unit, Laboratory 
of Malaria and Vector Research, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, Rockville, MD, United States, 
3Flow Cytometry Core, National Heart, Lung and Blood Institute, National 
Institutes of Health, Bethesda, MD, United States
Visceral leishmaniasis (VL) caused by Leishmania donovani is a vector-
borne anthroponotic disease transmitted by sand fly bite with no 
available human vaccines. Following vaccination, animals protected 
against cutaneous leishmaniasis upon needle challenge failed against the 
virulence of a sand fly-initiated infection. This highlights the significance 
of developing models of vector-transmission for VL, particularly in vaccine 
evaluation. Here, we present models of visceral leishmaniasis in BALB/c 
mice and Golden Syrian hamsters using Lutzomyia longipalpis sand 
flies infected with L. donovani. Sand flies with transmissible infections 
were allowed to feed on animal ears for 2 hours. In BALB/c mice, most 
animals developed Leishmania-specific IgG antibodies around 5 weeks 
post-infection. Ten weeks post-infection, the parasites had disseminated 
into the spleen and liver reaching a maximum burden of 1x106 and 
2x103 in the spleen and liver, respectively, at 20-25 weeks. Thirty weeks 
post-infection, the mice had not cleared the infection displaying a 
significant number of parasites (6.5x104) in the spleen although none were 
detectable in the liver. The progressive growth of parasites in the spleen 
and liver of infected mice following vector-initiated infection demonstrates 
the utility of this model to study VL. In hamsters, the animals succumbed 
to disease within 3-9 months post-sand fly transmission showing parasite 
visceralization accompanied by clinical manifestations of VL including 
enlarged spleens and livers whose mean weight was 5.8- and 1.3-fold 
higher, respectively, than those of naïve hamsters. Currently, studies in 
BALB/c mice and hamsters are focusing on the comparative evaluation 
of the immune response following infection with either sand fly bite or 
needle injection and also are oriented towards testing promising vaccines 
that protected against needle-challenge. Overall, these models facilitate 
our understanding of the host immune response to vector-initiated VL 
and represent an improved tool for the assessment of potential drugs and 
vaccine candidates.
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HUMAN AFRICAN TRYPANOSOMIASIS RESERVOIR STATUS IN 
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Human African Trypanosomiasis (HAT) is transmitted by Glossina species. 
Livestock and wildlife play an important role in maintaining the disease as 
reservoirs. A study was conducted to assess the reservoir status of livestock 
from three sites in Tanzania namely north western near the Serengeti 
ecosystem, western zone (Ugalla) and Rufiji in the south. The study was 
conducted during the onset of dry season of 2010 and 2011. From 
Serengeti ecosystem, 150 cattle were screened and only one cattle was 
parasitological positive, and by PCR, the infection rate by the Trypanosoma 
brucei types were 5/150 (3.3%) and all were SRA LAMP positive. From 
western zone screening involved 574 cattle, 108 Goats and 21 Dogs. 
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Parasitological positive were 34/574 cattle, 2/108 goats and 1/21 dogs. 
PCR analysis recorded an infection rate of 66/300 (22%) in cattle, for T 
brucei and 30 (45.4%) of 66 were positive by SRA LAMP. PCR analysis 
recorded 16/108 (14.8%) infection for T. brucei but negative by SRA LAMP 
in Goats. PCR recorded 4/11 T. brucei infections in dogs which were all 
negative by SRA LAMP. From Southern Tanzania, a total of 404 animals 
were screened which included 202 cattle, 85 sheep, 10 dogs, 5 donkeys 
and 102 goats. Microscopic analysis recorded 4 animals infected by T. 
congolense types of trypanosomes. PCR analysis of 69 animal blood out of 
404, recorded 38/69 (55%) positive for T. brucei types. All animal species 
were equally affected by the T. brucei types as infection in cattle was 
33/48 (68.7%); 2/6 for sheep and one each (1/5) for donkeys, goats and 
dogs. All T. brucei positive samples from southern Tanzania were negative 
by SRA LAMP. Results from this study indicate that livestock especially 
cattle may play an important role in the epidemiology of HAT and control 
of the vector, Glossina, supplemented with treatment of animals is an 
important measure for control of human infective trypanosomes, and 
HAT epidemiology. Of importance is the finding that many animals were 
positive for T. brucei, which in some cases like northern and western sites 
could be of zoonotic importance as confirmed by SRA LAMP. Presence of 
human serum resistance associated (SRA) gene confirms the presence of 
human infective trypanosomes that cause the T. brucei rhodesiense form 
of HAT.
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TOWARDS TRYPANOSOMA CRUZI LINEAGE-SPECIFIC 
SEROLOGY FOR CHAGAS DISEASE
Tapan Bhattacharyya, Michael A. Miles
London School of Hygiene & Tropical Medicine, London, United Kingdom
Chagas disease, caused by the protozoan Trypanosoma cruzi, remains 
an important parasitic disease in the Americas. It can be fatal in the 
acute phase, but life-long chronic infection may be asymptomatic, or 
lead to debilitation and death by cardiac and/or intestinal complications. 
Genetically diverse, T. cruzi is classified into the intra-species lineages 
TcI-TcVI, displaying disparate geographical distributions and ecologies. 
The varying disease outcomes may be linked to parasite lineage, and 
complicated by mixed infections. The work presented here addresses the 
development of lineage-specific serology to identify an individual’s history 
of exposure to T. cruzi lineages. The molecular diversity of the parasite 
surface antigen TSSA was analysed across a panel of reference biological 
clones encompassing T. cruzi  genetic and ecological diversity, revealing 
lineage-specific B-cell epitopes. We demonstrate here the capacity 
of synthetic peptides based on the TcII/V/VI common epitope to be 
recognised by antibodies in human sera from Brazil, Chile, and reported 
for the first time, Ecuador. Further, we report the first TcIII- and TcIV-
specific serology, from experimental murine models. A genomic approach 
to identify T. cruzi lineage-specific epitopes can be used successfully in 
developing a differential serology to investigate an individual’s history of 
T. cruzi lineage exposure, and lead to a greater insight into the link with 
Chagas disease outcome. Overall, this approach represents a potential 
new tool in Chagas disease epidemiology.
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COMPARATIVE GENOMICS AND PHYLOGENOMICS OF THE 
PROTOZOAN PATHOGEN, TRYPANOSOMA BRUCEI
Mark Sistrom1, Benjamin Evans1, Robert Bjornson1, Wendy 
Gibson2, Oliver Balmer3, Pascal Maser3, Serap Aksoy1, Richard 
Echodu4, Barbara Nerima5, John Enyaru6, Adalgisa Caccone1
1Yale University, New Haven, CT, United States, 2University of Bristol, 
Bristol, United Kingdom, 3Swiss Tropical and Public Health Institute, Basel, 
Switzerland, 4Gulu University, Gulu, Uganda, 5Uganda Virus Institute, 
Entebbe, Uganda, 6Makerere University, Kampala, Uganda
The protozoan pathogen, Trypanosoma brucei is the causative agent of 
Human African Trypanosomiasis (HAT) which affects mainly poor rural 
populations across sub-Saharan Africa. T. brucei is separated into three 
subspecies based on the disease forms they cause: T. b gambiense - which 
causes a chronic form of HAT, T. b. rhodesiense - which causes an acute 
for of HAT and T. b. brucei - which causes the livestock wasting disease 
Nagana. We conducted whole genome sequencing of 16 isolates from 
across the distribution of T. brucei, followed by a referenced alignment 
to the annotated TREU927 T. brucei genome and identified 352,505 
single nucleotide polymorphisms (SNPs) across the genome. Selection and 
repetition were estimated to provide a comparative genomic framework 
across the T. brucei genome. In addition, to test the validity of subspecies 
designations and competing evolutionary hypotheses in T. brucei, we 
developed a phylogenomic framework of 9,500 neutrally evolving, 
independent and unique sequence loci from 500 - 5,500 base pairs in 
length. Using species tree methods, we estimated the phylogeny of the T. 
brucei complex to determine relationships between T. brucei subspecies 
and identify the ancestral lineage within the species complex.
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ROLE OF THE CHROMATIN REMODELING ENZYME HDAC1 IN 
LEISHMANIA AMAZONENSIS INFECTION: IMPLICATIONS FOR 
HOST TRANSCRIPTION REPRESSION
Teresa Cristina Calegari-Silva, Aislan Carvalho Vivarini, Gisele M. 
Silva, Gilherme Rodrigo R. dos Santos, Ulisses Gazos Lopes
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Leishmania parasites subvert important host cell signaling pathways 
involved in the control of the infection. NF-κB is an important 
transcriptional factor which modulates the expression of genes involved 
in the immune response. Recent results from our group demonstrated the 
activation of NF-κB transcriptional repressor homodimer (p50/p50) in L. 
amazonensis- infected macrophages, treated or not with LPS. As a result 
of this homodimer complex activation, we observed the down-regulation 
of the expression of nitric oxide synthase (iNOS) in infected macrophages 
treated with gamma Interferon. Besides the activation of transcriptional 
factors, chromatin epigenetic modifications are pivotal regulators of gene 
transcription. Chromatin remodeling proteins such as deacetylase histones 
(HDAC) are involved with transcriptional repression and may be associated 
with transcriptional factors, forming large repressor complexes. In this 
work, we have studied in details the iNOS transcriptional repression during 
L. amazonensis infection through the analysis of iNOS promoter occupancy 
by p50/p50 NF-κB complex and the participation of HDAC 1 in these 
events. We have found that the increased occupancy of p50/p50 iNOS 
promoter depends on PI3K/Akt pathway in L. amazonensis infected cells. 
Consistent with transcription repression, we have detected an increase in 
HDAC1 mRNA and protein levels, as well as an increased activity of total 
histone deacetylase in infected macrophages. We have verified a relevant 
reduction of L. amazonensis amastigote growth in macrophages silenced 
for HDAC1 expression. We also verified the mRNA iNOS increased levels in 
infected macropages during HDAC1 silencing, showing the participation 
of this deacetylase in iNOS promotor regulation. In fact, we have observed 
an increased occupancy of HDAC1 in NF-κB promoter-binding site and a 
decreased occupancy of acetylated histone 3 (Lys 9). These results indicate 
that important epigenetic modifications associated with p50/p50 NF-κB 




MONOCYTE-DERIVED TNF-α AND METALLOPROTEINASE 9 
IN PATIENTS WITH CUTANEOUS LEISHMANIASIS
Sara T. Passos1, Tais Menezes1, Rúbia Costa1, David Mosser2, 
Phillip Scott3, Edgar M. Carvalho1, Lucas P. Carvalho1
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Department of Cell Biology and Molecular Genetics, Baltimore, MD, 
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Cutaneous leishmaniasis (CL) caused by Leishmania braziliensis is 
characterized by the presence of one or more ulcerated lesions with 
elevated borders. High levels of IFN-γ and TNF-α are detected in these 
patients and these proinflammatory cytokines are known to play a role 
in the pathogenesis of CL, by inducing tissue damage. Upon infection 
with Leishmania or in presence of SLA, monocytes from CL individuals 
produce high levels of TNF-alpha involved in recruitment of monocytes. 
Recent studies have shown that circulating monocytes constitute a 
heterogeneous population based on expression of CD14 and CD16, 
these cells can be divided in classical (CD14+CD16-), intermediate 
(CD14+CD16+) and non-classical (CD14-CD16+) monocytes. Intermediate 
and non-classical monocytes are known to migrate to inflamed sites and 
secrete inflammatory mediators, and high frequency of these cells has 
been associated with pathogenesis of many inflammatory diseases. TNF-α 
can mediate the pathology of the disease through various mechanisms 
including induction of nitric oxide, expression of metalloproteinases 
(MMPs) and increased cytotoxicity. MMP-9 is a zinc-dependent enzyme 
that degrades collagen and has been associated with skin inflammatory 
diseases. Although the mechanism underlying ulcer development in CL is 
not known, it´s likely that MMP-9 contribute to tissue damage. Thus, our 
goal was to investigate the contribution of sub-populations of monocytes 
to TNF-α and MMP-9 secretion in CL patients. We found that early 
after infection (pre-ulcerative phase) the frequency of intermediate and 
non-classical monocytes is elevated in blood of CL patients. Also, while 
intermediate monocytes produced more TNF- α in response to Leishmania, 
non-classical ones were the main source of MMP-9 in most CL patients. 
Similarly, the biopsies study reveled that non-classical monocytes were 
the main MMP-9 producing cells. These results show that monocytes 
subpopulations contribute differently to the immunopathology observed 
in CL patients.
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BASED IMMUNOASSAY FOR USE AS A SURVEILLANCE TOOL 
FOLLOWING CESSATION OF MASS DRUG ADMINISTRATION 
IN A W. BANCROFTI -ENDEMIC AREA OF MALI
Joseph Kubofcik1, Yaya I. Coulibaly2, Salif S. Doumbia2, Sory I. 
Keita2, Zana L. Sanogo2, Massitan Dembele3, Thomas B. Nutman1
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of Bamako, Bamako, Mali, 3National Program for the Elimination of 
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Significant progress has been made toward the global goal to eliminate 
lymphatic filariasis (LF) by 2020 though the tools for monitoring control 
success and certification of transmission interruption need to be refined. 
Recently modified WHO guidelines for transmission assessment surveys 
(TAS) have recently been proposed to guide decisions about stopping mass 
drug administration (MDA), but the tools for post MDA surveillance are 
likely to involve antibody testing. To assess the utility of antibody testing 
in a target (6-7 year olds) population, we assessed antibody reactivity to 
Wb123, a Wuchereria bancrofti (Wb)-specific antigen that is expressed 
early in parasite development and has been shown to be a sensitive and 
specific marker of exposure to Wb infective stage larvae (L3). Wb123 
antibody was compared to calibrated thick smear of midnight blood. 
298 children 6-7 years old from two villages in Mali one year following 
the cessation of 5 rounds of MDA were assessed. Using bloodspots for 
Wb123 antibody levels and a Wb123 luciferase immunoprecipitation 
assay systems (LIPS), only 1 of the 298 (0.3%) children tested were 
positive for anti-Wb123 antibody; a similar prevalence was seen on night 
blood smears (Wb microfilaria prevalence 0.3%). These data suggest 
that Wb123-specific antibody testing in children can be a sensitive and 
specific tool for monitoring transmission following MDA cessation. Given 
the prevalence of 0.3% (well less than 1%) continued yearly follow-up of 
prevalence in 6-7 year olds will provide insight into the continued utility 
of Wb123 immunoassays for Wb transmission assessment following MDA 
not only in this area of Mali, but throughout Africa where co-incident 
filarial infections have limited the use of other recombinant antigen-based 
immunoassays.
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HOST CHOICE BY ONCHOCERCIASIS VECTORS AND 
ONGOING TRANSMISSION IN AREAS UNDER IVERMECTIN 
CONTROL
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1Imperial College London, London, United Kingdom, 2University of 
Greenwich, Chatham, United Kingdom, 3Council for Scientific and 
Industrial Research, Accra, Ghana, 4University of Ghana, Legon, Ghana, 
5London School of Hygiene and Tropical Medicine, London, United 
Kingdom
The ability of mathematical models to predict intervention impact on 
vector-borne diseases will be affected by whether the proportion of 
bloodmeals taken on humans depends on vector and/or host density. 
Empirical data on onchocerciasis transmission and vector host choice in 
areas which have received prolonged vector control and mass annual 
ivermectin treatments will enable locality- and vector-specific prediction 
of Onchocerca transmission. Seven study sites in four regions of Ghana 
were visited from 2009 to 2011 in both rainy and dry seasons, to study 
variation in blackfly and host densities, and host choice. Surveys of wild 
birds and mammals, households and domestic animals were conducted. 
Blackflies (15,466; 85% Simulium damnosum s.l.) were collected by 
host-dependent and host-independent methods, assessed for parity, 
and stored for molecular and morphological analysis for identification 
of fly and Onchocerca species, and bloodmeal origin. The size of human 
populations varied from 188 to 5,202; of domestic animals from 489 to 
11,143; and the number of bird species from 31 to 61. Blackfly biting 
rates ranged from 0 to 298 bites/person/day, and parity rates from 18 to 
27% (wet season) and from 30 to 46% (dry season). Three of the villages 
had levels of L3 larvae/1,000 parous flies above the WHO threshold for 
morbidity and transmission control (range 1.4 to 115.1 L3/1,000 parous 
flies) despite annual distributions of ivermectin for up to 23 years in one 
village. In these villages exposure to infective L3 larvae was between 0.04 
and 3.66 L3/person/day. Flies had fed on a range of hosts, predominantly 
humans and pigs. Onchocerca spp. other than O. volvulus were recorded. 
Results indicate that blackflies have multiple blood hosts and that active 
transmission is still occurring despite annual or biannual ivermectin 
treatment. Such data will inform control programmes about the feasibility 





MOSQUITO-PARASITE INTERACTIONS AND IMPLICATIONS 
FOR FILARIASIS TRANSMISSION IN PAPUA NEW GUINEA
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In Papua New Guinea, filariasis is transmitted by members of the 
Anopheles punctulatus group of mosquitoes while culicines, major 
vectors in neighboring regions of the Pacific, are considered unimportant 
for transmission. In a diverse vector environment such as Papua New 
Guinea, it is likely that not all species contribute equally to transmission. 
Transmission potential can be influenced by vector competence to W. 
bancrofti as well as vector-host and vector-parasite interactions. To test this 
hypothesis, we exposed multiple vector species to microfilaremic blood 
of varying densities to measure time to development of infective-stage 
larvae (L3s) as well as prevalence and intensity of infection. At lower mf 
densities (30-60 mf/20ml) 30% of An. farauti s.s. harbored L3s (mean 
intensity 2.0) and 7% of An. punctulatus harbored L3s (mean intensity 
1.0). At higher densities (130-160 mf/20 ml), 83% of An. farauti and 
28% of An. punctulatus were permissive to the development of L3s with 
a mean intensity of 4.6 and 3.1 respectively. The extrinsic incubation 
period was equal in both species. In Culex annulirostris, no L3s were 
observed and development was halted at the first or second larval stage. 
To put this into the context of transmission in Papua New Guinea we 
also investigated mosquito parity rates, mosquito biting behavior and 
availability of microfilariae in peripheral blood. Both An. farauti s.s. and 
An. punctulatus had comparable age structures. Although An. farauti s.s. 
is a more competent vector, this species might have a lower capacity to 
transmit filariasis because of asynchrony between peak biting times and 
W. bancrofti periodicity. An. farauti s.s. has a peak biting time of 1900h, 
five hours earlier than the peak density of circulating microfilaria. As a 
result, An. farauti s.s. is exposed to approximately 33% of the mf that are 
available at the peak biting time for An. punctulatus. Filariasis elimination 
efforts can be greatly enhanced by the integration of vector control; 
however, a greater understanding of the influence of vector behaviors 
and vector-parasite dynamics on transmission is necessary to inform these 
strategies.
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THE COST-EFFECTIVENESS OF DOXYCYCLINE THERAPY FOR 
THE CONTROL OF HUMAN ONCHOCERCIASIS IN AREAS CO-
ENDEMIC WITH LOIASIS
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Buea, Cameroon, 3University Hospital Bonn, Bonn, Germany, 4Liverpool 
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The control of onchocerciasis in Africa is based on annual or biannual 
community-directed treatment with ivermectin (CDTI). However, CDTI 
is contraindicated in areas where loiasis is co-endemic, including large 
parts of central Africa, because of the risk of severe adverse effects (SAEs) 
associated with rapid microfilarial killing and blockage of brain vasculature 
leading to encephalopathy. An alternative strategy in these areas is to 
treat with doxycycline, which given daily for 4-6 weeks, is macrofilaricidal 
against Onchocerca volvulus, causing sustained reductions in adult worm 
and microfilarial loads. Crucially, Wolbachia is not present in Loa loa, 
which mitigates the risk of SAEs. Furthermore, the feasibility of achieving 
high levels of coverage and compliance with a six-week course of mass-
distributed doxycycline and its long-term impact has been demonstrated 
in Cameroon. An onchocerciasis transmission model (EpiOncho) is used 
to show that community-directed treatment with doxycycline (CDTD) 
is approximately twice as effective in preventing cases of O. volvulus 
infection compared with CDTI and more than twice as effective in 
reducing levels of transmission. Moreover, CDTD is about as cost-effective 
as CDTI in loiasis co-endemic areas. This is partly because CDTD can be 
delivered less frequently than CDTI, and partly because of the high cost 
associated with implementing the additional monitoring and surveillance 
components of CDTI, which attempt to minimise the occurrence and 
impact of SAEs. We conclude that CDTD is a safe, viable and cost-effective 
alternative to CDTI for the control of onchocerciasis where loiasis is co-
endemic.
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The World Health Organization recommends five years of annual mass 
drug administration (MDA) in areas where Lymphatic Filariasis (LF) 
prevalence exceeds 1%, followed by a Transmission Assessment Survey 
(TAS) in 6–7 year olds to determine if transmission has been interrupted. 
It is not clear if 5 rounds of MDA are necessary where the initial antigen 
prevalence is >1%, but <10%. LF mapping performed in Haiti in 2001 
showed that 73% of country’s implementation units (IUs) fell within this 
prevalence range. For a country with limited resources, guidelines stating 
that <5 rounds of MDA are ample in low prevalence areas would allow 
for a re-evaluation of transmission within the vast majority of the country. 
This may result in stopping MDA, and refocusing efforts and resources on 
the remaining 27% of the IUs. In 2002 the prevalence of LF on La Tortue, 
Haiti was found to be 6%, and 2 rounds of MDA were performed, ending 
in 2005. A follow-up convenience sample of >1600 persons of all ages in 
2006 found a prevalence of 0.6%. We performed a modified school-based 
TAS in 11–12 year old children on La Tortue to determine if transmission 
has been interrupted. Using Survey Sample Builder, we calculated a sample 
size of 909 children from 32 randomly selected schools with a critical cut-
off of 11. After informed consent, we collected blood for ICT and filter 
paper testing, and GPS, demographic, migration, and risk factor data. We 
sampled 1082 children from 29 schools. A total of 7 children were positive 
for LF (prevalence 0.645%, 95% confidence interval: 0.389–0.901), below 
the critical threshold for transmission. Of the 7 positive children, only 1 
child had migrated to the island. Data are being collected from the final 
three schools and filter papers are being run for antibody testing. Our 
results suggest that LF prevalence on La Tortue is below the accepted 
threshold for transmission interruption, and MDA does not need to be 
restarted. These findings suggest that 5 rounds of MDA may not be 




OPTIMISM FOR LYMPHATIC FILARIASIS ELIMINATION: 
A CASE STUDY OF TANDAHIMBA DISTRICT, SOUTHERN 
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Lymphatic Filariasis is endemic in almost all districts in Tanzania. The 
National Lymphatic Filariasis Elimination Program strategy includes 
interruption of transmission via Mass Drug Administration (MDA) and 
morbidity control. Tandahimba District had five annual rounds of MDA 
with Mectizan and Albendazole, and the coverage was above 65% at 
each round. Baseline data were collected in 2002, and sentinel site data 
were collected after three and five rounds of MDA in 2006 and 2008, 
respectively. Results from four sentinel sites indicated that the microfilaria 
(mf) prevalence decreased from 6.8% before MDA to 0.4% after five 
rounds of MDA. As part of a multi-country survey, a first Transmission 
Assessment Survey (TAS) was conducted in 2009 by following the newly 
developed Global Guidelines for Monitoring and stopping MDAs.In 2011, 
two years after stopping MDA, a second TAS was conducted. Sampling 
for TAS was based on Enumeration Areas (hamlets), with a cluster-sample 
household survey of 6-7 year-old children. Circulating filarial antigens 
(CFA) were detected using Immunochromatographic Test cards (ICT).Each 
positive ICT case was traced and examined at night for Microfilaremia (mf).
In 2009, a total of 1558 children from 69 hamlets were tested for CFA. 
Ten (0.64%) were positive and only one of these (10%) was mf positive. 
The follow-up TAS conducted in 2011 involved 1605 children and only 9 
(0.56%) were ICT positive. None of these were night blood mf positive. 
The findings from the TAS surveys indicated that the ICT prevalence was 
well below the critical cut-off value of 2% for stopping MDA,as defined 
in the new WHO guidelines. On the basis of the significantly decreased LF 
transmission in Tandahimba District, it was decided to discontinue MDA 
and to intensify surveillance. This is the first district in Tanzania to have 
reached the critical cut off point for stopping MDA
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Bangladesh has a long history of lymphatic filariasis (LF) caused by the 
parasite Wuchereria bancrofti, and is estimated to have 70 million people 
at risk of infection, with up to 10 million suffering from various forms of 
clinical deformity. The National LF Elimination Programme was one of the 
first to start the elimination process in 2001 with mass drug administration 
(MDA) using albendazole and diethylecarbamazine (DEC) in endemic 
areas. Of the 19 districts implementing MDA, five districts have received 
>5 rounds of MDA and sentinel sites have shown <1% microfilaria (Mf). 
Therefore, to determine if transmission has been interrupted, the new 
WHO Transmission Assessment Survey (TAS) was carried out in Meherpur, 
Barguna, Patuakhali, Rajshahi and Dinajpur districts. A school based survey 
was undertaken with 6 and 7 year old children as the target population. 
LF prevalence was measured using Immunochromatographic test (ICT), 
with sample sizes and critical cut off numbers calculated using the Sample 
Survey Builder. The TAS was carried out over a two month period, using 
trained field teams. The number of children sampled ranged from 1556 
to 1692, with cut offs of 18 and 20 respectively. In total 9 children were 
found to be ICT positive. No positive cases were found in Meherpur and 
Patuakhali, however, seven positive cases were found in Dinajpur and one 
positive case in both Barguna and Rajshahi districts. These results indicate 
that LF transmission has been interrupted and MDA can stop in these 
districts. This success may be attributed to high MDA coverage facilitated 
by Government support, timely and coordinated efforts of the Programme 
and successful partnerships. This is promising for Bangladesh, however, it 
will be critical to develop and maintain a systematic post-MDA surveillance 
strategy to fully confirm the interruption of transmission and reach its goal 
of LF elimination by 2015.
485
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Soil transmitted helminth (STH) infections are associated with significant 
morbidity as well as decreases in cognitive function and growth 
retardation. In most countries with a significant STH burden, school-age 
children (SAC) are at greatest risk of infection, but preschool age children 
(PSAC) may also be infected. Data on STH prevalence by age is lacking 
for most of Guatemala and there is little information on PSAC. Data on 
community prevalence of STH is generally gathered through community-
based surveys, but these are expensive and coverage is limited. We 
explored the use of STH prevalence data generated from stool testing 
for diarrhea surveillance in Guatemala as a proxy for community-based 
surveys. Sentinel surveillance for diarrhea (> 3 loose stools in a 24 hour 
period) is conducted in selected peripheral health facilities in the county 
of Nueva Santa Rosa (NSR). For comparison, we estimated community 
prevalence between July and August 2010 by collecting stool samples 
from residents ≥ 1 year of age in randomly selected households in NSR, 
irrespective of their history of diarrhea. Stool samples were tested for 
Ascaris sp., Trichuris sp., and hookworm using the Kato-Katz method. 
Individuals positive for any of the three parasites were considered infected. 
Facility-based surveillance data included 643 stool samples from 776 
cases of diarrhea in 2010; 19 (3%) were positive for STH. Facility-level 
prevalence was highest among SAC (6%, 6/98), though 4% (10/267) of 
PSAC and 2% (3/135) of adults were also infected. The community survey 
included 324 residents, and 41 (13%) were infected with STH. Prevalence 
was highest among SAC (18%, 19/104), though 13% (7/54) of PSAC 
and 9% (15/166) of adults also tested positive. A larger proportion of 
the health facility STH cases were in PSAC compared to the community 
survey (53% vs. 17%) and the age distribution was significantly different 
(P=0.01). Our findings indicate that the use of stool samples from health 
facility patients presenting with diarrhea underestimates community-
level STH burden and skews the age distribution of cases towards PSAC, 
possibly because more young children were brought to health facilities for 
diarrhea. However, both data sources indicate that both PSAC and SAC 
should be targeted for treatment to prevent negative outcomes associated 
with STH infection. Furthermore, consideration should be given to treating 




SOIL-TRANSMITTED HELMINTHS IN URBAN SCHOOL- 
AND PRE-SCHOOL-AGED CHILDREN: PREVALENCE AND 
MORBIDITY IN KIBERA, NAIROBI
Stephanie M. Davis1, Caitlin M. Worrell1, Parminder Suchdev2, 
Laird Ruth2, Gerard Lopez3, Ryan Wiegand3, Kennedy Odero4, 
Leonard Cosmas4, John Neatherlin4, Sammy Njenga5, Joel M. 
Montgomery4, LeAnne Fox1
1Parasitic Diseases Branch, Centers for Disease Control and Prevention, 
Atlanta, GA, United States, 2Division of Nutrition, Physical Activity and 
Obesity, Centers for Disease Control and Prevention, Atlanta, GA, United 
States, 3Division of Parasitic Diseases and Malaria, Centers for Disease 
Control and Prevention, Atlanta, GA, United States, 4Global Disease 
Detection Branch, Centers for Disease Control and Prevention, Nairobi, 
Kenya, 5Eastern and Southern Centre for International Parasite Control, 
Kenya Medical Research Institute, Nairobi, Kenya
Soil-transmitted helminth (STH) control programs face an increasing 
need to assess urban transmission. At the same time, while most 
prevalence studies and World Health Organization (WHO) deworming 
recommendations focus on school-aged children (SAC), STH burden and 
potential treatment benefit among pre-school-aged children (PSAC) are 
less known. We conducted a study of pediatric STH infection prevalence 
and morbidity in the Kibera informal settlement in Nairobi, Kenya. 899 
SAC (5-14 years) and 293 PSAC (6-59 months) were randomly selected 
as index children from the enrollment registry of the community-based 
surveillance platform run by the CDC’s International Emerging Infections 
Program in Kibera. Data from index children include a target of 3 stools 
tested by the Kato-Katz method for STH ova, anthropometry, hemoglobin, 
and family-reported febrile, diarrheal or respiratory illness. For SAC, 
sibling stools were tested for STH. Results from subjects with at least 1 
stool (n=493 PSAC, 1225 SAC) were analyzed for STH prevalence and 
differences between age groups. In index children (n= 212 PSAC, 509 
SAC), any STH infection was tested for correlation with anemia (based 
on age and altitude hemoglobin cutoffs as per WHO) and moderate or 
severe stunting, wasting or underweight as per WHO. All statistical testing 
was by chi-square. Prevalences were: any STH 42.3% (PSAC 39.0%, 
SAC 43.6%, p=.08); Ascaris 25.3% (PSAC 25.8%, SAC 25.1%, p=.76); 
Trichuris 27.8% (PSAC 21.9%, SAC 30.1%, p<.01); hookworm <0.1%; 
any co-infection 10.9% (PSAC 8.7%, SAC 11.8%, p=.06). Prevalence of 
anemia was 20.9% and of any malnutrition, 21.7%; no correlations with 
STH infection were found. STH infection is common in this population. 
PSAC and SAC have similar STH infection prevalences and both should 
be considered in control plans. Assessment of sibling STH infections as 
risk factors for index child infection and correlation of STH infection with 
micronutrient deficiencies and reported child illnesses will be discussed.
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SCREENING FOR STRONGYLOIDES INFECTION IN AN 
IMMIGRANT POPULATION IN BRONX, NEW YORK
Fabiola Espinoza1, Herbert Tanowitz1, Phyllis Andrews2, Inessa 
Gendlina2, Jacinth S. Ruddock2, Christina Coyle1
1Albert Einstein College of Medicine, Bronx, NY, United States, 2Jacobi 
Medical Center, Bronx, NY, United States
Chronic infection with Strongyloidiasis may transform into a fatal illness 
as a result of immunosuppression or HTLV-1 co-infection. The aim of this 
study was to define whether a routine screening program using serology 
for Strongyloides in immigrants from endemic regions is beneficial. 
Screening was conducted from 2004 to 2012, in inpatient and outpatient 
settings, at Jacobi Medical Center, Bronx, New York. Strongyloides 
serology was performed by serum ELISA. Blood cell counts performed in 
all patients. If a positive serology was detected, IgE level, HTLV-1 serology 
and stool ova/parasite were performed when feasible. A total of 631 
individuals (317 male [50.2%]) were screened, mean age of 56±17 years. 
No differences related to age/sex were found between sero-positive and 
-negative patients The majority of patients were from Puerto Rico (21.9%), 
Jamaica (15.4%), Dominican Republic (6.5%), Mexico (5.4%), Guyana 
(4.4%), Bangladesh (3.8%), Ecuador (3.6%). Eighty-nine percent of 
patients were screened during inpatient admissions. IgG antibodies were 
detected in 86 (14%) patients. Mean time from immigration was 25±18 
years, with no difference between the 2 groups. There was no difference 
regarding history of walking barefoot in home country, asthma, steroid 
use, complaints of abdominal pain or skin rash. Ser-positive patients were 
more likely to have eosinophilia (absolute count >500 cells/ml) compared 
to ser-negative patients (p<.001). Elevated IgE level (mean 522±634 UI/
ml) was observed in 32 (67%) patients who screened positive; 16/26 
(62%) sero-positive patients with a normal eosinophil count had elevated 
IgE levels. Stool exams were performed in 51/86 positive patients and 
6 had larvae. Co-infection with HTLV-1 was found in 4/57 (7%) sero-
positive patients. Those with positive serology were more likely to have 
eosinophilia and 62% of those without eosinophilia had elevated IgE. 
Immigrants with either eosinophilia or elevated IgE are candidates for 
routine screening, despite long-term residency in the USA.
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A NOVEL MULTI-PARALLEL REAL-TIME PCR APPROACH FOR 
EIGHT GASTROINTESTINAL PARASITES PROVIDES IMPROVED 
DIAGNOSTIC CAPABILITIES TO RESOURCE-LIMITED “AT RISK” 
POPULATIONS
Rojelio Mejia1, Yosselin Vicuña2, Nely Broncano2, Carlos 
Sandoval2, Martha Chico2, Phil J. Cooper2, Thomas B. Nutman1
1National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Bethesda, MD, United States, 2FEPIS, Quito, Ecuador
Diagnosis of gastrointestinal parasites has traditionally relied on stool 
microscopy that has low diagnostic sensitivity and specificity, is time 
consuming and labor intensive. To overcome these existing barriers, we 
have developed a novel rapid, high throughput molecular diagnostic 
platform. Species-specific primers and probes were generated and used 
for the 8 most common gastrointestinal parasite pathogens -- Ascaris 
lumbricoides, Necator americanus, Ancylostoma duodenale, Giardia 
lamblia, Cryptosporidium parvum, Entamoeba histolytica, Trichuris 
trichiuria and Strongyloides stercoralis – in a standardized and quantitative 
multi-parallel fast chemistry-based real time PCR (qPCR) high throughput 
assay. This was then used to analyze stool samples collected from 540 
children in rural Ecuador and compared to standard stool microscopy. 
The qPCR improved the sensitivity for Ascaris by 21.9% and had 97.8% 
specificity and 96.8% negative predictive value.  Moreover there was a 
direct relationship between the egg counts by stool examination with 
nanograms of Ascaris DNA (spearman r: 0.69, p=0.0001). qPCR improved 
the sensitivity for Giardia by 81.7%  (126/400 for qPCR vs. 23/400 for 
stool examination p=0.001) In addition, the qPCR assays were able to 
detect infections for Ancylostoma, Cryptosporidium, Strongyloides not 
seen by microscopy.  It further provided methods to distinguish the 
pathogenic Entamoeba histolytica from the non-pathogenic E. dispar. 
Finally, by using a novel DNA extraction protocol, we were able to detect 
Trichuris, with an improved sensitivity of 75% and a direct correlation 
to DNA (spearman r: 0.74, p=0.0001). Thus, we have developed a 
high throughput, rapid, operator-independent molecular-based system 
to improve the diagnostic accuracy of stool based parasite pathogen 
detection.  This approach has been field tested in rural Ecuador and will be 
useful to refine treatment options for affected populations and ultimately 




EVALUATION OF ALTERNATIVE DIAGNOSTIC METHODS FOR 
SCABIES AND STRONGYLOIDIASIS
Deborah C. Holt1, Therese Kearns1, Tegan Harris1, Linda 
Viberg1, Nadine Kurz1, Jenny Shield1, Ross M. Andrews1, James S. 
McCarthy2
1Menzies School of Health Research, Darwin, Australia, 2Queensland 
Institute of Medical Research, Brisbane, Australia
Scabies and strongyloidiasis are neglected tropical diseases which 
are responsible for considerable morbidity worldwide, primarily in 
disadvantaged and overcrowded communities. Scabies is a highly 
infectious skin disease caused by infestation of the skin with the 
ectoparasitic mite Sarcoptes scabiei. Up to 300 million people worldwide 
estimated to be afflicted at any time. In addition the scabies mite causes 
mange in many livestock, companion and wild animal populations. 
Strongyloidiasis is caused by infection with the parasitic nematode 
Strongyloides stercoralis and is associated with high mortality in 
immunosuppressed individuals. Each of these diseases is endemic in many 
remote Indigenous communities in the tropical north of Australia. A mass 
drug administration trial for the control of scabies and strongyloidiasis was 
conducted in a remote Indigenous community in the Northern Territory 
of Australia. Diagnosis of scabies was made by a clinical evaluation of 
participant’s skin. Diagnosis of strongyloides in children was made by 
direct microscopic examination of faecal samples followed by agar plate 
culture and formalin sedimentation. This study aimed to investigate: i) 
methods for the diagnosis of strongyloidiasis which are more logistically 
appropriate for use in remote and resource poor settings and; ii) improved 
methods of diagnosis of scabies compared with clinical diagnosis which 
lacks sensitivity. PCR based methods were trialled for the identification 
of S. scabiei in skin samples and of S. stercoralis in faecal specimens. S. 
scabiei gene specific PCR was more sensitive than microscopic examination 
for the detection of S. scabiei in skin samples and is highly specific. PCR 
targeting the 18S rRNA gene was at least as sensitive as microscopy 
and agar plate culture for the detection of S. stercoralis. Thus PCR may 
be a useful alternative to the clinical diagnosis of scabies and when 
parasitological analysis of fresh faecal samples is the field is logistically 
difficult.
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ASYMMETRICAL ISOTHERMAL AMPLIFICATION METHOD 
FOR GENOTYPING MUTATIONS, IN HUMAN SOIL-
TRANSMITTED HELMINTHS, THAT HAVE BEEN ASSOCIATED 
WITH BENZIMIDAZOLE RESISTANCE
Nour Rashwan
Institute of Parasitology, McGill University, Montreal, QC, Canada
Soil-transmitted helminths (STHs), Ascaris lumbricoides and Necator 
americanus, are gastrointestinal nematodes causing human morbidity in 
tropical areas of the world. Benzimidazole (BZ) drugs, albendazole and 
mebendazole have been used extensively for large-scale treatment of 
STHs. A growing concern is that extensive use of anthelmintics to control 
human parasites is likely to exert selection on parasite populations as has 
occurred in gastrointestinal nematodes of livestock. The egg reduction rate 
has been used to monitor drug efficacy and to detect the development 
of resistance in the field. This assay is very insensitive for the detection 
of low levels of drug resistance. Previous molecular assays for putative 
resistance mutations have been based mainly on sequencing. However, 
sequencing is a time consuming and complicated procedure, not suitable 
for routine clinical use or for resource constrained situations.Therefore, 
development of simple, rapid and cost-effective molecular tools for 
detecting BZ resistance, that could be adaptable to field conditions, would 
be very helpful for sustainable control of STHs. We developed a novel 
genotyping assay based on the Smart Amplification Process (SmartAmp2) 
to detect mutations of the β-tubulin isotype 1 gene associated with 
BZ resistance under isothermal conditions without PCR amplification. 
This isothermal method uses asymmetrical primers and the mismatch-
binding protein MutS to prevent mismatch amplification giving high 
specificity. For experimental development, real-time PCR monitoring of 
the amplification was achieved within 40-60 min with suppression of the 
mismatch amplification. Wild-type and mutant plasmids were employed to 
develop and optimize the assay. The assays were applied to analyze fecal 
samples of eggs and larvae using full-match and mismatched primer sets. 
A SmartAmp2 assay was developed for genotyping the mutations in the 
β-tubulin gene in A. lumbricoides and N. americanus and the reliability 
of the method was validated using the conventional PCR method. Work 
is being conducted to use end point detection system to enable this 
technique to detect mutations associated with BZ resistance in the field.
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THE EFFECTS OF HOST DIETARY FACTORS ON CURE RATE 
AND FECAL EGG COUNT REDUCTION FOLLOWING SINGLE 
DOSE ALBENDAZOLE (400 MG) AMONG SCHOOL-AGE 
CHILDREN INFECTED WITH HOOKWORM IN THE KINTAMPO 
NORTH DISTRICT OF GHANA
Sara A. Nguyen1, Debbie Humphries1, Joseph Otchere2, Sunny 
Kumar3, Jon J. Vermeire4, Rebecca Treger3, Martin Keil3, Josephine 
E. Quagraine2, Lisa M. Harrison4, Daniel A. Boakye2, Michael 
Wilson2, Michael Cappello4
1Yale School of Public Health, New Haven, CT, United States, 2Noguchi 
Memorial Institute for Medical Research, Accra, Ghana, 3Yale University, 
New Haven, CT, United States, 4Yale School of Medicine, New Haven, CT, 
United States
Ghanaian school-age children (n=141) from five communities previously 
identified as having high prevalence of hookworm infection and reduced 
cure rates were enrolled in a cross-sectional study investigating host 
predictors of treatment response. Household surveys were used to collect 
dietary patterns, socioeconomic and demographic information, and 
other health indicators. Infection status and dietary diversity data were 
assessed to identify modifiable host factors that might affect treatment 
response. Prevalence of hookworm infection was 56% (79/141). Those 
positive for hookworm were treated with single-dose albendazole (400 
mg). Immediately prior to treatment, a brief screening questionnaire 
was administered to identify recent dietary patterns and diarrhea. 
Consumption of more diverse food groups in the twenty-four hours prior 
to treatment, as indicated by dietary diversity scores above the median, 
was associated with better rates of hookworm clearance after treatment 
(48.2% cure rate) compared to those consuming fewer food groups 
(12.5% cure rate) (χ2; p < 0.01). Dietary protein showed a stronger effect 
than dietary diversity: all children below the population median of protein 
food groups remained infected with hookworm following treatment, and 
children above the median had a 42% cure rate. Individuals who had not 
eaten six hours prior to treatment had better drug responses and were 
5.0 times more likely to experience higher egg reduction rates than those 
who ate in the six hours prior to treatment (p < 0.05). Dietary diversity 
also significantly impacted fecal egg reduction rates in treated individuals. 
Those with higher dietary diversity were 3.1 times more likely to be in 
the highest category of egg reduction rate than those with lower dietary 
diversity (p < 0.05). These findings provide new data on the relevance of 
dietary patterns in affecting cure rates and egg reduction rates following 
single-dose albendazole therapy. Further work is needed to determine 
whether these factors could be used to improve operational effectiveness 




HELMINTH INDUCED ALTERNATIVE MACROPHAGE 
ACTIVATION AND MYCOBACTERIAL (BCG) INFECTIONS
Soumya Chatterjee1, Kawsar R. Talaat2, Carl Feng1, Roshanak T. 
Semnani1, Thomas B. Nutman1
1National Institutes of Health/National Institute of Allergy and Infectious 
Diseases, Bethesda, MD, United States, 2Center for Immunization 
Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, 
MD, United States
Filarial and other tissue invasive helminth infections have been associated 
with alternative activation of macrophages (AAM), a process felt to 
reflect the influence of Type 2 responses (IL-4/IL-13) on macrophage 
differentiation. In contrast, Mycobacterium tuberculosis (Mtb) infection 
requires a strong Type 1 (IL-12/IFN-γ) response to control the infection in 
the macrophage. The intersection of these two highly prevalent infections 
was studied initially in C57BL/6 mice injected intravenously with B. malayi 
microfilariae (mf) prior to an aerosolized infection with Mtb. We found 
by RT-PCR that filarial infection was associated with a two fold induction 
of YM1 and CD206 in the lungs of microfilaremic mice with an almost 
100 fold decrease in the expression of iNOS, findings consistent with the 
generation of AAM in the lungs. This AAM phenotype was overcome 
in the context of Mtb co-infection. Since the macrophage is thought 
to be critical to innate control of mycobacterial infection, we sought 
to address the role of AAM in the control of mycobacterial infection in 
the context of filarial/mycobacterial co-infection using an in vitro model 
system. Purified human monocytes were used to generate macrophages 
(M-CSF for 7 days) after which both classically activated ([CAM] with LPS 
and interferon gamma (IFN-)) and AAM (with interleukin-4 [IL-4]) were 
generated. After 48 hours of polarization, infection with mycobacteriae 
(BCG) at an MOI of 5 was performed and 24 later responses were 
contrasted between CAMs and AAMs. With the exception of CCL13 and 
CCL22 production in the AAMs, there were no differences between the 
CAM and AAM in the spontaneous mRNA expression of chemokines 
such as CCL-17, CCL-18, IL-18,PDCDL1G,CLEC10A, CADH1,CD274 or 
IL-12p40,TNF,IL-6,IL-1a,IL-1b,IL-10 protein (by Luminex™). In contrast, 
following infection with BCG, AAM had significantly increased production 
of IL-10 (median=1162 pg/ml vs. 504.77 pg/ml, p= 0.03) and decreased 
production of IL-1b (median=384.2 pg/ml vs. 1563.09 pg/ml, p=0.01) 
and IL-6 (median=3296.8 pg/ml vs 11357.16 pg/ml, p=0.03) in the 8 
monocyte donors tested. CCL13 expression, in contrast was significantly 
downregulated following BCG infection in the AAMs (~10 fold decrease 
in expression, p=. 007) compared to CAMs. These data suggest that 
an altered response to mycobacterial infection is exhibited by AAMs 
compared to CAMs that may alter the outcome of these infections.
493
IMMUNOLOGICAL BASIS OF SUPERIOR PROTECTION 
FOLLOWING INFECTION-TREATMENT IMMUNIZATION 
COMPARED TO IRRADIATED SPOROZOITE IMMUNIZATION
Katherine Doll, Noah Butler, John Harty
University of Iowa, Iowa City, IA, United States
Immunization of both humans and rodents with either radiation-
attenuated Plasmodium sporozoites (RAS) or infection-treatment 
sporozoite immunization (ITI) elicits sterilizing anti-malarial immunity 
against subsequent sporozoite challenge. In rodent models, protection 
following RAS or ITI requires the induction and activity of parasite-specific 
CD8 T cells. Here we show that both ITI and RAS vaccinations elicit 
parasite-specific CD8 T cells exhibiting equivalent expression of molecules 
associated with T cell activation, inhibition, migration, and survival. 
However, compared to RAS, ITI requires fewer immunizing sporozoites to 
elicit sterilizing immunity. Moreover, single dose ITI induces larger effector 
and memory CD8 T cell responses leading to complete protection upon 
sporozoite challenge. Importantly, ITI-induced CD8 T cells exhibit specificity 
for a broader profile of parasite antigens compared to RAS. Consistent 
with this, we find that sterilizing protection following ITI is associated 
with a short duration (4-6 days) and low magnitude (up to 4-7%) level 
of blood-stage breakthrough parasitemia shortly following chloroquine 
cessation. Further, ITI mice resist challenge with blood-stage parasites. 
Collectively, our data show the cellular basis for potent cross-stage 
immunity elicited by ITI depends on the induction of CD8 T cell responses 
and exposure to blood-stage parasites.
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DEVELOPMENT OF TRYPANOSOMA CRUZI GENETICALLY 
ATTENUATED KNOCKOUT LINES WITH POTENTIAL USE AS 
TRANSMISSION BLOCKING VACCINES
Juan M. Bustamante1, Ashley N. Hartley1, Ellen M. Dotson2, 
Cecilia Perez Brandan3, Rick L. Tarleton4
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Emerging Global Diseases and Department of Cellular Biology, University 
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Chagas disease, caused by the protozoan Trypanosoma cruzi, is the 
most important parasitic burden in Latin America. There are no effective 
vaccines to prevent this infection. In endemic areas, dogs are important 
sources of infection for the insect vector and therefore represent a critical 
control point for T. cruzi transmission. A transmission-blocking vaccine 
for dogs would greatly reduce the prevalence of T. cruzi infection in the 
canine and consequently, in the human population. Live attenuated 
parasites can be used as experimental vaccines. In this work we report 
on the generation of T. cruzi attenuated lines (KO5: Serine/threonine 
protein phosphatase like-protein; KO10: Hypothetical protein; KO121: 
Protein kinase and ECH: Enoyl-CoA hydratase/isomerase family protein) 
by disruption of genes, whose products are predicted to be critical for 
parasite replication in mammals. We evaluated whether C57BL/6 mice 
immunized with these attenuated parasites would develop protective 
immune responses that would prevent the establishment of vector 
transmittable infection upon rechallenge with T. cruzi. Mice immunized 
with any of the attenuated lines elicited strong T. cruzi -specific CD8+ T 
cells responses. However, the frequencies of T. cruzi -specific CD8+ T cells 
in mice immunized with the KO10 line decreased to undetectable levels 
in the blood after ~70 days post immunization (dpi). At 300 dpi, parasite-
specific CD8+ T cells from mice immunized with KO5 and ECH showed 
relatively high expression of the central memory marker CD127 and low 
expression of recent activation marker KLRG1 compared with their wild 
type and KO121 counterparts. The magnitude and the phenotype of T. 
cruzi -specific CD8+ T cells suggest that these lines could be ideal for a 
transmission blocking vaccine for dogs. Current studies are focused on 
determining parasite persistence and on whether mice immunized with 
these attenuated lines and rechallenged with a virulent T. cruzi strain 
will not develop blood parasite levels sufficiently high to infect the insect 
vectors and therefore block the transmission of the infection.
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IDENTIFICATION OF NOVEL HIGHLY PROTECTIVE PRE-
ERYTHROCYTIC ANTIGENS FOR MALARIA VACCINE 
DEVELOPMENT
Ping Chen1, Greg Ekberg1, Bennett Myers Myers1, Elena Curti2, 
Emily Smith2, Joao Aguiar2, Keith Limbach2, Noelle B. Patterson2, 
Matha Sedegah2, Thomas L. Richie2, Denise L. Doolan3, Joseph T. 
Bruder1
1GenVec Inc., Gaithersburg, MD, United States, 2Naval Medical Research 
Center, U.S. Military Malaria Vaccine Program, Silver Spring, MD, United 
States, 3The Bancroft Centre (K01), Brisbane, QLD, Australia
Malaria is the most devastating parasitic disease affecting humans. There 
is no licensed malaria vaccine. Efforts to develop an effective malaria 
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vaccine have been limited by the small number of known antigens, which 
represent < 0.5% of the 5300 encoded proteins in the Plasmodium 
falciparum genome. Most vaccines under clinical evaluation today contain 
only one antigen and are only partially protective. The most advanced 
candidate, RTS,S, provides about 50% protection. Thus, there is a great 
need for an effective malaria vaccine that could provide robust protection 
and contribute to the control and eventually eradication of malaria. Our 
vaccine rationale is based on the fact that immunization with radiation-
attenuated sporozoites (RAS) provides high level (>90%) protection 
against sporozoite challenge in both mice and humans, and this protection 
is dependent on the induction of CD8+ T cells targeting multiple antigens 
expressed in the pre-erythrocytic stages of the parasite life cycle. The 
circumsporozoite protein (CSP) is one of the targets of protective T cell 
responses induced by RAS immunization. However, other unknown 
antigens clearly contribute to protection. The goal of our research was to 
identify novel antigens that are the targets of protective T cell responses 
in mice immunized with protective regimens of RAS. We have identified 
several new and highly protective pre-erythrocytic stage antigens using 
a novel high-throughput genomics screening approach. Our antigen 
discovery system utilizes an array of adenovirus vectors carrying 300 highly 
expressed P. yoelii pre-erythrocytic genes with identifiable P. falciparum 
orthologues. In the antigen discovery screen, antigen presenting cells 
were infected with individual adenovectors from the array and then 
mixed with splenocytes from mice immunized with protective regimens 
of RAS. We prioritized antigens based on the frequency of CD8+ T cell 
recall responses to each of the 300 antigens. We selected 20 antigens 
that recalled the most robust T cell responses and tested their capacity to 
protect mice from a P. yoelii sporozoite challenge. Outbred CD1 mice were 
immunized with a DNA prime - Ad boost regimen and sterile protection 
was measured following sporozoite challenge. Several of the prioritized 
antigens induced higher levels of protection than CSP. The P. falciparum 
orthologues of these antigens are being considered for advancement to 
clinical development.
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THE TRANSCRIPTION FACTOR T-BET REGULATES 
PARASITEMIA AND PROMOTES PATHOGENESIS DURING 
MURINE MALARIA
Miranda S. Oakley, Leda Lotspeich Cole, Bikash Sahu, Nehal 
R. Solanki, Victoria Majam, Steven C. Derrick, Sheldon L. Morris, 
Sanjai Kumar
Food and Drug Administration, Bethesda, MD, United States
We investigated the role of the transcription factor T-bet (the master 
regulator of Th1) cells during murine malaria infections. Using mice 
deficient for T-bet, we report that T-bet interferes with the formation of 
a protective immune response during Plasmodium yoelii 17XNL murine 
malaria. On day 12 post-infection, T-bet deficient mice (5.7 ± 1.6%) had 
2.9 fold lower parasitemia (p=0.0013) than wildtype controls (16.8 ± 
1.7%). Although T-bet deficient mice had diminished levels of total IgG 
antibody, these mice had significantly higher levels of IgG1 (81,920 ± 
12,540) compared to wildtype controls (16,640 ± 3840) indicating that 
this antibody isotype may be important for malaria protective immunity 
(p=0.0011, Student T test). In the Plasmodium berghei ANKA murine 
model of experimental cerebral malaria (ECM), we demonstrate that while 
T-bet regulates parasite burden, it also promotes the pathogenesis of ECM 
possibly by impeding the formation of an anti-inflammatory Th2 immune 
response. T-bet deficient mice had higher parasitemia than wildtype 
controls during the ECM phase of disease (17.7 ± 3.1% verses 10.9 ± 
1.5%). In addition, while 100% (10/10) of wildtype mice developed 
ECM by day 9 post-infection, only 30% (3/10) of T-bet deficient mice 
succumbed to disease during the cerebral phase of infection (p=0.000029, 
Log rank). Resistance to ECM in T-bet deficient mice was associated with 
a Th2 immune response characterized by enhanced production of GATA-
3+ CD4+ T cells and elevated levels of the eotaxin, MCP-1, and G-CSF 
cytokines. Our results suggest that in the mouse models studied, Th1-type 
immune responses render deleterious outcomes as they interfere with the 
acquisition of immunity and mediate the pathogenic features of cerebral 
malaria.
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ANTIBODY DYNAMICS AFTER ACUTE MALARIA INFECTION 
IN CHILDREN
Arlene E. Dent1, Rhonda Kimmel1, John Vulule2, Ann Moormann3
1Case Western Reserve University, Cleveland, OH, United States, 2Kenya 
Medical Research Institute, Kisumu, Kenya, 3University of Massachusetts, 
Worcester, MA, United States
Naturally acquired antibodies directed against Plasmodium  falciparum 
are acquired slowly with repeated infections and protect against  malaria 
disease. However children have been shown to generate short-lived 
anti-malaria antibodies. While this may be due in part to a less  mature 
immune system, malaria infection may also exert immuno-modulatory 
effect. Our goal was to examine children’s antibody signature after acute 
clinical malaria in order to categorize stability of responses. Children 
(n=89, mean age 25 months (range 1 - 66 mo)) were recruited from 
Chulaimbo sub-District Hospital in western Kenya upon presentation 
with a febrile illness. Participants diagnosed with acute malaria provided 
a venous blood sample, were treated with 6-doses of CoArtem™ 
(Artemether/Lumefantrin), and examined 4 weeks later (recovery) when 
another blood sample was drawn. Plasma samples were examined for 
the  prevalence and magnitude of anti-malaria antibodies by a) luminex 
multiplex serology to 13 malaria antigens and b) functional antibody-
mediated growth inhibition of cultured parasites. We found that total IgG 
to MSP-142 (3D7, FVO, and FUP) and PfCelTOS declined from acute to 
recovery time points. No change was detected in IgG levels to AMA1 (3D7 
or FVO), PfCSP, EBA140, EBA175, EBA181, and SERA5 (two variants). In 
contrast, functional sialic-dependent pathway inhibitory antibodies and 
global growth inhibition antibodies against W2mef were boosted after an 
episode of symptomatic malaria. MSP119 invasion inhibitory antibodies and 
global growth inhibition antibodies against PfD10 remained unchanged 
after infection. In addition, we found that IgG to measles decreased after  
an episode of malaria. Total IgG did not however change significantly 
between the time points. Thus, acute clinical malaria infections 
differentially influence the maintenance of anti-malaria antibodies as well 
as have potential detrimental consequences for immunity against measles.
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RHOPTRY NECK PROTEIN 2 IS PRODUCED IN OOCYST-
DERIVED SPOROZOITES AND REQUIRED FOR SALIVARY 
GLAND INVASION
Tomoko Ishino1, Eri Murata2, Naohito Tokunaga2, Mayumi 
Tachibana1, Takafumi Tsuboi3, Motomi Torii1
1Department of Molecular Parasitology, Graduated School of Medicine, 
Ehime University, Toon, Japan, 2Venture Business Laboratory, Ehime 
University, Matsuyama, Japan, 3Malaria Research Unit, Cell-Free Science 
and Technology Research Center, Ehime University, Matsuyama, Japan
During apicomplexan parasite invasion, it is revealed that tight junction is 
formed between parasite and target cells, which confers parasite move 
inside cells. Recently in Plasmodium merozoite, it was reported that 
rhoptry neck protein 2 (RON2) is secreted to the tight junction and RON2 
and AMA1 interaction is important during erythrocyte invasion. However, 
ron2 disrupted transgenic parasite has never been successfully generated 
presumably because RON2 is essential for proliferation in the blood stage. 
Here, using Plasmodium berghei, we showed that RON2 is produced also 
in sporozoites and localized to rhoptry. Interestingly, ron2 transcription 
is restricted to midgut sporozoites, however RON2 protein can be 
detected through sporozoite migration from midguts to salivary glands. 
To elucidate sporozoite RON2 function, we generated sporozoite stage 
specific RON2 silencing transgenic parasites by swapping ron2 promoter 
to merozoite specific promoter. The number of sporozoites collected from 
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salivary glands was greatly reduced by ron2 silencing, despite sporogony, 
sporozoite release into hemocoel and their motility were normal. These 
results showed that RON2 is required for salivary gland invasion. This is the 
first genetical approach to show that RON2 has an important role in target 
cell invasion.
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IDENTIFICATION AND CHARACTERIZATION OF A 
PLASMODIUM FALCIPARUM ORTHOLOGUE OF THE YEAST 
UBIQUINONE-BINDING PROTEIN, COQ10P
Bethany J. Jenkins, Joanne M. Morrisey, Thomas M. Daly, 
Michael W. Mather, Akhil B. Vaidya, Lawrence W. Bergman
Drexel University College of Medicine, Philadelphia, PA, United States
Coenzyme Q (CoQ, ubiquinone) is a central electron carrier in 
mitochondrial respiration. CoQ is synthesized through multiple steps 
involving a number of different proteins. The prevailing view that the 
CoQ used in respiration exists as a free pool that diffuses throughout 
the mitochondrial inner membrane bilayer has recently been challenged. 
In the yeast Saccharomyces cerevisiae, deletion of the gene encoding 
Coq10p results in respiration deficiency without altering total size of the 
available CoQ pool, suggesting that the Coq10p is critical for the delivery 
of CoQ to the site(s) of respiration. The precise mechanism by which 
this is achieved remains unknown at present. Because mitochondrial 
respiration is a validated target for antimalarial drugs such as atovaquone, 
we are interested in examining its regulation in malaria parasites. We have 
identified an orthologue of Coq10p, PfCoq10, in P. falciparum, the most 
virulent species of malaria parasite, and demonstrated that a GFP-tagged 
version of PfCoq10 localized to the parasite mitochondrion. Expression of 
PfCoq10 in the S. cerevisiae coq10 deletion strain restored the capability 
of the yeast to grow on respiratory substrates, suggesting a remarkable 
functional conservation of this protein over a vast evolutionary distance, 
and despite a relatively low level of amino acid sequence identity. We are 
currently assessing effects of PfCoq10 overexpression on the atovaquone 
sensitivity of P. falciparum. We are also examining the possibility of altered 
response to atovaquone in yeast mitochondria expressing the parasite 
Coq10. These studies may provide insights into respiration regulation in 
general, as well as in malaria parasites.
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ROLE OF PFRAD54 AND REPLICATION PROTEIN A IN RAD51-
MEDIATED DNA STRAND EXCHANGE AND REPAIR OF DNA 
DAMAGE INDUCED BY MMS IN PLASMODIUM FALCIPARUM
Anusha M. Gopalakrishnan, Nirbhay Kumar
Tulane University School of Public Health, New Orleans, LA, United States
Exploiting the recombination machinery and its molecular characterization 
in the malaria parasite would provide mechanistic understanding of 
recombinational rearrangements leading to immune evasion via antigenic 
switching, a major impediment in developing an effective vaccine against 
these protozoan parasites. Bacterial RecA protein and its eukaryotic 
homologue Rad51 play a central role in homologous DNA strand 
exchange reaction during recombination and DNA repair. Previously, our 
lab has shown that PfRad51, the Plasmodium falciparum homologue of 
Rad51, exhibited ATPase activity and promoted DNA strand exchange in 
vitro, as reported previously. Here, we evaluated the catalytic functions 
of PfRad51 in the presence of putative interacting partners, especially 
P. falciparum homologues of Rad54 and Replication protein-A (RPA). 
PfRad54 accelerated PfRad51 mediated pairing between ssDNA and its 
homologous linear dsDNA in the presence of 0.5mM CaCl2. We also 
present evidence that recombinant PfRPA1L protein serves the function 
of bacterial homologue SSB in initiating homologous pairing and strand 
exchange activity but its function was negatively regulated in a dose-
dependent manner by PfRPA1S, another RPA homologue in P. falciparum. 
We also present in vivo evidence through comet assays for methyl 
methanesulfonate (MMS)- induced DNA damage in malaria parasites 
and accompanying upregulation of PfRad51, PfRad54, PfRPA1L and 
PfRPA1S at the level of transcript and protein. This study provides new 
insights into the role of putative Rad51-interacting proteins involved in 
homologous recombination and emphasizes physiological role of DNA 
damage repair during the growth of parasites. We are now characterizing 
the recombiantion macromolecular complex which is likely to be important 
in DNA damage and repair and validating molecular interactions between 
PfRad51 and its putative interacting partners. Besides understanding 
molecular machinery involved in DNA repair and recombination, we wish 
to extend our studies to understand the biochemical and genetic basis of 
gene rearrangements at the var gene locus associated with phenomenon 
like antigenic variation.
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A SINGLE NUCLEOTIDE POLYMORPHISM IN THE PROMOTER 
OF STROMAL CELL-DERIVED FACTOR (SDF)-1α (C-1002T) IS 
ASSOCIATED WITH PROTECTION AGAINST PLASMODIUM 
FALCIPARUM INFECTION IN KENYAN CHILDREN
Grace Okello1, Zachary Karim1, Prakasha Kempaiah1, Eric Otieno2, 
James Hittner3, John Vulule4, John Ong’echa4, Douglas Perkins1, 
Tom Were4
1Center for Global Health - University of New Mexico, Albuquerque, 
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Stromal cell-derived factor (SDF)-1α (CXCL12) is a pleiotropic chemokine 
with diverse functions including induction of anti-pathogen immunity 
and inhibition of erythropoiesis. In murine malaria, increased expression 
of SDF-1α promotes control of parasitemia. Although several studies 
indicate that SDF1A genetic variation regulates outcomes in the context 
of HIV-1 infection, hematopoiesis, and cancer, the role of genetic 
variability in SDF1A in Plasmodium falciparum infections has not been 
explored. The effect of SDF1A (C-1002T, rs2839686) variation was 
therefore, investigated in Kenyan children (2.0-38.0mos., n=873) residing 
in a holoendemic P. falciparum transmission region of western Kenya. 
Children were stratified into aparasitemic (n=212) and parasitemic (n=661) 
groups with parasitemic children being further categorized into SMA 
(hemoglobin, Hb<5.0g/dL; n=236) vs. non-SMA (Hb≥5.0g/dL; n=425), 
high-density parasitemia (HDP; ≥10,000 parasites/µL; n=477) vs. low-
density parasitemia (LDP; <10,000 parasites/µL; n=184), and reticulocyte 
production index (RPI<2.0) vs. (RPI≥2.0). Multivariate logistic regression 
modeling controlling for age, gender, bacteremia, glucose-6-phosphate 
dehydrogenase, alpha-thalasemia, and sickle cell and HIV-1 status did not 
show any significant associations between carriage of C-1002T genotypes 
and SMA, RPI<2.0, and HDP. However, carriage of the CC genotype was 
associated with protection against the acquisition of P. falciparum infection 
compared to the TT genotype (Odds ratio, OR, 0.311; 95% CI, 0.115-
0.842; P=0.022). These results demonstrate that although variation at 
1002 in the SDF1A promoter appears to protect against acquisition of P. 
falciparum infection, this variant may not affect malaria disease outcomes 
once an individual becomes infected.
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GENOMIC DIVERSITY AND EVOLUTIONARY HISTORY OF 
PLASMODIUM VIVAX
Ernest R. Chan1, Didier Menard2, Odile Mercereau-Puijalon3, 
Peter Zimmerman4, David Serre1
1Cleveland Clinic Foundation, Cleveland, OH, United States, 2Institut 
Pasteur du Cambodge, Phnom Penh, Cambodia, 3Institut Pasteur, Paris, 
France, 4Case Western Reserve University, Cleveland, OH, United States
Most studies of genetic diversity in Plasmodium vivax have focused 
on microsatellites or selected loci and do not provide a genome-wide 
perspective. We have sequenced the genomes of ten P. vivax field isolates 
